activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1734320	CHEMBL871586	Inhibition of human PI3Kbeta	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	IC50	nM	20000.0	CHEMBL3145	Homo sapiens	IC50	nM	20000.0
	1734320	CHEMBL871586	Inhibition of human PI3Kbeta	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	IC50	nM	20000.0	CHEMBL3145	Homo sapiens	IC50	nM	20000.0
	1734334	CHEMBL871586	Inhibition of human PI3Kbeta	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	1734470	CHEMBL871586	Inhibition of human PI3Kbeta	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	306.0	CHEMBL3145	Homo sapiens	IC50	nM	306.0
	1734921	CHEMBL871586	Inhibition of human PI3Kbeta	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccccc3O)o2)S1		CHEMBL208652	=	IC50	nM	20000.0	CHEMBL3145	Homo sapiens	IC50	nM	20000.0
	1853177	CHEMBL919696	Inhibition of GST-tagged human PI3K p110-beta by SPA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	340.0	CHEMBL3145	Homo sapiens	IC50	uM	0.34
	1853180	CHEMBL919696	Inhibition of GST-tagged human PI3K p110-beta by SPA	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)c1nc(-c2cnc3ccc(Cl)cn23)cs1.Cl		CHEMBL541133	=	IC50	nM	170.0	CHEMBL3145	Homo sapiens	IC50	uM	0.17
	1888039	CHEMBL906675	Inhibition of GST-tagged human p110-beta expressed in SF9/Baculovirus system by SPA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	340.0	CHEMBL3145	Homo sapiens	IC50	uM	0.34
	1888040	CHEMBL906675	Inhibition of GST-tagged human p110-beta expressed in SF9/Baculovirus system by SPA	B	Cl.Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL538346	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	uM	0.003
	1888041	CHEMBL906675	Inhibition of GST-tagged human p110-beta expressed in SF9/Baculovirus system by SPA	B	Cl.Oc1cccc(-c2nc(N3CCOCC3)c3sccc3n2)c1		CHEMBL541643	=	IC50	nM	16.0	CHEMBL3145	Homo sapiens	IC50	uM	0.016
	1888042	CHEMBL906675	Inhibition of GST-tagged human p110-beta expressed in SF9/Baculovirus system by SPA	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2ccc(Br)cn12.Cl		CHEMBL556399	=	IC50	nM	850.0	CHEMBL3145	Homo sapiens	IC50	uM	0.85
	1897550	CHEMBL887588	Inhibition of p110beta	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	340.0	CHEMBL3145	Homo sapiens	IC50	uM	0.34
	1897584	CHEMBL887588	Inhibition of p110beta	B	Cl.Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL538346	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	uM	0.003
	1897591	CHEMBL887588	Inhibition of p110beta	B	Cl.Oc1cccc(-c2nc(N3CCOCC3)c3sccc3n2)c1		CHEMBL541643	=	IC50	nM	16.0	CHEMBL3145	Homo sapiens	IC50	uM	0.016
	1918375	CHEMBL895748	Inhibition of recombinant PI3Kbeta	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	IC50	nM	1200.0	CHEMBL3145	Homo sapiens	IC50	nM	1200.0
	1988772	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2ccc(Br)cn12		CHEMBL393525	=	IC50	nM	340.0	CHEMBL3145	Homo sapiens	IC50	uM	0.34
	1988776	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2ccccn12		CHEMBL239050	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	1988777	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cncc2c(Br)cccc12		CHEMBL397780	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	1988778	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cncc2cc(Br)ccc12		CHEMBL397105	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	1988779	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cncc2ccc(Br)cc12		CHEMBL240336	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	1988780	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cncc2ccccc12		CHEMBL240335	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	1988781	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2ccccc2c1		CHEMBL240118	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	1988782	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1ccnc2ccccc12		CHEMBL393747	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	1988783	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cccc2ccccc12		CHEMBL413803	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	1988784	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1csc2ccccc12		CHEMBL413802	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	1988785	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1coc2ccccc12		CHEMBL392071	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	1988786	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1onc2ccccc12		CHEMBL392070	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	1988787	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cn(C)c2ccccc12		CHEMBL239475	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	1988788	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1ncn2ccccc12		CHEMBL239052	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	1988789	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1ncc2ccccn12		CHEMBL393526	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	1988790	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cncn1C		CHEMBL397796	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	1988791	CHEMBL899008	Inhibition of human recombinant p110beta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2n1CCCC2		CHEMBL239051	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	2106311	CHEMBL947156	Inhibition of PI3K p110beta	B	N#CCc1ccc(-n2cnc3cnc4ccc(C#Cc5cccnc5)cc4c32)cc1		CHEMBL272265	=	IC50	nM	432.0	CHEMBL3145	Homo sapiens	IC50	nM	432.0
	2106316	CHEMBL947156	Inhibition of PI3K p110beta	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(C#Cc4cccnc4)ccc3ncc21		CHEMBL255592	=	IC50	nM	2336.0	CHEMBL3145	Homo sapiens	IC50	nM	2336.0
	2106317	CHEMBL947156	Inhibition of PI3K p110beta	B	Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(C(C)C#N)cc1		CHEMBL270638	=	IC50	nM	446.0	CHEMBL3145	Homo sapiens	IC50	nM	446.0
	2110276	CHEMBL950967	Inhibition of PI3Kbeta	B	COC[C@H]1OC(=O)/C(=C/N(C)CCCN(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C		CHEMBL410643	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	uM	0.013
	2137301	CHEMBL936949	Inhibition of p110-beta PI kinase	B	Cl.Oc1cccc(-c2nc(N3CCOCC3)c3sccc3n2)c1		CHEMBL541643	=	IC50	nM	16.0	CHEMBL3145	Homo sapiens	IC50	nM	16.0
	2147343	CHEMBL922028	Activity of human PI 3-kinase beta at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	104.0	CHEMBL3145	Homo sapiens	Activity	%	104.0
	2260814	CHEMBL997691	Inhibition of PI3Kbeta	B	COCC(O)Cn1cc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)cn1		CHEMBL496332	=	IC50	nM	222.0	CHEMBL3145	Homo sapiens	IC50	nM	222.0
	2260815	CHEMBL997691	Inhibition of PI3Kbeta	B	Cc1ccc(Nc2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)nn1		CHEMBL490428	=	IC50	nM	23.0	CHEMBL3145	Homo sapiens	IC50	nM	23.0
	2360395	CHEMBL980851	Inhibition of human recombinant PI3K p110beta expressed in Sf9 cells coexpressing p85alpha by radiometric scintillation proximity assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	33.0	CHEMBL3145	Homo sapiens	IC50	uM	0.033
	2470354	CHEMBL995033	Inhibition of PIK3CB at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3145	Homo sapiens	INH	%	10.0
	2564124	CHEMBL989176	Inhibition of PI3Kbeta	B	CC1(C)CC(=O)c2sc(N3CCOCC3)nc2C1		CHEMBL469099	=	IC50	nM	693.0	CHEMBL3145	Homo sapiens	IC50	nM	693.0
	2564146	CHEMBL989176	Inhibition of PI3Kbeta	B	CC1(C)CC(=O)c2sc(N3CCOC[C@@H]3Cc3csc4ccccc34)nc2C1		CHEMBL478633	=	IC50	nM	2545.0	CHEMBL3145	Homo sapiens	IC50	nM	2545.0
	2564147	CHEMBL989176	Inhibition of PI3Kbeta	B	CC1(C)CC(=O)c2sc(N3CCOCC3Cc3c[nH]c4ncccc34)nc2C1		CHEMBL478425	=	IC50	nM	481.0	CHEMBL3145	Homo sapiens	IC50	nM	481.0
	2564148	CHEMBL989176	Inhibition of PI3Kbeta	B	CC1(C)CC(=O)c2sc(N3CCOC[C@@H]3Cc3c[nH]c4ccccc34)nc2C1		CHEMBL513924	=	IC50	nM	1157.0	CHEMBL3145	Homo sapiens	IC50	nM	1157.0
	2564149	CHEMBL989176	Inhibition of PI3Kbeta	B	CC1(C)CC(=O)c2sc(N3CCOC[C@H]3Cc3c[nH]c4ccccc34)nc2C1		CHEMBL514061	>	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	nM	50000.0
	2564150	CHEMBL989176	Inhibition of PI3Kbeta	B	CC1(C)CC(=O)c2sc(N3CCOCC3Cc3ccc4ccccc4c3)nc2C1		CHEMBL476953	>	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	nM	50000.0
	2564151	CHEMBL989176	Inhibition of PI3Kbeta	B	CC1(C)CC(=O)c2sc(N3CCOCC3Cc3cccc4ccccc34)nc2C1		CHEMBL477999	=	IC50	nM	6943.0	CHEMBL3145	Homo sapiens	IC50	nM	6943.0
	2564152	CHEMBL989176	Inhibition of PI3Kbeta	B	CC1(C)CC(=O)c2sc(N3CCOC[C@@H]3Cc3ccccc3)nc2C1		CHEMBL453232	=	IC50	nM	20730.0	CHEMBL3145	Homo sapiens	IC50	nM	20730.0
	2564153	CHEMBL989176	Inhibition of PI3Kbeta	B	CC1(C)CC(=O)c2sc(N3CCOC[C@H]3Cc3ccccc3)nc2C1		CHEMBL477787	>	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	nM	50000.0
	2564154	CHEMBL989176	Inhibition of PI3Kbeta	B	CC1(C)CC(=O)c2sc(N3CCOC[C@@H]3c3ccccc3)nc2C1		CHEMBL469059	>	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	nM	50000.0
	2564155	CHEMBL989176	Inhibition of PI3Kbeta	B	CC1(C)CC(=O)c2sc(N3CCOC[C@H]3c3ccccc3)nc2C1		CHEMBL512470	>	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	nM	50000.0
	2564156	CHEMBL989176	Inhibition of PI3Kbeta	B	CC1(C)CC(=O)c2sc(-c3ccncc3)nc2C1		CHEMBL469057	=	IC50	nM	4163.0	CHEMBL3145	Homo sapiens	IC50	nM	4163.0
	2564157	CHEMBL989176	Inhibition of PI3Kbeta	B	COCCNc1nc2c(s1)C(=O)CC(C)(C)C2		CHEMBL463606	>	IC50	nM	40000.0	CHEMBL3145	Homo sapiens	IC50	nM	40000.0
	2564158	CHEMBL989176	Inhibition of PI3Kbeta	B	CC1(C)CC(=O)c2sc(N3CCCCC3)nc2C1		CHEMBL469058	>	IC50	nM	40000.0	CHEMBL3145	Homo sapiens	IC50	nM	40000.0
	2564159	CHEMBL989176	Inhibition of PI3Kbeta	B	O=C1CC2(CCCCC2)Cc2nc(N3CCOCC3)sc21		CHEMBL469052	=	IC50	nM	1609.0	CHEMBL3145	Homo sapiens	IC50	nM	1609.0
	2564160	CHEMBL989176	Inhibition of PI3Kbeta	B	O=C1CC2(CCCC2)Cc2nc(N3CCOCC3)sc21		CHEMBL512293	=	IC50	nM	1279.0	CHEMBL3145	Homo sapiens	IC50	nM	1279.0
	2564161	CHEMBL989176	Inhibition of PI3Kbeta	B	O=C1CCCc2nc(N3CCOCC3)sc21		CHEMBL466962	=	IC50	nM	3581.0	CHEMBL3145	Homo sapiens	IC50	nM	3581.0
	2564162	CHEMBL989176	Inhibition of PI3Kbeta	B	O=C1CC(c2ccccc2)Cc2nc(N3CCOCC3)sc21		CHEMBL466957	=	IC50	nM	14020.0	CHEMBL3145	Homo sapiens	IC50	nM	14020.0
	2564163	CHEMBL989176	Inhibition of PI3Kbeta	B	CCCC1CC(=O)c2sc(N3CCOCC3)nc2C1		CHEMBL466106	=	IC50	nM	11460.0	CHEMBL3145	Homo sapiens	IC50	nM	11460.0
	2564164	CHEMBL989176	Inhibition of PI3Kbeta	B	CC1CC(=O)c2sc(N3CCOCC3)nc2C1		CHEMBL466956	=	IC50	nM	4200.0	CHEMBL3145	Homo sapiens	IC50	nM	4200.0
	2564204	CHEMBL989176	Inhibition of PI3Kbeta	B	CC1(C)CNC(=O)c2sc(N3CCOC[C@@H]3Cc3c[nH]c4ccccc34)nc2C1		CHEMBL514869	=	IC50	nM	1006.0	CHEMBL3145	Homo sapiens	IC50	nM	1006.0
	2571514	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)CC(=O)c2sc(N3CCOCC3)nc2C1		CHEMBL469099	=	IC50	nM	693.0	CHEMBL3145	Homo sapiens	IC50	nM	693.0
	2571515	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)CC(=O)c2sc(N3CCOc4ccc(-c5ccccc5)cc43)nc2C1		CHEMBL469200	=	IC50	nM	7991.0	CHEMBL3145	Homo sapiens	IC50	nM	7991.0
	2571516	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)CC(=O)c2sc(N3CCOc4ccc(Br)cc43)nc2C1		CHEMBL469035	=	IC50	nM	1919.0	CHEMBL3145	Homo sapiens	IC50	nM	1919.0
	2571517	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)Cc2nc(N3CCOc4ccc(Br)cc43)sc2C(=O)N1		CHEMBL453240	=	IC50	nM	1625.0	CHEMBL3145	Homo sapiens	IC50	nM	1625.0
	2571518	CHEMBL1001355	Inhibition of PI3K beta	B	Cc1ccc2c(c1)N(c1nc3c(s1)C(=O)NC(C)(C)C3)CCO2		CHEMBL467966	=	IC50	nM	964.0	CHEMBL3145	Homo sapiens	IC50	nM	964.0
	2571519	CHEMBL1001355	Inhibition of PI3K beta	B	COc1ccc2c(c1)OCCN2c1nc2c(s1)C(=O)NC(C)(C)C2		CHEMBL512624	=	IC50	nM	1593.0	CHEMBL3145	Homo sapiens	IC50	nM	1593.0
	2571520	CHEMBL1001355	Inhibition of PI3K beta	B	Cn1cc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)CC(C)(C)C4)CCO3)cn1		CHEMBL504616	=	IC50	nM	336.0	CHEMBL3145	Homo sapiens	IC50	nM	336.0
	2571521	CHEMBL1001355	Inhibition of PI3K beta	B	Cn1cc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)cn1		CHEMBL512440	=	IC50	nM	540.0	CHEMBL3145	Homo sapiens	IC50	nM	540.0
	2571522	CHEMBL1001355	Inhibition of PI3K beta	B	Cn1ccnc1-c1ccc2c(c1)N(c1nc3c(s1)C(=O)NC(C)(C)C3)CCO2		CHEMBL467561	=	IC50	nM	3521.0	CHEMBL3145	Homo sapiens	IC50	nM	3521.0
	2571523	CHEMBL1001355	Inhibition of PI3K beta	B	Cc1nc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)c[nH]1		CHEMBL467395	=	IC50	nM	325.0	CHEMBL3145	Homo sapiens	IC50	nM	325.0
	2571524	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5ccn[nH]5)cc43)sc2C(=O)N1		CHEMBL511228	=	IC50	nM	1470.0	CHEMBL3145	Homo sapiens	IC50	nM	1470.0
	2571525	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)CC(=O)c2sc(N3CCOc4ccc(-c5cn[nH]c5)cc43)nc2C1		CHEMBL467394	=	IC50	nM	298.0	CHEMBL3145	Homo sapiens	IC50	nM	298.0
	2571526	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5cn[nH]c5)cc43)sc2C(=O)N1		CHEMBL512092	=	IC50	nM	156.0	CHEMBL3145	Homo sapiens	IC50	nM	156.0
	2571527	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5cnc[nH]5)cc43)sc2C(=O)N1		CHEMBL467553	=	IC50	nM	727.0	CHEMBL3145	Homo sapiens	IC50	nM	727.0
	2571528	CHEMBL1001355	Inhibition of PI3K beta	B	Cc1ccc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)nn1		CHEMBL469209	=	IC50	nM	1325.0	CHEMBL3145	Homo sapiens	IC50	nM	1325.0
	2571529	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5ncccn5)cc43)sc2C(=O)N1		CHEMBL469208	=	IC50	nM	623.0	CHEMBL3145	Homo sapiens	IC50	nM	623.0
	2571530	CHEMBL1001355	Inhibition of PI3K beta	B	Cc1ccc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)CC(C)(C)C4)CCO3)cn1		CHEMBL512834	=	IC50	nM	308.0	CHEMBL3145	Homo sapiens	IC50	nM	308.0
	2571531	CHEMBL1001355	Inhibition of PI3K beta	B	Cc1ccc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)cn1		CHEMBL469202	=	IC50	nM	452.0	CHEMBL3145	Homo sapiens	IC50	nM	452.0
	2571532	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)CC(=O)c2sc(N3CCOc4ccc(-c5ccncc5)cc43)nc2C1		CHEMBL512650	=	IC50	nM	1048.0	CHEMBL3145	Homo sapiens	IC50	nM	1048.0
	2571533	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)CC(=O)c2sc(N3CCOc4ccc(-c5cccnc5)cc43)nc2C1		CHEMBL512648	=	IC50	nM	376.0	CHEMBL3145	Homo sapiens	IC50	nM	376.0
	2571534	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)CC(=O)c2sc(N3CCOc4ccc(-c5ccccn5)cc43)nc2C1		CHEMBL469194	=	IC50	nM	2001.0	CHEMBL3145	Homo sapiens	IC50	nM	2001.0
	2571535	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)CC(=O)c2sc(N3CCOc4ncccc43)nc2C1		CHEMBL469193	=	IC50	nM	5309.0	CHEMBL3145	Homo sapiens	IC50	nM	5309.0
Not Determined	2571536	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)Cc2nc(N3CCOc4ncccc43)sc2C(=O)N1		CHEMBL469029		IC50			CHEMBL3145	Homo sapiens	IC50		
	2571537	CHEMBL1001355	Inhibition of PI3K beta	B	CN(C)Cc1ccc2c(c1)N(c1nc3c(s1)C(=O)NC(C)(C)C3)CCO2		CHEMBL467552	=	IC50	nM	10320.0	CHEMBL3145	Homo sapiens	IC50	nM	10320.0
	2571538	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)Cc2nc(N3CCOc4ccc(C5CC5)cc43)sc2C(=O)N1		CHEMBL512091	=	IC50	nM	834.0	CHEMBL3145	Homo sapiens	IC50	nM	834.0
	2571539	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5ccccc5)cc43)sc2C(=O)N1		CHEMBL511605	=	IC50	nM	3656.0	CHEMBL3145	Homo sapiens	IC50	nM	3656.0
Not Determined	2571540	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)CC(=O)c2sc(N3CCOc4cc(-c5ccccc5)ccc43)nc2C1		CHEMBL469271		IC50			CHEMBL3145	Homo sapiens	IC50		
	2571541	CHEMBL1001355	Inhibition of PI3K beta	B	CC(=O)c1ccc2c(c1)N(c1nc3c(s1)C(=O)NC(C)(C)C3)CCO2		CHEMBL469270	=	IC50	nM	1448.0	CHEMBL3145	Homo sapiens	IC50	nM	1448.0
	2571542	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)CC(=O)c2sc(N3CCOc4cc(Br)ccc43)nc2C1		CHEMBL512815	=	IC50	nM	5344.0	CHEMBL3145	Homo sapiens	IC50	nM	5344.0
	2571543	CHEMBL1001355	Inhibition of PI3K beta	B	Cc1ccc2c(c1)OCCN2c1nc2c(s1)C(=O)NC(C)(C)C2		CHEMBL451883	=	IC50	nM	1621.0	CHEMBL3145	Homo sapiens	IC50	nM	1621.0
	2571544	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)Cc2nc(N3CCOc4cc(F)ccc43)sc2C(=O)N1		CHEMBL449786	=	IC50	nM	1245.0	CHEMBL3145	Homo sapiens	IC50	nM	1245.0
Not Determined	2571545	CHEMBL1001355	Inhibition of PI3K beta	B	Cc1cccc2c1OCCN2c1nc2c(s1)C(=O)NC(C)(C)C2		CHEMBL469249		IC50			CHEMBL3145	Homo sapiens	IC50		
	2571546	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)Cc2nc(N3CCOc4c(F)cccc43)sc2C(=O)N1		CHEMBL469248	=	IC50	nM	11690.0	CHEMBL3145	Homo sapiens	IC50	nM	11690.0
	2571547	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)Cc2nc(N3CCOc4ccccc43)sc2C(=O)N1		CHEMBL468218	=	IC50	nM	1226.0	CHEMBL3145	Homo sapiens	IC50	nM	1226.0
	2571548	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)CC(=O)c2sc(N3CCOc4ccccc43)nc2C1		CHEMBL469201	=	IC50	nM	511.0	CHEMBL3145	Homo sapiens	IC50	nM	511.0
	2571549	CHEMBL1001355	Inhibition of PI3K beta	B	CC1(C)Cc2nc(N3CCOCC3)sc2C(=O)N1		CHEMBL449049	=	IC50	nM	450.0	CHEMBL3145	Homo sapiens	IC50	nM	450.0
	2721683	CHEMBL1054309	Inhibition of PI3-kinasebeta at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3145	Homo sapiens	INH	%	50.0
	2921215	CHEMBL1057588	Inhibition of PIK3CB assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL3145	Homo sapiens	Activity	%	100.0
	2949065	CHEMBL1047618	Inhibition of PI3Kbeta	B	COC(=O)N1CCC(n2ncc3c(N4CC5CCC(C4)O5)nc(-c4ccc(NC(=O)NC5CC5)cc4)nc32)CC1		CHEMBL583874	=	IC50	nM	2629.0	CHEMBL3145	Homo sapiens	IC50	nM	2629.0
	2991197	CHEMBL1039200	Inhibition of PI3Kbeta	B	CN1CCN(c2ccc(NC(=O)Nc3ccc(-c4nc(N5CC6CCC(C5)O6)c5cnn(CC(F)(F)F)c5n4)cc3)cc2)CC1		CHEMBL570833	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	2993574	CHEMBL1040949	Inhibition of human recombinant PI3Kbeta	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	3016061	CHEMBL1039897	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells	B	COc1nc(-c2ccccc2)ccc1-c1noc(-c2ccncc2)n1		CHEMBL565432	>	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3016062	CHEMBL1039897	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells	B	O=c1oc2cc(O)ccc2cc1-c1nc2ccccc2s1		CHEMBL437770	=	IC50	nM	14000.0	CHEMBL3145	Homo sapiens	IC50	uM	14.0
	3016063	CHEMBL1039897	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells	B	COC(=O)c1ccc(CSc2ncnc3sc(C)c(C)c23)o1		CHEMBL579219	>	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
Not Determined	3016064	CHEMBL1039897	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells	B	COc1ccccc1-c1nc(-c2cc3cc(C)ccc3[nH]c2=O)no1		CHEMBL567914		IC50			CHEMBL3145	Homo sapiens	IC50		
	3016065	CHEMBL1039897	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells	B	Cc1ccc2cc3c(OC(=O)COc4ccccc4)nn(C)c3nc2c1		CHEMBL568574	>	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3016066	CHEMBL1039897	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells	B	COc1cccc(-c2nc(-c3cc4cc(OC)ccc4[nH]c3=O)no2)c1		CHEMBL566046	=	IC50	nM	3000.0	CHEMBL3145	Homo sapiens	IC50	uM	3.0
	3016067	CHEMBL1039897	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells	B	O=C(CCn1c(=O)oc2cc(Cl)ccc21)Nc1ccccc1		CHEMBL577499	=	IC50	nM	12000.0	CHEMBL3145	Homo sapiens	IC50	uM	12.0
	3016068	CHEMBL1039897	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	900.0	CHEMBL3145	Homo sapiens	IC50	uM	0.9
	3016078	CHEMBL1039895	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells at 100 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	>=	Inhibition	%	40.0	CHEMBL3145	Homo sapiens	INH	%	40.0
	3016082	CHEMBL1039895	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells at 100 uM	B	O=C(CCn1c(=O)oc2cc(Cl)ccc21)Nc1ccccc1		CHEMBL577499	>=	Inhibition	%	40.0	CHEMBL3145	Homo sapiens	INH	%	40.0
	3016086	CHEMBL1039895	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells at 100 uM	B	COc1cccc(-c2nc(-c3cc4cc(OC)ccc4[nH]c3=O)no2)c1		CHEMBL566046	>=	Inhibition	%	40.0	CHEMBL3145	Homo sapiens	INH	%	40.0
	3016090	CHEMBL1039895	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells at 100 uM	B	Cc1ccc2cc3c(OC(=O)COc4ccccc4)nn(C)c3nc2c1		CHEMBL568574	>=	Inhibition	%	40.0	CHEMBL3145	Homo sapiens	INH	%	40.0
	3016094	CHEMBL1039895	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells at 100 uM	B	COc1ccccc1-c1nc(-c2cc3cc(C)ccc3[nH]c2=O)no1		CHEMBL567914	>=	Inhibition	%	40.0	CHEMBL3145	Homo sapiens	INH	%	40.0
	3016098	CHEMBL1039895	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells at 100 uM	B	COC(=O)c1ccc(CSc2ncnc3sc(C)c(C)c23)o1		CHEMBL579219	>=	Inhibition	%	40.0	CHEMBL3145	Homo sapiens	INH	%	40.0
	3016102	CHEMBL1039895	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells at 100 uM	B	O=c1oc2cc(O)ccc2cc1-c1nc2ccccc2s1		CHEMBL437770	>=	Inhibition	%	40.0	CHEMBL3145	Homo sapiens	INH	%	40.0
	3016106	CHEMBL1039895	Inhibition of human recombinant PI3Kbeta expressed in baculovirus-infected Sf21 cells at 100 uM	B	COc1nc(-c2ccccc2)ccc1-c1noc(-c2ccncc2)n1		CHEMBL565432	>=	Inhibition	%	40.0	CHEMBL3145	Homo sapiens	INH	%	40.0
	3098436	CHEMBL1067033	Inhibition of human PI3Kbeta at 0.1 uM	B	COc1ccccc1NC(=O)CC(Nc1ccc(Oc2ccnc3cc(-c4cn(C)cn4)sc23)c(F)c1)C(F)(F)F		CHEMBL591924	<	Inhibition	%	50.0	CHEMBL3145	Homo sapiens	INH	%	50.0
	3121470	CHEMBL1065060	Inhibition of PI3Kbeta	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
	3132779	CHEMBL1068076	Inhibition of PI3Kbeta	B	CCn1nnc2c(N3CCOCC3)nc(-c3ccc(NC(=O)Nc4ccc(C(=O)N5CCN(C)CC5)cc4)cc3)nc21		CHEMBL589258	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	nM	7.0
	3198616	CHEMBL1108626	Inhibition of recombinant PI3Kbeta assessed as PIP3 product formation by fluorescence polarization assay	B	Cc1nc(N)ncc1-c1nc(N2CCOCC2)c2sc(C(C)(C)O)cc2n1		CHEMBL1085178	=	IC50	nM	25.0	CHEMBL3145	Homo sapiens	IC50	nM	25.0
	3198622	CHEMBL1108626	Inhibition of recombinant PI3Kbeta assessed as PIP3 product formation by fluorescence polarization assay	B	Cc1nc(N)ncc1-c1nc(N2CCOCC2)c2sc(CN3CCN(S(C)(=O)=O)CC3)cc2n1		CHEMBL1085177	=	IC50	nM	6.2	CHEMBL3145	Homo sapiens	IC50	nM	6.2
	3198627	CHEMBL1108626	Inhibition of recombinant PI3Kbeta assessed as PIP3 product formation by fluorescence polarization assay	B	CC(C)(O)c1cc2nc(-c3cnc(N)nc3)nc(N3CCOCC3)c2s1		CHEMBL1084926	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	nM	12.0
Not Determined	3198631	CHEMBL1108626	Inhibition of recombinant PI3Kbeta assessed as PIP3 product formation by fluorescence polarization assay	B	CC(C)(O)c1cc2nc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2s1		CHEMBL1083508		IC50			CHEMBL3145	Homo sapiens	IC50		
	3198730	CHEMBL1108626	Inhibition of recombinant PI3Kbeta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1083192	=	IC50	nM	38.0	CHEMBL3145	Homo sapiens	IC50	nM	38.0
	3198731	CHEMBL1108626	Inhibition of recombinant PI3Kbeta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4ccc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1083810	=	IC50	nM	60.0	CHEMBL3145	Homo sapiens	IC50	nM	60.0
	3198732	CHEMBL1108626	Inhibition of recombinant PI3Kbeta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4ccc(N)cc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1083809	=	IC50	nM	1400.0	CHEMBL3145	Homo sapiens	IC50	nM	1400.0
	3198733	CHEMBL1108626	Inhibition of recombinant PI3Kbeta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc(CO)c4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1085160	=	IC50	nM	14.0	CHEMBL3145	Homo sapiens	IC50	nM	14.0
Not Determined	3198734	CHEMBL1108626	Inhibition of recombinant PI3Kbeta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4ccccc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1085159		IC50			CHEMBL3145	Homo sapiens	IC50		
	3198735	CHEMBL1108626	Inhibition of recombinant PI3Kbeta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4ccncc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1077023	=	IC50	nM	5400.0	CHEMBL3145	Homo sapiens	IC50	nM	5400.0
	3198736	CHEMBL1108626	Inhibition of recombinant PI3Kbeta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccnc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1086924	=	IC50	nM	14.0	CHEMBL3145	Homo sapiens	IC50	nM	14.0
	3198737	CHEMBL1108626	Inhibition of recombinant PI3Kbeta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc(O)c4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1086923	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
	3198738	CHEMBL1108626	Inhibition of recombinant PI3Kbeta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	32.0	CHEMBL3145	Homo sapiens	IC50	nM	32.0
	3227658	CHEMBL1107745	Inhibition PI3K-beta-mediated PIP2 phosphorylation after 20 mins by alphascreen competition assay	B	COc1ccc(-c2ccc3c(N4CCOCC4)nc(N4C[C@H](C)O[C@H](C)C4)nc3n2)cc1CO		CHEMBL1078983	>	IC50	nM	30000.0	CHEMBL3145	Homo sapiens	IC50	uM	30.0
	3235129	CHEMBL1111662	Inhibition of PI3Kbeta	B	Cc1c(CN2CCN(S(C)(=O)=O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1091978	=	IC50	nM	86.0	CHEMBL3145	Homo sapiens	IC50	nM	86.0
	3264505	CHEMBL1104685	Inhibition of PI3Kbeta	B	CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5cccnc5)CC4)c3n2)cc1		CHEMBL551440	=	IC50	nM	141.0	CHEMBL3145	Homo sapiens	IC50	nM	141.0
	3294624	CHEMBL1103936	Inhibition of PI3Kbeta	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)c5cnn(-c6ccccc6)c5C(F)(F)F)cc4F)c3s2)c1		CHEMBL1094718	<	Inhibition	%	40.0	CHEMBL3145	Homo sapiens	INH	%	40.0
	3313719	CHEMBL1119661	Inhibition of PI3Kbeta	B	COc1cc(F)c2[nH]c(-c3c(C)nn(C)c3C)c(/C=C3/Oc4ccc(NC(=O)Nc5ccc(C(=O)N(C)CCN(C)C)cc5)cc4C3=O)c2c1		CHEMBL1082621	=	IC50	nM	0.7	CHEMBL3145	Homo sapiens	IC50	nM	0.7
	3332092	CHEMBL1166803	Inhibition of PIK3CB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3145	Homo sapiens	INH	%	50.0
	3333507	CHEMBL1166803	Inhibition of PIK3CB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3145	Homo sapiens	INH	%	50.0
	3334912	CHEMBL1166803	Inhibition of PIK3CB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3145	Homo sapiens	INH	%	50.0
	3336332	CHEMBL1166803	Inhibition of PIK3CB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3145	Homo sapiens	INH	%	50.0
	3341874	CHEMBL1166803	Inhibition of PIK3CB at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3145	Homo sapiens	INH	%	50.0
	3343321	CHEMBL1166803	Inhibition of PIK3CB at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3145	Homo sapiens	INH	%	50.0
	3358743	CHEMBL1175209	Inhibition of PIK3CB at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL3145	Homo sapiens	INH	%	100.0
	3359185	CHEMBL1175209	Inhibition of PIK3CB at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	85.0	CHEMBL3145	Homo sapiens	INH	%	85.0
	3389765	CHEMBL1216941	Inhibition of p110beta	B	Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213082	=	IC50	nM	16000.0	CHEMBL3145	Homo sapiens	IC50	nM	16000.0
	3389769	CHEMBL1216941	Inhibition of p110beta	B	COc1ccccc1-n1c(CSc2ncnc3[nH]cnc23)nc2cccc(Cl)c2c1=O		CHEMBL1213083	=	IC50	nM	11000.0	CHEMBL3145	Homo sapiens	IC50	nM	11000.0
	3389773	CHEMBL1216941	Inhibition of p110beta	B	Cc1ccccc1-n1c(Cn2nc(-c3cc(O)cc(F)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213084	=	IC50	nM	220.0	CHEMBL3145	Homo sapiens	IC50	nM	220.0
	3389777	CHEMBL1216941	Inhibition of p110beta	B	Cc1ccccc1-n1c(Cn2nc(-c3ccc(O)c(F)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213085	=	IC50	nM	697.0	CHEMBL3145	Homo sapiens	IC50	nM	697.0
	3389781	CHEMBL1216941	Inhibition of p110beta	B	Cc1ccccc1-n1c(Cn2nc(C#CCO)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213116	=	IC50	nM	750.0	CHEMBL3145	Homo sapiens	IC50	nM	750.0
	3389785	CHEMBL1216941	Inhibition of p110beta	B	CC(=O)Nc1nc2ccc(-c3nn(Cc4cc5ccccc5nc4N4CCN(C)CC4)c4ncnc(N)c34)cc2s1		CHEMBL1213117	=	IC50	nM	23.0	CHEMBL3145	Homo sapiens	IC50	nM	23.0
	3389789	CHEMBL1216941	Inhibition of p110beta	B	CN1CCN(c2nc3ccccc3cc2Cn2nc(-c3ccc4nc(N)sc4c3)c3c(N)ncnc32)CC1		CHEMBL1213118	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	nM	9.0
	3389793	CHEMBL1216941	Inhibition of p110beta	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	44.0	CHEMBL3145	Homo sapiens	IC50	nM	44.0
	3389797	CHEMBL1216941	Inhibition of p110beta	B	CC(C)n1nc(C#Cc2cccnc2)c2c(N)ncnc21		CHEMBL1213119	=	IC50	nM	664.0	CHEMBL3145	Homo sapiens	IC50	nM	664.0
	3389801	CHEMBL1216941	Inhibition of p110beta	B	CC(C)n1nc(C#Cc2cccc(O)c2)c2c(N)ncnc21		CHEMBL1213120	=	IC50	nM	316.0	CHEMBL3145	Homo sapiens	IC50	nM	316.0
	3389805	CHEMBL1216941	Inhibition of p110beta	B	COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(F)cc2)cc(OC)c1		CHEMBL1213168	=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	3389809	CHEMBL1216941	Inhibition of p110beta	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	33.0	CHEMBL3145	Homo sapiens	IC50	nM	33.0
	3389813	CHEMBL1216941	Inhibition of p110beta	B	COc1ccccc1-n1c(SCC(=O)Nc2ccc3nccnc3c2)nc2c(c1=O)CCCC2		CHEMBL1213169	=	IC50	nM	4230.0	CHEMBL3145	Homo sapiens	IC50	nM	4230.0
	3406874	CHEMBL1219264	Inhibition of PI3Kbeta at 3 uM	B	COc1ccc2c(c1)C[C@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCC1CCN(C)CC1)NC2		CHEMBL1215304	=	Inhibition	%	74.0	CHEMBL3145	Homo sapiens	INH	%	74.0
	3440715	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(O)cc(Br)c2)c2c(N)ncnc21		CHEMBL1242285	=	IC50	nM	255.0	CHEMBL3145	Homo sapiens	IC50	uM	0.255
	3440729	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COCOc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1Br		CHEMBL1242286	=	IC50	nM	4600.0	CHEMBL3145	Homo sapiens	IC50	uM	4.6
	3440743	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241299	=	IC50	nM	173.0	CHEMBL3145	Homo sapiens	IC50	uM	0.173
	3440757	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1CCC1		CHEMBL1242287	=	IC50	nM	235.0	CHEMBL3145	Homo sapiens	IC50	uM	0.235
	3440771	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1CCCC1		CHEMBL1242376	=	IC50	nM	320.0	CHEMBL3145	Homo sapiens	IC50	uM	0.32
	3440785	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242377	=	IC50	nM	613.0	CHEMBL3145	Homo sapiens	IC50	uM	0.613
	3440799	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@H](CN)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242378	=	IC50	nM	6470.0	CHEMBL3145	Homo sapiens	IC50	uM	6.47
	3440813	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@@H](CN)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242468	=	IC50	nM	16300.0	CHEMBL3145	Homo sapiens	IC50	uM	16.3
	3440827	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	N#CCCCn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242469	=	IC50	nM	481.0	CHEMBL3145	Homo sapiens	IC50	uM	0.481
	3440841	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	N#CCCCCn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242470	=	IC50	nM	169.0	CHEMBL3145	Homo sapiens	IC50	uM	0.169
	3440855	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCC1		CHEMBL1242566	=	IC50	nM	1580.0	CHEMBL3145	Homo sapiens	IC50	uM	1.58
	3440869	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CNC1		CHEMBL1242567	=	IC50	nM	364.0	CHEMBL3145	Homo sapiens	IC50	uM	0.364
	3440883	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCCC1		CHEMBL1242568	=	IC50	nM	1020.0	CHEMBL3145	Homo sapiens	IC50	uM	1.02
	3440897	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC1CCC(n2nc(-c3ccc(F)c(O)c3)c3c(N)ncnc32)C1		CHEMBL1242656	=	IC50	nM	1240.0	CHEMBL3145	Homo sapiens	IC50	uM	1.24
	3440911	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@H]1CCNC1		CHEMBL1242657	=	IC50	nM	432.0	CHEMBL3145	Homo sapiens	IC50	uM	0.432
	3440925	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@@H]1CCNC1		CHEMBL1242658	=	IC50	nM	1420.0	CHEMBL3145	Homo sapiens	IC50	uM	1.42
	3440939	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@H]1CCOC1		CHEMBL1242748	=	IC50	nM	1860.0	CHEMBL3145	Homo sapiens	IC50	uM	1.86
	3440953	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@@H]1CCOC1		CHEMBL1242749	=	IC50	nM	715.0	CHEMBL3145	Homo sapiens	IC50	uM	0.715
	3440967	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCCCCC1		CHEMBL1242750	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3440981	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2CC1CCNCC1		CHEMBL1242844	=	IC50	nM	5690.0	CHEMBL3145	Homo sapiens	IC50	uM	5.69
	3440995	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1nn(-c2ccccc2)nc1Cn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242845	=	IC50	nM	2820.0	CHEMBL3145	Homo sapiens	IC50	uM	2.82
	3441009	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2Cc1ocnc1-c1ccccc1		CHEMBL1241482	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3441023	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1F		CHEMBL1241483	=	IC50	nM	3210.0	CHEMBL3145	Homo sapiens	IC50	uM	3.21
	3441037	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21		CHEMBL1241484	=	IC50	nM	660.0	CHEMBL3145	Homo sapiens	IC50	uM	0.66
	3441051	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@H](CN)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21		CHEMBL1241579	=	IC50	nM	3620.0	CHEMBL3145	Homo sapiens	IC50	uM	3.62
	3441065	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@@H](CN)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21		CHEMBL1240544	=	IC50	nM	3530.0	CHEMBL3145	Homo sapiens	IC50	uM	3.53
	3441079	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2C1CCC1		CHEMBL1241580	=	IC50	nM	1350.0	CHEMBL3145	Homo sapiens	IC50	uM	1.35
	3441616	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C		CHEMBL1241481	>	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
	3441630	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	IC50	nM	240.0	CHEMBL3145	Homo sapiens	IC50	uM	0.24
	3441644	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	IC50	nM	1400.0	CHEMBL3145	Homo sapiens	IC50	uM	1.4
	3441658	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	IC50	nM	240.0	CHEMBL3145	Homo sapiens	IC50	uM	0.24
	3441672	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	IC50	nM	130.0	CHEMBL3145	Homo sapiens	IC50	uM	0.13
	3441686	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	IC50	nM	2200.0	CHEMBL3145	Homo sapiens	IC50	uM	2.2
	3441700	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccn3ccnc3c1)nn2C1CCCC1		CHEMBL1241675	=	IC50	nM	15000.0	CHEMBL3145	Homo sapiens	IC50	uM	15.0
	3441714	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccccc1-n1c(Cn2nc(-c3cccc(O)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1241767	=	IC50	nM	670.0	CHEMBL3145	Homo sapiens	IC50	uM	0.67
	3441856	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	IC50	nM	8600.0	CHEMBL3145	Homo sapiens	IC50	uM	8.6
	3441870	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	IC50	nM	16000.0	CHEMBL3145	Homo sapiens	IC50	uM	16.0
	3441884	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccccc3)c12		CHEMBL1241104	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3441898	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1		CHEMBL1241142	=	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
	3441912	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cccc(-c2n[nH]c3ncnc(N)c23)c1		CHEMBL1241143	=	IC50	nM	23000.0	CHEMBL3145	Homo sapiens	IC50	uM	23.0
	3441926	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccccc1-c1n[nH]c2ncnc(N)c12		CHEMBL1241144	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3441940	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cccc(-c2n[nH]c3ncnc(N)c23)c1C		CHEMBL1241145	=	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
	3441954	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)(C)c1ccc(-c2n[nH]c3ncnc(N)c23)cc1		CHEMBL1241240	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3441968	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(O)cc2)c2c(N)ncnc21		CHEMBL1241241	=	IC50	nM	380.0	CHEMBL3145	Homo sapiens	IC50	uM	0.38
	3441982	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(O)c3)c12		CHEMBL1241242	=	IC50	nM	25000.0	CHEMBL3145	Homo sapiens	IC50	uM	25.0
	3441996	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1241269	=	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
	3442010	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CNc1ncnc2c1c(-c1cccc(O)c1)nn2C(C)C		CHEMBL1241942	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442024	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cc(O)ccc1-c1nn(C(C)C)c2ncnc(N)c12		CHEMBL1242024	=	IC50	nM	8600.0	CHEMBL3145	Homo sapiens	IC50	uM	8.6
	3442038	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1OCc1ccccc1		CHEMBL1242025	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442052	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1O		CHEMBL1241270	=	IC50	nM	5870.0	CHEMBL3145	Homo sapiens	IC50	uM	5.87
	3442066	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2nn(C)c3ncnc(N)c23)cc1O		CHEMBL1241271	=	IC50	nM	3130.0	CHEMBL3145	Homo sapiens	IC50	uM	3.13
	3442080	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1O		CHEMBL1242026	=	IC50	nM	1720.0	CHEMBL3145	Homo sapiens	IC50	uM	1.72
	3442094	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCC(C)n1nc(-c2ccc(C)c(O)c2)c2c(N)ncnc21		CHEMBL1242109	=	IC50	nM	5290.0	CHEMBL3145	Homo sapiens	IC50	uM	5.29
	3442108	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2F)c2c(N)ncnc21		CHEMBL1242110	=	IC50	nM	5810.0	CHEMBL3145	Homo sapiens	IC50	uM	5.81
	3442122	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1F)nn2C1CCCC1		CHEMBL1242111	=	IC50	nM	5610.0	CHEMBL3145	Homo sapiens	IC50	uM	5.61
	3442136	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(O)cc(F)c2)c2c(N)ncnc21		CHEMBL1242198	=	IC50	nM	350.0	CHEMBL3145	Homo sapiens	IC50	uM	0.35
	3442150	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cc(O)cc(F)c1)nn2C1CCCC1		CHEMBL1242199	=	IC50	nM	343.0	CHEMBL3145	Homo sapiens	IC50	uM	0.343
	3442164	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(Br)cc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1242200	=	IC50	nM	50300.0	CHEMBL3145	Homo sapiens	IC50	uM	50.3
	3442188	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C[C@@H](C)CO)c3ncnc(N)c23)cc1OC		CHEMBL1242381	=	IC50	nM	3800.0	CHEMBL3145	Homo sapiens	IC50	uM	3.8
	3442202	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1OC		CHEMBL1240553	=	IC50	nM	232.0	CHEMBL3145	Homo sapiens	IC50	uM	0.232
	3442216	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2n[nH]c3ncnc(N)c23)cc1OC		CHEMBL1242471	=	IC50	nM	4820.0	CHEMBL3145	Homo sapiens	IC50	uM	4.82
	3442230	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1OC		CHEMBL1242472	=	IC50	nM	1670.0	CHEMBL3145	Homo sapiens	IC50	uM	1.67
	3442244	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C=CCn1nc(-c2ccc(OCC)c(OC)c2)c2c(N)ncnc21		CHEMBL1242569	=	IC50	nM	2450.0	CHEMBL3145	Homo sapiens	IC50	uM	2.45
	3442258	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1OC		CHEMBL1240554	=	IC50	nM	294.0	CHEMBL3145	Homo sapiens	IC50	uM	0.294
	3442272	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C3CCCCC3)c3ncnc(N)c23)cc1OC		CHEMBL1242659	=	IC50	nM	9860.0	CHEMBL3145	Homo sapiens	IC50	uM	9.86
	3442286	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)cc(OC)c1OC		CHEMBL1242660	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442300	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1OC		CHEMBL1242751	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442314	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1OC		CHEMBL1242752	=	IC50	nM	492.0	CHEMBL3145	Homo sapiens	IC50	uM	0.492
	3442328	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1cc(-c2nn(CCO)c3ncnc(N)c23)ccc1OC		CHEMBL1242753	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442342	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ncc(-c2nn(C(C)C)c3ncnc(N)c23)c(OC)n1		CHEMBL1242846	=	IC50	nM	1610.0	CHEMBL3145	Homo sapiens	IC50	uM	1.61
	3442356	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL1242847	=	IC50	nM	1500.0	CHEMBL3145	Homo sapiens	IC50	uM	1.5
	3442370	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccccc3O)c12		CHEMBL1241355	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442384	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(N)c(O)c2)c2c(N)ncnc21		CHEMBL1242848	=	IC50	nM	14200.0	CHEMBL3145	Homo sapiens	IC50	uM	14.2
	3442398	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1N		CHEMBL1241485	=	IC50	nM	3500.0	CHEMBL3145	Homo sapiens	IC50	uM	3.5
	3442412	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1NC(C)CO		CHEMBL1241486	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442426	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O		CHEMBL1241487	=	IC50	nM	5230.0	CHEMBL3145	Homo sapiens	IC50	uM	5.23
	3442440	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C3CCCC3)c3ncnc(N)c23)ccc1N		CHEMBL1241581	=	IC50	nM	2880.0	CHEMBL3145	Homo sapiens	IC50	uM	2.88
	3442454	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ccc(-c2n[nH]c3ncnc(N)c23)cc1		CHEMBL1241356	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442468	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1cccc(-c2n[nH]c3ncnc(N)c23)c1		CHEMBL1241357	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442482	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc([N+](=O)[O-])cc3)c12		CHEMBL1241358	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442496	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc([N+](=O)[O-])c3)c12		CHEMBL1241389	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442510	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(CO)c2)c2c(N)ncnc21		CHEMBL1241582	=	IC50	nM	6100.0	CHEMBL3145	Homo sapiens	IC50	uM	6.1
	3442524	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(CC#N)c2)c2c(N)ncnc21		CHEMBL1241583	=	IC50	nM	7200.0	CHEMBL3145	Homo sapiens	IC50	uM	7.2
	3442538	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(CC#N)cc2)c2c(N)ncnc21		CHEMBL1240545	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442565	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(F)c(C#N)c2)c2c(N)ncnc21		CHEMBL1241680	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442579	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C#N)c(F)c2)c2c(N)ncnc21		CHEMBL1241771	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442593	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C#N)nc2)c2c(N)ncnc21		CHEMBL1241772	=	IC50	nM	6100.0	CHEMBL3145	Homo sapiens	IC50	uM	6.1
	3442607	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccnc2)c2c(N)ncnc21		CHEMBL1241390	=	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
	3442621	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cncnc2)c2c(N)ncnc21		CHEMBL1241391	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442635	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(=O)c1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL1241773	=	IC50	nM	3300.0	CHEMBL3145	Homo sapiens	IC50	uM	3.3
	3442649	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C=O)c(F)c2)c2c(N)ncnc21		CHEMBL1241860	=	IC50	nM	5900.0	CHEMBL3145	Homo sapiens	IC50	uM	5.9
	3442663	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(F)c(C=O)c(F)c2)c2c(N)ncnc21		CHEMBL1241861	=	IC50	nM	7200.0	CHEMBL3145	Homo sapiens	IC50	uM	7.2
	3442677	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C(N)=O)c(Cl)c2)c2c(N)ncnc21		CHEMBL1241862	=	IC50	nM	7000.0	CHEMBL3145	Homo sapiens	IC50	uM	7.0
	3442691	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(=O)c1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1241946	=	IC50	nM	8000.0	CHEMBL3145	Homo sapiens	IC50	uM	8.0
Not Determined	3442705	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(C=O)co2)c2c(N)ncnc21		CHEMBL1241439		IC50			CHEMBL3145	Homo sapiens	IC50		
	3442719	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cc(-c2nn(C(C)C)c3ncnc(N)c23)sc1C=O		CHEMBL1241947	=	IC50	nM	80000.0	CHEMBL3145	Homo sapiens	IC50	uM	80.0
	3442759	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(S(N)(=O)=O)c2)c2c(N)ncnc21		CHEMBL1242031	=	IC50	nM	2100.0	CHEMBL3145	Homo sapiens	IC50	uM	2.1
	3442773	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(S(N)(=O)=O)cc2)c2c(N)ncnc21		CHEMBL1242032	=	IC50	nM	5200.0	CHEMBL3145	Homo sapiens	IC50	uM	5.2
	3442787	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(C(=O)NC3=NCCS3)c2)c2c(N)ncnc21		CHEMBL1242115	=	IC50	nM	5800.0	CHEMBL3145	Homo sapiens	IC50	uM	5.8
	3442801	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc(NC(=O)c4ccc(-c5ccccc5)cc4)cc3)c12		CHEMBL1242116	=	IC50	nM	25000.0	CHEMBL3145	Homo sapiens	IC50	uM	25.0
	3442815	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc(Oc4ccccc4)cc3)c12		CHEMBL1242204	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442829	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(Oc4ccccc4)c3)c12		CHEMBL1242205	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442843	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc(OCc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL1242206	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442857	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1242291	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442871	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(OCc4c(Cl)cccc4Cl)c3)c12		CHEMBL1242292	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442885	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2CCc1ccccc1		CHEMBL1242382	=	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
	3442899	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	NC(=O)Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242383	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442913	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2CC1CC1		CHEMBL1242473	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3442927	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242474	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
Not Determined	3442941	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2C/C=C/c1ccccc1		CHEMBL1242570		IC50			CHEMBL3145	Homo sapiens	IC50		
	3442952	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2C1CCCC1		CHEMBL1241676	=	IC50	nM	941.0	CHEMBL3145	Homo sapiens	IC50	uM	0.941
	3442966	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@@H]1CCNC1		CHEMBL1241677	=	IC50	nM	864.0	CHEMBL3145	Homo sapiens	IC50	uM	0.864
	3442980	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@H]1CCOC1		CHEMBL1241678	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	uM	0.55
	3442994	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@@H]1CCOC1		CHEMBL1241768	=	IC50	nM	809.0	CHEMBL3145	Homo sapiens	IC50	uM	0.809
	3443008	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCCN1		CHEMBL1241769	=	IC50	nM	6980.0	CHEMBL3145	Homo sapiens	IC50	uM	6.98
	3443022	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCNC1		CHEMBL1241770	=	IC50	nM	962.0	CHEMBL3145	Homo sapiens	IC50	uM	0.962
	3443036	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCCNC1		CHEMBL1241858	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3443050	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCNCC1		CHEMBL1241859	=	IC50	nM	2700.0	CHEMBL3145	Homo sapiens	IC50	uM	2.7
	3443064	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CCC1CCCNC1		CHEMBL1241943	=	IC50	nM	2640.0	CHEMBL3145	Homo sapiens	IC50	uM	2.64
	3443078	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C#N)c(O)c2)c2c(N)ncnc21		CHEMBL1241944	=	IC50	nM	742.0	CHEMBL3145	Homo sapiens	IC50	uM	0.742
	3443092	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(O)c(F)c2)c2c(N)ncnc21		CHEMBL1241945	=	IC50	nM	1450.0	CHEMBL3145	Homo sapiens	IC50	uM	1.45
	3443106	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(F)c(-c2nn(C(C)C)c3ncnc(N)c23)cc1F		CHEMBL1242027	=	IC50	nM	1280.0	CHEMBL3145	Homo sapiens	IC50	uM	1.28
	3443120	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(F)c(O)cc2F)c2c(N)ncnc21		CHEMBL1242028	=	IC50	nM	2530.0	CHEMBL3145	Homo sapiens	IC50	uM	2.53
	3443134	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1242029	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3443148	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1O		CHEMBL1242112	=	IC50	nM	2100.0	CHEMBL3145	Homo sapiens	IC50	uM	2.1
	3443162	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2n[nH]c3ncnc(N)c23)cc1O		CHEMBL1241300	=	IC50	nM	1360.0	CHEMBL3145	Homo sapiens	IC50	uM	1.36
	3443176	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C)c3ncnc(N)c23)cc1O		CHEMBL1241301	=	IC50	nM	216.0	CHEMBL3145	Homo sapiens	IC50	uM	0.216
	3443190	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCn1nc(-c2ccc(OC)c(O)c2)c2c(N)ncnc21		CHEMBL1242113	=	IC50	nM	809.0	CHEMBL3145	Homo sapiens	IC50	uM	0.809
	3443204	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1O		CHEMBL1242114	=	IC50	nM	697.0	CHEMBL3145	Homo sapiens	IC50	uM	0.697
	3443218	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O		CHEMBL1242201	=	IC50	nM	261.0	CHEMBL3145	Homo sapiens	IC50	uM	0.261
	3443232	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC(C)C3)c3ncnc(N)c23)cc1O		CHEMBL1242202	=	IC50	nM	949.0	CHEMBL3145	Homo sapiens	IC50	uM	0.949
	3443246	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CNC3)c3ncnc(N)c23)cc1O		CHEMBL1242203	=	IC50	nM	2670.0	CHEMBL3145	Homo sapiens	IC50	uM	2.67
	3443260	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn([C@@H]3CCNC3)c3ncnc(N)c23)cc1O		CHEMBL1242288	=	IC50	nM	2270.0	CHEMBL3145	Homo sapiens	IC50	uM	2.27
	3443274	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O		CHEMBL1242289	=	IC50	nM	3180.0	CHEMBL3145	Homo sapiens	IC50	uM	3.18
	3443288	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1OC		CHEMBL1242290	=	IC50	nM	230.0	CHEMBL3145	Homo sapiens	IC50	uM	0.23
	3443302	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1OC		CHEMBL1242379	=	IC50	nM	525.0	CHEMBL3145	Homo sapiens	IC50	uM	0.525
	3443316	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C[C@H](C)CO)c3ncnc(N)c23)cc1OC		CHEMBL1242380	=	IC50	nM	5400.0	CHEMBL3145	Homo sapiens	IC50	uM	5.4
Not Determined	3443749	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C#CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242571		IC50			CHEMBL3145	Homo sapiens	IC50		
	3443763	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc2cc(-c3nn(C)c4ncnc(N)c34)ccc2c1		CHEMBL1242661	=	IC50	nM	5300.0	CHEMBL3145	Homo sapiens	IC50	uM	5.3
	3443777	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cc(O)ccc3c2)c2c(N)ncnc21		CHEMBL1242662	=	IC50	nM	3200.0	CHEMBL3145	Homo sapiens	IC50	uM	3.2
	3443791	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3ccccc3nc2Cl)c2c(N)ncnc21		CHEMBL1242663	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3443805	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cnc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242754	=	IC50	nM	16000.0	CHEMBL3145	Homo sapiens	IC50	uM	16.0
	3443819	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3ccccc3c1)nn2C1CCCC1		CHEMBL1242755	=	IC50	nM	2700.0	CHEMBL3145	Homo sapiens	IC50	uM	2.7
	3443833	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1242756	=	IC50	nM	1400.0	CHEMBL3145	Homo sapiens	IC50	uM	1.4
	3443847	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2cccc(-c3ccccc3)c2)c2c(N)ncnc21		CHEMBL1242849	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3443861	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc(-c4ccccc4)cc3)c12		CHEMBL1242850	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3443875	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(C3CCc4ccccc4C3)c12		CHEMBL1241440	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3443889	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc4ccccc4c3)c12		CHEMBL1241441	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
Not Determined	3443903	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242851		IC50			CHEMBL3145	Homo sapiens	IC50		
	3443917	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C=CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1241488	=	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
	3443931	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1241489	=	IC50	nM	32000.0	CHEMBL3145	Homo sapiens	IC50	uM	32.0
	3443945	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)(C)n1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1231371	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3443959	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2C1CCCC1		CHEMBL1241584	=	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
	3443973	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2Cc1ccccc1		CHEMBL1241585	=	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
	3443987	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ncccc3c1)nn2C1CCCC1		CHEMBL1241681	=	IC50	nM	2700.0	CHEMBL3145	Homo sapiens	IC50	uM	2.7
	3444001	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2n1		CHEMBL1241682	=	IC50	nM	1600.0	CHEMBL3145	Homo sapiens	IC50	uM	1.6
	3444015	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc(Cl)ccc3c2)c2c(N)ncnc21		CHEMBL1241683	=	IC50	nM	5500.0	CHEMBL3145	Homo sapiens	IC50	uM	5.5
	3444029	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nccnc3c2)c2c(N)ncnc21		CHEMBL1241774	=	IC50	nM	975.0	CHEMBL3145	Homo sapiens	IC50	uM	0.975
	3444043	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cnc3nccnc3c2)c2c(N)ncnc21		CHEMBL1241775	=	IC50	nM	6500.0	CHEMBL3145	Homo sapiens	IC50	uM	6.5
	3444057	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc[nH]c(=O)c3c2)c2c(N)ncnc21		CHEMBL1241776	=	IC50	nM	467.0	CHEMBL3145	Homo sapiens	IC50	uM	0.467
	3444071	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]c(=O)ccc3c2)c2c(N)ncnc21		CHEMBL1241863	=	IC50	nM	15000.0	CHEMBL3145	Homo sapiens	IC50	uM	15.0
	3444085	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3[nH]c(=O)ccc3c1)nn2C1CCCC1		CHEMBL1241864	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3444099	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc(N)ccc3c2)c2c(N)ncnc21		CHEMBL1241949	=	IC50	nM	500.0	CHEMBL3145	Homo sapiens	IC50	uM	0.5
	3444113	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc(NN)ccc3c2)c2c(N)ncnc21		CHEMBL1241950	=	IC50	nM	4600.0	CHEMBL3145	Homo sapiens	IC50	uM	4.6
	3444127	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nccc(NC(=O)OC(C)(C)C)c3c2)c2c(N)ncnc21		CHEMBL1242033	=	IC50	nM	8900.0	CHEMBL3145	Homo sapiens	IC50	uM	8.9
	3444141	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nccc(N)c3c2)c2c(N)ncnc21		CHEMBL1242034	=	IC50	nM	12000.0	CHEMBL3145	Homo sapiens	IC50	uM	12.0
	3444155	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3occc(=O)c3c2)c2c(N)ncnc21		CHEMBL1242117	=	IC50	nM	8100.0	CHEMBL3145	Homo sapiens	IC50	uM	8.1
	3444169	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3occc(=O)c3c2)c2c(N)ncnc21		CHEMBL1242118	=	IC50	nM	25000.0	CHEMBL3145	Homo sapiens	IC50	uM	25.0
	3444183	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3occc(=O)c3c1)nn2C1CCCC1		CHEMBL1242119	=	IC50	nM	1100.0	CHEMBL3145	Homo sapiens	IC50	uM	1.1
	3444197	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cnccc3c2)c2c(N)ncnc21		CHEMBL1242207	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3444211	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ccncc3c2)c2c(N)ncnc21		CHEMBL1242208	=	IC50	nM	1300.0	CHEMBL3145	Homo sapiens	IC50	uM	1.3
	3444225	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc2ccc(-c3nn(C(C)C)c4ncnc(N)c34)cc2n1		CHEMBL1242209	=	IC50	nM	476.0	CHEMBL3145	Homo sapiens	IC50	uM	0.476
	3444239	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21		CHEMBL1240565	=	IC50	nM	1600.0	CHEMBL3145	Homo sapiens	IC50	uM	1.6
	3444253	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21		CHEMBL1242293	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	3444267	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]ccc3c2)c2c(N)ncnc21		CHEMBL1242294	=	IC50	nM	3220.0	CHEMBL3145	Homo sapiens	IC50	uM	3.22
	3444281	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1242295	=	IC50	nM	4100.0	CHEMBL3145	Homo sapiens	IC50	uM	4.1
	3444295	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(ccn3C)c2)c2c(N)ncnc21		CHEMBL1242384	=	IC50	nM	854.0	CHEMBL3145	Homo sapiens	IC50	uM	0.854
	3444309	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1ccc2cc(-c3nn(C4CCCC4)c4ncnc(N)c34)ccc21		CHEMBL1242385	=	IC50	nM	1100.0	CHEMBL3145	Homo sapiens	IC50	uM	1.1
	3444323	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]ncc3c2)c2c(N)ncnc21		CHEMBL1242386	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	uM	0.55
	3444337	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3[nH]ncc3c1)nn2C1CCCC1		CHEMBL1242475	=	IC50	nM	1500.0	CHEMBL3145	Homo sapiens	IC50	uM	1.5
	3444351	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(N)n[nH]c3c2)c2c(N)ncnc21		CHEMBL1242476	=	IC50	nM	658.0	CHEMBL3145	Homo sapiens	IC50	uM	0.658
	3444365	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cn[nH]c3c2)c2c(N)ncnc21		CHEMBL1242477	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	3444379	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3cn[nH]c3c1)nn2C1CCCC1		CHEMBL1242572	=	IC50	nM	1900.0	CHEMBL3145	Homo sapiens	IC50	uM	1.9
	3444393	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(F)c3cn[nH]c3c2)c2c(N)ncnc21		CHEMBL1242573	=	IC50	nM	548.0	CHEMBL3145	Homo sapiens	IC50	uM	0.548
	3444407	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3cc[nH]c3c2)c2c(N)ncnc21		CHEMBL1240566	=	IC50	nM	2900.0	CHEMBL3145	Homo sapiens	IC50	uM	2.9
	3444421	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cc[nH]c3c2)c2c(N)ncnc21		CHEMBL1242574	=	IC50	nM	5000.0	CHEMBL3145	Homo sapiens	IC50	uM	5.0
	3444435	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3cc[nH]c3c1)nn2C1CCCC1		CHEMBL1242664	=	IC50	nM	7000.0	CHEMBL3145	Homo sapiens	IC50	uM	7.0
	3444449	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccn3ccnc3c2)c2c(N)ncnc21		CHEMBL1242665	=	IC50	nM	52000.0	CHEMBL3145	Homo sapiens	IC50	uM	52.0
Not Determined	3444463	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(C=O)c[nH]c3c2)c2c(N)ncnc21		CHEMBL1242666		IC50			CHEMBL3145	Homo sapiens	IC50		
	3444477	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc3[nH]ccc23)c2c(N)ncnc21		CHEMBL1242757	=	IC50	nM	4750.0	CHEMBL3145	Homo sapiens	IC50	uM	4.75
	3444491	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cccc3[nH]ccc13)nn2C1CCCC1		CHEMBL1242758	=	IC50	nM	10600.0	CHEMBL3145	Homo sapiens	IC50	uM	10.6
	3444505	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(ccn3C(=O)OC(C)(C)C)c2)c2c(N)ncnc21		CHEMBL1242852	=	IC50	nM	45000.0	CHEMBL3145	Homo sapiens	IC50	uM	45.0
	3444519	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)(C)OC(=O)n1ccc2cc(-c3nn(C4CCCC4)c4ncnc(N)c34)ccc21		CHEMBL1242853	=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	3444533	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3occc3c2)c2c(N)ncnc21		CHEMBL1241490	=	IC50	nM	67200.0	CHEMBL3145	Homo sapiens	IC50	uM	67.2
	3444547	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3occc3c1)nn2C1CCCC1		CHEMBL1241491	=	IC50	nM	28700.0	CHEMBL3145	Homo sapiens	IC50	uM	28.7
	3444561	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nonc3c2)c2c(N)ncnc21		CHEMBL1241492	=	IC50	nM	440.0	CHEMBL3145	Homo sapiens	IC50	uM	0.44
	3444575	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]c(=O)[nH]c3c2)c2c(N)ncnc21		CHEMBL1241586	=	IC50	nM	9200.0	CHEMBL3145	Homo sapiens	IC50	uM	9.2
	3444589	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(c2)CCO3)c2c(N)ncnc21		CHEMBL1241587	=	IC50	nM	46800.0	CHEMBL3145	Homo sapiens	IC50	uM	46.8
	3444603	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc4c(c3)OCO4)c12		CHEMBL1240567	=	IC50	nM	30000.0	CHEMBL3145	Homo sapiens	IC50	uM	30.0
	3444617	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(c2)OCCO3)c2c(N)ncnc21		CHEMBL1241588	=	IC50	nM	1400.0	CHEMBL3145	Homo sapiens	IC50	uM	1.4
	3444631	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2cc3ccccc3s2)c2c(N)ncnc21		CHEMBL1240594	=	IC50	nM	15000.0	CHEMBL3145	Homo sapiens	IC50	uM	15.0
	3444645	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(C=O)ccc3s2)c2c(N)ncnc21		CHEMBL1241684	=	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
	3444659	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
	3444672	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
	3444685	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
	3446162	CHEMBL1243966	Inhibition of recombinant PI3Kbeta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
	3448565	CHEMBL1244918	Binding affinity to PIK3CB	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	uM	10.0
	3449796	CHEMBL1244918	Binding affinity to PIK3CB	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	uM	10.0
	3449953	CHEMBL1244918	Binding affinity to PIK3CB	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	uM	10.0
	3450191	CHEMBL1244918	Binding affinity to PIK3CB	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	uM	10.0
	3450392	CHEMBL1244918	Binding affinity to PIK3CB	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	uM	10.0
	3450846	CHEMBL1244918	Binding affinity to PIK3CB	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	uM	10.0
	3451112	CHEMBL1244918	Binding affinity to PIK3CB	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	uM	10.0
	3499260	CHEMBL1260067	Inhibition of PI3K-beta	B	O=C(Nc1ccncc1)Nc1ccc(-c2nc(N3CCOCC3)nc(N3C4CCC3COC4)n2)cc1		CHEMBL1258517	=	IC50	nM	24.0	CHEMBL3145	Homo sapiens	IC50	nM	24.0
	3506979	CHEMBL1260890	Inhibition of PI3Kbeta	B	Cn1ncc2c(Oc3ccc(S(C)(=O)=O)cc3)cc(-c3cccc4[nH]ncc34)nc21		CHEMBL1257653	=	IC50	nM	31.0	CHEMBL3145	Homo sapiens	IC50	uM	0.031
	3561325	CHEMBL1287081	Inhibition of PI3Kbeta at 10	B	Cc1c2c(=O)n(-c3ccccc3Cl)[nH]c2cc(=O)n1Cc1ccccn1		CHEMBL1276946	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	3590236	CHEMBL1292108	Inhibition of PI3Kbeta	B	Oc1cccc(-c2cc(Nc3ccc4[nH]ncc4c3)nc(N3CCOCC3)n2)c1		CHEMBL1289975	=	IC50	nM	240.0	CHEMBL3145	Homo sapiens	IC50	uM	0.24
	3590237	CHEMBL1292108	Inhibition of PI3Kbeta	B	COc1ccc(Nc2cc(-c3cccc(O)c3)nc(N3CCOCC3)n2)cn1		CHEMBL1290744	=	IC50	nM	240.0	CHEMBL3145	Homo sapiens	IC50	uM	0.24
	5132945	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	IC50	nM	15.0	CHEMBL3145	Homo sapiens	IC50	uM	0.015
	5132946	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	c1cc(-c2cnc3[nH]ccc3c2)ccn1		CHEMBL1645094	=	IC50	nM	17000.0	CHEMBL3145	Homo sapiens	IC50	uM	17.0
	5132947	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	Nc1ncnc2sc(-c3ccncc3)nc12		CHEMBL1645095	=	IC50	nM	17000.0	CHEMBL3145	Homo sapiens	IC50	uM	17.0
	5132948	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	N#Cc1cc(-c2ccncc2)cnc1O		CHEMBL58782	=	IC50	nM	21000.0	CHEMBL3145	Homo sapiens	IC50	uM	21.0
	5132949	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	Oc1ccc2oc(-c3ccncc3)nc2c1		CHEMBL1645096	=	IC50	nM	32000.0	CHEMBL3145	Homo sapiens	IC50	uM	32.0
	5132950	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	Cc1cc(-c2cnc(N)c(C(N)=O)c2)ccn1		CHEMBL1645097	=	IC50	nM	48000.0	CHEMBL3145	Homo sapiens	IC50	uM	48.0
	5132951	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	Nc1nc2nc(-c3ccncc3)ccn2n1		CHEMBL1645098	=	IC50	nM	62000.0	CHEMBL3145	Homo sapiens	IC50	uM	62.0
	5132952	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	Nc1ccc2oc(-c3ccncc3)nc2c1		CHEMBL1645099	=	IC50	nM	81000.0	CHEMBL3145	Homo sapiens	IC50	uM	81.0
	5132953	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	O=c1[nH]cnc2cc(N3CCOCC3)ccc12		CHEMBL1645100	=	IC50	nM	5800.0	CHEMBL3145	Homo sapiens	IC50	uM	5.8
	5132954	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	c1cc(N2CCOCC2)c2cn[nH]c2n1		CHEMBL1645101	=	IC50	nM	17000.0	CHEMBL3145	Homo sapiens	IC50	uM	17.0
	5132955	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL1645102	=	IC50	nM	17000.0	CHEMBL3145	Homo sapiens	IC50	uM	17.0
	5132956	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	Nc1ncnc2nc(N3CCOCC3)ncc12		CHEMBL1645103	=	IC50	nM	30000.0	CHEMBL3145	Homo sapiens	IC50	uM	30.0
	5132957	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	CN(C)c1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL1645104	=	IC50	nM	34000.0	CHEMBL3145	Homo sapiens	IC50	uM	34.0
	5132958	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	COc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL1645105	=	IC50	nM	3600.0	CHEMBL3145	Homo sapiens	IC50	uM	3.6
	5132959	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	Nc1nc2cc(-c3ccncc3)ccc2s1		CHEMBL1645106	=	IC50	nM	4800.0	CHEMBL3145	Homo sapiens	IC50	uM	4.8
	5132960	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	Nc1nc2ccc(-c3ccncc3)cc2s1		CHEMBL1645107	=	IC50	nM	9000.0	CHEMBL3145	Homo sapiens	IC50	uM	9.0
	5132961	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	Nc1nc2ccc(-c3cccc(O)c3)cc2s1		CHEMBL1645108	=	IC50	nM	12000.0	CHEMBL3145	Homo sapiens	IC50	uM	12.0
	5132962	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	Cn1ccc2cc(N)ncc21		CHEMBL1645109	=	IC50	nM	57000.0	CHEMBL3145	Homo sapiens	IC50	uM	57.0
	5132963	CHEMBL1646726	Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay	B	Nc1nonc1-c1noc(Cc2cccs2)n1		CHEMBL1645110	=	IC50	nM	14200.0	CHEMBL3145	Homo sapiens	IC50	uM	14.2
	5137213	CHEMBL1648644	Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assay	B	Oc1cccc(-c2nc(-c3ccccn3)cc(N3CCOCC3)n2)c1		CHEMBL1644558	=	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	uM	0.1
	5137214	CHEMBL1648644	Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assay	B	Oc1cccc(-c2nc(-c3cccnc3)cc(N3CCOCC3)n2)c1		CHEMBL1644559	=	IC50	nM	440.0	CHEMBL3145	Homo sapiens	IC50	uM	0.44
	5137215	CHEMBL1648644	Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assay	B	Oc1cccc(-c2nc(-c3ccncc3)cc(N3CCOCC3)n2)c1		CHEMBL1644560	=	IC50	nM	200.0	CHEMBL3145	Homo sapiens	IC50	uM	0.2
	5137216	CHEMBL1648644	Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assay	B	Oc1cccc(-c2cc(NCc3ccccn3)nc(N3CCOCC3)n2)c1		CHEMBL1644563	=	IC50	nM	2300.0	CHEMBL3145	Homo sapiens	IC50	uM	2.3
	5137217	CHEMBL1648644	Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assay	B	Oc1cccc(-c2cc(NCCc3ccccn3)nc(N3CCOCC3)n2)c1		CHEMBL1644565	=	IC50	nM	2600.0	CHEMBL3145	Homo sapiens	IC50	uM	2.6
	5137218	CHEMBL1648644	Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assay	B	Oc1cccc(-c2cc(NCCc3cccnc3)nc(N3CCOCC3)n2)c1		CHEMBL1644566	=	IC50	nM	1900.0	CHEMBL3145	Homo sapiens	IC50	uM	1.9
	5137219	CHEMBL1648644	Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assay	B	Oc1cccc(-c2cc(NCCc3ccncc3)nc(N3CCOCC3)n2)c1		CHEMBL1644567	=	IC50	nM	1600.0	CHEMBL3145	Homo sapiens	IC50	uM	1.6
	5137220	CHEMBL1648644	Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assay	B	Oc1cccc(-c2cc(N3CCOCC3)nc(NCCc3ccccn3)n2)c1		CHEMBL1644571	=	IC50	nM	5200.0	CHEMBL3145	Homo sapiens	IC50	uM	5.2
	5137221	CHEMBL1648644	Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assay	B	Oc1cccc(-c2cc(OCc3ccccn3)nc(N3CCOCC3)n2)c1		CHEMBL1644574	=	IC50	nM	370.0	CHEMBL3145	Homo sapiens	IC50	uM	0.37
	5207834	CHEMBL1680116	Inhibition of PI3Kbeta after 15 mins	B	COc1ccc(Nc2cc(-c3cnc(N)nc3)nc(N3CCOCC3)n2)cn1		CHEMBL1672328	=	IC50	nM	92.0	CHEMBL3145	Homo sapiens	IC50	uM	0.092
	5247285	CHEMBL1686445	Inhibition of PI3Kbeta	B	CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21		CHEMBL1684984	=	IC50	nM	120.0	CHEMBL3145	Homo sapiens	IC50	uM	0.12
	6157551	CHEMBL1763563	Inhibition of PI3Kbeta	B	N#CCNc1ncnc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL1615182	=	IC50	nM	380.0	CHEMBL3145	Homo sapiens	IC50	uM	0.38
	6157686	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL1762788	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	uM	0.009
	6157687	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(Nc3ccccc3)nc3ccccc32)n1		CHEMBL1762789	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	6157688	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(Nc3cc(O)cc(O)c3)nc3ccccc32)n1		CHEMBL1762790	=	IC50	nM	0.2	CHEMBL3145	Homo sapiens	IC50	uM	0.0002
	6157689	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(Nc3cccc(C(N)=O)c3)nc3ccccc32)n1		CHEMBL1760153	=	IC50	nM	1030.0	CHEMBL3145	Homo sapiens	IC50	uM	1.03
	6157690	CHEMBL1763563	Inhibition of PI3Kbeta	B	CNC(=O)Nc1ccc(Nc2nc3ccccc3n2-c2nc(C)nc(N)n2)cc1		CHEMBL1760154	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	uM	0.017
	6157691	CHEMBL1763563	Inhibition of PI3Kbeta	B	CC(=O)Nc1ccc(Nc2nc3ccccc3n2-c2nc(C)nc(N)n2)cc1		CHEMBL1760155	=	IC50	nM	410.0	CHEMBL3145	Homo sapiens	IC50	uM	0.41
	6157692	CHEMBL1763563	Inhibition of PI3Kbeta	B	CC(=O)Nc1cccc(Nc2nc3ccccc3n2-c2nc(C)nc(N)n2)c1		CHEMBL1760156	=	IC50	nM	1400.0	CHEMBL3145	Homo sapiens	IC50	uM	1.4
	6157693	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(Nc3ccc4cc[nH]c4c3)nc3ccccc32)n1		CHEMBL1760157	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	6157694	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(Nc3ccc4cn[nH]c4c3)nc3ccccc32)n1		CHEMBL1760158	=	IC50	nM	630.0	CHEMBL3145	Homo sapiens	IC50	uM	0.63
	6157695	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1		CHEMBL1615183	=	IC50	nM	870.0	CHEMBL3145	Homo sapiens	IC50	uM	0.87
	6157696	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(Nc3ccn(C)n3)nc3ccccc32)n1		CHEMBL1760159	=	IC50	nM	28800.0	CHEMBL3145	Homo sapiens	IC50	uM	28.8
	6157697	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(Nc3ccn(C(F)F)n3)nc3ccccc32)n1		CHEMBL1760160	=	IC50	nM	22300.0	CHEMBL3145	Homo sapiens	IC50	uM	22.3
	6157698	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(Nc3ccon3)nc3ccccc32)n1		CHEMBL1760161	=	IC50	nM	3100.0	CHEMBL3145	Homo sapiens	IC50	uM	3.1
	6157699	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(Nc3n[nH]c4ccccc34)nc3ccccc32)n1		CHEMBL1760162	=	IC50	nM	420.0	CHEMBL3145	Homo sapiens	IC50	uM	0.42
	6157700	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(Nc3cn[nH]c3)nc3ccccc32)n1		CHEMBL1760163	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	6157701	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(Nc3ccnn3C)nc3ccccc32)n1		CHEMBL1760164	=	IC50	nM	6900.0	CHEMBL3145	Homo sapiens	IC50	uM	6.9
	6157702	CHEMBL1763563	Inhibition of PI3Kbeta	B	CNC(=O)c1ccc(Nc2nc3ccccc3n2-c2nc(C)nc(N)n2)o1		CHEMBL1760165	=	IC50	nM	1800.0	CHEMBL3145	Homo sapiens	IC50	uM	1.8
Not Determined	6157703	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(Nc3nc[nH]n3)nc3ccccc32)n1		CHEMBL1760166		IC50			CHEMBL3145	Homo sapiens	IC50		
	6157704	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(NC3CCOCC3)nc3ccccc32)n1		CHEMBL1760167	=	IC50	nM	2400.0	CHEMBL3145	Homo sapiens	IC50	uM	2.4
	6157705	CHEMBL1763563	Inhibition of PI3Kbeta	B	CNc1nc(C)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1		CHEMBL1760168	=	IC50	nM	4500.0	CHEMBL3145	Homo sapiens	IC50	uM	4.5
	6157706	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(NCC#N)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1		CHEMBL1760169	=	IC50	nM	8500.0	CHEMBL3145	Homo sapiens	IC50	uM	8.5
	6157707	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(NCCC#N)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1		CHEMBL1760170	=	IC50	nM	15400.0	CHEMBL3145	Homo sapiens	IC50	uM	15.4
	6157708	CHEMBL1763563	Inhibition of PI3Kbeta	B	C#CCNc1nc(C)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1		CHEMBL1760171	=	IC50	nM	3700.0	CHEMBL3145	Homo sapiens	IC50	uM	3.7
	6157709	CHEMBL1763563	Inhibition of PI3Kbeta	B	Cc1nc(N)nc(-n2c(Nc3cc[nH]n3)nc3cc(F)c(F)cc32)n1		CHEMBL1760172	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	6165976	CHEMBL1768723	Binding affinity to PIK3CB at 10 uM by high-throughput binding assay relative to control	B	Cc1nc(-c2cnc3ccc(-c4cncc(NS(=O)(=O)c5ccccc5)c4)cn23)no1		CHEMBL1765464	=	Activity	%	0.015	CHEMBL3145	Homo sapiens	Activity	%	0.015
	6165977	CHEMBL1768724	Binding affinity to PIK3CB by high-throughput binding assay	B	Cc1nc(-c2cnc3ccc(-c4cncc(NS(=O)(=O)c5ccccc5)c4)cn23)no1		CHEMBL1765464	=	Kd	nM	25.0	CHEMBL3145	Homo sapiens	Kd	nM	25.0
	6189355	CHEMBL1775867	Inhibition of human PI3Kbeta expressed in Sf9 cells	B	CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1		CHEMBL1615189	=	Ki	nM	2.0	CHEMBL3145	Homo sapiens	Ki	nM	2.0
	6265766	CHEMBL1798655	Inhibition of PI3Kbeta	B	CNC(=O)c1ccc2c(c1)OCCc1cc(C(=O)N(C)c3ccc(C(=O)N(C)C)cc3Cl)sc1-2		CHEMBL1796761	=	IC50	nM	60.0	CHEMBL3145	Homo sapiens	IC50	nM	60.0
	6339864	CHEMBL1828450	Inhibition of human N-terminal His-tagged PI3Kbeta expressed in insect Sf9 cells using PI(4,5)P2 as substrate after 20 mins by alphascreen assay in presence of 20 uM ATP	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Ki	nM	3.5	CHEMBL3145	Homo sapiens	Ki	nM	3.5
	6339874	CHEMBL1826073	Activity of PIK3CB kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	0.0	CHEMBL3145	Homo sapiens	Activity	%	0.0
	6386328	CHEMBL1839913	Inhibition of recombinant PI3Kbeta by luminescent kinase assay	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	9000.0	CHEMBL3145	Homo sapiens	IC50	uM	9.0
	7567444	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7567932	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7568400	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7568832	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7569435	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7569907	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7570370	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7570797	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7570951	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7571408	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7571884	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7572347	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Kd	nM	1.7	CHEMBL3145	Homo sapiens	Kd	nM	1.7
	7572763	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7572932	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7573389	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7573865	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7574334	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7574742	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	80.0	CHEMBL3145	Homo sapiens	Kd	nM	80.0
	7574910	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7575371	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7575842	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7576884	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7577343	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7577821	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7577849	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7578254	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7578892	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7579266	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7579716	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7580217	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	120.0	CHEMBL3145	Homo sapiens	Kd	nM	120.0
	7580620	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7581250	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7581635	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7582109	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7582573	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7582973	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7583596	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7583996	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7584467	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7584929	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7585333	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7585892	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7586338	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	Kd	nM	16.0	CHEMBL3145	Homo sapiens	Kd	nM	16.0
	7586809	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7587263	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7587445	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7587864	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7588317	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7588788	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7589239	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7589410	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7589834	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	6700.0	CHEMBL3145	Homo sapiens	Kd	nM	6700.0
	7590301	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7590775	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7591226	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7591383	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7591805	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7592277	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	2000.0	CHEMBL3145	Homo sapiens	Kd	nM	2000.0
	7592750	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7593350	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7593785	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7594257	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7594740	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7595318	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7595762	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7596265	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7596712	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7597290	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7597743	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7597774	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7598244	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7598686	CHEMBL1908743	Binding constant for PIK3CB kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
	7846778	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	4.8	CHEMBL3145	Homo sapiens	IC50	nM	4.8
	7846779	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	c1ccc2c(c1)ncn2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910988	=	IC50	nM	1540.0	CHEMBL3145	Homo sapiens	IC50	nM	1540.0
	7846780	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	Cc1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910989	=	IC50	nM	289.0	CHEMBL3145	Homo sapiens	IC50	nM	289.0
	7846781	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	FCc1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910990	=	IC50	nM	53.0	CHEMBL3145	Homo sapiens	IC50	nM	53.0
	7846782	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	FC(F)(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910991	=	IC50	nM	461.0	CHEMBL3145	Homo sapiens	IC50	nM	461.0
	7846783	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	OCc1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910992	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7846784	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	CSCc1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910993	=	IC50	nM	39.0	CHEMBL3145	Homo sapiens	IC50	nM	39.0
	7846785	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	C[S+]([O-])Cc1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910994	=	IC50	nM	230.0	CHEMBL3145	Homo sapiens	IC50	nM	230.0
	7846786	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	CS(=O)(=O)Cc1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910995	=	IC50	nM	250.0	CHEMBL3145	Homo sapiens	IC50	nM	250.0
	7846787	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	CSc1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910996	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7846788	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	CS(=O)(=O)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910997	=	IC50	nM	383.0	CHEMBL3145	Homo sapiens	IC50	nM	383.0
	7846789	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	Oc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910998	=	IC50	nM	0.68	CHEMBL3145	Homo sapiens	IC50	nM	0.68
	7846790	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910999	=	IC50	nM	25.0	CHEMBL3145	Homo sapiens	IC50	nM	25.0
	7846791	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	CCOc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911000	=	IC50	nM	104.0	CHEMBL3145	Homo sapiens	IC50	nM	104.0
	7846792	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	CCCOc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1909655	=	IC50	nM	518.0	CHEMBL3145	Homo sapiens	IC50	nM	518.0
	7846793	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	CCCCOc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911001	=	IC50	nM	2400.0	CHEMBL3145	Homo sapiens	IC50	nM	2400.0
	7846794	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	FC(F)Oc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911002	=	IC50	nM	56.0	CHEMBL3145	Homo sapiens	IC50	nM	56.0
	7846795	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	CC(C)Oc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911003	=	IC50	nM	2100.0	CHEMBL3145	Homo sapiens	IC50	nM	2100.0
	7846796	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	CS(=O)(=O)Oc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911004	=	IC50	nM	570.0	CHEMBL3145	Homo sapiens	IC50	nM	570.0
	7846797	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	Nc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911005	=	IC50	nM	41.0	CHEMBL3145	Homo sapiens	IC50	nM	41.0
	7846798	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	CNc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911006	=	IC50	nM	480.0	CHEMBL3145	Homo sapiens	IC50	nM	480.0
	7846799	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	CN(C)c1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911007	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7846800	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	OCc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911008	=	IC50	nM	68.0	CHEMBL3145	Homo sapiens	IC50	nM	68.0
	7846801	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	COC(=O)c1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911009	=	IC50	nM	310.0	CHEMBL3145	Homo sapiens	IC50	nM	310.0
	7846802	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	NC(=O)c1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911010	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7846803	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	CNC(=O)c1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911011	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7846804	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	CN(C)C(=O)c1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911012	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7846805	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	N#Cc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911013	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7846806	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	FC(F)c1nc2c3c(ccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1)OCO3		CHEMBL1911014	=	IC50	nM	47.0	CHEMBL3145	Homo sapiens	IC50	nM	47.0
	7846807	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	COc1ccc2c(nc(C(F)F)n2-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)c1OC		CHEMBL1911015	=	IC50	nM	801.0	CHEMBL3145	Homo sapiens	IC50	nM	801.0
	7846808	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	COc1ccc2c(nc(C(F)F)n2-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)c1O		CHEMBL1911114	=	IC50	nM	6.7	CHEMBL3145	Homo sapiens	IC50	nM	6.7
	7846809	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	COc1c(O)ccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911115	=	IC50	nM	94.0	CHEMBL3145	Homo sapiens	IC50	nM	94.0
	7846810	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	COc1cc(OC)c2nc(C(F)F)n(-c3nc(N4CCOCC4)nc(N4CCOCC4)n3)c2c1		CHEMBL1911116	=	IC50	nM	118.0	CHEMBL3145	Homo sapiens	IC50	nM	118.0
	7846811	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	COc1cc(N)cc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911117	=	IC50	nM	1.4	CHEMBL3145	Homo sapiens	IC50	nM	1.4
	7846812	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	CNc1cc(OC)c2nc(C(F)F)n(-c3nc(N4CCOCC4)nc(N4CCOCC4)n3)c2c1		CHEMBL1911118	=	IC50	nM	0.91	CHEMBL3145	Homo sapiens	IC50	nM	0.91
	7846813	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	COc1cc(N(C)C)cc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911119	=	IC50	nM	18.5	CHEMBL3145	Homo sapiens	IC50	nM	18.5
	7846814	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	COc1cncc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911120	=	IC50	nM	1030.0	CHEMBL3145	Homo sapiens	IC50	nM	1030.0
	7846815	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)cc(N2CCOCC2)n1		CHEMBL1911121	=	IC50	nM	72.0	CHEMBL3145	Homo sapiens	IC50	nM	72.0
	7846816	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	Oc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)cc(N2CCOCC2)n1		CHEMBL1911122	=	IC50	nM	0.81	CHEMBL3145	Homo sapiens	IC50	nM	0.81
	7846817	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)cc(N2CCOCC2)n1		CHEMBL1911123	=	IC50	nM	35.0	CHEMBL3145	Homo sapiens	IC50	nM	35.0
	7846818	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	FC(F)c1nc2ccccc2n1-c1cc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911124	=	IC50	nM	170.0	CHEMBL3145	Homo sapiens	IC50	nM	170.0
	7846819	CHEMBL1914128	Inhibition of human recombinant PI3K p110beta expressed in Sf21 insect cells using phosphatidylinositol as substrate after 1 hr by phosphoimaging	B	COc1cccc2c1nc(C(F)F)n2-c1cc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911125	=	IC50	nM	40.0	CHEMBL3145	Homo sapiens	IC50	nM	40.0
	7846947	CHEMBL1914123	Inhibition of human His-tagged PI3K p110beta after 2 hrs by HTRF assay	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	58.0	CHEMBL3145	Homo sapiens	IC50	nM	58.0
	7846953	CHEMBL1914123	Inhibition of human His-tagged PI3K p110beta after 2 hrs by HTRF assay	B	Oc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910998	=	IC50	nM	3.5	CHEMBL3145	Homo sapiens	IC50	nM	3.5
	7846959	CHEMBL1914123	Inhibition of human His-tagged PI3K p110beta after 2 hrs by HTRF assay	B	FC(F)Oc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911002	>	IC50	nM	2500.0	CHEMBL3145	Homo sapiens	IC50	nM	2500.0
	7846965	CHEMBL1914123	Inhibition of human His-tagged PI3K p110beta after 2 hrs by HTRF assay	B	COc1ccc2c(nc(C(F)F)n2-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)c1O		CHEMBL1911114	=	IC50	nM	44.0	CHEMBL3145	Homo sapiens	IC50	nM	44.0
	7846971	CHEMBL1914123	Inhibition of human His-tagged PI3K p110beta after 2 hrs by HTRF assay	B	COc1cc(N)cc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911117	=	IC50	nM	27.0	CHEMBL3145	Homo sapiens	IC50	nM	27.0
	7922915	CHEMBL1919682	Inhibition of N-terminus polyHis-tagged human recombinant PI3Kbeta expressed in baculovirus infected insect Sf9 cells using phosphoinositol-4,5-bisphosphate as substrate after 1.5 hrs by spectrophotometric analysis	B	O=S(=O)(Nc1cc(-c2ccc3nccc(-c4ccncc4)c3c2)cnc1Cl)c1ccc(F)cc1		CHEMBL1914727	=	IC50	nM	15.0	CHEMBL3145	Homo sapiens	IC50	nM	15.0
	7922916	CHEMBL1919682	Inhibition of N-terminus polyHis-tagged human recombinant PI3Kbeta expressed in baculovirus infected insect Sf9 cells using phosphoinositol-4,5-bisphosphate as substrate after 1.5 hrs by spectrophotometric analysis	B	O=S(=O)(Nc1cc(-c2ccc3nccc(N4CCN(Cc5ccncc5)CC4)c3c2)cnc1Cl)c1ccc(F)cc1		CHEMBL1914724	=	IC50	nM	15.0	CHEMBL3145	Homo sapiens	IC50	nM	15.0
	7922917	CHEMBL1919682	Inhibition of N-terminus polyHis-tagged human recombinant PI3Kbeta expressed in baculovirus infected insect Sf9 cells using phosphoinositol-4,5-bisphosphate as substrate after 1.5 hrs by spectrophotometric analysis	B	CC(C)N1CCN(c2cnc3ccc(-c4cnc(Cl)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc3n2)CC1		CHEMBL1914742	=	IC50	nM	9.6	CHEMBL3145	Homo sapiens	IC50	nM	9.6
	7922918	CHEMBL1919682	Inhibition of N-terminus polyHis-tagged human recombinant PI3Kbeta expressed in baculovirus infected insect Sf9 cells using phosphoinositol-4,5-bisphosphate as substrate after 1.5 hrs by spectrophotometric analysis	B	O=S(=O)(Nc1cc(-c2ccc3ncc(NCCN4CCOCC4)nc3c2)cnc1Cl)c1ccc(F)cc1		CHEMBL1914736	=	IC50	nM	9.8	CHEMBL3145	Homo sapiens	IC50	nM	9.8
	7922919	CHEMBL1919682	Inhibition of N-terminus polyHis-tagged human recombinant PI3Kbeta expressed in baculovirus infected insect Sf9 cells using phosphoinositol-4,5-bisphosphate as substrate after 1.5 hrs by spectrophotometric analysis	B	O=S(=O)(Nc1cc(-c2ccc3nccc(-c4cccnc4)c3c2)cnc1Cl)c1ccc(F)cc1		CHEMBL1914726	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	7922920	CHEMBL1919682	Inhibition of N-terminus polyHis-tagged human recombinant PI3Kbeta expressed in baculovirus infected insect Sf9 cells using phosphoinositol-4,5-bisphosphate as substrate after 1.5 hrs by spectrophotometric analysis	B	O=S(=O)(Nc1cc(-c2ccc3nccc(N4CCOCC4)c3c2)cnc1Cl)c1ccc(F)cc1		CHEMBL1738719	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	nM	13.0
	7922921	CHEMBL1919682	Inhibition of N-terminus polyHis-tagged human recombinant PI3Kbeta expressed in baculovirus infected insect Sf9 cells using phosphoinositol-4,5-bisphosphate as substrate after 1.5 hrs by spectrophotometric analysis	B	O=S(=O)(Nc1cc(-c2ccc3ncc(N4CCOCC4)nc3c2)cnc1Cl)c1ccc(F)cc1		CHEMBL1914743	=	IC50	nM	15.0	CHEMBL3145	Homo sapiens	IC50	nM	15.0
	7947846	CHEMBL1925469	Inhibition of PI3K subunit p110beta assessed as formation of phosphatidylinositide-3-phosphate product formation after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(C(=O)CN)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922090	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
	7947847	CHEMBL1925469	Inhibition of PI3K subunit p110beta assessed as formation of phosphatidylinositide-3-phosphate product formation after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(C(=O)[C@H](C)N)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922091	=	IC50	nM	29.0	CHEMBL3145	Homo sapiens	IC50	nM	29.0
	7947848	CHEMBL1925469	Inhibition of PI3K subunit p110beta assessed as formation of phosphatidylinositide-3-phosphate product formation after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(C(=O)C(C)(C)N)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922092	=	IC50	nM	44.0	CHEMBL3145	Homo sapiens	IC50	nM	44.0
	7947849	CHEMBL1925469	Inhibition of PI3K subunit p110beta assessed as formation of phosphatidylinositide-3-phosphate product formation after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	=	IC50	nM	27.0	CHEMBL3145	Homo sapiens	IC50	nM	27.0
	7947850	CHEMBL1925469	Inhibition of PI3K subunit p110beta assessed as formation of phosphatidylinositide-3-phosphate product formation after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(C(=O)[C@@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1921986	=	IC50	nM	145.0	CHEMBL3145	Homo sapiens	IC50	nM	145.0
	7947851	CHEMBL1925469	Inhibition of PI3K subunit p110beta assessed as formation of phosphatidylinositide-3-phosphate product formation after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(C(=O)C(C)(C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922095	=	IC50	nM	45.0	CHEMBL3145	Homo sapiens	IC50	nM	45.0
	7948543	CHEMBL1925469	Inhibition of PI3K subunit p110beta assessed as formation of phosphatidylinositide-3-phosphate product formation after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(C(=O)CO)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922093	=	IC50	nM	19.0	CHEMBL3145	Homo sapiens	IC50	nM	19.0
	7954354	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	Nc1ncc2cc(-c3cncc(NS(=O)(=O)c4ccccc4)c3)ccc2n1		CHEMBL1922770	=	Activity	%	0.0	CHEMBL3145	Homo sapiens	Activity	%	0.0
	7954355	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	O=S(=O)(Nc1cncc(-c2cnc3[nH]ccc3c2)c1)c1ccccc1		CHEMBL1290550	=	Activity	%	4.9	CHEMBL3145	Homo sapiens	Activity	%	4.9
	7954356	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	O=S(=O)(Nc1cncc(-c2ccc3nccn3c2)c1)c1ccccc1		CHEMBL1765460	=	Activity	%	0.6	CHEMBL3145	Homo sapiens	Activity	%	0.6
	7954357	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	O=S(=O)(Nc1cncc(-c2cnc3nccn3c2)c1)c1ccccc1		CHEMBL1922771	=	Activity	%	39.0	CHEMBL3145	Homo sapiens	Activity	%	39.0
	7954358	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	O=S(=O)(Nc1cncc(-c2cccnc2)c1)c1ccccc1		CHEMBL1922772	=	Activity	%	7.4	CHEMBL3145	Homo sapiens	Activity	%	7.4
	7954359	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	Nc1ncc(-c2cncc(NS(=O)(=O)c3ccccc3)c2)cn1		CHEMBL1922773	=	Activity	%	1.4	CHEMBL3145	Homo sapiens	Activity	%	1.4
	7954360	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	Cc1nc(N)ncc1-c1cncc(NS(=O)(=O)c2ccccc2)c1		CHEMBL1922774	=	Activity	%	5.2	CHEMBL3145	Homo sapiens	Activity	%	5.2
	7954361	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	Cc1nc(N)nc(C)c1-c1cncc(NS(=O)(=O)c2ccccc2)c1		CHEMBL1922775	=	Activity	%	18.0	CHEMBL3145	Homo sapiens	Activity	%	18.0
	7954362	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	CNc1ncc(-c2cncc(NS(=O)(=O)c3ccccc3)c2)cn1		CHEMBL1922776	=	Activity	%	5.2	CHEMBL3145	Homo sapiens	Activity	%	5.2
	7954363	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	CN(C)c1ncc(-c2cncc(NS(=O)(=O)c3ccccc3)c2)cn1		CHEMBL1922777	=	Activity	%	66.0	CHEMBL3145	Homo sapiens	Activity	%	66.0
	7954364	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	CC(=O)Nc1ncc(-c2cncc(NS(=O)(=O)c3ccccc3)c2)cn1		CHEMBL1922778	=	Activity	%	34.0	CHEMBL3145	Homo sapiens	Activity	%	34.0
	7954365	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	Nc1cncc(-c2cnc(N)nc2)c1		CHEMBL1922779	=	Activity	%	86.0	CHEMBL3145	Homo sapiens	Activity	%	86.0
	7954366	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	CC(=O)Nc1cncc(-c2cnc(N)nc2)c1		CHEMBL1922780	=	Activity	%	69.0	CHEMBL3145	Homo sapiens	Activity	%	69.0
	7954367	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	CS(=O)(=O)Nc1cncc(-c2cnc(N)nc2)c1		CHEMBL1922781	=	Activity	%	28.0	CHEMBL3145	Homo sapiens	Activity	%	28.0
	7954368	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	Nc1ncc(-c2cncc(NS(=O)(=O)c3cccc(C(F)(F)F)c3)c2)cn1		CHEMBL1922782	=	Activity	%	1.2	CHEMBL3145	Homo sapiens	Activity	%	1.2
	7954369	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	Nc1ncc(-c2cncc(NS(=O)(=O)c3ccc(F)cc3F)c2)cn1		CHEMBL1922907	=	Activity	%	0.7	CHEMBL3145	Homo sapiens	Activity	%	0.7
	7954370	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	Cc1ccc(S(=O)(=O)Nc2cncc(-c3cnc(N)nc3)c2)cc1[N+](=O)[O-]		CHEMBL1922908	=	Activity	%	0.7	CHEMBL3145	Homo sapiens	Activity	%	0.7
	7954371	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	Cc1ccc(S(=O)(=O)Nc2cncc(-c3cnc(N)nc3)c2)cc1		CHEMBL1922909	=	Activity	%	0.5	CHEMBL3145	Homo sapiens	Activity	%	0.5
	7954372	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	Nc1ncc(-c2cncc(NS(=O)(=O)c3ccc([N+](=O)[O-])cc3)c2)cn1		CHEMBL1922910	=	Activity	%	1.6	CHEMBL3145	Homo sapiens	Activity	%	1.6
	7954373	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	COc1ccc(S(=O)(=O)Nc2cncc(-c3cnc(N)nc3)c2)cc1		CHEMBL1922911	=	Activity	%	1.7	CHEMBL3145	Homo sapiens	Activity	%	1.7
	7954374	CHEMBL1925528	Inhibition of PI3Kbeta assessed as enzyme activity at 10 uM relative to control	B	Nc1ncc(-c2cncc(NS(=O)(=O)c3ccc4ccccc4c3)c2)cn1		CHEMBL1922912	=	Activity	%	1.0	CHEMBL3145	Homo sapiens	Activity	%	1.0
	7954396	CHEMBL1925530	Binding affinity to PI3Kbeta	B	Nc1ncc(-c2cncc(NS(=O)(=O)c3ccccc3)c2)cn1		CHEMBL1922773	=	Kd	nM	360.0	CHEMBL3145	Homo sapiens	Kd	uM	0.36
	7954397	CHEMBL1925530	Binding affinity to PI3Kbeta	B	Nc1cncc(-c2cnc(N)nc2)c1		CHEMBL1922779	>	Kd	nM	40000.0	CHEMBL3145	Homo sapiens	Kd	uM	40.0
	7954398	CHEMBL1925530	Binding affinity to PI3Kbeta	B	CC(=O)Nc1cncc(-c2cnc(N)nc2)c1		CHEMBL1922780	>	Kd	nM	20000.0	CHEMBL3145	Homo sapiens	Kd	uM	20.0
	7954399	CHEMBL1925530	Binding affinity to PI3Kbeta	B	CS(=O)(=O)Nc1cncc(-c2cnc(N)nc2)c1		CHEMBL1922781	=	Kd	nM	5200.0	CHEMBL3145	Homo sapiens	Kd	uM	5.2
	7954400	CHEMBL1925530	Binding affinity to PI3Kbeta	B	Nc1ncc(-c2cncc(NS(=O)(=O)c3cccc(C(F)(F)F)c3)c2)cn1		CHEMBL1922782	=	Kd	nM	430.0	CHEMBL3145	Homo sapiens	Kd	uM	0.43
	7954401	CHEMBL1925530	Binding affinity to PI3Kbeta	B	Nc1ncc(-c2cncc(NS(=O)(=O)c3ccc(F)cc3F)c2)cn1		CHEMBL1922907	=	Kd	nM	220.0	CHEMBL3145	Homo sapiens	Kd	uM	0.22
	7954402	CHEMBL1925530	Binding affinity to PI3Kbeta	B	Cc1ccc(S(=O)(=O)Nc2cncc(-c3cnc(N)nc3)c2)cc1[N+](=O)[O-]		CHEMBL1922908	=	Kd	nM	250.0	CHEMBL3145	Homo sapiens	Kd	uM	0.25
	7954403	CHEMBL1925530	Binding affinity to PI3Kbeta	B	Cc1ccc(S(=O)(=O)Nc2cncc(-c3cnc(N)nc3)c2)cc1		CHEMBL1922909	=	Kd	nM	100.0	CHEMBL3145	Homo sapiens	Kd	uM	0.1
	7954404	CHEMBL1925530	Binding affinity to PI3Kbeta	B	Nc1ncc(-c2cncc(NS(=O)(=O)c3ccc([N+](=O)[O-])cc3)c2)cn1		CHEMBL1922910	=	Kd	nM	550.0	CHEMBL3145	Homo sapiens	Kd	uM	0.55
	7954405	CHEMBL1925530	Binding affinity to PI3Kbeta	B	COc1ccc(S(=O)(=O)Nc2cncc(-c3cnc(N)nc3)c2)cc1		CHEMBL1922911	=	Kd	nM	500.0	CHEMBL3145	Homo sapiens	Kd	uM	0.5
	7954406	CHEMBL1925530	Binding affinity to PI3Kbeta	B	Nc1ncc(-c2cncc(NS(=O)(=O)c3ccc4ccccc4c3)c2)cn1		CHEMBL1922912	=	Kd	nM	230.0	CHEMBL3145	Homo sapiens	Kd	uM	0.23
	7959404	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccccc12		CHEMBL1928522	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	7959405	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2cc(Br)ccc12		CHEMBL1928523	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959406	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2cccc(Br)c12		CHEMBL1928524	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959407	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(Br)cc12		CHEMBL1928525	=	IC50	nM	230.0	CHEMBL3145	Homo sapiens	IC50	nM	230.0
	7959408	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2c(C)cccc12		CHEMBL1928526	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959409	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc2c(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)cnn2c1		CHEMBL1928527	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959410	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2cccc(C)c12		CHEMBL1928528	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959411	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928529	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959412	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CCc1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928530	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959413	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C(F)(F)F)cc12		CHEMBL1928531	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959414	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(-c3ccccc3)cc12		CHEMBL1928532	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959415	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(I)cc12		CHEMBL1926704	=	IC50	nM	370.0	CHEMBL3145	Homo sapiens	IC50	nM	370.0
	7959416	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(Cl)cc12		CHEMBL1928533	=	IC50	nM	390.0	CHEMBL3145	Homo sapiens	IC50	nM	390.0
	7959417	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C3CC3)cc12		CHEMBL1928534	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959418	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	C=Cc1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928535	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959419	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	C#Cc1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928536	=	IC50	nM	30.0	CHEMBL3145	Homo sapiens	IC50	nM	30.0
	7959420	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	COC(=O)c1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928537	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959421	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C(N)=O)cc12		CHEMBL1928538	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959422	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CNC(=O)c1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928539	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959423	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C(=O)N(C)C)cc12		CHEMBL1928540	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959424	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928541	=	IC50	nM	46.0	CHEMBL3145	Homo sapiens	IC50	nM	46.0
	7959425	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2cc(F)c(C#N)cc12		CHEMBL1928542	=	IC50	nM	1800.0	CHEMBL3145	Homo sapiens	IC50	nM	1800.0
	7959426	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	COc1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928543	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959427	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(O)cc12		CHEMBL1928544	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959428	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CC(=O)Oc1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928545	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959429	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928546	=	IC50	nM	620.0	CHEMBL3145	Homo sapiens	IC50	nM	620.0
	7959430	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	C/C(=N\NS(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(C#N)cc12		CHEMBL1928547	=	IC50	nM	410.0	CHEMBL3145	Homo sapiens	IC50	nM	410.0
	7959431	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CC/C(=N\NS(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(C#N)cc12		CHEMBL1928548	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959432	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CCC/C(=N\NS(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(C#N)cc12		CHEMBL1928549	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959433	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	C/C(=N\NS(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(Br)cc12		CHEMBL1928550	=	IC50	nM	480.0	CHEMBL3145	Homo sapiens	IC50	nM	480.0
	7959434	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	C/C(=N\N(C)S(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(C#N)cc12		CHEMBL1928551	=	IC50	nM	600.0	CHEMBL3145	Homo sapiens	IC50	nM	600.0
	7959435	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CC/C(=N\N(C)S(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(C#N)cc12		CHEMBL1928552	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959436	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CCC/C(=N\N(C)S(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(C#N)cc12		CHEMBL1928553	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7959437	CHEMBL1932527	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	C/C(=N\N(C)S(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(Br)cc12		CHEMBL1928554	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7960847	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928541	=	IC50	nM	46.0	CHEMBL3145	Homo sapiens	IC50	nM	46.0
	7960848	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CCN(/N=C/c1cnn2ccc(C#N)cc12)S(=O)(=O)c1cc([N+](=O)[O-])ccc1C		CHEMBL1928555	=	IC50	nM	62.0	CHEMBL3145	Homo sapiens	IC50	nM	62.0
	7960849	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(Cc1ccccc1)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928556	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7960850	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(CCN(C)C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928557	=	IC50	nM	490.0	CHEMBL3145	Homo sapiens	IC50	nM	490.0
	7960851	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CCN(CC)CCN(/N=C/c1cnn2ccc(C#N)cc12)S(=O)(=O)c1cc([N+](=O)[O-])ccc1C		CHEMBL1928558	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7960852	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(CCN1CCOCC1)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928559	=	IC50	nM	230.0	CHEMBL3145	Homo sapiens	IC50	nM	230.0
	7960853	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(CCN1CCCCC1)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928560	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7960854	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(CCO)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928561	=	IC50	nM	51.0	CHEMBL3145	Homo sapiens	IC50	nM	51.0
	7960855	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccccc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928562	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7960856	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1c([N+](=O)[O-])cccc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928563	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7960857	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1cc([N+](=O)[O-])ccc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928564	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7960858	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1cccc([N+](=O)[O-])c1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928565	=	IC50	nM	340.0	CHEMBL3145	Homo sapiens	IC50	nM	340.0
	7960859	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CC(=O)Nc1ccc(C)c(S(=O)(=O)N(C)/N=C/c2cnn3ccc(C#N)cc23)c1		CHEMBL1928566	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7960860	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(NC(=O)C(F)(F)F)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928567	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7960861	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(N)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928568	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7960862	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(C(=O)O)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928569	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7960863	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	COC(=O)c1ccc(C)c(S(=O)(=O)N(C)/N=C/c2cnn3ccc(C#N)cc23)c1		CHEMBL1928570	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7960864	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(C#N)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928571	=	IC50	nM	130.0	CHEMBL3145	Homo sapiens	IC50	nM	130.0
	7960865	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(S(C)(=O)=O)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928572	=	IC50	nM	830.0	CHEMBL3145	Homo sapiens	IC50	nM	830.0
	7960866	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(C(F)(F)F)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928573	=	IC50	nM	60.0	CHEMBL3145	Homo sapiens	IC50	nM	60.0
	7960867	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(C)c(S(=O)(=O)N(C)/N=C/c2cnn3ccc(C#N)cc23)c1		CHEMBL1928717	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	7960868	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(F)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928718	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
	7960869	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(Cl)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928719	=	IC50	nM	360.0	CHEMBL3145	Homo sapiens	IC50	nM	360.0
	7960870	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(Br)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928720	=	IC50	nM	620.0	CHEMBL3145	Homo sapiens	IC50	nM	620.0
	7960871	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CN(/N=C/c1cnn2ccc(C#N)cc12)S(=O)(=O)c1cccc([N+](=O)[O-])c1		CHEMBL1928721	=	IC50	nM	1200.0	CHEMBL3145	Homo sapiens	IC50	nM	1200.0
	7960872	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CCc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928722	=	IC50	nM	280.0	CHEMBL3145	Homo sapiens	IC50	nM	280.0
	7960873	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CC(C)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928723	=	IC50	nM	300.0	CHEMBL3145	Homo sapiens	IC50	nM	300.0
	7960874	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CN(/N=C/c1cnn2ccc(C#N)cc12)S(=O)(=O)c1cc([N+](=O)[O-])ccc1F		CHEMBL1928724	=	IC50	nM	44.0	CHEMBL3145	Homo sapiens	IC50	nM	44.0
	7960875	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CN(/N=C/c1cnn2ccc(C#N)cc12)S(=O)(=O)c1cc([N+](=O)[O-])ccc1Cl		CHEMBL1928725	=	IC50	nM	64.0	CHEMBL3145	Homo sapiens	IC50	nM	64.0
	7960876	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928726	=	IC50	nM	63.0	CHEMBL3145	Homo sapiens	IC50	nM	63.0
	7960877	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CN(C)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928727	=	IC50	nM	44.0	CHEMBL3145	Homo sapiens	IC50	nM	44.0
	7960878	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1C(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928728	=	IC50	nM	68.0	CHEMBL3145	Homo sapiens	IC50	nM	68.0
	7960879	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CN(/N=C/c1cnn2ccc(C#N)cc12)C(=O)c1cccc([N+](=O)[O-])c1		CHEMBL1928729	=	IC50	nM	67.0	CHEMBL3145	Homo sapiens	IC50	nM	67.0
	7960880	CHEMBL1932609	Inhibition of recombinant PI3K p110beta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1CN(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928730	=	IC50	nM	79.0	CHEMBL3145	Homo sapiens	IC50	nM	79.0
	8003516	CHEMBL1942469	Inhibition of human PIK3CB in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL3145	Homo sapiens	INH	%	35.0
	8003517	CHEMBL1942469	Inhibition of human PIK3CB in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL3145	Homo sapiens	INH	%	35.0
	8003518	CHEMBL1942469	Inhibition of human PIK3CB in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL3145	Homo sapiens	INH	%	35.0
	8003519	CHEMBL1942469	Inhibition of human PIK3CB in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL3145	Homo sapiens	INH	%	35.0
	8013121	CHEMBL1948358	Inhibition of PI3Kbeta using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	=	IC50	nM	8600.0	CHEMBL3145	Homo sapiens	IC50	uM	8.6
	8042091	CHEMBL1954958	Inhibition of PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(S(C)(=O)=O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1091978	=	IC50	nM	86.0	CHEMBL3145	Homo sapiens	IC50	nM	86.0
	8042092	CHEMBL1954958	Inhibition of PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cccc5[nH]ncc45)nc3s2)CC1		CHEMBL1949908	=	IC50	nM	332.0	CHEMBL3145	Homo sapiens	IC50	nM	332.0
	8042093	CHEMBL1954958	Inhibition of PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3o2)CC1		CHEMBL1949909	=	IC50	nM	194.0	CHEMBL3145	Homo sapiens	IC50	nM	194.0
	8042094	CHEMBL1954958	Inhibition of PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CS(=O)(=O)N1CCC(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)nc3s2)CC1		CHEMBL1949915	=	IC50	nM	75.0	CHEMBL3145	Homo sapiens	IC50	nM	75.0
	8042095	CHEMBL1954958	Inhibition of PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CNC(=O)c1ccc2c(c1)OCCc1cc(C(=O)N(C)c3ccc(C(=O)N(C)C)cc3Cl)sc1-2		CHEMBL1796761	=	IC50	nM	22.0	CHEMBL3145	Homo sapiens	IC50	nM	22.0
	8042096	CHEMBL1954958	Inhibition of PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CNC(=O)c1ccc2c(c1)OCCc1cc(C(=O)N(C)c3cc(C(=O)N(C)C)ccc3Cl)sc1-2		CHEMBL1796763	=	IC50	nM	204.0	CHEMBL3145	Homo sapiens	IC50	nM	204.0
	8042130	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)nc3s2)CC1		CHEMBL1949910	=	Ki	nM	69.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	69.0
	8042131	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	c1cc(-c2nc(N3CCOCC3)c3ccsc3n2)c2cn[nH]c2c1		CHEMBL1949911	=	Ki	nM	1167.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	1167.0
	8042132	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	Nc1ncc(-c2nc(N3CCOCC3)c3ccsc3n2)cn1		CHEMBL1949912	=	Ki	nM	41.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	41.0
	8042133	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CN1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)nc3s2)CC1		CHEMBL1949913	=	Ki	nM	7.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	7.0
	8042134	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	Nc1ncc(-c2nc(N3CCOCC3)c3cc(CC4CCN(CC(F)(F)F)CC4)sc3n2)cn1		CHEMBL1949914	=	Ki	nM	18.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	18.0
	8042135	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CS(=O)(=O)N1CCC(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)nc3s2)CC1		CHEMBL1949915	=	Ki	nM	25.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	25.0
	8042136	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CS(=O)(=O)C1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)nc3s2)CC1		CHEMBL1949916	=	Ki	nM	42.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	42.0
	8042137	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CN(Cc1cc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc2s1)S(C)(=O)=O		CHEMBL1949917	=	Ki	nM	39.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	39.0
	8042138	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CN(C)C(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)nc3s2)CC1		CHEMBL1949918	=	Ki	nM	108.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	108.0
	8042139	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CS(=O)(=O)c1cccc(-c2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)nc3s2)c1		CHEMBL1949919	=	Ki	nM	43.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	43.0
	8042140	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CN(C(=O)c1cc2c(s1)-c1ccccc1OCC2)c1ccccc1Cl		CHEMBL1796271	=	Ki	nM	272.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	272.0
	8042141	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CN(C(=O)c1cc2c(s1)-c1ccc(-c3ccn[nH]3)cc1OCC2)c1ccccc1Cl		CHEMBL1949920	=	Ki	nM	247.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	247.0
	8042142	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CN(C(=O)c1cc2c(s1)-c1ccc(C#N)cc1OCC2)c1ccccc1Cl		CHEMBL1949921	=	Ki	nM	582.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	582.0
	8042143	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CC(=O)Nc1ccc2c(c1)OCCc1cc(C(=O)N(C)c3ccccc3Cl)sc1-2		CHEMBL1796273	=	Ki	nM	114.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	114.0
	8042144	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CNC(=O)c1ccc2c(c1)OCCc1cc(C(=O)N(C)c3ccccc3Cl)sc1-2		CHEMBL1796276	=	Ki	nM	87.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	87.0
	8042145	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CCNC(=O)c1ccc2c(c1)OCCc1cc(C(=O)N(C)c3ccccc3Cl)sc1-2		CHEMBL1949922	=	Ki	nM	55.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	55.0
	8042146	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CNCc1ccc2c(c1)OCCc1cc(C(=O)N(C)c3ccccc3Cl)sc1-2		CHEMBL1949923	=	Ki	nM	33.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	33.0
	8042147	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CN(C(=O)c1cc2c(s1)-c1ccc(C(=O)NCCN)cc1OCC2)c1ccccc1Cl		CHEMBL1949924	=	Ki	nM	31.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	31.0
	8042148	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CN(C(=O)c1cc2c(s1)-c1ccc(-c3cccc(CC(=O)O)c3)cc1OCC2)c1ccccc1Cl		CHEMBL1949925	=	Ki	nM	2900.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	2900.0
	8042149	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CN(C(=O)c1cc2c(s1)-c1ccc(-c3cccc(CN)c3)cc1OCC2)c1ccccc1Cl		CHEMBL1949926	=	Ki	nM	643.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	643.0
	8042150	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CN(C(=O)c1cc2c(s1)-c1cc(C(N)=O)ccc1OCC2)c1ccccc1Cl		CHEMBL1950034	=	Ki	nM	30.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	30.0
	8042151	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CCNC(=O)c1ccc2c(c1)-c1sc(C(=O)N(C)c3ccccc3Cl)cc1CCO2		CHEMBL1950035	=	Ki	nM	55.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	55.0
	8042152	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CN(C(=O)c1cc2c(s1)-c1cc(C#N)ccc1OCC2)c1ccccc1Cl		CHEMBL1950036	=	Ki	nM	144.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	144.0
	8042153	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CNC(=O)c1ccc2c(c1)OCCc1cc(C(=O)N(C)c3ccc(C(=O)N(C)C)cc3Cl)sc1-2		CHEMBL1796761	=	Ki	nM	19.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	19.0
	8042154	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CNC(=O)c1ccc2c(c1)OCCc1cc(C(=O)N(C)c3cc(C(=O)N(C)C)ccc3Cl)sc1-2		CHEMBL1796763	=	Ki	nM	204.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	204.0
	8042155	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CNC(=O)c1ccc2c(c1)OCCc1cc(C(=O)N(C)c3ccc(C(=O)N4CCN(C)CC4)cc3Cl)sc1-2		CHEMBL1950037	=	Ki	nM	199.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	199.0
	8042156	CHEMBL1954961	Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	CNC(=O)c1ccc2c(c1)OCCc1cc(C(=O)N(C)c3cc(C(=O)N4CCN(C)CC4)ccc3Cl)sc1-2		CHEMBL1950038	=	Ki	nM	3870.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	3870.0
	8047753	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3ccccc3F)ccn12		CHEMBL1957844	=	IC50	nM	400.0	CHEMBL3145	Homo sapiens	IC50	uM	0.4
	8047754	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(F)c3)ccn12		CHEMBL1957845	=	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	uM	0.1
	8047755	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3ccc(F)cc3)ccn12		CHEMBL1957846	=	IC50	nM	250.0	CHEMBL3145	Homo sapiens	IC50	uM	0.25
	8047756	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3ccccc3Cl)ccn12		CHEMBL1957847	=	IC50	nM	80.0	CHEMBL3145	Homo sapiens	IC50	uM	0.08
	8047757	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(Cl)c3)ccn12		CHEMBL1957848	=	IC50	nM	25.0	CHEMBL3145	Homo sapiens	IC50	uM	0.025
	8047758	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3ccc(Cl)cc3)ccn12		CHEMBL1957849	=	IC50	nM	400.0	CHEMBL3145	Homo sapiens	IC50	uM	0.4
	8047759	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	Cc1ccccc1Cn1ccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL1957850	=	IC50	nM	40.0	CHEMBL3145	Homo sapiens	IC50	uM	0.04
	8047760	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	Cc1cccc(Cn2ccn3c(=O)cc(N4CCOCC4)nc23)c1		CHEMBL1957851	=	IC50	nM	63.0	CHEMBL3145	Homo sapiens	IC50	uM	0.063
	8047761	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(C(F)(F)F)c3)ccn12		CHEMBL1957852	=	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	uM	0.1
	8047762	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3ccc(Cl)c(Cl)c3)ccn12		CHEMBL1957853	=	IC50	nM	32.0	CHEMBL3145	Homo sapiens	IC50	uM	0.032
	8047763	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3ccc(F)c(Cl)c3)ccn12		CHEMBL1957854	=	IC50	nM	40.0	CHEMBL3145	Homo sapiens	IC50	uM	0.04
	8047764	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(Cl)c3Cl)ccn12		CHEMBL1957840	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	uM	0.013
	8047765	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc4ccccc34)ccn12		CHEMBL1957841	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	uM	0.003
	8047766	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	Cc1c(Cn2ccn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957855	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	uM	0.003
	8047767	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	Cc1cn2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL1957856	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	uM	0.002
	8047768	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	Cc1c(Cn2c(C)cn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957857	=	IC50	nM	1.0	CHEMBL3145	Homo sapiens	IC50	uM	0.001
	8047769	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	CCc1cn2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(C(F)(F)F)c1C		CHEMBL1957858	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	uM	0.002
	8047770	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(Cl)c3Cl)c3ccccc3n12		CHEMBL1957859	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	uM	0.008
	8047771	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	Cc1c(C)n2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL1957860	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	uM	0.013
	8047772	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	Cc1c(Cn2c(C)c(C)n3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957861	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	uM	0.006
	8047773	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc4ccccc34)c3ccccc3n12		CHEMBL1957862	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	uM	0.004
	8047774	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	Cc1c(Cn2c3ccccc3n3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957863	=	IC50	nM	32.0	CHEMBL3145	Homo sapiens	IC50	uM	0.032
	8047775	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1c(F)c(N2CCOCC2)nc2n(Cc3cccc(Cl)c3Cl)ccn12		CHEMBL1957864	=	IC50	nM	25.0	CHEMBL3145	Homo sapiens	IC50	uM	0.025
	8047776	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1nc(N2CCOCC2)cc2n(Cc3cccc(Cl)c3Cl)ccn12		CHEMBL1955886	=	IC50	nM	79.0	CHEMBL3145	Homo sapiens	IC50	uM	0.079
	8047777	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	Cc1c(Cn2ccn3c(=O)nc(N4CCOCC4)cc23)cccc1C(F)(F)F		CHEMBL1957865	=	IC50	nM	32.0	CHEMBL3145	Homo sapiens	IC50	uM	0.032
	8047778	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	CC1CN(c2cc(=O)n3ccn(Cc4cccc(Cl)c4Cl)c3n2)CCO1		CHEMBL1957866	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	uM	0.013
	8047779	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	CC1CN(c2cc(=O)n3ccn(Cc4cccc(Cl)c4Cl)c3n2)CCO1		CHEMBL1957866	=	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	uM	0.1
	8047780	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	CC1CN(c2cc(=O)n3ccn(Cc4cccc(Cl)c4Cl)c3n2)CCO1		CHEMBL1957866	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	uM	0.002
	8047781	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	CC1(C)CN(c2cc(=O)n3ccn(Cc4cccc(Cl)c4Cl)c3n2)CCO1		CHEMBL1957867	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	8047782	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	Cc1c(Cn2ccn3c(=O)cc(N4CCOC(C)C4)nc23)cccc1C(F)(F)F		CHEMBL1957868	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	uM	0.006
	8047783	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	Cc1c(Cn2ccn3c(=O)cc(N4CCO[C@@H](C)C4)nc23)cccc1C(F)(F)F		CHEMBL1957869	=	IC50	nM	25.0	CHEMBL3145	Homo sapiens	IC50	uM	0.025
	8047784	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	Cc1c(Cn2ccn3c(=O)cc(N4CCO[C@H](C)C4)nc23)cccc1C(F)(F)F		CHEMBL1957870	=	IC50	nM	1.0	CHEMBL3145	Homo sapiens	IC50	uM	0.001
	8047785	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOC(CO)C2)nc2n(Cc3cccc(Cl)c3Cl)ccn12		CHEMBL1957871	=	IC50	nM	20.0	CHEMBL3145	Homo sapiens	IC50	uM	0.02
	8047786	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	Cc1c(Cn2ccn3c(=O)cc(C4=CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957872	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	uM	0.013
	8047787	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	Cc1c(Cn2ccn3c(=O)cc(C4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957873	=	IC50	nM	320.0	CHEMBL3145	Homo sapiens	IC50	uM	0.32
	8047788	CHEMBL1958672	Inhibition of PI3Kbeta by time-resolved FRET displacement assay	B	O=c1cc(N2CCSCC2)nc2n(Cc3cccc(Cl)c3Cl)ccn12		CHEMBL1957874	=	IC50	nM	2000.0	CHEMBL3145	Homo sapiens	IC50	uM	2.0
	8047859	CHEMBL1958675	Inhibition of PI3Kbeta-mediated AKT SER473 phosphorylation in human MDA-MB-468 cells after 30 mins	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(Cl)c3Cl)ccn12		CHEMBL1957840	=	IC50	nM	110.0	CHEMBL3145	Homo sapiens	IC50	uM	0.11
	8047860	CHEMBL1958675	Inhibition of PI3Kbeta-mediated AKT SER473 phosphorylation in human MDA-MB-468 cells after 30 mins	B	Cc1c(Cn2ccn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957855	=	IC50	nM	90.0	CHEMBL3145	Homo sapiens	IC50	uM	0.09
	8047861	CHEMBL1958675	Inhibition of PI3Kbeta-mediated AKT SER473 phosphorylation in human MDA-MB-468 cells after 30 mins	B	Cc1c(Cn2c(C)cn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957857	=	IC50	nM	78.0	CHEMBL3145	Homo sapiens	IC50	uM	0.078
	8047862	CHEMBL1958675	Inhibition of PI3Kbeta-mediated AKT SER473 phosphorylation in human MDA-MB-468 cells after 30 mins	B	Cc1c(Cn2ccn3c(=O)cc(N4CCO[C@H](C)C4)nc23)cccc1C(F)(F)F		CHEMBL1957870	=	IC50	nM	190.0	CHEMBL3145	Homo sapiens	IC50	uM	0.19
	8047867	CHEMBL1958670	Inhibition of PI3Kbeta	B	Cc1cc([C@@H](C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1957875	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	uM	0.006
	8047868	CHEMBL1958670	Inhibition of PI3Kbeta	B	Cc1cc([C@H](C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1957876	=	IC50	nM	800.0	CHEMBL3145	Homo sapiens	IC50	uM	0.8
	8056176	CHEMBL1960283	Inhibition of recombinant PI3Kbeta HTRF assay	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	44.0	CHEMBL3145	Homo sapiens	IC50	nM	44.0
	10849269	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1c(Cn2c(C)cn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957857	=	IC50	nM	1.3	CHEMBL3145	Homo sapiens	IC50	uM	0.0013
	10849271	CHEMBL2019377	Inhibition of PI3K beta-mediated AKT phosphorylation at serine 473 in PTEN deficient human MDA-MB-468 cells after 30 mins	B	Cc1c(Cn2c(C)cn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957857	=	IC50	nM	78.0	CHEMBL3145	Homo sapiens	IC50	uM	0.078
	10849275	CHEMBL2019381	Inhibition of PI3K beta-mediated AKT phosphorylation at serine 473 in PTEN wild type human HCC1954 cells	B	Cc1c(Cn2c(C)cn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957857	>	IC50	nM	29000.0	CHEMBL3145	Homo sapiens	IC50	uM	29.0
	10849278	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1nn2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2018214	=	IC50	nM	1.3	CHEMBL3145	Homo sapiens	IC50	uM	0.0013
	10849281	CHEMBL2019377	Inhibition of PI3K beta-mediated AKT phosphorylation at serine 473 in PTEN deficient human MDA-MB-468 cells after 30 mins	B	Cc1nn2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2018214	=	IC50	nM	34.0	CHEMBL3145	Homo sapiens	IC50	uM	0.034
	10849284	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	CSc1nn2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2018215	=	IC50	nM	1.6	CHEMBL3145	Homo sapiens	IC50	uM	0.0016
	10849287	CHEMBL2019377	Inhibition of PI3K beta-mediated AKT phosphorylation at serine 473 in PTEN deficient human MDA-MB-468 cells after 30 mins	B	CSc1nn2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2018215	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	uM	0.013
	10849290	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(Cl)c3Cl)c(C3CC3)nn12		CHEMBL2018216	=	IC50	nM	2.5	CHEMBL3145	Homo sapiens	IC50	uM	0.0025
	10849293	CHEMBL2019377	Inhibition of PI3K beta-mediated AKT phosphorylation at serine 473 in PTEN deficient human MDA-MB-468 cells after 30 mins	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(Cl)c3Cl)c(C3CC3)nn12		CHEMBL2018216	=	IC50	nM	20.0	CHEMBL3145	Homo sapiens	IC50	uM	0.02
	10849296	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1nn2c(=O)cc(N3CCOC(C)C3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2018217	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	uM	0.002
	10849300	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	CSc1nn2c(=O)cc(-c3ccncc3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2018218	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	uM	0.013
	10849304	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1c(Cn2c(C)nn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL2018219	=	IC50	nM	0.6	CHEMBL3145	Homo sapiens	IC50	uM	0.0006
	10849307	CHEMBL2019377	Inhibition of PI3K beta-mediated AKT phosphorylation at serine 473 in PTEN deficient human MDA-MB-468 cells after 30 mins	B	Cc1c(Cn2c(C)nn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL2018219	=	IC50	nM	1.5	CHEMBL3145	Homo sapiens	IC50	uM	0.0015
	10849311	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	CSc1nn2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(C(F)(F)F)c1C		CHEMBL2018220	=	IC50	nM	0.4	CHEMBL3145	Homo sapiens	IC50	uM	0.0004
	10849314	CHEMBL2019377	Inhibition of PI3K beta-mediated AKT phosphorylation at serine 473 in PTEN deficient human MDA-MB-468 cells after 30 mins	B	CSc1nn2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(C(F)(F)F)c1C		CHEMBL2018220	=	IC50	nM	5.1	CHEMBL3145	Homo sapiens	IC50	uM	0.0051
	10849317	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1c(Cn2c(C3CC3)nn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL2018221	=	IC50	nM	1.3	CHEMBL3145	Homo sapiens	IC50	uM	0.0013
	10849320	CHEMBL2019377	Inhibition of PI3K beta-mediated AKT phosphorylation at serine 473 in PTEN deficient human MDA-MB-468 cells after 30 mins	B	Cc1c(Cn2c(C3CC3)nn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL2018221	=	IC50	nM	4.1	CHEMBL3145	Homo sapiens	IC50	uM	0.0041
	10849323	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1c(Cn2c(C)nn3c(=O)cc(N4CCOC(C)C4)nc23)cccc1C(F)(F)F		CHEMBL2018222	=	IC50	nM	1.3	CHEMBL3145	Homo sapiens	IC50	uM	0.0013
	10849326	CHEMBL2019377	Inhibition of PI3K beta-mediated AKT phosphorylation at serine 473 in PTEN deficient human MDA-MB-468 cells after 30 mins	B	Cc1c(Cn2c(C)nn3c(=O)cc(N4CCOC(C)C4)nc23)cccc1C(F)(F)F		CHEMBL2018222	=	IC50	nM	2.7	CHEMBL3145	Homo sapiens	IC50	uM	0.0027
	10849329	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	CSc1nn2c(=O)cc(N3CCOC(C)C3)nc2n1Cc1cccc(C(F)(F)F)c1C		CHEMBL2018360	=	IC50	nM	1.0	CHEMBL3145	Homo sapiens	IC50	uM	0.001
	10849332	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1c(Cn2c(C)nn3c(=O)nc(N4CCOCC4)cc23)cccc1C(F)(F)F		CHEMBL2018361	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	uM	0.002
	10849333	CHEMBL2019377	Inhibition of PI3K beta-mediated AKT phosphorylation at serine 473 in PTEN deficient human MDA-MB-468 cells after 30 mins	B	Cc1c(Cn2c(C)nn3c(=O)nc(N4CCOCC4)cc23)cccc1C(F)(F)F		CHEMBL2018361	=	IC50	nM	92.0	CHEMBL3145	Homo sapiens	IC50	uM	0.092
	10849337	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1c(Cn2c(C)nn3c(=O)cc(N4CCOC(C)C4)nc23)cccc1C(F)(F)F		CHEMBL2018222	=	IC50	nM	3.1	CHEMBL3145	Homo sapiens	IC50	uM	0.0031
	10849340	CHEMBL2019377	Inhibition of PI3K beta-mediated AKT phosphorylation at serine 473 in PTEN deficient human MDA-MB-468 cells after 30 mins	B	Cc1c(Cn2c(C)nn3c(=O)cc(N4CCOC(C)C4)nc23)cccc1C(F)(F)F		CHEMBL2018222	=	IC50	nM	7.9	CHEMBL3145	Homo sapiens	IC50	uM	0.0079
	10849343	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1c(Cn2c(C)nn3c(=O)cc(N4CCOC(C)C4)nc23)cccc1C(F)(F)F		CHEMBL2018222	=	IC50	nM	0.3	CHEMBL3145	Homo sapiens	IC50	uM	0.0003
	10849347	CHEMBL2019377	Inhibition of PI3K beta-mediated AKT phosphorylation at serine 473 in PTEN deficient human MDA-MB-468 cells after 30 mins	B	Cc1c(Cn2c(C)nn3c(=O)cc(N4CCOC(C)C4)nc23)cccc1C(F)(F)F		CHEMBL2018222	=	IC50	nM	0.5	CHEMBL3145	Homo sapiens	IC50	uM	0.0005
	10849351	CHEMBL2019381	Inhibition of PI3K beta-mediated AKT phosphorylation at serine 473 in PTEN wild type human HCC1954 cells	B	Cc1c(Cn2c(C)nn3c(=O)cc(N4CCOC(C)C4)nc23)cccc1C(F)(F)F		CHEMBL2018222	=	IC50	nM	2500.0	CHEMBL3145	Homo sapiens	IC50	uM	2.5
	10849356	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1nn2c(=O)cc(N3CCOC(C)C3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2018217	=	IC50	nM	25.0	CHEMBL3145	Homo sapiens	IC50	uM	0.025
	10849360	CHEMBL2019373	Inhibition of PI3Kbeta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1nn2c(=O)cc(N3CCOC(C)C3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2018217	=	IC50	nM	1.3	CHEMBL3145	Homo sapiens	IC50	uM	0.0013
	10849363	CHEMBL2019377	Inhibition of PI3K beta-mediated AKT phosphorylation at serine 473 in PTEN deficient human MDA-MB-468 cells after 30 mins	B	Cc1nn2c(=O)cc(N3CCOC(C)C3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2018217	=	IC50	nM	3.4	CHEMBL3145	Homo sapiens	IC50	uM	0.0034
	10852413	CHEMBL2020173	Inhibition of PI3K p110beta subunit using [gamma33P]ATP by filter binding assay	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	=	IC50	nM	166.0	CHEMBL3145	Homo sapiens	IC50	uM	0.166
	10860020	CHEMBL2021235	Inhibition of human wild type PI3Kbeta expressed in Sf21 cells co-expressing N-terminal His-tagged human p85a using L-alpha-phosphatidylinositol substrate by TLC based phosphor imaging	B	COc1ccc(-c2nnc(SCc3cccc(Cl)c3)o2)c(O)c1		CHEMBL2018263	=	IC50	nM	43670.0	CHEMBL3145	Homo sapiens	IC50	uM	43.67
	10860021	CHEMBL2021235	Inhibition of human wild type PI3Kbeta expressed in Sf21 cells co-expressing N-terminal His-tagged human p85a using L-alpha-phosphatidylinositol substrate by TLC based phosphor imaging	B	COc1ccc(-c2nnc(SCc3ccccc3F)o2)c(O)c1		CHEMBL2018265	=	IC50	nM	51750.0	CHEMBL3145	Homo sapiens	IC50	uM	51.75
	10860022	CHEMBL2021235	Inhibition of human wild type PI3Kbeta expressed in Sf21 cells co-expressing N-terminal His-tagged human p85a using L-alpha-phosphatidylinositol substrate by TLC based phosphor imaging	B	COc1ccc(-c2nnc(SCc3ccc(F)cc3)o2)c(O)c1		CHEMBL2018266	>	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	10860023	CHEMBL2021235	Inhibition of human wild type PI3Kbeta expressed in Sf21 cells co-expressing N-terminal His-tagged human p85a using L-alpha-phosphatidylinositol substrate by TLC based phosphor imaging	B	COc1ccc(-c2nnc(SCc3cccc([N+](=O)[O-])c3)o2)c(O)c1		CHEMBL2018271	>	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	10860024	CHEMBL2021235	Inhibition of human wild type PI3Kbeta expressed in Sf21 cells co-expressing N-terminal His-tagged human p85a using L-alpha-phosphatidylinositol substrate by TLC based phosphor imaging	B	COc1cccc(CSc2nnc(-c3ccc(C)cc3O)o2)c1		CHEMBL2018409	=	IC50	nM	13620.0	CHEMBL3145	Homo sapiens	IC50	uM	13.62
	10860025	CHEMBL2021235	Inhibition of human wild type PI3Kbeta expressed in Sf21 cells co-expressing N-terminal His-tagged human p85a using L-alpha-phosphatidylinositol substrate by TLC based phosphor imaging	B	Cc1ccc(-c2nnc(SCc3ccc([N+](=O)[O-])cc3)o2)c(O)c1		CHEMBL2018413	>	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	10860026	CHEMBL2021235	Inhibition of human wild type PI3Kbeta expressed in Sf21 cells co-expressing N-terminal His-tagged human p85a using L-alpha-phosphatidylinositol substrate by TLC based phosphor imaging	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	970.0	CHEMBL3145	Homo sapiens	IC50	uM	0.97
	10886520	CHEMBL2033425	Inhibition of PIK3-CB in human HEK293 cells after 1 hr by competition binding assay	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	10000.0	CHEMBL3145	Homo sapiens	Kd	nM	10000.0
Not Determined	10957616	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CC(=O)Nc1nc2ccc(-c3cncc(S(C)(=O)=O)c3)cn2n1		CHEMBL2059907		pIC50			CHEMBL3145	Homo sapiens	pIC50		
	10957617	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CS(=O)(=O)c1cncc(-c2ccc3nc(N)nn3c2)c1		CHEMBL2059908	=	IC50	nM	2511.89	CHEMBL3145	Homo sapiens	pIC50		5.6
	10957618	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(N)nn3c2)c1		CHEMBL2059909	=	IC50	nM	199.53	CHEMBL3145	Homo sapiens	pIC50		6.7
	10957619	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CNC(=O)Nc1nc2ccc(-c3cncc(S(=O)(=O)NC(C)(C)C)c3)cn2n1		CHEMBL2059910	=	IC50	nM	398.11	CHEMBL3145	Homo sapiens	pIC50		6.4
	10957620	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)N4CCOCC4)nn3c2)c1		CHEMBL2059911	=	IC50	nM	3981.07	CHEMBL3145	Homo sapiens	pIC50		5.4
	10957621	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CN(C)CCNC(=O)Nc1nc2ccc(-c3cncc(S(=O)(=O)NC(C)(C)C)c3)cn2n1		CHEMBL2059912	<	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
	10957622	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)nn3c2)c1		CHEMBL2059913	<	IC50	nM	199.53	CHEMBL3145	Homo sapiens	pIC50		6.7
	10957623	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)Nc4ccccc4)nn3c2)c1		CHEMBL2057359	<	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	pIC50		4.0
	10957624	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCc4ccccc4)nn3c2)c1		CHEMBL2057360	=	IC50	nM	3162.28	CHEMBL3145	Homo sapiens	pIC50		5.5
	10957625	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCCc4ccccc4)nn3c2)c1		CHEMBL2057361	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
	10957626	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	Cc1noc(C)c1CCNC(=O)Nc1nc2ccc(-c3cncc(S(=O)(=O)NC(C)(C)C)c3)cn2n1		CHEMBL2057362	=	IC50	nM	79.43	CHEMBL3145	Homo sapiens	pIC50		7.1
	10957627	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CN(C)C(=O)CNC(=O)Nc1nc2ccc(-c3cncc(S(=O)(=O)NC(C)(C)C)c3)cn2n1		CHEMBL2057363	=	IC50	nM	1258.93	CHEMBL3145	Homo sapiens	pIC50		5.9
	10957628	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCCn4cccn4)nn3c2)c1		CHEMBL2057364	=	IC50	nM	630.96	CHEMBL3145	Homo sapiens	pIC50		6.2
	10957629	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	Cc1nc(CCNC(=O)Nc2nc3ccc(-c4cncc(S(=O)(=O)NC(C)(C)C)c4)cn3n2)cs1		CHEMBL2057365	<	IC50	nM	199.53	CHEMBL3145	Homo sapiens	pIC50		6.7
	10957630	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCCc4cnccn4)nn3c2)c1		CHEMBL2057366	=	IC50	nM	125.89	CHEMBL3145	Homo sapiens	pIC50		6.9
	10957631	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCCc4nnc(C5CC5)o4)nn3c2)c1		CHEMBL2057367	=	IC50	nM	251.19	CHEMBL3145	Homo sapiens	pIC50		6.6
	10957632	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCCn4nnc(C5CC5)n4)nn3c2)c1		CHEMBL2057368	=	IC50	nM	63.1	CHEMBL3145	Homo sapiens	pIC50		7.2
	10957633	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCCCn4nnc(C5CC5)n4)nn3c2)c1		CHEMBL2057369	=	IC50	nM	2511.89	CHEMBL3145	Homo sapiens	pIC50		5.6
	10957634	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CNC(=O)CNC(=O)Nc1nc2ccc(-c3cncc(S(=O)(=O)NC(C)(C)C)c3)cn2n1		CHEMBL2057370	<	IC50	nM	1995.26	CHEMBL3145	Homo sapiens	pIC50		5.7
	10957635	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCC(=O)N4CCCC4)nn3c2)c1		CHEMBL2057371	=	IC50	nM	1258.93	CHEMBL3145	Homo sapiens	pIC50		5.9
	10957636	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCC(=O)N4CCOCC4)nn3c2)c1		CHEMBL2057372	=	IC50	nM	398.11	CHEMBL3145	Homo sapiens	pIC50		6.4
	10957637	CHEMBL2062044	Inhibition of PI3Kbeta in human HL60 cell lysate by kinobead assay	B	CN1CCN(C(=O)CNC(=O)Nc2nc3ccc(-c4cncc(S(=O)(=O)NC(C)(C)C)c4)cn3n2)CC1		CHEMBL2057373	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
Active	10957665	CHEMBL2062050	Inhibition of PI3Kbeta at 1 uM	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCC(=O)N4CCOCC4)nn3c2)c1		CHEMBL2057372		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	10960503	CHEMBL2060303	Inhibition of human PI3Kbeta by HTRF assay	B	COCCNC(=O)c1nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)cn2c1C		CHEMBL2058172	=	Ki	nM	94.1	CHEMBL3145	Homo sapiens	Ki(app)	nM	94.1
	10968630	CHEMBL2065221	Inhibition of PI3Kbeta by high throughput chemoproteomics binding assay	B	COc1ccccc1-c1ccc2nc(NC(C)=O)nn2c1		CHEMBL2064478	<	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	pIC50		4.0
	10968631	CHEMBL2065221	Inhibition of PI3Kbeta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3cc(C)c(O)c(C)c3)cn2n1		CHEMBL2064479	=	IC50	nM	19952.62	CHEMBL3145	Homo sapiens	pIC50		4.7
	10968632	CHEMBL2065221	Inhibition of PI3Kbeta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2c(C)cc(-c3cncc(S(C)(=O)=O)c3)cn2n1		CHEMBL2064514	=	IC50	nM	19952.62	CHEMBL3145	Homo sapiens	pIC50		4.7
	10968633	CHEMBL2065221	Inhibition of PI3Kbeta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2cc(C)c(-c3cncc(S(C)(=O)=O)c3)cn2n1	Outside typical range	CHEMBL2064566	=	IC50	nM	199526.23	CHEMBL3145	Homo sapiens	pIC50		3.7
	10968634	CHEMBL2065221	Inhibition of PI3Kbeta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3cncc(S(C)(=O)=O)c3)c(C)n2n1		CHEMBL2064567	=	IC50	nM	25118.86	CHEMBL3145	Homo sapiens	pIC50		4.6
	10968635	CHEMBL2065221	Inhibition of PI3Kbeta by high throughput chemoproteomics binding assay	B	CS(=O)(=O)c1cncc(-c2cc(Cl)c3nc(N)nn3c2)c1		CHEMBL2064569	<	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	pIC50		4.0
	10968636	CHEMBL2065221	Inhibition of PI3Kbeta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2c(F)cc(-c3cncc(S(C)(=O)=O)c3)cn2n1		CHEMBL2064570	=	IC50	nM	19952.62	CHEMBL3145	Homo sapiens	pIC50		4.7
	10968637	CHEMBL2065221	Inhibition of PI3Kbeta by high throughput chemoproteomics binding assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2cc(F)c3nc(N)nn3c2)c1		CHEMBL2064571	=	IC50	nM	1258.93	CHEMBL3145	Homo sapiens	pIC50		5.9
	10968638	CHEMBL2065221	Inhibition of PI3Kbeta by high throughput chemoproteomics binding assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2cn3nc(N)nc3cc2F)c1		CHEMBL2064572	<	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	pIC50		4.0
	10975395	CHEMBL2067908	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at T308 residue expressed in PTEN-deficient human PC3 cells after 2 hrs by Western blot analysis	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
	10975396	CHEMBL2067908	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at T308 residue expressed in PTEN-deficient human PC3 cells after 2 hrs by Western blot analysis	B	Cc1cc(C(C)Nc2ccccc2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL2064328	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
	10975397	CHEMBL2067908	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at T308 residue expressed in PTEN-deficient human PC3 cells after 2 hrs by Western blot analysis	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(F)ccc3[nH]2)[nH]1		CHEMBL2064331	=	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
	10975398	CHEMBL2067908	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at T308 residue expressed in PTEN-deficient human PC3 cells after 2 hrs by Western blot analysis	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccccc21		CHEMBL2064330	=	IC50	nM	188.0	CHEMBL3145	Homo sapiens	IC50	nM	188.0
	10975528	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	30.0	CHEMBL3145	Homo sapiens	IC50	nM	30.0
	10975529	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cc1cc(F)ccc1Oc1cccc2c(=O)cc(N3CCOCC3)[nH]c12		CHEMBL2064327	=	IC50	nM	32.0	CHEMBL3145	Homo sapiens	IC50	nM	32.0
	10975530	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cc1cc(C(C)Nc2ccccc2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL2064328	=	IC50	nM	28.0	CHEMBL3145	Homo sapiens	IC50	nM	28.0
	10975531	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4ccccc4)c(F)ccc3o2)[nH]1		CHEMBL2064417	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	nM	8.0
	10975532	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4ccncc4)cccc3o2)[nH]1		CHEMBL2064416	=	IC50	nM	158.0	CHEMBL3145	Homo sapiens	IC50	nM	158.0
	10975533	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4cccnc4)cccc3o2)[nH]1		CHEMBL2064415	=	IC50	nM	156.0	CHEMBL3145	Homo sapiens	IC50	nM	156.0
	10975534	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4ccccn4)cccc3o2)[nH]1		CHEMBL2064414	=	IC50	nM	336.0	CHEMBL3145	Homo sapiens	IC50	nM	336.0
	10975535	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4cccs4)cccc3o2)[nH]1		CHEMBL2064413	=	IC50	nM	46.0	CHEMBL3145	Homo sapiens	IC50	nM	46.0
	10975536	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cccc(-c4ccccc4)c3o2)[nH]1		CHEMBL2064412	=	IC50	nM	90.0	CHEMBL3145	Homo sapiens	IC50	nM	90.0
	10975537	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4ccccc4)cccc3o2)[nH]1		CHEMBL2064411	=	IC50	nM	19.0	CHEMBL3145	Homo sapiens	IC50	nM	19.0
	10975538	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(Br)cccc3o2)[nH]1		CHEMBL2064410	=	IC50	nM	585.0	CHEMBL3145	Homo sapiens	IC50	nM	585.0
	10975539	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cc1cccc2nc(Cc3nc(N4CCOCC4)cc(=O)[nH]3)oc12		CHEMBL2064409	=	IC50	nM	425.0	CHEMBL3145	Homo sapiens	IC50	nM	425.0
	10975540	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cc1ccc2nc(Cc3nc(N4CCOCC4)cc(=O)[nH]3)oc2c1		CHEMBL2064408	=	IC50	nM	526.0	CHEMBL3145	Homo sapiens	IC50	nM	526.0
	10975541	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cc1ccc2oc(Cc3nc(N4CCOCC4)cc(=O)[nH]3)nc2c1		CHEMBL2064407	=	IC50	nM	960.0	CHEMBL3145	Homo sapiens	IC50	nM	960.0
	10975542	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cc1cccc2oc(Cc3nc(N4CCOCC4)cc(=O)[nH]3)nc12		CHEMBL2064406	=	IC50	nM	461.0	CHEMBL3145	Homo sapiens	IC50	nM	461.0
	10975543	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc3ccccc3o2)nc(N2CCOCC2)cc1=O		CHEMBL2064405	=	IC50	nM	1333.0	CHEMBL3145	Homo sapiens	IC50	nM	1333.0
	10975544	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cccc(F)c3o2)[nH]1		CHEMBL2064354	=	IC50	nM	373.0	CHEMBL3145	Homo sapiens	IC50	nM	373.0
	10975545	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccc(F)cc3o2)[nH]1		CHEMBL2064353	=	IC50	nM	126.0	CHEMBL3145	Homo sapiens	IC50	nM	126.0
	10975546	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(F)ccc3o2)[nH]1		CHEMBL2064352	=	IC50	nM	46.0	CHEMBL3145	Homo sapiens	IC50	nM	46.0
	10975547	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(F)cccc3o2)[nH]1		CHEMBL2064351	=	IC50	nM	567.0	CHEMBL3145	Homo sapiens	IC50	nM	567.0
	10975548	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccc(-c3ccccc3)cc21		CHEMBL2064350	=	IC50	nM	3410.0	CHEMBL3145	Homo sapiens	IC50	nM	3410.0
	10975549	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2cc(-c3ccccc3)ccc21		CHEMBL2064349	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	10975550	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2cccc(-c3ccccc3)c21		CHEMBL2064348	=	IC50	nM	60.0	CHEMBL3145	Homo sapiens	IC50	nM	60.0
	10975551	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2c(-c3ccccc3)cccc21		CHEMBL2064347	=	IC50	nM	57.0	CHEMBL3145	Homo sapiens	IC50	nM	57.0
	10975552	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4ccccc4)cccc3[nH]2)[nH]1		CHEMBL2064346	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	10975553	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccccc3n2Cc2ccccc2)[nH]1		CHEMBL2064345	=	IC50	nM	111.0	CHEMBL3145	Homo sapiens	IC50	nM	111.0
	10975554	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccccc3n2-c2ccccc2)[nH]1		CHEMBL2064344	=	IC50	nM	75.0	CHEMBL3145	Homo sapiens	IC50	nM	75.0
	10975555	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccccc3n2C2CCCCC2)[nH]1		CHEMBL2064343	=	IC50	nM	90.0	CHEMBL3145	Homo sapiens	IC50	nM	90.0
	10975556	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	COCCn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2cc(F)ccc21		CHEMBL2064342	=	IC50	nM	205.0	CHEMBL3145	Homo sapiens	IC50	nM	205.0
	10975557	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(F)ccc3n2C2CC2)[nH]1		CHEMBL2064341	=	IC50	nM	29.0	CHEMBL3145	Homo sapiens	IC50	nM	29.0
	10975558	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	CCn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccccc21		CHEMBL2064340	=	IC50	nM	72.0	CHEMBL3145	Homo sapiens	IC50	nM	72.0
	10975559	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(C(F)(F)F)ccc3[nH]2)[nH]1		CHEMBL2064339	=	IC50	nM	386.0	CHEMBL3145	Homo sapiens	IC50	nM	386.0
	10975560	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	COc1ccc2[nH]c(Cc3nc(N4CCOCC4)cc(=O)[nH]3)nc2c1		CHEMBL2064338	=	IC50	nM	193.0	CHEMBL3145	Homo sapiens	IC50	nM	193.0
	10975561	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cc1ccc2[nH]c(Cc3nc(N4CCOCC4)cc(=O)[nH]3)nc2c1		CHEMBL2064337	=	IC50	nM	450.0	CHEMBL3145	Homo sapiens	IC50	nM	450.0
	10975562	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(Cl)ccc3[nH]2)[nH]1		CHEMBL2064336	=	IC50	nM	99.0	CHEMBL3145	Homo sapiens	IC50	nM	99.0
	10975563	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(Br)ccc3[nH]2)[nH]1		CHEMBL2064335	=	IC50	nM	91.0	CHEMBL3145	Homo sapiens	IC50	nM	91.0
	10975564	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccc(F)cc21		CHEMBL2064334	=	IC50	nM	290.0	CHEMBL3145	Homo sapiens	IC50	nM	290.0
	10975565	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2cc(F)ccc21		CHEMBL2064333	=	IC50	nM	82.0	CHEMBL3145	Homo sapiens	IC50	nM	82.0
	10975566	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc3cc(F)ccc3[nH]2)nc(N2CCOCC2)cc1=O		CHEMBL2064332	=	IC50	nM	739.0	CHEMBL3145	Homo sapiens	IC50	nM	739.0
	10975567	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(F)ccc3[nH]2)[nH]1		CHEMBL2064331	=	IC50	nM	30.0	CHEMBL3145	Homo sapiens	IC50	nM	30.0
	10975568	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccccc21		CHEMBL2064330	=	IC50	nM	99.0	CHEMBL3145	Homo sapiens	IC50	nM	99.0
	10975569	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccccc3o2)[nH]1		CHEMBL2064418	=	IC50	nM	82.0	CHEMBL3145	Homo sapiens	IC50	nM	82.0
	10975570	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccccc3[nH]2)[nH]1		CHEMBL2064329	=	IC50	nM	158.0	CHEMBL3145	Homo sapiens	IC50	nM	158.0
	10975571	CHEMBL2067456	Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccccc1		CHEMBL2064419	=	IC50	nM	42.0	CHEMBL3145	Homo sapiens	IC50	nM	42.0
	10975618	CHEMBL2067917	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in mouse MEF-3T3 cells after 0.5 to 2 hrs by Western blot analysis	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccccc21		CHEMBL2064330	=	IC50	nM	86.0	CHEMBL3145	Homo sapiens	IC50	nM	86.0
	10975619	CHEMBL2067917	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in mouse MEF-3T3 cells after 0.5 to 2 hrs by Western blot analysis	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
	10976902	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccccc3[nH]2)[nH]1		CHEMBL2064329	=	IC50	nM	665.0	CHEMBL3145	Homo sapiens	IC50	nM	665.0
	10976903	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccccc3o2)[nH]1		CHEMBL2064418	=	IC50	nM	62.0	CHEMBL3145	Homo sapiens	IC50	nM	62.0
	10976904	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccccc21		CHEMBL2064330	=	IC50	nM	76.0	CHEMBL3145	Homo sapiens	IC50	nM	76.0
	10976905	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(F)ccc3[nH]2)[nH]1		CHEMBL2064331	=	IC50	nM	41.0	CHEMBL3145	Homo sapiens	IC50	nM	41.0
	10976906	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2cc(F)ccc21		CHEMBL2064333	=	IC50	nM	16.0	CHEMBL3145	Homo sapiens	IC50	nM	16.0
	10976907	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccc(F)cc21		CHEMBL2064334	=	IC50	nM	289.0	CHEMBL3145	Homo sapiens	IC50	nM	289.0
	10976908	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(Br)ccc3[nH]2)[nH]1		CHEMBL2064335	=	IC50	nM	85.0	CHEMBL3145	Homo sapiens	IC50	nM	85.0
	10976909	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(Cl)ccc3[nH]2)[nH]1		CHEMBL2064336	=	IC50	nM	63.0	CHEMBL3145	Homo sapiens	IC50	nM	63.0
	10976910	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	Cc1ccc2[nH]c(Cc3nc(N4CCOCC4)cc(=O)[nH]3)nc2c1		CHEMBL2064337	=	IC50	nM	140.0	CHEMBL3145	Homo sapiens	IC50	nM	140.0
	10976911	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	COc1ccc2[nH]c(Cc3nc(N4CCOCC4)cc(=O)[nH]3)nc2c1		CHEMBL2064338	=	IC50	nM	475.0	CHEMBL3145	Homo sapiens	IC50	nM	475.0
	10976912	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(C(F)(F)F)ccc3[nH]2)[nH]1		CHEMBL2064339	=	IC50	nM	961.0	CHEMBL3145	Homo sapiens	IC50	nM	961.0
	10976913	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	CCn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccccc21		CHEMBL2064340	=	IC50	nM	26.0	CHEMBL3145	Homo sapiens	IC50	nM	26.0
	10976914	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(F)ccc3n2C2CC2)[nH]1		CHEMBL2064341	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	nM	9.0
	10976915	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	COCCn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2cc(F)ccc21		CHEMBL2064342	=	IC50	nM	109.0	CHEMBL3145	Homo sapiens	IC50	nM	109.0
	10976916	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccccc3n2C2CCCCC2)[nH]1		CHEMBL2064343	=	IC50	nM	142.0	CHEMBL3145	Homo sapiens	IC50	nM	142.0
	10976917	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccccc3n2-c2ccccc2)[nH]1		CHEMBL2064344	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	nM	8.0
	10976918	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccccc3n2Cc2ccccc2)[nH]1		CHEMBL2064345	=	IC50	nM	105.0	CHEMBL3145	Homo sapiens	IC50	nM	105.0
	10976919	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4ccccc4)cccc3[nH]2)[nH]1		CHEMBL2064346	=	IC50	nM	65.0	CHEMBL3145	Homo sapiens	IC50	nM	65.0
	10976920	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2c(-c3ccccc3)cccc21		CHEMBL2064347	=	IC50	nM	26.0	CHEMBL3145	Homo sapiens	IC50	nM	26.0
	10976921	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2cccc(-c3ccccc3)c21		CHEMBL2064348	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	nM	17.0
	10976922	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(F)cccc3o2)[nH]1		CHEMBL2064351	=	IC50	nM	125.0	CHEMBL3145	Homo sapiens	IC50	nM	125.0
	10976923	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(F)ccc3o2)[nH]1		CHEMBL2064352	=	IC50	nM	26.0	CHEMBL3145	Homo sapiens	IC50	nM	26.0
	10976924	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccc(F)cc3o2)[nH]1		CHEMBL2064353	=	IC50	nM	49.0	CHEMBL3145	Homo sapiens	IC50	nM	49.0
	10976925	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cccc(F)c3o2)[nH]1		CHEMBL2064354	=	IC50	nM	88.0	CHEMBL3145	Homo sapiens	IC50	nM	88.0
	10976926	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	Cc1cccc2oc(Cc3nc(N4CCOCC4)cc(=O)[nH]3)nc12		CHEMBL2064406	=	IC50	nM	75.0	CHEMBL3145	Homo sapiens	IC50	nM	75.0
	10976927	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	Cc1ccc2oc(Cc3nc(N4CCOCC4)cc(=O)[nH]3)nc2c1		CHEMBL2064407	=	IC50	nM	233.0	CHEMBL3145	Homo sapiens	IC50	nM	233.0
	10976928	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	Cc1ccc2nc(Cc3nc(N4CCOCC4)cc(=O)[nH]3)oc2c1		CHEMBL2064408	=	IC50	nM	143.0	CHEMBL3145	Homo sapiens	IC50	nM	143.0
	10976929	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	Cc1cccc2nc(Cc3nc(N4CCOCC4)cc(=O)[nH]3)oc12		CHEMBL2064409	=	IC50	nM	202.0	CHEMBL3145	Homo sapiens	IC50	nM	202.0
	10976930	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(Br)cccc3o2)[nH]1		CHEMBL2064410	=	IC50	nM	127.0	CHEMBL3145	Homo sapiens	IC50	nM	127.0
	10976931	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4ccccc4)cccc3o2)[nH]1		CHEMBL2064411	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	nM	13.0
	10976932	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cccc(-c4ccccc4)c3o2)[nH]1		CHEMBL2064412	=	IC50	nM	177.0	CHEMBL3145	Homo sapiens	IC50	nM	177.0
	10976933	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4cccs4)cccc3o2)[nH]1		CHEMBL2064413	=	IC50	nM	22.0	CHEMBL3145	Homo sapiens	IC50	nM	22.0
	10976934	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4ccccn4)cccc3o2)[nH]1		CHEMBL2064414	=	IC50	nM	113.0	CHEMBL3145	Homo sapiens	IC50	nM	113.0
	10976935	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4cccnc4)cccc3o2)[nH]1		CHEMBL2064415	=	IC50	nM	44.0	CHEMBL3145	Homo sapiens	IC50	nM	44.0
	10976936	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4ccncc4)cccc3o2)[nH]1		CHEMBL2064416	=	IC50	nM	47.0	CHEMBL3145	Homo sapiens	IC50	nM	47.0
	10976937	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4ccccc4)c(F)ccc3o2)[nH]1		CHEMBL2064417	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
	10976938	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	Cc1cc(C(C)Nc2ccccc2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL2064328	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
	10976939	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	Cc1cc(F)ccc1Oc1cccc2c(=O)cc(N3CCOCC3)[nH]c12		CHEMBL2064327	=	IC50	nM	72.0	CHEMBL3145	Homo sapiens	IC50	nM	72.0
	10976940	CHEMBL2066371	Inhibition of human PI3Kbeta-mediated Akt phosphorylation at Ser473 residue expressed in PTEN-deficient human PC3 cells by chemiluminescence assay	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	10996262	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(S(N)(=O)=O)cc2)s1		CHEMBL2071326	=	Ki	nM	1430.0	CHEMBL3145	Homo sapiens	Ki	uM	1.43
	10996263	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(S(C)(=O)=O)cc2)s1		CHEMBL2071327	=	Ki	nM	1360.0	CHEMBL3145	Homo sapiens	Ki	uM	1.36
	10996264	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(S(C)(=O)=O)c(Cl)c2)s1		CHEMBL2071328	=	Ki	nM	1300.0	CHEMBL3145	Homo sapiens	Ki	uM	1.3
	10996265	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(S(C)(=O)=O)c(Br)c2)s1		CHEMBL2071329	=	Ki	nM	550.0	CHEMBL3145	Homo sapiens	Ki	uM	0.55
	10996266	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(S(C)(=O)=O)c(F)c2)s1		CHEMBL2071330	=	Ki	nM	1410.0	CHEMBL3145	Homo sapiens	Ki	uM	1.41
	10996267	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(S(C)(=O)=O)c(C#N)c2)s1		CHEMBL2071331	=	Ki	nM	760.0	CHEMBL3145	Homo sapiens	Ki	uM	0.76
	10996268	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(S(C)(=O)=O)c(C(F)(F)F)c2)s1		CHEMBL2071332	=	Ki	nM	870.0	CHEMBL3145	Homo sapiens	Ki	uM	0.87
	10996269	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(-n3cccn3)cc2)s1		CHEMBL2071333	=	Ki	nM	410.0	CHEMBL3145	Homo sapiens	Ki	uM	0.41
	10996270	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(C(C)=O)cc2)s1		CHEMBL2071334	=	Ki	nM	1940.0	CHEMBL3145	Homo sapiens	Ki	uM	1.94
	10996271	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccc(S(C)(=O)=O)cc1		CHEMBL2071335	>	Ki	nM	10000.0	CHEMBL3145	Homo sapiens	Ki	uM	10.0
	10996272	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccc(S(C)(=O)=O)c(F)c1		CHEMBL2071336	>	Ki	nM	10000.0	CHEMBL3145	Homo sapiens	Ki	uM	10.0
	10996273	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccc(S(C)(=O)=O)c(C(F)(F)F)c1		CHEMBL2071337	>	Ki	nM	10000.0	CHEMBL3145	Homo sapiens	Ki	uM	10.0
	10996274	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccc(-n2cccn2)cc1		CHEMBL2071338	=	Ki	nM	2000.0	CHEMBL3145	Homo sapiens	Ki	uM	2.0
	10996275	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(S(C)(=O)=O)c(F)c3)s2)no1		CHEMBL2071340	=	Ki	nM	860.0	CHEMBL3145	Homo sapiens	Ki	uM	0.86
	10996276	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	=	Ki	nM	340.0	CHEMBL3145	Homo sapiens	Ki	uM	0.34
	10996277	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	Cc1nc(NC(=O)NCCC(=O)OC(C)(C)C)sc1-c1ccc(S(C)(=O)=O)c(F)c1		CHEMBL2071341	=	Ki	nM	90.0	CHEMBL3145	Homo sapiens	Ki	uM	0.09
	10996278	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)c1ccc(-c2sc(NC(=O)NCCC(=O)NC(C)(C)C)nc2C)cc1		CHEMBL2069328	=	Ki	nM	250.0	CHEMBL3145	Homo sapiens	Ki	uM	0.25
	10996279	CHEMBL2072999	Inhibition of recombinant GST-tagged PI3K p110beta using [32P]ATP after 60 mins by scintillation proximity assay	B	CCn1nnc(CCNC(=O)Nc2nc(C)c(-c3ccc(S(C)(=O)=O)c(F)c3)s2)n1		CHEMBL2071342	=	Ki	nM	320.0	CHEMBL3145	Homo sapiens	Ki	uM	0.32
	10996358	CHEMBL2073031	Inhibition of recombinant GST-tagged PI3K p110beta by KinaseGlo assay	B	NC(=O)[C@@H]1CCCN1C(=O)Nc1nc2ccc(-c3cnc(N)c(C(F)(F)F)c3)cc2s1		CHEMBL2071339	=	IC50	nM	2940.0	CHEMBL3145	Homo sapiens	IC50	uM	2.94
	11007463	CHEMBL2090371	Inhibition of PI3K beta in human PTEN-deficient MDA-MB-468 cells assessed as inhibition of Akt Ser473 phosphorylation	B	Cc1c(Cl)cccc1Cn1c(N)nc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089120	=	EC50	nM	3.0	CHEMBL3145	Homo sapiens	EC50	uM	0.003
	11007464	CHEMBL2090371	Inhibition of PI3K beta in human PTEN-deficient MDA-MB-468 cells assessed as inhibition of Akt Ser473 phosphorylation	B	COc1nc(=O)c2sc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1C		CHEMBL2089116	=	EC50	nM	6.0	CHEMBL3145	Homo sapiens	EC50	uM	0.006
	11007465	CHEMBL2090371	Inhibition of PI3K beta in human PTEN-deficient MDA-MB-468 cells assessed as inhibition of Akt Ser473 phosphorylation	B	Cc1c(Cl)cccc1Cn1c(CO)nc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089114	=	EC50	nM	6.0	CHEMBL3145	Homo sapiens	EC50	uM	0.006
	11007466	CHEMBL2090371	Inhibition of PI3K beta in human PTEN-deficient MDA-MB-468 cells assessed as inhibition of Akt Ser473 phosphorylation	B	Cc1c(Cn2c(C3CC3)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089109	=	EC50	nM	9.0	CHEMBL3145	Homo sapiens	EC50	uM	0.009
	11007467	CHEMBL2090371	Inhibition of PI3K beta in human PTEN-deficient MDA-MB-468 cells assessed as inhibition of Akt Ser473 phosphorylation	B	CCc1nc(=O)c2sc(N3CCOCC3)nc2n1Cc1cccc(C(F)(F)F)c1C		CHEMBL2089108	=	EC50	nM	16.0	CHEMBL3145	Homo sapiens	EC50	uM	0.016
	11007468	CHEMBL2090371	Inhibition of PI3K beta in human PTEN-deficient MDA-MB-468 cells assessed as inhibition of Akt Ser473 phosphorylation	B	Cc1c(Cl)cccc1Cn1c(C)nc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089107	=	EC50	nM	19.0	CHEMBL3145	Homo sapiens	EC50	uM	0.019
	11007469	CHEMBL2090371	Inhibition of PI3K beta in human PTEN-deficient MDA-MB-468 cells assessed as inhibition of Akt Ser473 phosphorylation	B	Cc1c(Cn2c(C)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089106	=	EC50	nM	24.0	CHEMBL3145	Homo sapiens	EC50	uM	0.024
	11007520	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	Cc1c(Cl)cccc1Cn1c(N)nc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089120	=	IC50	nM	0.2	CHEMBL3145	Homo sapiens	IC50	uM	0.0002
	11007521	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	Cc1c(Cl)cccc1Cn1c(SCC(=O)O)nc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089119	=	IC50	nM	0.05	CHEMBL3145	Homo sapiens	IC50	uM	0.00005
	11007522	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	CSc1nc(=O)c2sc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1C		CHEMBL2089118	=	IC50	nM	0.3	CHEMBL3145	Homo sapiens	IC50	uM	0.0003
	11007523	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	Cc1c(Cl)cccc1Cn1c(S)nc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089117	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	uM	0.005
	11007524	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	COc1nc(=O)c2sc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1C		CHEMBL2089116	=	IC50	nM	0.3	CHEMBL3145	Homo sapiens	IC50	uM	0.0003
	11007525	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	Cc1c(Cl)cccc1Cn1c(=O)[nH]c(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089115	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	uM	0.008
	11007526	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	Cc1c(Cl)cccc1Cn1c(CO)nc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089114	=	IC50	nM	0.1	CHEMBL3145	Homo sapiens	IC50	uM	0.0001
	11007527	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	Cc1c(Cn2c(CN)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089113	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	uM	0.003
	11007528	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	Cc1c(Cn2c(CO)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089112	=	IC50	nM	0.2	CHEMBL3145	Homo sapiens	IC50	uM	0.0002
	11007529	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	Cc1c(Cn2c(Cc3ccccc3)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089111	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	uM	0.003
	11007530	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	Cc1c(Cn2c(-c3ccccc3)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089110	=	IC50	nM	50.0	CHEMBL3145	Homo sapiens	IC50	uM	0.05
	11007531	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	Cc1c(Cn2c(C3CC3)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089109	=	IC50	nM	0.5	CHEMBL3145	Homo sapiens	IC50	uM	0.0005
	11007532	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	CCc1nc(=O)c2sc(N3CCOCC3)nc2n1Cc1cccc(C(F)(F)F)c1C		CHEMBL2089108	=	IC50	nM	0.5	CHEMBL3145	Homo sapiens	IC50	uM	0.0005
	11007533	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	Cc1c(Cl)cccc1Cn1c(C)nc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089107	=	IC50	nM	0.5	CHEMBL3145	Homo sapiens	IC50	uM	0.0005
	11007534	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	Cc1c(Cn2c(C)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089106	=	IC50	nM	0.6	CHEMBL3145	Homo sapiens	IC50	uM	0.0006
	11007535	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	Cc1c(Cl)cccc1Cn1cnc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089105	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	uM	0.003
	11007536	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	Cc1c(Cn2cnc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089104	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	uM	0.003
	11007537	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	O=c1ncn(Cc2cccc(Cl)c2Cl)c2nc(N3CCOCC3)sc12		CHEMBL2089103	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	uM	0.01
	11007538	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	O=c1ncn(Cc2cccc(Cl)c2)c2nc(N3CCOCC3)sc12		CHEMBL2089102	=	IC50	nM	79.0	CHEMBL3145	Homo sapiens	IC50	uM	0.079
	11007539	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	O=c1ncn(Cc2ccsc2Cl)c2nc(N3CCOCC3)sc12		CHEMBL2089101	=	IC50	nM	790.0	CHEMBL3145	Homo sapiens	IC50	uM	0.79
	11007540	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	O=c1ncn(Cc2ccccc2Cl)c2nc(N3CCOCC3)sc12		CHEMBL2089100	=	IC50	nM	160.0	CHEMBL3145	Homo sapiens	IC50	uM	0.16
	11007541	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	O=c1ncn(CCc2ccccc2)c2nc(N3CCOCC3)sc12		CHEMBL2089099	=	IC50	nM	790.0	CHEMBL3145	Homo sapiens	IC50	uM	0.79
	11007542	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	CC(c1ccccc1)n1cnc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089098	=	IC50	nM	400.0	CHEMBL3145	Homo sapiens	IC50	uM	0.4
	11007543	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	Cc1ccccc1Cn1cnc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089097	=	IC50	nM	25.0	CHEMBL3145	Homo sapiens	IC50	uM	0.025
	11007544	CHEMBL2090368	Inhibition of PI3K beta by continuous TR-FRET assay	B	O=c1ncn(Cc2ccccc2)c2nc(N3CCOCC3)sc12		CHEMBL2089096	=	IC50	nM	320.0	CHEMBL3145	Homo sapiens	IC50	uM	0.32
	12059667	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	COc1ccc(-c2cccc(S(=O)(=O)N3CCN(c4nccnc4-c4ccc(OC)cc4)CC3)c2)cc1		CHEMBL2152124	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	12059668	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cccc(-c3nnn[nH]3)c2)cnc1N		CHEMBL2152125	=	IC50	nM	6201.0	CHEMBL3145	Homo sapiens	IC50	nM	6201.0
	12059669	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	COc1ccc(-c2nccnc2N2CCN(S(=O)(=O)c3cccc(-c4cnc(N)nc4)c3)CC2)cc1		CHEMBL2151050	=	IC50	nM	1970.0	CHEMBL3145	Homo sapiens	IC50	nM	1970.0
	12059670	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CC(C)c1ccc(-c2nccnc2N2CCN(S(=O)(=O)c3cccc(-c4cnc(N)nc4)c3)CC2)cc1		CHEMBL2152126	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	12059671	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CC(C)c1ccc(-c2ncccc2N2CCN(S(=O)(=O)c3cccc(-c4cnc(N)nc4)c3)CC2)cc1		CHEMBL2152127	=	IC50	nM	3512.0	CHEMBL3145	Homo sapiens	IC50	nM	3512.0
	12059672	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cccc(C(F)(F)F)c2)cnc1N		CHEMBL2152128	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	12059673	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cccc(S(=O)(=O)Nc3ccccc3)c2)cnc1N		CHEMBL2152129	=	IC50	nM	2970.0	CHEMBL3145	Homo sapiens	IC50	nM	2970.0
	12059674	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3ccccc3)c2)cnc1N		CHEMBL2152130	=	IC50	nM	578.0	CHEMBL3145	Homo sapiens	IC50	nM	578.0
	12059675	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)NC)c2)cnc1N		CHEMBL2152131	=	IC50	nM	1563.0	CHEMBL3145	Homo sapiens	IC50	nM	1563.0
	12059676	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(N)(=O)=O)c2)cnc1N		CHEMBL2152132	=	IC50	nM	701.0	CHEMBL3145	Homo sapiens	IC50	nM	701.0
	12059677	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)NCC(F)(F)F)c2)cnc1N		CHEMBL2152133	=	IC50	nM	2511.0	CHEMBL3145	Homo sapiens	IC50	nM	2511.0
	12059678	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(OC)c(S(=O)(=O)Nc3ccccc3)c2)cnc1N		CHEMBL2152134	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	12059679	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(F)c(S(=O)(=O)Nc3ccccc3)c2)cnc1N		CHEMBL2152135	=	IC50	nM	3370.0	CHEMBL3145	Homo sapiens	IC50	nM	3370.0
	12059680	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cnc(N)c(S(=O)(=O)Nc3ccccc3)c2)cnc1N		CHEMBL2152136	=	IC50	nM	362.0	CHEMBL3145	Homo sapiens	IC50	nM	362.0
	12059681	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cccc(NS(=O)(=O)c3ccccc3)c2)cnc1N		CHEMBL2152137	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	12059682	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cccc(NS(=O)(=O)c3cccc(Cl)c3)c2)cnc1N		CHEMBL2152138	=	IC50	nM	6343.0	CHEMBL3145	Homo sapiens	IC50	nM	6343.0
	12059683	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(NS(=O)(=O)c3cccc(Cl)c3)c2)cnc1N		CHEMBL2152139	=	IC50	nM	64.0	CHEMBL3145	Homo sapiens	IC50	nM	64.0
	12059684	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(C)c3)c2)cnc1N		CHEMBL2152140	=	IC50	nM	2075.0	CHEMBL3145	Homo sapiens	IC50	nM	2075.0
	12059685	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3)c2)cnc1N		CHEMBL2152141	=	IC50	nM	1611.0	CHEMBL3145	Homo sapiens	IC50	nM	1611.0
	12059686	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(OC)c3)c2)cnc1N		CHEMBL2152142	=	IC50	nM	1656.0	CHEMBL3145	Homo sapiens	IC50	nM	1656.0
	12059687	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(C(F)(F)F)c3)c2)cnc1N		CHEMBL2152143	=	IC50	nM	5070.0	CHEMBL3145	Homo sapiens	IC50	nM	5070.0
	12059688	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(Cl)c3)c2)cnc1N		CHEMBL2152144	=	IC50	nM	1130.0	CHEMBL3145	Homo sapiens	IC50	nM	1130.0
	12059689	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3ccccc3Cl)c2)cnc1N		CHEMBL2152145	=	IC50	nM	2404.0	CHEMBL3145	Homo sapiens	IC50	nM	2404.0
	12059690	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3ccc(Cl)cc3)c2)cnc1N		CHEMBL2152146	=	IC50	nM	1263.0	CHEMBL3145	Homo sapiens	IC50	nM	1263.0
	12059691	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cccc(S(=O)(=O)Nc3cccc(Cl)c3)c2)cnc1N		CHEMBL2152147	=	IC50	nM	4774.0	CHEMBL3145	Homo sapiens	IC50	nM	4774.0
	12059692	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3ccc(F)cc3Cl)c2)cnc1N		CHEMBL2152148	=	IC50	nM	1069.0	CHEMBL3145	Homo sapiens	IC50	nM	1069.0
	12059693	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3Cl)c2)cnc1N		CHEMBL2152149	=	IC50	nM	4442.0	CHEMBL3145	Homo sapiens	IC50	nM	4442.0
	12059694	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3ccc(Cl)cc3Cl)c2)cnc1N		CHEMBL2152150	=	IC50	nM	1964.0	CHEMBL3145	Homo sapiens	IC50	nM	1964.0
	12059695	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(Cl)c3Cl)c2)cnc1N		CHEMBL2152250	=	IC50	nM	1968.0	CHEMBL3145	Homo sapiens	IC50	nM	1968.0
	12059696	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cccc(S(=O)(=O)Nc3cccc(F)c3F)c2)cnc1N		CHEMBL2152251	=	IC50	nM	5016.0	CHEMBL3145	Homo sapiens	IC50	nM	5016.0
	12059697	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cnc1N		CHEMBL2152252	=	IC50	nM	2059.0	CHEMBL3145	Homo sapiens	IC50	nM	2059.0
	12059698	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3C)c2)cnc1N		CHEMBL2152253	=	IC50	nM	1148.0	CHEMBL3145	Homo sapiens	IC50	nM	1148.0
	12059699	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	Nc1cnc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cn1		CHEMBL2152254	=	IC50	nM	6275.0	CHEMBL3145	Homo sapiens	IC50	nM	6275.0
	12059700	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	Nc1ncc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cn1		CHEMBL2152255	=	IC50	nM	2643.0	CHEMBL3145	Homo sapiens	IC50	nM	2643.0
	12059701	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	COc1nc(N)ncc1-c1ccc(Cl)c(S(=O)(=O)Nc2cccc(F)c2F)c1		CHEMBL2152256	=	IC50	nM	54.0	CHEMBL3145	Homo sapiens	IC50	nM	54.0
	12059702	CHEMBL2157135	Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	Nc1ncc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)c(OCC(F)(F)F)n1		CHEMBL2152257	=	IC50	nM	39.0	CHEMBL3145	Homo sapiens	IC50	nM	39.0
	12062341	CHEMBL2156789	Inhibition of PI3Kbeta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccccc1		CHEMBL2064419	=	IC50	nM	42.0	CHEMBL3145	Homo sapiens	IC50	nM	42.0
	12062342	CHEMBL2156789	Inhibition of PI3Kbeta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccccc1F		CHEMBL2151819	=	IC50	nM	142.0	CHEMBL3145	Homo sapiens	IC50	nM	142.0
	12062343	CHEMBL2156789	Inhibition of PI3Kbeta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(F)c1		CHEMBL2151820	=	IC50	nM	81.0	CHEMBL3145	Homo sapiens	IC50	nM	81.0
	12062344	CHEMBL2156789	Inhibition of PI3Kbeta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)cc1		CHEMBL2151821	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	nM	13.0
	12062345	CHEMBL2156789	Inhibition of PI3Kbeta	B	Cc1ccccc1NC(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL2151822	=	IC50	nM	236.0	CHEMBL3145	Homo sapiens	IC50	nM	236.0
	12062346	CHEMBL2156789	Inhibition of PI3Kbeta	B	Cc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1		CHEMBL2151919	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	nM	17.0
	12062347	CHEMBL2156789	Inhibition of PI3Kbeta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(Cl)cc1		CHEMBL2151920	=	IC50	nM	398.0	CHEMBL3145	Homo sapiens	IC50	nM	398.0
	12062348	CHEMBL2156789	Inhibition of PI3Kbeta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(Cl)c1		CHEMBL2151921	=	IC50	nM	33.0	CHEMBL3145	Homo sapiens	IC50	nM	33.0
	12062349	CHEMBL2156789	Inhibition of PI3Kbeta	B	COc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1		CHEMBL2151922	=	IC50	nM	15.0	CHEMBL3145	Homo sapiens	IC50	nM	15.0
	12062350	CHEMBL2156789	Inhibition of PI3Kbeta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(Br)c1		CHEMBL2151923	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
	12062351	CHEMBL2156789	Inhibition of PI3Kbeta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(F)c1		CHEMBL2151924	=	IC50	nM	53.0	CHEMBL3145	Homo sapiens	IC50	nM	53.0
	12062352	CHEMBL2156789	Inhibition of PI3Kbeta	B	Cc1cc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)ccc1F		CHEMBL2151925	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
	12062353	CHEMBL2156789	Inhibition of PI3Kbeta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(Cl)c1		CHEMBL2151926	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	nM	2.0
	12062354	CHEMBL2156789	Inhibition of PI3Kbeta	B	COc1cc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)ccc1F		CHEMBL2151927	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
	12062355	CHEMBL2156789	Inhibition of PI3Kbeta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(Br)c1		CHEMBL2151048	=	IC50	nM	26.0	CHEMBL3145	Homo sapiens	IC50	nM	26.0
	12062356	CHEMBL2156789	Inhibition of PI3Kbeta	B	COC(=O)c1cc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)ccc1F		CHEMBL2151928	=	IC50	nM	175.0	CHEMBL3145	Homo sapiens	IC50	nM	175.0
	12062357	CHEMBL2156789	Inhibition of PI3Kbeta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c([N+](=O)[O-])c1		CHEMBL2151929	=	IC50	nM	47.0	CHEMBL3145	Homo sapiens	IC50	nM	47.0
	12062358	CHEMBL2156789	Inhibition of PI3Kbeta	B	Cn1c(CC(=O)Nc2ccccc2)nc(N2CCOCC2)cc1=O		CHEMBL2151930	=	IC50	nM	469.0	CHEMBL3145	Homo sapiens	IC50	nM	469.0
	12062359	CHEMBL2156789	Inhibition of PI3Kbeta	B	Cn1c(CC(=O)Nc2ccc(F)cc2)nc(N2CCOCC2)cc1=O		CHEMBL2151931	=	IC50	nM	244.0	CHEMBL3145	Homo sapiens	IC50	nM	244.0
	12062360	CHEMBL2156789	Inhibition of PI3Kbeta	B	Cn1c(CC(=O)Nc2ccc(F)c(F)c2)nc(N2CCOCC2)cc1=O		CHEMBL2151932	=	IC50	nM	262.0	CHEMBL3145	Homo sapiens	IC50	nM	262.0
	12062361	CHEMBL2156789	Inhibition of PI3Kbeta	B	Cn1c(CC(=O)Nc2ccc(F)c(Br)c2)nc(N2CCOCC2)cc1=O		CHEMBL2151933	=	IC50	nM	387.0	CHEMBL3145	Homo sapiens	IC50	nM	387.0
	12062362	CHEMBL2156789	Inhibition of PI3Kbeta	B	COc1cc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)n2C)ccc1F		CHEMBL2151934	=	IC50	nM	104.0	CHEMBL3145	Homo sapiens	IC50	nM	104.0
	12062363	CHEMBL2156789	Inhibition of PI3Kbeta	B	Cn1c(CC(=O)Nc2ccc(F)c(Cl)c2)nc(N2CCOCC2)cc1=O		CHEMBL2151935	=	IC50	nM	42.0	CHEMBL3145	Homo sapiens	IC50	nM	42.0
	12072324	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1cc(NCc2ccccc2)[nH]c(N2CCOCC2)c1		CHEMBL2158426	=	IC50	nM	34000.0	CHEMBL3145	Homo sapiens	IC50	uM	34.0
	12072325	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	COC(=O)c1cc(NCc2ccccc2)nc(N2CCOCC2)c1		CHEMBL2158434	=	IC50	nM	32000.0	CHEMBL3145	Homo sapiens	IC50	uM	32.0
	12072326	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1nc(N2CCOCC2)cc(NCc2ccccc2)[nH]1		CHEMBL2158424	=	IC50	nM	29000.0	CHEMBL3145	Homo sapiens	IC50	uM	29.0
	12072327	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	CN(C)C(=O)c1cc(N2CCOCC2)nc(NCc2ccccc2)n1		CHEMBL2158429	=	IC50	nM	25000.0	CHEMBL3145	Homo sapiens	IC50	uM	25.0
	12072328	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	CNC(=O)c1cc(N2CCOCC2)nc(NCc2ccccc2)n1		CHEMBL2158428	=	IC50	nM	23000.0	CHEMBL3145	Homo sapiens	IC50	uM	23.0
	12072329	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	C[C@H](Nc1cc(N2CCOCC2)nc(=O)[nH]1)c1cccc2ccccc12		CHEMBL2158444	=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	12072330	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1nc(N2CCOCC2)cc(NCc2cccc3ccccc23)[nH]1		CHEMBL2158442	=	IC50	nM	2600.0	CHEMBL3145	Homo sapiens	IC50	uM	2.6
	12072345	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	N#Cc1nc(NCc2ccccc2)cc(N2CCOCC2)n1		CHEMBL2158431	=	IC50	nM	1600.0	CHEMBL3145	Homo sapiens	IC50	uM	1.6
	12072346	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1cc(N2CCOCC2)nc(NCc2ccccc2)[nH]1		CHEMBL2158390	=	IC50	nM	1900.0	CHEMBL3145	Homo sapiens	IC50	uM	1.9
	12072347	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	NC(=O)c1cc(N2CCOCC2)nc(NCc2ccccc2)n1		CHEMBL2158427	=	IC50	nM	2500.0	CHEMBL3145	Homo sapiens	IC50	uM	2.5
	12072350	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1cc(N2CCOCC2)nc(NCc2c(Cl)cccc2Cl)[nH]1		CHEMBL2158441	=	IC50	nM	1500.0	CHEMBL3145	Homo sapiens	IC50	uM	1.5
	12072351	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1nc(N2CCOCC2)cc(NCc2cccc(Cl)c2Cl)[nH]1		CHEMBL2158443	=	IC50	nM	1500.0	CHEMBL3145	Homo sapiens	IC50	uM	1.5
	12072372	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	Cc1cc(N2CCOCC2)nc(NCc2ccccc2)n1		CHEMBL1327614	=	IC50	nM	130000.0	CHEMBL3145	Homo sapiens	IC50	uM	130.0
	12072373	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1cc(N2CCOCC2)nc(NCc2cc(Cl)ccc2Cl)[nH]1		CHEMBL2158440	=	IC50	nM	1400.0	CHEMBL3145	Homo sapiens	IC50	uM	1.4
	12072374	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1cc(N2CCOCC2)nc(NCc2ccccc2Cl)[nH]1		CHEMBL2158439	=	IC50	nM	570.0	CHEMBL3145	Homo sapiens	IC50	uM	0.57
	12072375	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1cc(N2CCOCC2)nc(NCc2cccc(Cl)c2)[nH]1		CHEMBL2158438	=	IC50	nM	470.0	CHEMBL3145	Homo sapiens	IC50	uM	0.47
	12072376	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1cc(N2CCOCC2)nc(NCc2cccc3ccccc23)[nH]1		CHEMBL2158436	=	IC50	nM	93.0	CHEMBL3145	Homo sapiens	IC50	uM	0.093
	12072377	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1cc(N2CCOCC2)nc(NCc2cccc(Cl)c2Cl)[nH]1		CHEMBL2158437	=	IC50	nM	84.0	CHEMBL3145	Homo sapiens	IC50	uM	0.084
	12072378	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	49.0	CHEMBL3145	Homo sapiens	IC50	uM	0.049
	12072379	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	Nc1nc(NCc2ccccc2)cc(N2CCOCC2)n1		CHEMBL2158430	=	IC50	nM	110000.0	CHEMBL3145	Homo sapiens	IC50	uM	110.0
	12072380	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	NCc1nc(NCc2ccccc2)cc(N2CCOCC2)n1		CHEMBL2158432	=	IC50	nM	87000.0	CHEMBL3145	Homo sapiens	IC50	uM	87.0
	12072381	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1cc(NCc2ccccc2)nc(N2CCOCC2)[nH]1		CHEMBL2158425	=	IC50	nM	63000.0	CHEMBL3145	Homo sapiens	IC50	uM	63.0
	12072382	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	OCc1cc(NCc2ccccc2)nc(N2CCOCC2)c1		CHEMBL2158435	=	IC50	nM	43000.0	CHEMBL3145	Homo sapiens	IC50	uM	43.0
	12072383	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	C[C@@H](Nc1cc(N2CCOCC2)nc(=O)[nH]1)c1cccc2ccccc12		CHEMBL2158445	=	IC50	nM	36000.0	CHEMBL3145	Homo sapiens	IC50	uM	36.0
	12072384	CHEMBL2161659	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	c1ccc(CNc2cc(N3CCOCC3)ncn2)cc1		CHEMBL2158433	=	IC50	nM	36000.0	CHEMBL3145	Homo sapiens	IC50	uM	36.0
	12092950	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(Cc3ccc(S(C)(=O)=O)cc3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165007	=	Ki	nM	2.0	CHEMBL3145	Homo sapiens	Ki	nM	2.0
	12092951	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(Cc3ccccc3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165006	=	Ki	nM	48.0	CHEMBL3145	Homo sapiens	Ki	nM	48.0
	12092952	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCS(=O)(=O)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165005	=	Ki	nM	13.0	CHEMBL3145	Homo sapiens	Ki	nM	13.0
	12092953	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCC(S(C)(=O)=O)C3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165004	=	Ki	nM	5.0	CHEMBL3145	Homo sapiens	Ki	nM	5.0
	12092954	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165003	=	Ki	nM	61.0	CHEMBL3145	Homo sapiens	Ki	nM	61.0
	12092955	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CC3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165020	=	Ki	nM	15.0	CHEMBL3145	Homo sapiens	Ki	nM	15.0
	12092956	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCC(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165019	=	Ki	nM	5.0	CHEMBL3145	Homo sapiens	Ki	nM	5.0
	12092957	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCN(S(=O)(=O)N(C)C)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165018	=	Ki	nM	7.0	CHEMBL3145	Homo sapiens	Ki	nM	7.0
	12092958	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165017	=	Ki	nM	5.0	CHEMBL3145	Homo sapiens	Ki	nM	5.0
	12092959	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCN(C(=O)N(C)C)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165016	=	Ki	nM	16.0	CHEMBL3145	Homo sapiens	Ki	nM	16.0
	12092960	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COC(=O)N1CCN(Cc2cnc(Nc3ccc(OC)nc3)c(-c3nc(C)nc(N)n3)c2)CC1		CHEMBL2165015	=	Ki	nM	18.0	CHEMBL3145	Homo sapiens	Ki	nM	18.0
	12092961	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCN(C)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165014	=	Ki	nM	44.0	CHEMBL3145	Homo sapiens	Ki	nM	44.0
	12092962	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCNCC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165013	=	Ki	nM	17.0	CHEMBL3145	Homo sapiens	Ki	nM	17.0
	12092963	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CC[C@@H](CO)C3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165012	=	Ki	nM	59.0	CHEMBL3145	Homo sapiens	Ki	nM	59.0
	12092964	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCC(O)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165011	=	Ki	nM	41.0	CHEMBL3145	Homo sapiens	Ki	nM	41.0
	12092965	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCOCC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165010	=	Ki	nM	7.0	CHEMBL3145	Homo sapiens	Ki	nM	7.0
	12092966	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCCCC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165009	=	Ki	nM	11.0	CHEMBL3145	Homo sapiens	Ki	nM	11.0
	12092967	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCCC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165008	=	Ki	nM	65.0	CHEMBL3145	Homo sapiens	Ki	nM	65.0
	12092968	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165034	=	Ki	nM	22.0	CHEMBL3145	Homo sapiens	Ki	nM	22.0
	12092969	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(-c3cnn(C)c3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165033	=	Ki	nM	6.0	CHEMBL3145	Homo sapiens	Ki	nM	6.0
	12092970	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(-c3ccc(C)nc3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165032	=	Ki	nM	89.0	CHEMBL3145	Homo sapiens	Ki	nM	89.0
	12092971	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(N3CCN(C)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165031	=	Ki	nM	7.0	CHEMBL3145	Homo sapiens	Ki	nM	7.0
	12092972	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(C3=CCOCC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165030	=	Ki	nM	3.0	CHEMBL3145	Homo sapiens	Ki	nM	3.0
	12092973	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(N3CCOCC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165029	=	Ki	nM	9.0	CHEMBL3145	Homo sapiens	Ki	nM	9.0
	12092974	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COCCNCc1cnc(Nc2ccc(OC)nc2)c(-c2nc(C)nc(N)n2)c1		CHEMBL2165028	=	Ki	nM	67.0	CHEMBL3145	Homo sapiens	Ki	nM	67.0
	12092975	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COCc1cnc(Nc2ccc(OC)nc2)c(-c2nc(C)nc(N)n2)c1		CHEMBL2165027	=	Ki	nM	20.0	CHEMBL3145	Homo sapiens	Ki	nM	20.0
	12092976	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CO)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165026	=	Ki	nM	56.0	CHEMBL3145	Homo sapiens	Ki	nM	56.0
	12092977	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1cnc(Nc2ccc(OC)nc2)c(-c2nc(C)nc(N)n2)c1		CHEMBL2165025	=	Ki	nM	15.0	CHEMBL3145	Homo sapiens	Ki	nM	15.0
	12092978	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(C)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165024	=	Ki	nM	86.0	CHEMBL3145	Homo sapiens	Ki	nM	86.0
	12092979	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(Br)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165023	=	Ki	nM	75.0	CHEMBL3145	Homo sapiens	Ki	nM	75.0
	12092980	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(Cl)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165022	=	Ki	nM	38.0	CHEMBL3145	Homo sapiens	Ki	nM	38.0
	12092981	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2nccnc2-c2cc(N)nc(C)n2)cn1		CHEMBL2165021	=	Ki	nM	130.0	CHEMBL3145	Homo sapiens	Ki	nM	130.0
	12092982	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2nccnc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165050	=	Ki	nM	740.0	CHEMBL3145	Homo sapiens	Ki	nM	740.0
	12092983	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncncc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165049	=	Ki	nM	81.0	CHEMBL3145	Homo sapiens	Ki	nM	81.0
	12092984	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2cccnc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165048	=	Ki	nM	610.0	CHEMBL3145	Homo sapiens	Ki	nM	610.0
	12092985	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2cnccc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165047	=	Ki	nM	320.0	CHEMBL3145	Homo sapiens	Ki	nM	320.0
	12092986	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ccccc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165046	=	Ki	nM	580.0	CHEMBL3145	Homo sapiens	Ki	nM	580.0
	12092987	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1cc(-c2cccnc2Nc2cccc(O)c2)nc(N)n1		CHEMBL2165045	>	Ki	nM	10000.0	CHEMBL3145	Homo sapiens	Ki	nM	10000.0
	12092988	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(N(C)c2ncccc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165044	>	Ki	nM	10000.0	CHEMBL3145	Homo sapiens	Ki	nM	10000.0
	12092989	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1cc(-c2cccnc2Oc2cccc3[nH]ccc23)nc(N)n1		CHEMBL2165043	>	Ki	nM	10000.0	CHEMBL3145	Homo sapiens	Ki	nM	10000.0
	12092990	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(-c2cccnc2Nc2cccc3n[nH]cc23)c2c[nH]nc2n1		CHEMBL2165042	=	Ki	nM	2300.0	CHEMBL3145	Homo sapiens	Ki	nM	2300.0
	12092991	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncccc2-c2ncnc3nc[nH]c23)cn1		CHEMBL2165041	>	Ki	nM	10000.0	CHEMBL3145	Homo sapiens	Ki	nM	10000.0
	12092992	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	c1cnc(Nc2cccc3n[nH]cc23)c(-c2ncnc3nc[nH]c23)c1		CHEMBL2165040	=	Ki	nM	9700.0	CHEMBL3145	Homo sapiens	Ki	nM	9700.0
	12092993	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncccc2-c2nc(C)nc3nc[nH]c23)cn1		CHEMBL2165039	=	Ki	nM	45.0	CHEMBL3145	Homo sapiens	Ki	nM	45.0
	12092994	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(-c2cccnc2Nc2cccc3[nH]ccc23)c2[nH]cnc2n1		CHEMBL2165038	=	Ki	nM	130.0	CHEMBL3145	Homo sapiens	Ki	nM	130.0
	12092995	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(-c2cccnc2Nc2cccc3n[nH]cc23)c2[nH]cnc2n1		CHEMBL2165037	=	Ki	nM	28.0	CHEMBL3145	Homo sapiens	Ki	nM	28.0
	12092996	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Nc1cc(-c2cccnc2Nc2cccc3[nH]ncc23)nc(C(F)(F)F)n1		CHEMBL2165036	=	Ki	nM	1300.0	CHEMBL3145	Homo sapiens	Ki	nM	1300.0
	12092997	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(N)c(F)c(-c2cccnc2Nc2cccc3[nH]ncc23)n1		CHEMBL2165035	=	Ki	nM	990.0	CHEMBL3145	Homo sapiens	Ki	nM	990.0
	12092998	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(N)cc(-c2cccnc2Nc2cccc3[nH]ncc23)n1		CHEMBL2165271	=	Ki	nM	110.0	CHEMBL3145	Homo sapiens	Ki	nM	110.0
	12092999	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(N)cc(-c2cccnc2Nc2cccc(O)c2)n1		CHEMBL2165270	=	Ki	nM	35.0	CHEMBL3145	Homo sapiens	Ki	nM	35.0
	12093000	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncccc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165269	=	Ki	nM	23.0	CHEMBL3145	Homo sapiens	Ki	nM	23.0
	12093001	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(N)nc(-c2cccnc2Nc2cccc3[nH]ccc23)n1		CHEMBL2165268	=	Ki	nM	9.0	CHEMBL3145	Homo sapiens	Ki	nM	9.0
	12093002	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(N)nc(-c2cccnc2Nc2cccc3[nH]ncc23)n1		CHEMBL2165053	=	Ki	nM	51.0	CHEMBL3145	Homo sapiens	Ki	nM	51.0
	12093003	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(N)nc(-c2cccnc2Nc2cccc(O)c2)n1		CHEMBL2165052	=	Ki	nM	3.0	CHEMBL3145	Homo sapiens	Ki	nM	3.0
	12093004	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1ncnc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL2165051	=	Ki	nM	4.0	CHEMBL3145	Homo sapiens	Ki	nM	4.0
	12093005	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(NCC#N)nc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL1762782	=	Ki	nM	43.0	CHEMBL3145	Homo sapiens	Ki	nM	43.0
	12093006	CHEMBL2166656	Inhibition of human N-terminal poly-His tagged-PI3Kbeta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	N#CCNc1ncnc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL1615182	=	Ki	nM	190.0	CHEMBL3145	Homo sapiens	Ki	nM	190.0
	12094733	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	uM	0.01
	12094755	CHEMBL2167601	Inhibition of human PI3K p110beta-mediated AKT phosphorylation at Ser473 in MDA-MB-468 cells after 2 hrs by fluorescence microplate cytometric analysis	B	C[C@H]1CN(c2cc(N(CCO)Cc3cccc4ccccc34)[nH]c(=O)n2)CCO1		CHEMBL2165189	=	IC50	nM	195.0	CHEMBL3145	Homo sapiens	IC50	nM	195.0
	12094815	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	C[C@@H]1CN(c2cc(N(CCO)Cc3cccc4ccccc34)[nH]c(=O)n2)CCO1		CHEMBL2165190	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	12094816	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	C[C@H]1CN(c2cc(N(CCO)Cc3cccc4ccccc34)[nH]c(=O)n2)CCO1		CHEMBL2165189	=	IC50	nM	38.0	CHEMBL3145	Homo sapiens	IC50	uM	0.038
	12094817	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	CN(C)CCCN(Cc1cccc2ccccc12)c1cc(N2CCOCC2)nc(=O)[nH]1		CHEMBL2165188	=	IC50	nM	1200.0	CHEMBL3145	Homo sapiens	IC50	uM	1.2
	12094818	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	CN(C)CCN(Cc1cccc2ccccc12)c1cc(N2CCOCC2)nc(=O)[nH]1		CHEMBL2165187	=	IC50	nM	3100.0	CHEMBL3145	Homo sapiens	IC50	uM	3.1
	12094819	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	CC(C)(CO)CN(Cc1cccc2ccccc12)c1cc(N2CCOCC2)nc(=O)[nH]1		CHEMBL2165186	=	IC50	nM	1400.0	CHEMBL3145	Homo sapiens	IC50	uM	1.4
	12094820	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1nc(N2CCOCC2)cc(N(Cc2cccc3ccccc23)CC(O)C(F)(F)F)[nH]1		CHEMBL2165185	=	IC50	nM	980.0	CHEMBL3145	Homo sapiens	IC50	uM	0.98
	12094821	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	CCC(O)CN(Cc1cccc2ccccc12)c1cc(N2CCOCC2)nc(=O)[nH]1		CHEMBL2165184	=	IC50	nM	220.0	CHEMBL3145	Homo sapiens	IC50	uM	0.22
	12094822	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	CC(O)CN(Cc1cccc2ccccc12)c1cc(N2CCOCC2)nc(=O)[nH]1		CHEMBL2165183	=	IC50	nM	140.0	CHEMBL3145	Homo sapiens	IC50	uM	0.14
	12094823	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1nc(N2CCOCC2)cc(N(CCCCO)Cc2cccc3ccccc23)[nH]1		CHEMBL2165182	=	IC50	nM	200.0	CHEMBL3145	Homo sapiens	IC50	uM	0.2
	12094824	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1nc(N2CCOCC2)cc(N(CCCO)Cc2cccc3ccccc23)[nH]1		CHEMBL2165181	=	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	uM	0.1
	12094825	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1nc(N2CCOCC2)cc(N(CCO)Cc2cccc3ccccc23)[nH]1		CHEMBL2165180	=	IC50	nM	90.0	CHEMBL3145	Homo sapiens	IC50	uM	0.09
	12094826	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1nc(N2CCOCC2)cc(N(Cc2cccc3ccccc23)C2CC2)[nH]1		CHEMBL2165179	=	IC50	nM	970.0	CHEMBL3145	Homo sapiens	IC50	uM	0.97
	12094827	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	CCN(Cc1cccc2ccccc12)c1cc(N2CCOCC2)nc(=O)[nH]1		CHEMBL2165178	=	IC50	nM	130.0	CHEMBL3145	Homo sapiens	IC50	uM	0.13
	12094828	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	CN(Cc1cccc2ccccc12)c1cc(N2CCOCC2)nc(=O)[nH]1		CHEMBL2165177	=	IC50	nM	600.0	CHEMBL3145	Homo sapiens	IC50	uM	0.6
	12094829	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1cc(-c2cn[nH]c2)nc(NCc2cccc3ccccc23)[nH]1		CHEMBL2165176	=	IC50	nM	11000.0	CHEMBL3145	Homo sapiens	IC50	uM	11.0
	12094830	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	Cc1cc(-c2cc(=O)[nH]c(NCc3cccc4ccccc34)n2)ccn1		CHEMBL2165175	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	uM	0.007
	12094831	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	O=c1cc(N2CCC(O)CC2)nc(NCc2cccc3ccccc23)[nH]1		CHEMBL2165194	=	IC50	nM	31000.0	CHEMBL3145	Homo sapiens	IC50	uM	31.0
	12094832	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	COC1CN(c2cc(=O)[nH]c(NCc3cccc4ccccc34)n2)C1		CHEMBL2165193	=	IC50	nM	24000.0	CHEMBL3145	Homo sapiens	IC50	uM	24.0
	12094833	CHEMBL2167591	Inhibition of human recombinant His6-tagged PI3K p110beta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	CC1CN(c2cc(=O)[nH]c(NCc3cccc4ccccc34)n2)CCO1		CHEMBL2165192	=	IC50	nM	34.0	CHEMBL3145	Homo sapiens	IC50	uM	0.034
	12100988	CHEMBL2173157	Inhibition of PI3Kbeta	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	12104417	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ccc(-c3ccncc3)cc21		CHEMBL2171926	=	IC50	nM	81.0	CHEMBL3145	Homo sapiens	IC50	nM	81.0
	12104421	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ccc(-c3ccnc(N)n3)cc21		CHEMBL2171927	=	Ki	nM	54.0	CHEMBL3145	Homo sapiens	Ki	nM	54.0
	12104423	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC2(CCOCC2)c2ncc(N3CCOCC3)cc21		CHEMBL2171931	=	Ki	nM	44.0	CHEMBL3145	Homo sapiens	Ki	nM	44.0
	12104426	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC2(CS(=O)(=O)C2)c2ccc(N3CCOCC3)cc21		CHEMBL2171924	=	Ki	nM	395.0	CHEMBL3145	Homo sapiens	Ki	nM	395.0
	12104428	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ncc(N3CCOCC3)cc21		CHEMBL2171929	=	Ki	nM	30.0	CHEMBL3145	Homo sapiens	Ki	nM	30.0
	12104430	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(CO)(CO)c2ccc(N3CCOCC3)cc21		CHEMBL2171925	=	Ki	nM	269.0	CHEMBL3145	Homo sapiens	Ki	nM	269.0
	12104433	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ncc(-c3ccnc(N)n3)cc21		CHEMBL2171930	=	Ki	nM	18.0	CHEMBL3145	Homo sapiens	Ki	nM	18.0
	12104446	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cccc(F)c2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171919	=	IC50	nM	720.0	CHEMBL3145	Homo sapiens	IC50	nM	720.0
	12104456	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC2(CCOCC2)c2ccc(N3CCOCC3)cc21		CHEMBL2171923	=	IC50	nM	143.0	CHEMBL3145	Homo sapiens	IC50	nM	143.0
	12104460	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccc2)nc2ccccc2c1N1CC2(CCOCC2)c2ccc(N3CCOCC3)cc21		CHEMBL2171922	=	IC50	nM	105.0	CHEMBL3145	Homo sapiens	IC50	nM	105.0
	12104485	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1nc2ccc(Cl)cc2c(N2CC(C)(C)c3ccc(N4CCOCC4)cc32)c1C		CHEMBL2171933	=	IC50	nM	60.0	CHEMBL3145	Homo sapiens	IC50	nM	60.0
	12104486	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1nc2ccccc2c(N2CC(C)(C)c3ccc(N4CCOCC4)cc32)c1C		CHEMBL2171932	=	IC50	nM	60.0	CHEMBL3145	Homo sapiens	IC50	nM	60.0
	12104487	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccc2)nc2ccccc2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171934	=	IC50	nM	59.0	CHEMBL3145	Homo sapiens	IC50	nM	59.0
	12104489	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171918	=	IC50	nM	58.0	CHEMBL3145	Homo sapiens	IC50	nM	58.0
	12104492	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1nc2ccccc2c(N2CC3(CCOCC3)c3ccc(N4CCOCC4)cc32)c1C		CHEMBL2171921	=	IC50	nM	54.0	CHEMBL3145	Homo sapiens	IC50	nM	54.0
	12104493	CHEMBL2176626	Inhibition of PI3Kbeta-mediated AKT Ser473 phosphorylation in human MDA-MB-468 cells after 120 mins by meso scale discover assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171918	=	IC50	nM	53.0	CHEMBL3145	Homo sapiens	IC50	nM	53.0
	12104497	CHEMBL2176626	Inhibition of PI3Kbeta-mediated AKT Ser473 phosphorylation in human MDA-MB-468 cells after 120 mins by meso scale discover assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ncc(N3CCOCC3)cc21		CHEMBL2171929	=	IC50	nM	51.0	CHEMBL3145	Homo sapiens	IC50	nM	51.0
	12104507	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2cccnc2)nc2cc(F)ccc2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171920	=	IC50	nM	39.0	CHEMBL3145	Homo sapiens	IC50	nM	39.0
	12104508	CHEMBL2176626	Inhibition of PI3Kbeta-mediated AKT Ser473 phosphorylation in human MDA-MB-468 cells after 120 mins by meso scale discover assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC2(CCOCC2)c2ncc(N3CCOCC3)cc21		CHEMBL2171931	=	IC50	nM	36.0	CHEMBL3145	Homo sapiens	IC50	nM	36.0
	12104511	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccc2F)nc2ccccc2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171935	=	IC50	nM	35.0	CHEMBL3145	Homo sapiens	IC50	nM	35.0
	12104542	CHEMBL2176626	Inhibition of PI3Kbeta-mediated AKT Ser473 phosphorylation in human MDA-MB-468 cells after 120 mins by meso scale discover assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ncc(-c3ccnc(N)n3)cc21		CHEMBL2171930	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	12104573	CHEMBL2174951	Inhibition of PI3Kbeta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1cc(-c2ccc3c(c2)N(c2c(C)c(-c4ccccn4)nc4cc(F)ccc24)CC3(C)C)nc(N)n1	Outside typical range	CHEMBL2171928	>	Ki	nM	125000.0	CHEMBL3145	Homo sapiens	Ki	nM	125000.0
	12104608	CHEMBL2174978	Inhibition of PI3Kbeta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2171944	=	IC50	nM	547.0	CHEMBL3145	Homo sapiens	IC50	nM	547.0
	12107714	CHEMBL2175552	Inhibition of PI3Kbeta by AlphaScreen assay	B	Cc1nc(N)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1		CHEMBL1615183	=	IC50	nM	875.0	CHEMBL3145	Homo sapiens	IC50	nM	875.0
	12108932	CHEMBL2175552	Inhibition of PI3Kbeta by AlphaScreen assay	B	Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccccn23)n1		CHEMBL2172637	=	IC50	nM	1130.0	CHEMBL3145	Homo sapiens	IC50	nM	1130.0
	12166169	CHEMBL2214051	Inhibition of human N-terminal polyHis-tagged PI3K p110beta expressed in baculovirus infected Hi5 cells using Phosphatidylinositol-4,5-bisphosphate as substrate after 20 mins by AlphaScreen assay	B	COCCOc1cnc(Nc2cnc(Cl)c(NS(C)(=O)=O)c2)c(-c2nc(C)nc(N)n2)c1		CHEMBL2206906	=	Ki	nM	16.0	CHEMBL3145	Homo sapiens	Ki	nM	16.0
	12166170	CHEMBL2214051	Inhibition of human N-terminal polyHis-tagged PI3K p110beta expressed in baculovirus infected Hi5 cells using Phosphatidylinositol-4,5-bisphosphate as substrate after 20 mins by AlphaScreen assay	B	COc1cnc(Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)c(-c2nc(C)nc(N)n2)c1		CHEMBL2206904	=	Ki	nM	4.7	CHEMBL3145	Homo sapiens	Ki	nM	4.7
	12166171	CHEMBL2214051	Inhibition of human N-terminal polyHis-tagged PI3K p110beta expressed in baculovirus infected Hi5 cells using Phosphatidylinositol-4,5-bisphosphate as substrate after 20 mins by AlphaScreen assay	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	=	Ki	nM	0.6	CHEMBL3145	Homo sapiens	Ki	nM	0.6
	12166172	CHEMBL2214051	Inhibition of human N-terminal polyHis-tagged PI3K p110beta expressed in baculovirus infected Hi5 cells using Phosphatidylinositol-4,5-bisphosphate as substrate after 20 mins by AlphaScreen assay	B	Cc1nc(N)nc(-c2cccnc2Nc2cnc(Cl)c(NS(C)(=O)=O)c2)n1		CHEMBL2206913	=	Ki	nM	4.4	CHEMBL3145	Homo sapiens	Ki	nM	4.4
	12172274	CHEMBL2212504	Inhibition of PIK3CB assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL3145	Homo sapiens	Activity	%	100.0
	12176879	CHEMBL2214582	Inhibition of PI3Kbeta by HTRF assay in presence of ATP	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	uM	0.009
	12176882	CHEMBL2214582	Inhibition of PI3Kbeta by HTRF assay in presence of ATP	B	Nc1ccc(-c2cccc3c(=O)nc(N4CCOCC4)oc23)c(F)c1		CHEMBL2204552	=	IC50	nM	540.0	CHEMBL3145	Homo sapiens	IC50	uM	0.54
	12176885	CHEMBL2214582	Inhibition of PI3Kbeta by HTRF assay in presence of ATP	B	Nc1ccc(-c2cccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL2204551	=	IC50	nM	2340.0	CHEMBL3145	Homo sapiens	IC50	uM	2.34
	12176911	CHEMBL2214582	Inhibition of PI3Kbeta by HTRF assay in presence of ATP	B	Cc1c(OCc2cccnc2)ccc2c(=O)nc(N3CCOCC3)oc12		CHEMBL1276684	=	IC50	nM	140.0	CHEMBL3145	Homo sapiens	IC50	uM	0.14
	12176920	CHEMBL2214582	Inhibition of PI3Kbeta by HTRF assay in presence of ATP	B	Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)nc(N3CCOCC3)oc12		CHEMBL244672	>=	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	uM	100.0
	12176927	CHEMBL2214582	Inhibition of PI3Kbeta by HTRF assay in presence of ATP	B	O=c1nc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL243810	=	IC50	nM	3360.0	CHEMBL3145	Homo sapiens	IC50	uM	3.36
	12185200	CHEMBL2211981	Inhibition of PIK3Cb	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	=	IC50	nM	489.78	CHEMBL3145	Homo sapiens	pIC50		6.31
	12185209	CHEMBL2215895	Inhibition of PI3Kbeta assessed as change in pIC50 by kinobeads assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2cc(F)c3nc(N)nn3c2)c1		CHEMBL2064571	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
	12185237	CHEMBL2215895	Inhibition of PI3Kbeta assessed as change in pIC50 by kinobeads assay	B	Nc1nc2cc(-c3cncc(S(=O)(=O)NCC(F)(F)F)c3)ccn2n1	Outside typical range	CHEMBL2205767	=	IC50	nM	12589254.12	CHEMBL3145	Homo sapiens	pIC50		1.9
	12185249	CHEMBL2215895	Inhibition of PI3Kbeta assessed as change in pIC50 by kinobeads assay	B	CCN(CC)S(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1	Outside typical range	CHEMBL2205771	=	IC50	nM	25118864.32	CHEMBL3145	Homo sapiens	pIC50		1.6
	12185250	CHEMBL2215895	Inhibition of PI3Kbeta assessed as change in pIC50 by kinobeads assay	B	Nc1nc2cc(-c3cncc(S(=O)(=O)NCc4ccccc4)c3)ccn2n1	Outside typical range	CHEMBL2205770	=	IC50	nM	25118864.32	CHEMBL3145	Homo sapiens	pIC50		1.6
	12185255	CHEMBL2215895	Inhibition of PI3Kbeta assessed as change in pIC50 by kinobeads assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2cc(F)n3nc(N)nc3c2)c1	Outside typical range	CHEMBL2205763	=	IC50	nM	31622776.6	CHEMBL3145	Homo sapiens	pIC50		1.5
	12185256	CHEMBL2215895	Inhibition of PI3Kbeta assessed as change in pIC50 by kinobeads assay	B	Nc1nc2cc(-c3cncc(S(=O)(=O)Nc4ccccc4)c3)ccn2n1	Outside typical range	CHEMBL2205769	=	IC50	nM	31622776.6	CHEMBL3145	Homo sapiens	pIC50		1.5
	12185257	CHEMBL2215895	Inhibition of PI3Kbeta assessed as change in pIC50 by kinobeads assay	B	CC(C)(NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1)C(F)(F)F	Outside typical range	CHEMBL2205768	=	IC50	nM	31622776.6	CHEMBL3145	Homo sapiens	pIC50		1.5
	12185258	CHEMBL2215895	Inhibition of PI3Kbeta assessed as change in pIC50 by kinobeads assay	B	CCCNS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1	Outside typical range	CHEMBL2205764	=	IC50	nM	31622776.6	CHEMBL3145	Homo sapiens	pIC50		1.5
	12185260	CHEMBL2215895	Inhibition of PI3Kbeta assessed as change in pIC50 by kinobeads assay	B	CNS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1	Outside typical range	CHEMBL2205774	=	IC50	nM	39810717.06	CHEMBL3145	Homo sapiens	pIC50		1.4
	12185261	CHEMBL2215895	Inhibition of PI3Kbeta assessed as change in pIC50 by kinobeads assay	B	Nc1nc2cc(-c3cncc(S(N)(=O)=O)c3)ccn2n1	Outside typical range	CHEMBL2205773	=	IC50	nM	39810717.06	CHEMBL3145	Homo sapiens	pIC50		1.4
	12185262	CHEMBL2215895	Inhibition of PI3Kbeta assessed as change in pIC50 by kinobeads assay	B	CS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1	Outside typical range	CHEMBL2203312	=	IC50	nM	39810717.06	CHEMBL3145	Homo sapiens	pIC50		1.4
	12185266	CHEMBL2215895	Inhibition of PI3Kbeta assessed as change in pIC50 by kinobeads assay	B	CC1(C)CCN1S(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1	Outside typical range	CHEMBL2205772	=	IC50	nM	50118723.36	CHEMBL3145	Homo sapiens	pIC50		1.3
	12185267	CHEMBL2215895	Inhibition of PI3Kbeta assessed as change in pIC50 by kinobeads assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1	Outside typical range	CHEMBL2205766	=	IC50	nM	50118723.36	CHEMBL3145	Homo sapiens	pIC50		1.3
	12185270	CHEMBL2215895	Inhibition of PI3Kbeta assessed as change in pIC50 by kinobeads assay	B	CC(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1	Outside typical range	CHEMBL2205765	=	IC50	nM	63095734.45	CHEMBL3145	Homo sapiens	pIC50		1.2
	12205264	CHEMBL2217288	Inhibition of PI3Kbeta at 1 uM	B	CC(c1oc2ccccc2c(=O)c1-c1cccc(F)c1)n1cnc2c(N)ncnc21		CHEMBL2216861	<	Inhibition	%	25.0	CHEMBL3145	Homo sapiens	INH	%	25.0
	12205435	CHEMBL2217272	Inhibition of PI3Kbeta in presence of 10 uM ATP	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	88.0	CHEMBL3145	Homo sapiens	IC50	uM	0.088
	12205436	CHEMBL2217272	Inhibition of PI3Kbeta in presence of 10 uM ATP	B	COc1ccc2c(c1OC)N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL1241857	=	IC50	nM	350.0	CHEMBL3145	Homo sapiens	IC50	uM	0.35
	12205437	CHEMBL2217272	Inhibition of PI3Kbeta in presence of 10 uM ATP	B	COc1ccccc1-n1c(CSc2ncnc3[nH]cnc23)nc2cccc(Cl)c2c1=O		CHEMBL1213083	=	IC50	nM	11000.0	CHEMBL3145	Homo sapiens	IC50	uM	11.0
	12205438	CHEMBL2217272	Inhibition of PI3Kbeta in presence of 10 uM ATP	B	Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213082	=	IC50	nM	16000.0	CHEMBL3145	Homo sapiens	IC50	uM	16.0
	12205448	CHEMBL2217268	Inhibition of PI3Kbeta using phosphatidylinositol as substrate by gamma33P[ATP] incorporation assay	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	310.0	CHEMBL3145	Homo sapiens	IC50	uM	0.31
	12205453	CHEMBL2217264	Inhibition of PI3Kbeta	B	O=C1NC(=O)/C(=C\c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL2216899	>	IC50	nM	20000.0	CHEMBL3145	Homo sapiens	IC50	uM	20.0
	12205454	CHEMBL2217264	Inhibition of PI3Kbeta	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	IC50	nM	14.0	CHEMBL3145	Homo sapiens	IC50	uM	0.014
Not Active	12625608	CHEMBL2317605	Binding affinity to human PI3Kbeta after 1 hr by MALDI TOF/TOF mass spectrometry	B	CC(C)=CC(=O)CCC(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2316958		Activity			CHEMBL3145	Homo sapiens	Activity		
	12625629	CHEMBL2317623	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	CC(C)=CC(=O)CCC(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2316958	=	IC50	nM	166.0	CHEMBL3145	Homo sapiens	IC50(app)	nM	166.0
Not Active	12645682	CHEMBL2330455	Binding affinity to PI3Kbeta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc(N4CCOCC4)cc3)csc12		CHEMBL2322238		Activity			CHEMBL3145	Homo sapiens	Activity		
Not Active	12645683	CHEMBL2330455	Binding affinity to PI3Kbeta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(N3CCCCC3)csc12		CHEMBL2322237		Activity			CHEMBL3145	Homo sapiens	Activity		
	12645728	CHEMBL2330613	Ratio of LY294002 IC50 to compound IC50 for PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)csc12		CHEMBL2322239	=	Ratio IC50		1.9	CHEMBL3145	Homo sapiens	Ratio IC50		1.9
	12645806	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	562.0	CHEMBL3145	Homo sapiens	IC50	nM	562.0
	12645807	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	CN1CCN(c2ncc(-c3csc4c(=O)cc(N5CCOCC5)oc34)cn2)CC1		CHEMBL2326951	=	IC50	nM	433.0	CHEMBL3145	Homo sapiens	IC50	nM	433.0
	12645808	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	COC(=O)c1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2326953	=	IC50	nM	3600.0	CHEMBL3145	Homo sapiens	IC50	nM	3600.0
	12645809	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	CCOC(=O)c1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2326952	=	IC50	nM	1750.0	CHEMBL3145	Homo sapiens	IC50	nM	1750.0
	12645810	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	S=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL2326965	=	IC50	nM	1161.0	CHEMBL3145	Homo sapiens	IC50	nM	1161.0
	12645811	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	736.0	CHEMBL3145	Homo sapiens	IC50	nM	736.0
	12645812	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=C(O)c1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2326956	=	IC50	nM	240.0	CHEMBL3145	Homo sapiens	IC50	nM	240.0
	12645813	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=C(Nc1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1)c1cccnc1		CHEMBL2326955	=	IC50	nM	244.0	CHEMBL3145	Homo sapiens	IC50	nM	244.0
	12645814	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	CNc1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2326954	=	IC50	nM	195.0	CHEMBL3145	Homo sapiens	IC50	nM	195.0
	12645815	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	CC(=O)Nc1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2322236	=	IC50	nM	8930.0	CHEMBL3145	Homo sapiens	IC50	nM	8930.0
	12645816	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc(C(F)(F)F)cc3)csc12		CHEMBL2322234	=	IC50	nM	632.0	CHEMBL3145	Homo sapiens	IC50	nM	632.0
	12645817	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc(Cl)c(Cl)c3)csc12		CHEMBL2322233	=	IC50	nM	139.0	CHEMBL3145	Homo sapiens	IC50	nM	139.0
	12645818	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)csc12		CHEMBL2322232	=	IC50	nM	418.0	CHEMBL3145	Homo sapiens	IC50	nM	418.0
	12645819	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	N#Cc1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2322231	>	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	nM	50000.0
	12645820	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(Cc3ccccc3)csc12		CHEMBL2322230	=	IC50	nM	150.0	CHEMBL3145	Homo sapiens	IC50	nM	150.0
	12645821	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	COc1cccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL2322229	=	IC50	nM	371.0	CHEMBL3145	Homo sapiens	IC50	nM	371.0
	12645822	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc4c(c3)OCCO4)csc12		CHEMBL2322228	=	IC50	nM	214.0	CHEMBL3145	Homo sapiens	IC50	nM	214.0
	12645823	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccoc3)csc12		CHEMBL2322227	=	IC50	nM	7047.0	CHEMBL3145	Homo sapiens	IC50	nM	7047.0
	12645824	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccsc3)csc12		CHEMBL2322226	=	IC50	nM	568.0	CHEMBL3145	Homo sapiens	IC50	nM	568.0
	12645825	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc4[nH]ccc4c3)csc12		CHEMBL2322225	=	IC50	nM	161.0	CHEMBL3145	Homo sapiens	IC50	nM	161.0
	12645826	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	Cc1cccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL2326971	=	IC50	nM	175.0	CHEMBL3145	Homo sapiens	IC50	nM	175.0
	12645827	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	Cc1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2326970	>	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	nM	50000.0
	12645828	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3cccs3)csc12		CHEMBL2326969	=	IC50	nM	1205.0	CHEMBL3145	Homo sapiens	IC50	nM	1205.0
	12645829	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	CS(=O)(=O)c1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2326968	=	IC50	nM	5241.0	CHEMBL3145	Homo sapiens	IC50	nM	5241.0
	12645830	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3cc4ccccc4[nH]3)csc12		CHEMBL2326967	=	IC50	nM	2757.0	CHEMBL3145	Homo sapiens	IC50	nM	2757.0
	12645831	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2ccsc12		CHEMBL2322246	=	IC50	nM	9247.0	CHEMBL3145	Homo sapiens	IC50	nM	9247.0
	12645832	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	CN(C)c1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2322245	=	IC50	nM	693.0	CHEMBL3145	Homo sapiens	IC50	nM	693.0
	12645833	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	COc1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2322244	=	IC50	nM	310.0	CHEMBL3145	Homo sapiens	IC50	nM	310.0
	12645834	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL2322243	=	IC50	nM	367.0	CHEMBL3145	Homo sapiens	IC50	nM	367.0
	12645835	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccco3)csc12		CHEMBL2322242	=	IC50	nM	134.0	CHEMBL3145	Homo sapiens	IC50	nM	134.0
	12645836	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccncc3)csc12		CHEMBL2322241	=	IC50	nM	2554.0	CHEMBL3145	Homo sapiens	IC50	nM	2554.0
	12645837	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3cccnc3)csc12		CHEMBL2322240	=	IC50	nM	1027.0	CHEMBL3145	Homo sapiens	IC50	nM	1027.0
	12645838	CHEMBL2330620	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)csc12		CHEMBL2322239	=	IC50	nM	378.0	CHEMBL3145	Homo sapiens	IC50	nM	378.0
	12655328	CHEMBL2328807	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in absence of serum	B	Cc1c(Cn2c(C)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089106	=	EC50	nM	6.31	CHEMBL3145	Homo sapiens	pEC50		8.2
	12655329	CHEMBL2328807	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in absence of serum	B	COc1nn2c(O)cc(-c3ccncc3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322344	=	EC50	nM	158.49	CHEMBL3145	Homo sapiens	pEC50		6.8
	12655330	CHEMBL2328807	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in absence of serum	B	Cc1c(Cc2cnn3c(O)cc(-c4ccncc4)nc23)cccc1C(F)(F)F		CHEMBL2322337	=	EC50	nM	25.12	CHEMBL3145	Homo sapiens	pEC50		7.6
	12655331	CHEMBL2328807	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in absence of serum	B	Cc1c(Cc2cnn3c(O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL2322336	=	EC50	nM	63.1	CHEMBL3145	Homo sapiens	pEC50		7.2
	12655332	CHEMBL2328807	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in absence of serum	B	Cc1nn2c(O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322331	=	EC50	nM	31.62	CHEMBL3145	Homo sapiens	pEC50		7.5
	12655333	CHEMBL2328808	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in presence of serum	B	Cc1c(Cn2c(C)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089106	=	EC50	nM	15.85	CHEMBL3145	Homo sapiens	pEC50		7.8
	12655337	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1c(Cn2c(C)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089106	=	IC50	nM	0.631	CHEMBL3145	Homo sapiens	pIC50		9.2
	12655341	CHEMBL2328808	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in presence of serum	B	Cc1nn2c(NC(N)=O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322356	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655342	CHEMBL2328808	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in presence of serum	B	Cc1nn2c(N)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322352	=	EC50	nM	1000.0	CHEMBL3145	Homo sapiens	pEC50		6.0
	12655343	CHEMBL2328808	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in presence of serum	B	Cc1nn2c(C(N)=O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322350	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655344	CHEMBL2328808	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in presence of serum	B	Cc1nn2c(C(=O)O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322349	=	EC50	nM	1000.0	CHEMBL3145	Homo sapiens	pEC50		6.0
	12655345	CHEMBL2328808	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in presence of serum	B	Nc1nn2c(O)cc(C3CCOCC3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322345	=	EC50	nM	1995.26	CHEMBL3145	Homo sapiens	pEC50		5.7
	12655346	CHEMBL2328808	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in presence of serum	B	COc1nn2c(O)cc(-c3ccncc3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322344	=	EC50	nM	12589.25	CHEMBL3145	Homo sapiens	pEC50		4.9
	12655347	CHEMBL2328808	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in presence of serum	B	Oc1cc(N2CCOCC2)nc2c(Cc3cccc(Cl)c3Cl)c(C(F)(F)F)nn12		CHEMBL2322340	=	EC50	nM	5011.87	CHEMBL3145	Homo sapiens	pEC50		5.3
	12655348	CHEMBL2328808	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in presence of serum	B	CCc1nn2c(O)cc(-c3ccncc3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322338	=	EC50	nM	19952.62	CHEMBL3145	Homo sapiens	pEC50		4.7
	12655349	CHEMBL2328808	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in presence of serum	B	Cc1c(Cc2cnn3c(O)cc(-c4ccncc4)nc23)cccc1C(F)(F)F		CHEMBL2322337	=	EC50	nM	3162.28	CHEMBL3145	Homo sapiens	pEC50		5.5
	12655350	CHEMBL2328808	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in presence of serum	B	Cc1c(Cc2cnn3c(O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL2322336	=	EC50	nM	1000.0	CHEMBL3145	Homo sapiens	pEC50		6.0
	12655351	CHEMBL2328808	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in presence of serum	B	Cc1nn2c(O)cc(C3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322333	=	EC50	nM	10000.0	CHEMBL3145	Homo sapiens	pEC50		5.0
	12655352	CHEMBL2328808	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in presence of serum	B	Cc1nn2c(O)cc(N3CCOCC3)nc2c1Cc1cccc2ccccc12		CHEMBL2322332	=	EC50	nM	1000.0	CHEMBL3145	Homo sapiens	pEC50		6.0
	12655353	CHEMBL2328808	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as reduction of AKT phosphorylation at Ser 473 in presence of serum	B	Cc1nn2c(O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322331	=	EC50	nM	1584.89	CHEMBL3145	Homo sapiens	pEC50		5.8
	12655356	CHEMBL2328814	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as reduction of AKT phosphorylation at Ser 473	B	Cc1nn2c(NC(N)=O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322356	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655357	CHEMBL2328814	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as reduction of AKT phosphorylation at Ser 473	B	Cc1nn2c(N)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322352	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655358	CHEMBL2328814	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as reduction of AKT phosphorylation at Ser 473	B	Cc1nn2c(C(N)=O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322350	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655359	CHEMBL2328814	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as reduction of AKT phosphorylation at Ser 473	B	Cc1nn2c(C(=O)O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322349	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655360	CHEMBL2328814	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as reduction of AKT phosphorylation at Ser 473	B	Nc1nn2c(O)cc(C3CCOCC3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322345	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655361	CHEMBL2328814	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as reduction of AKT phosphorylation at Ser 473	B	COc1nn2c(O)cc(-c3ccncc3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322344	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655362	CHEMBL2328814	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as reduction of AKT phosphorylation at Ser 473	B	Oc1cc(N2CCOCC2)nc2c(Cc3cccc(Cl)c3Cl)c(C(F)(F)F)nn12		CHEMBL2322340	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655363	CHEMBL2328814	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as reduction of AKT phosphorylation at Ser 473	B	CCc1nn2c(O)cc(-c3ccncc3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322338	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655364	CHEMBL2328814	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as reduction of AKT phosphorylation at Ser 473	B	Cc1c(Cc2cnn3c(O)cc(-c4ccncc4)nc23)cccc1C(F)(F)F		CHEMBL2322337	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655365	CHEMBL2328814	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as reduction of AKT phosphorylation at Ser 473	B	Cc1c(Cc2cnn3c(O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL2322336	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655366	CHEMBL2328814	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as reduction of AKT phosphorylation at Ser 473	B	Cc1nn2c(O)cc(C3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322333	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655367	CHEMBL2328814	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as reduction of AKT phosphorylation at Ser 473	B	Cc1nn2c(O)cc(N3CCOCC3)nc2c1Cc1cccc2ccccc12		CHEMBL2322332	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655368	CHEMBL2328814	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as reduction of AKT phosphorylation at Ser 473	B	Cc1nn2c(O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322331	<	EC50	nM	15848.93	CHEMBL3145	Homo sapiens	pEC50		4.8
	12655369	CHEMBL2328815	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as cell growth inhibition	B	Cc1nn2c(NC(N)=O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322356	=	EC50	nM	12589.25	CHEMBL3145	Homo sapiens	pEC50		4.9
	12655370	CHEMBL2328815	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as cell growth inhibition	B	Cc1nn2c(N)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322352	=	EC50	nM	12589.25	CHEMBL3145	Homo sapiens	pEC50		4.9
	12655371	CHEMBL2328815	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as cell growth inhibition	B	Cc1nn2c(C(N)=O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322350	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655372	CHEMBL2328815	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as cell growth inhibition	B	Cc1nn2c(C(=O)O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322349	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655373	CHEMBL2328815	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as cell growth inhibition	B	Nc1nn2c(O)cc(C3CCOCC3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322345	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655374	CHEMBL2328815	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as cell growth inhibition	B	COc1nn2c(O)cc(-c3ccncc3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322344	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655375	CHEMBL2328815	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as cell growth inhibition	B	Oc1cc(N2CCOCC2)nc2c(Cc3cccc(Cl)c3Cl)c(C(F)(F)F)nn12		CHEMBL2322340	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
Not Determined	12655376	CHEMBL2328815	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as cell growth inhibition	B	CCc1nn2c(O)cc(-c3ccncc3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322338		pEC50			CHEMBL3145	Homo sapiens	pEC50		
	12655377	CHEMBL2328815	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as cell growth inhibition	B	Cc1c(Cc2cnn3c(O)cc(-c4ccncc4)nc23)cccc1C(F)(F)F		CHEMBL2322337	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655378	CHEMBL2328815	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as cell growth inhibition	B	Cc1c(Cc2cnn3c(O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL2322336	=	EC50	nM	15848.93	CHEMBL3145	Homo sapiens	pEC50		4.8
	12655379	CHEMBL2328815	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as cell growth inhibition	B	Cc1nn2c(O)cc(C3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322333	=	EC50	nM	25118.86	CHEMBL3145	Homo sapiens	pEC50		4.6
	12655380	CHEMBL2328815	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as cell growth inhibition	B	Cc1nn2c(O)cc(N3CCOCC3)nc2c1Cc1cccc2ccccc12		CHEMBL2322332	=	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
	12655381	CHEMBL2328815	Inhibition of PI3Kbeta human in PTEN wild type HCC1954 cells assessed as cell growth inhibition	B	Cc1nn2c(O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322331	=	EC50	nM	15848.93	CHEMBL3145	Homo sapiens	pEC50		4.8
	12655382	CHEMBL2328817	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as cell growth inhibition	B	Cc1nn2c(NC(N)=O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322356	=	EC50	nM	1258.93	CHEMBL3145	Homo sapiens	pEC50		5.9
	12655383	CHEMBL2328817	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as cell growth inhibition	B	Cc1nn2c(N)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322352	=	EC50	nM	12589.25	CHEMBL3145	Homo sapiens	pEC50		4.9
	12655384	CHEMBL2328817	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as cell growth inhibition	B	Cc1nn2c(C(N)=O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322350	=	EC50	nM	1995.26	CHEMBL3145	Homo sapiens	pEC50		5.7
	12655385	CHEMBL2328817	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as cell growth inhibition	B	Cc1nn2c(C(=O)O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322349	=	EC50	nM	3162.28	CHEMBL3145	Homo sapiens	pEC50		5.5
	12655386	CHEMBL2328817	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as cell growth inhibition	B	Nc1nn2c(O)cc(C3CCOCC3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322345	=	EC50	nM	10000.0	CHEMBL3145	Homo sapiens	pEC50		5.0
	12655387	CHEMBL2328817	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as cell growth inhibition	B	COc1nn2c(O)cc(-c3ccncc3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322344	=	EC50	nM	25118.86	CHEMBL3145	Homo sapiens	pEC50		4.6
	12655388	CHEMBL2328817	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as cell growth inhibition	B	Oc1cc(N2CCOCC2)nc2c(Cc3cccc(Cl)c3Cl)c(C(F)(F)F)nn12		CHEMBL2322340	<	EC50	nM	31622.78	CHEMBL3145	Homo sapiens	pEC50		4.5
Not Determined	12655389	CHEMBL2328817	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as cell growth inhibition	B	CCc1nn2c(O)cc(-c3ccncc3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322338		pEC50			CHEMBL3145	Homo sapiens	pEC50		
	12655390	CHEMBL2328817	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as cell growth inhibition	B	Cc1c(Cc2cnn3c(O)cc(-c4ccncc4)nc23)cccc1C(F)(F)F		CHEMBL2322337	=	EC50	nM	15848.93	CHEMBL3145	Homo sapiens	pEC50		4.8
	12655391	CHEMBL2328817	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as cell growth inhibition	B	Cc1c(Cc2cnn3c(O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL2322336	=	EC50	nM	3162.28	CHEMBL3145	Homo sapiens	pEC50		5.5
	12655392	CHEMBL2328817	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as cell growth inhibition	B	Cc1nn2c(O)cc(C3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322333	=	EC50	nM	15848.93	CHEMBL3145	Homo sapiens	pEC50		4.8
	12655393	CHEMBL2328817	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as cell growth inhibition	B	Cc1nn2c(O)cc(N3CCOCC3)nc2c1Cc1cccc2ccccc12		CHEMBL2322332	=	EC50	nM	3981.07	CHEMBL3145	Homo sapiens	pEC50		5.4
	12655394	CHEMBL2328817	Inhibition of PI3Kbeta human in PTEN-null MDA-MB-468 cells assessed as cell growth inhibition	B	Cc1nn2c(O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322331	=	EC50	nM	5011.87	CHEMBL3145	Homo sapiens	pEC50		5.3
	12655449	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nn2c(NC(N)=O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322356	=	IC50	nM	19.95	CHEMBL3145	Homo sapiens	pIC50		7.7
	12655450	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	CC(=O)Nc1cc(N2CCOCC2)nc2c(Cc3cccc(C(F)(F)F)c3C)c(C)nn12		CHEMBL2322355	<	IC50	nM	1258.93	CHEMBL3145	Homo sapiens	pIC50		5.9
	12655451	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nn2c(NCCO)cc(C3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322354	=	IC50	nM	1258.93	CHEMBL3145	Homo sapiens	pIC50		5.9
	12655452	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nn2c(NO)cc(C3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322353	=	IC50	nM	39.81	CHEMBL3145	Homo sapiens	pIC50		7.4
	12655453	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	CNc1cc(N2CCOCC2)nc2c(Cc3cccc(C(F)(F)F)c3C)c(C)nn12		CHEMBL2321882	<	IC50	nM	3162.28	CHEMBL3145	Homo sapiens	pIC50		5.5
	12655454	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nn2c(N)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322352	=	IC50	nM	39.81	CHEMBL3145	Homo sapiens	pIC50		7.4
	12655455	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nn2c(C#N)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322351	<	IC50	nM	1258.93	CHEMBL3145	Homo sapiens	pIC50		5.9
	12655456	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nn2c(C(N)=O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322350	=	IC50	nM	25.12	CHEMBL3145	Homo sapiens	pIC50		7.6
	12655457	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nn2c(C(=O)O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322349	=	IC50	nM	5.012	CHEMBL3145	Homo sapiens	pIC50		8.3
	12655458	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nn2ccc(C3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322348	=	IC50	nM	794.33	CHEMBL3145	Homo sapiens	pIC50		6.1
	12655459	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1c(Cc2cnn3c(Cl)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL2322347	=	IC50	nM	316.23	CHEMBL3145	Homo sapiens	pIC50		6.5
	12655460	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	COc1cc(N2CCOCC2)nc2c(Cc3cccc(C(F)(F)F)c3C)cnn12		CHEMBL2322346	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
	12655461	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Nc1nn2c(O)cc(C3CCOCC3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322345	=	IC50	nM	7.943	CHEMBL3145	Homo sapiens	pIC50		8.1
	12655462	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	COc1nn2c(O)cc(-c3ccncc3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322344	=	IC50	nM	1.259	CHEMBL3145	Homo sapiens	pIC50		8.9
	12655463	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1c(Cc2c(=O)[nH]n3c(=O)cc(C4CCOCC4)[nH]c23)cccc1C(F)(F)F		CHEMBL3145359	=	IC50	nM	63.1	CHEMBL3145	Homo sapiens	pIC50		7.2
	12655464	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Oc1cc(C2CCOCC2)nc2c(Cc3cccc(Cl)c3Cl)c(C(F)(F)F)nn12		CHEMBL2322342	=	IC50	nM	6.31	CHEMBL3145	Homo sapiens	pIC50		8.2
	12655465	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Oc1cc(-c2ccncc2)nc2c(Cc3cccc(Cl)c3Cl)c(C(F)(F)F)nn12		CHEMBL2322341	=	IC50	nM	2.512	CHEMBL3145	Homo sapiens	pIC50		8.6
	12655466	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Oc1cc(N2CCOCC2)nc2c(Cc3cccc(Cl)c3Cl)c(C(F)(F)F)nn12		CHEMBL2322340	=	IC50	nM	0.3981	CHEMBL3145	Homo sapiens	pIC50		9.4
	12655467	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	CCc1nn2c(O)cc(C3CCOCC3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322339	=	IC50	nM	12.59	CHEMBL3145	Homo sapiens	pIC50		7.9
	12655468	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	CCc1nn2c(O)cc(-c3ccncc3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322338	=	IC50	nM	0.631	CHEMBL3145	Homo sapiens	pIC50		9.2
	12655469	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1c(Cc2cnn3c(O)cc(-c4ccncc4)nc23)cccc1C(F)(F)F		CHEMBL2322337	=	IC50	nM	2.512	CHEMBL3145	Homo sapiens	pIC50		8.6
	12655470	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1c(Cc2cnn3c(O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL2322336	=	IC50	nM	5.012	CHEMBL3145	Homo sapiens	pIC50		8.3
	12655471	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nn2c(O)cc(N3CCOC(C)C3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322335	=	IC50	nM	2.512	CHEMBL3145	Homo sapiens	pIC50		8.6
	12655472	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nn2c(O)cc(N3CCOCC3=O)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322334	=	IC50	nM	316.23	CHEMBL3145	Homo sapiens	pIC50		6.5
	12655473	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nn2c(O)cc(C3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322333	=	IC50	nM	3.981	CHEMBL3145	Homo sapiens	pIC50		8.4
	12655474	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nn2c(O)cc(N3CCOCC3)nc2c1Cc1cccc2ccccc12		CHEMBL2322332	=	IC50	nM	1.0	CHEMBL3145	Homo sapiens	pIC50		9.0
	12655475	CHEMBL2328820	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nn2c(O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322331	=	IC50	nM	0.3981	CHEMBL3145	Homo sapiens	pIC50		9.4
	12656664	CHEMBL2328961	Inhibition of recombinant PI3K-beta D862Q mutant (unknown origin) expressed in baculovirus infected Sf21 cells assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 100 uM ATP as substrate measured after 60 mins by luminescence assay	B	CC[C@H](C)[C@H](N)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322666	=	IC50	nM	1400.0	CHEMBL3145	Homo sapiens	IC50	nM	1400.0
	12656665	CHEMBL2328961	Inhibition of recombinant PI3K-beta D862Q mutant (unknown origin) expressed in baculovirus infected Sf21 cells assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 100 uM ATP as substrate measured after 60 mins by luminescence assay	B	N[C@@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322664	=	IC50	nM	6000.0	CHEMBL3145	Homo sapiens	IC50	nM	6000.0
	12656666	CHEMBL2328961	Inhibition of recombinant PI3K-beta D862Q mutant (unknown origin) expressed in baculovirus infected Sf21 cells assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 100 uM ATP as substrate measured after 60 mins by luminescence assay	B	C[C@H](N)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322662	=	IC50	nM	890.0	CHEMBL3145	Homo sapiens	IC50	nM	890.0
	12656677	CHEMBL2328965	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 100 uM ATP as substrate measured after 60 mins by luminescence assay	B	CC[C@H](C)[C@H](N)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322666	=	IC50	nM	140.0	CHEMBL3145	Homo sapiens	IC50	nM	140.0
	12656678	CHEMBL2328965	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 100 uM ATP as substrate measured after 60 mins by luminescence assay	B	N[C@@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322664	=	IC50	nM	74.0	CHEMBL3145	Homo sapiens	IC50	nM	74.0
	12656679	CHEMBL2328965	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 100 uM ATP as substrate measured after 60 mins by luminescence assay	B	C[C@H](N)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322662	=	IC50	nM	62.0	CHEMBL3145	Homo sapiens	IC50	nM	62.0
	12656725	CHEMBL2328970	Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	CN(C)CC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322672	=	IC50	nM	2400.0	CHEMBL3145	Homo sapiens	IC50	nM	2400.0
	12656726	CHEMBL2328970	Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	CN[C@@H](C)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322671	=	IC50	nM	260.0	CHEMBL3145	Homo sapiens	IC50	nM	260.0
	12656727	CHEMBL2328970	Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	NCCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322670	=	IC50	nM	98.0	CHEMBL3145	Homo sapiens	IC50	nM	98.0
	12656728	CHEMBL2328970	Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	NCCCC[C@H](N)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322669	=	IC50	nM	50.0	CHEMBL3145	Homo sapiens	IC50	nM	50.0
	12656729	CHEMBL2328970	Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	O=C([C@@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322668	=	IC50	nM	26.0	CHEMBL3145	Homo sapiens	IC50	nM	26.0
	12656730	CHEMBL2328970	Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322667	=	IC50	nM	220.0	CHEMBL3145	Homo sapiens	IC50	nM	220.0
	12656731	CHEMBL2328970	Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	CC[C@H](C)[C@H](N)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322666	=	IC50	nM	67.0	CHEMBL3145	Homo sapiens	IC50	nM	67.0
	12656732	CHEMBL2328970	Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	N[C@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322665	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	12656733	CHEMBL2328970	Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	N[C@@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322664	=	IC50	nM	63.0	CHEMBL3145	Homo sapiens	IC50	nM	63.0
	12656734	CHEMBL2328970	Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	C[C@@H](N)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322663	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	12656735	CHEMBL2328970	Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	C[C@H](N)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322662	=	IC50	nM	31.0	CHEMBL3145	Homo sapiens	IC50	nM	31.0
	12656736	CHEMBL2328970	Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	CC(=O)NCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322661	=	IC50	nM	54.0	CHEMBL3145	Homo sapiens	IC50	nM	54.0
	12656737	CHEMBL2328970	Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	NCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322660	=	IC50	nM	35.0	CHEMBL3145	Homo sapiens	IC50	nM	35.0
	12656738	CHEMBL2328970	Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
	12662873	CHEMBL2328238	Inhibition of PI3Kbeta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2c(c1)nc(C(C)C)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL2323118	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	12662874	CHEMBL2328238	Inhibition of PI3Kbeta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2c(c1)nc(C)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL2323115	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	12662875	CHEMBL2328238	Inhibition of PI3Kbeta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2c(c1)nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL2323113	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	12662882	CHEMBL2328238	Inhibition of PI3Kbeta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2nc(C)n(-c3nc(N4CCOCC4)nc(N4CCOCC4)n3)c2c1		CHEMBL2323116	=	IC50	nM	1790.0	CHEMBL3145	Homo sapiens	IC50	uM	1.79
	12662886	CHEMBL2328238	Inhibition of PI3Kbeta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2nc(C(C)C)n(-c3nc(N4CCOCC4)nc(N4CCOCC4)n3)c2c1		CHEMBL2323119	=	IC50	nM	726.0	CHEMBL3145	Homo sapiens	IC50	uM	0.726
	12662887	CHEMBL2328238	Inhibition of PI3Kbeta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	Cc1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910989	=	IC50	nM	523.0	CHEMBL3145	Homo sapiens	IC50	uM	0.523
	12662891	CHEMBL2328238	Inhibition of PI3Kbeta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	CC(C)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL2323117	=	IC50	nM	419.0	CHEMBL3145	Homo sapiens	IC50	uM	0.419
	12662894	CHEMBL2328238	Inhibition of PI3Kbeta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2nc(C(F)F)n(-c3nc(N4CCOCC4)nc(N4CCOCC4)n3)c2c1		CHEMBL2323114	=	IC50	nM	214.0	CHEMBL3145	Homo sapiens	IC50	uM	0.214
	12662899	CHEMBL2328238	Inhibition of PI3Kbeta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	uM	0.006
	12693276	CHEMBL2341977	Inhibition of PI3Kbeta (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	5000.0	CHEMBL3145	Homo sapiens	IC50	nM	5000.0
	12701742	CHEMBL2338830	Inhibition of PI3Kbeta (unknown origin) using lipid PIP2 as substrate	B	COc1ccc(-c2ccc3c(N4CCOCC4)nc(N4C[C@H](C)O[C@H](C)C4)nc3n2)cc1CO		CHEMBL1078983	>	IC50	nM	30000.0	CHEMBL3145	Homo sapiens	IC50	uM	30.0
	13312298	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3cnn(CCO)c3)ccc1-2		CHEMBL2381373	=	Ki	nM	15.0	CHEMBL3145	Homo sapiens	Ki(app)	nM	15.0
	13312538	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	nM	17.0
	13312539	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)(O)Cn1cc(-c2ccc3c(c2)OCCc2sc(-c4ncnn4CC(F)(F)F)nc2-3)cn1		CHEMBL2381379	=	IC50	nM	15.0	CHEMBL3145	Homo sapiens	IC50	nM	15.0
	13312540	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1c(-c2nc3c(s2)CCOc2cc(-c4cnn(CC(C)(C)O)c4)ccc2-3)n[nH]c1=O		CHEMBL2381381	=	IC50	nM	3.9	CHEMBL3145	Homo sapiens	IC50	nM	3.9
	13312541	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(N)nc1-c1nc2c(s1)CCOc1cc(-c3cnn(CC(C)(C)O)c3)ccc1-2		CHEMBL2381380	=	IC50	nM	9.2	CHEMBL3145	Homo sapiens	IC50	nM	9.2
	13312542	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(N)nc1-c1nc2c(s1)CCOc1cc(-c3cnn(CCO)c3)ccc1-2		CHEMBL2381382	=	IC50	nM	1.8	CHEMBL3145	Homo sapiens	IC50	nM	1.8
	13312543	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	Cc1nc(-c2nc3c(s2)CCOc2cc(-c4cnn(CCO)c4)ccc2-3)n(C(C)C)n1		CHEMBL2381378	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	nM	7.0
	13312544	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3cnn(C(C)(C)C(N)=O)c3)ccc1-2		CHEMBL2381377	=	IC50	nM	7.4	CHEMBL3145	Homo sapiens	IC50	nM	7.4
	13312545	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3cnn(CCN)c3)ccc1-2		CHEMBL2381376	=	IC50	nM	2.4	CHEMBL3145	Homo sapiens	IC50	nM	2.4
	13312546	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3cnn(CS(C)(=O)=O)c3)ccc1-2		CHEMBL2381375	=	IC50	nM	1.8	CHEMBL3145	Homo sapiens	IC50	nM	1.8
	13312547	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3cnn(CC(C)(C)O)c3)ccc1-2		CHEMBL2381374	=	IC50	nM	14.0	CHEMBL3145	Homo sapiens	IC50	nM	14.0
	13312548	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3cnn(CCO)c3)ccc1-2		CHEMBL2381373	=	IC50	nM	8.6	CHEMBL3145	Homo sapiens	IC50	nM	8.6
	13312549	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C3CN(C(C)(C)C(N)=O)C3)ccc1-2		CHEMBL2381279	=	IC50	nM	14.2	CHEMBL3145	Homo sapiens	IC50	nM	14.2
	13312830	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C3CN(C(=O)C(C)(C)N)C3)ccc1-2		CHEMBL2381278	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	nM	13.0
	13312831	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C3CN(C(=O)CO)C3)ccc1-2		CHEMBL2381277	=	IC50	nM	7.6	CHEMBL3145	Homo sapiens	IC50	nM	7.6
	13312832	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C3CN(CC(C)(C)O)C3)ccc1-2		CHEMBL2381276	=	IC50	nM	8.5	CHEMBL3145	Homo sapiens	IC50	nM	8.5
	13312833	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C3CN(C[C@H](O)CO)C3)ccc1-2		CHEMBL2381275	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
	13312834	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C3CN(CCO)C3)ccc1-2		CHEMBL2381274	=	IC50	nM	4.6	CHEMBL3145	Homo sapiens	IC50	nM	4.6
	13312835	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3ccc(N)nc3)ccc1-2		CHEMBL2381273	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	nM	13.0
	13312836	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3ccc[nH]c3=O)ccc1-2		CHEMBL2381272	=	IC50	nM	77.0	CHEMBL3145	Homo sapiens	IC50	nM	77.0
	13312837	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3cn(C)cn3)ccc1-2		CHEMBL2381271	=	IC50	nM	9.3	CHEMBL3145	Homo sapiens	IC50	nM	9.3
	13312838	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3ncc[nH]3)ccc1-2		CHEMBL2381270	=	IC50	nM	32.4	CHEMBL3145	Homo sapiens	IC50	nM	32.4
	13312839	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3cn[nH]c3)ccc1-2		CHEMBL2381269	=	IC50	nM	7.9	CHEMBL3145	Homo sapiens	IC50	nM	7.9
	13312840	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C3CCNCC3)ccc1-2		CHEMBL2381268	=	IC50	nM	8.4	CHEMBL3145	Homo sapiens	IC50	nM	8.4
	13312841	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C3CCCN3)ccc1-2		CHEMBL2381267	=	IC50	nM	5.4	CHEMBL3145	Homo sapiens	IC50	nM	5.4
	13312842	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C3CCNC3)ccc1-2		CHEMBL2381266	=	IC50	nM	3.9	CHEMBL3145	Homo sapiens	IC50	nM	3.9
	13312843	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C3CNC3)ccc1-2		CHEMBL2381265	=	IC50	nM	0.9	CHEMBL3145	Homo sapiens	IC50	nM	0.9
	13312844	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(CNCCO)ccc1-2		CHEMBL2381264	=	IC50	nM	17.4	CHEMBL3145	Homo sapiens	IC50	nM	17.4
	13312845	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(=O)NCc1ccc2c(c1)OCCc1sc(-c3ncnn3C(C)C)nc1-2		CHEMBL2381263	=	IC50	nM	63.0	CHEMBL3145	Homo sapiens	IC50	nM	63.0
	13312846	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C(O)CO)ccc1-2		CHEMBL2381262	=	IC50	nM	37.8	CHEMBL3145	Homo sapiens	IC50	nM	37.8
	13312847	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(CO)ccc1-2		CHEMBL2381261	=	IC50	nM	20.3	CHEMBL3145	Homo sapiens	IC50	nM	20.3
	13312848	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1ccccc1-2		CHEMBL2381253	=	IC50	nM	5.5	CHEMBL3145	Homo sapiens	IC50	nM	5.5
	13312849	CHEMBL2383018	Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1cc2c(s1)-c1ccc(C(N)=O)cc1OCC2		CHEMBL2322764	=	IC50	nM	29.0	CHEMBL3145	Homo sapiens	IC50	nM	29.0
	13313862	CHEMBL2388236	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C(C)(C)C(N)=O)c4)cc2OCC3)n(C(C)C)n1		CHEMBL2387080	=	Ki	nM	9.1	CHEMBL3145	Homo sapiens	Ki	nM	9.1
	13350657	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccc(-n2cccn2)cc1		CHEMBL2071338	=	IC50	nM	2100.0	CHEMBL3145	Homo sapiens	IC50	uM	2.1
	13350710	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C2(C)CC2)n1		CHEMBL2397199	=	IC50	nM	9600.0	CHEMBL3145	Homo sapiens	IC50	uM	9.6
	13350711	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	CCN(CC)c1nccc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2C)n1		CHEMBL2397198	=	IC50	nM	4400.0	CHEMBL3145	Homo sapiens	IC50	uM	4.4
	13350712	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	CC(C)(c1cc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2Cl)ccn1)C(F)(F)F		CHEMBL2397197	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	13350713	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	CC(C)(c1cc(-c2cnc(NC(=O)N3CCC[C@H]3C(N)=O)s2)ccn1)C(F)(F)F		CHEMBL2397196	=	IC50	nM	2400.0	CHEMBL3145	Homo sapiens	IC50	uM	2.4
	13350714	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1cc(C(C)C)ncn1		CHEMBL2397195	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	13350715	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C2CCC2)n1		CHEMBL2397194	=	IC50	nM	7300.0	CHEMBL3145	Homo sapiens	IC50	uM	7.3
	13350716	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)C)n1		CHEMBL2397193	=	IC50	nM	5900.0	CHEMBL3145	Homo sapiens	IC50	uM	5.9
	13350717	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C2(C#N)CC2)c1		CHEMBL2397192	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	13350718	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	=	IC50	nM	2200.0	CHEMBL3145	Homo sapiens	IC50	uM	2.2
	13350719	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397191	=	IC50	nM	6400.0	CHEMBL3145	Homo sapiens	IC50	uM	6.4
Not Determined	13350720	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)c1		CHEMBL2397190		IC50			CHEMBL3145	Homo sapiens	IC50		
	13350721	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCCC2)sc1-c1ccnc(C(C)(C)C)c1		CHEMBL2397189	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	13350722	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	CNC(=O)[C@@H]1CCCN1C(=O)Nc1nc(C)c(-c2ccnc(C(C)(C)C)c2)s1		CHEMBL2397188	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	13350723	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)c1		CHEMBL2397187	=	IC50	nM	8000.0	CHEMBL3145	Homo sapiens	IC50	uM	8.0
	13350724	CHEMBL2400725	Inhibition of N-terminal myristoylated P110beta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397186	=	IC50	nM	3100.0	CHEMBL3145	Homo sapiens	IC50	uM	3.1
	13350795	CHEMBL2400730	Inhibition of P110beta (unknown origin) using L-a-phosphatidylinositol as substrate by luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C2(C)CC2)n1		CHEMBL2397199	=	IC50	nM	3100.0	CHEMBL3145	Homo sapiens	IC50	uM	3.1
	13350796	CHEMBL2400730	Inhibition of P110beta (unknown origin) using L-a-phosphatidylinositol as substrate by luminescence assay	B	CCN(CC)c1nccc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2C)n1		CHEMBL2397198	=	IC50	nM	1200.0	CHEMBL3145	Homo sapiens	IC50	uM	1.2
	13350797	CHEMBL2400730	Inhibition of P110beta (unknown origin) using L-a-phosphatidylinositol as substrate by luminescence assay	B	CC(C)(c1cc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2Cl)ccn1)C(F)(F)F		CHEMBL2397197	=	IC50	nM	5500.0	CHEMBL3145	Homo sapiens	IC50	uM	5.5
	13350798	CHEMBL2400730	Inhibition of P110beta (unknown origin) using L-a-phosphatidylinositol as substrate by luminescence assay	B	CC(C)(c1cc(-c2cnc(NC(=O)N3CCC[C@H]3C(N)=O)s2)ccn1)C(F)(F)F		CHEMBL2397196	=	IC50	nM	3900.0	CHEMBL3145	Homo sapiens	IC50	uM	3.9
	13350799	CHEMBL2400730	Inhibition of P110beta (unknown origin) using L-a-phosphatidylinositol as substrate by luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1cc(C(C)C)ncn1		CHEMBL2397195	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	13350800	CHEMBL2400730	Inhibition of P110beta (unknown origin) using L-a-phosphatidylinositol as substrate by luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C2CCC2)n1		CHEMBL2397194	=	IC50	nM	1800.0	CHEMBL3145	Homo sapiens	IC50	uM	1.8
	13350801	CHEMBL2400730	Inhibition of P110beta (unknown origin) using L-a-phosphatidylinositol as substrate by luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)C)n1		CHEMBL2397193	=	IC50	nM	4000.0	CHEMBL3145	Homo sapiens	IC50	uM	4.0
	13350802	CHEMBL2400730	Inhibition of P110beta (unknown origin) using L-a-phosphatidylinositol as substrate by luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C2(C#N)CC2)c1		CHEMBL2397192	=	IC50	nM	4100.0	CHEMBL3145	Homo sapiens	IC50	uM	4.1
	13350803	CHEMBL2400730	Inhibition of P110beta (unknown origin) using L-a-phosphatidylinositol as substrate by luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	=	IC50	nM	1200.0	CHEMBL3145	Homo sapiens	IC50	uM	1.2
	13350804	CHEMBL2400730	Inhibition of P110beta (unknown origin) using L-a-phosphatidylinositol as substrate by luminescence assay	B	Cc1nc(NC(=O)N2CC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397191	=	IC50	nM	1200.0	CHEMBL3145	Homo sapiens	IC50	uM	1.2
	13350805	CHEMBL2400730	Inhibition of P110beta (unknown origin) using L-a-phosphatidylinositol as substrate by luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)c1		CHEMBL2397190	=	IC50	nM	8200.0	CHEMBL3145	Homo sapiens	IC50	uM	8.2
	13350806	CHEMBL2400730	Inhibition of P110beta (unknown origin) using L-a-phosphatidylinositol as substrate by luminescence assay	B	Cc1nc(NC(=O)N2CCCC2)sc1-c1ccnc(C(C)(C)C)c1		CHEMBL2397189	=	IC50	nM	4900.0	CHEMBL3145	Homo sapiens	IC50	uM	4.9
	13350807	CHEMBL2400730	Inhibition of P110beta (unknown origin) using L-a-phosphatidylinositol as substrate by luminescence assay	B	CNC(=O)[C@@H]1CCCN1C(=O)Nc1nc(C)c(-c2ccnc(C(C)(C)C)c2)s1		CHEMBL2397188	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	13350808	CHEMBL2400730	Inhibition of P110beta (unknown origin) using L-a-phosphatidylinositol as substrate by luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)c1		CHEMBL2397187	=	IC50	nM	4400.0	CHEMBL3145	Homo sapiens	IC50	uM	4.4
	13350809	CHEMBL2400730	Inhibition of P110beta (unknown origin) using L-a-phosphatidylinositol as substrate by luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397186	=	IC50	nM	1800.0	CHEMBL3145	Homo sapiens	IC50	uM	1.8
	13425353	CHEMBL2423276	Inhibition of PI3Kbeta (unknown origin) using 1alpha-phosphotidylinositol by luminescence assay	B	CC(=O)Nc1cn2cc(-c3cnc(N)c(C(F)(F)F)c3)ccc2n1		CHEMBL2418954	=	IC50	nM	270.0	CHEMBL3145	Homo sapiens	IC50	uM	0.27
	13425354	CHEMBL2423276	Inhibition of PI3Kbeta (unknown origin) using 1alpha-phosphotidylinositol by luminescence assay	B	COC(=O)c1ccc2nc(NC(C)=O)sc2c1		CHEMBL2418960	=	IC50	nM	23000.0	CHEMBL3145	Homo sapiens	IC50	uM	23.0
	13425749	CHEMBL2423426	Inhibition of PI-3K beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	270.0	CHEMBL3145	Homo sapiens	IC50	uM	0.27
	13425754	CHEMBL2423426	Inhibition of PI-3K beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12		CHEMBL188678	=	IC50	nM	16.0	CHEMBL3145	Homo sapiens	IC50	uM	0.016
	13425756	CHEMBL2423426	Inhibition of PI-3K beta (unknown origin)	B	CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c(=O)cc(N5CCOCC5)oc34)c3sc4ccccc4c23)CC1		CHEMBL1086377	=	IC50	nM	0.5	CHEMBL3145	Homo sapiens	IC50	uM	0.0005
	13438248	CHEMBL2422454	Inhibition of PIK3CB in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL3145	Homo sapiens	INH	%	35.0
	13438249	CHEMBL2422454	Inhibition of PIK3CB in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL3145	Homo sapiens	INH	%	35.0
	13438250	CHEMBL2422454	Inhibition of PIK3CB in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL3145	Homo sapiens	INH	%	35.0
	13438251	CHEMBL2422454	Inhibition of PIK3CB in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL3145	Homo sapiens	INH	%	35.0
	13438252	CHEMBL2422454	Inhibition of PIK3CB in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL3145	Homo sapiens	INH	%	35.0
	13438253	CHEMBL2422454	Inhibition of PIK3CB in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL3145	Homo sapiens	INH	%	35.0
	13438254	CHEMBL2422454	Inhibition of PIK3CB in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL3145	Homo sapiens	INH	%	35.0
	13438255	CHEMBL2422454	Inhibition of PIK3CB in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL3145	Homo sapiens	INH	%	35.0
	13438256	CHEMBL2422454	Inhibition of PIK3CB in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL3145	Homo sapiens	INH	%	35.0
	13438257	CHEMBL2422454	Inhibition of PIK3CB in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL3145	Homo sapiens	INH	%	35.0
	13438258	CHEMBL2422454	Inhibition of PIK3CB in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL3145	Homo sapiens	INH	%	35.0
	13438259	CHEMBL2422454	Inhibition of PIK3CB in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	=	Inhibition	%	37.1	CHEMBL3145	Homo sapiens	INH	%	37.1
	13462739	CHEMBL2433110	Inhibition of PI3Kbeta-mediated AKT phosphorylation at Ser473 in PTEN-deficient human MDA-MB-468 cells after 30 mins	B	Cc1c(Cl)cccc1Cn1c(C)nc2c(C(=O)O)cc(N3CCOCC3)nc21		CHEMBL2431396	=	IC50	nM	15.88	CHEMBL3145	Homo sapiens	IC50	nM	15.88
	13462740	CHEMBL2433110	Inhibition of PI3Kbeta-mediated AKT phosphorylation at Ser473 in PTEN-deficient human MDA-MB-468 cells after 30 mins	B	Cc1nc2c(C(=O)O)cc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2431397	=	IC50	nM	41.4	CHEMBL3145	Homo sapiens	IC50	nM	41.4
	13462741	CHEMBL2433110	Inhibition of PI3Kbeta-mediated AKT phosphorylation at Ser473 in PTEN-deficient human MDA-MB-468 cells after 30 mins	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2431398	=	IC50	nM	435.86	CHEMBL3145	Homo sapiens	IC50	nM	435.86
	13462742	CHEMBL2433111	Inhibition of PI3Kbeta (unknown origin) assessed as PIP2 conversion to PIP3 after 1 hr by HTRF assay	B	Cc1c(Cl)cccc1Cn1c(C)nc2c(C(=O)O)cc(N3CCOCC3)nc21		CHEMBL2431396	=	IC50	nM	1.585	CHEMBL3145	Homo sapiens	pIC50		8.8
	13462743	CHEMBL2433111	Inhibition of PI3Kbeta (unknown origin) assessed as PIP2 conversion to PIP3 after 1 hr by HTRF assay	B	Cc1nc2c(C(=O)O)cc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2431397	=	IC50	nM	5.012	CHEMBL3145	Homo sapiens	pIC50		8.3
	13462744	CHEMBL2433111	Inhibition of PI3Kbeta (unknown origin) assessed as PIP2 conversion to PIP3 after 1 hr by HTRF assay	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2431398	=	IC50	nM	5.012	CHEMBL3145	Homo sapiens	pIC50		8.3
Not Active	13508488	CHEMBL2447362	Inhibition of PI3Kbeta (unknown origin) at 30 uM	B	O=C(Nc1ccc2c(c1)B(O)OC2)c1c(C(F)(F)F)ccc(Cl)c1F		CHEMBL2441375		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	13895017	CHEMBL3111949	Inhibition of PIK3CB (unknown origin) assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	O=C(Nc1ccc(CO)cc1)Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109142	=	Activity	%	0.15	CHEMBL3145	Homo sapiens	Activity	%	0.15
	13913424	CHEMBL3119513	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in BRAF-V600E/PTEN-deficient human UACC62 cells	B	C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112866	=	IC90	nM	2000.0	CHEMBL3145	Homo sapiens	IC90	uM	2.0
	13913425	CHEMBL3119513	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in BRAF-V600E/PTEN-deficient human UACC62 cells	B	C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112866	=	IC50	nM	60.0	CHEMBL3145	Homo sapiens	IC50	uM	0.06
	13917186	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	C[C@@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112867	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	nM	12.0
	13917187	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112866	=	IC90	nM	2.0	CHEMBL3145	Homo sapiens	IC90	nM	2.0
	13917188	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112866	=	IC50	nM	49.0	CHEMBL3145	Homo sapiens	IC50	nM	49.0
	13917189	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	CC1(C)CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2ccccc21		CHEMBL3112865	=	IC50	nM	28.0	CHEMBL3145	Homo sapiens	IC50	nM	28.0
	13917190	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	CC1CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2ccccc21		CHEMBL3112864	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	nM	13.0
	13917191	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	CC1(C)Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112863	=	IC50	nM	78.0	CHEMBL3145	Homo sapiens	IC50	nM	78.0
	13917192	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	CC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112862	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
	13917193	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	Cn1c(CC(=O)N2CCc3ccccc32)nc(N2CCOCC2)cc1=O		CHEMBL3112861	=	IC50	nM	20.0	CHEMBL3145	Homo sapiens	IC50	nM	20.0
	13917194	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	CN1CCN(Cc2cccc3c2CCN3C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)CC1		CHEMBL3112860	=	IC50	nM	272.0	CHEMBL3145	Homo sapiens	IC50	nM	272.0
	13917195	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	CN1CCN(c2cccc3c2CCN3C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)CC1		CHEMBL3112859	=	IC50	nM	167.0	CHEMBL3145	Homo sapiens	IC50	nM	167.0
	13917196	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3ccncc3)cccc21		CHEMBL3112858	=	IC50	nM	94.0	CHEMBL3145	Homo sapiens	IC50	nM	94.0
	13917197	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3cccnc3)cccc21		CHEMBL3112857	=	IC50	nM	53.0	CHEMBL3145	Homo sapiens	IC50	nM	53.0
	13917198	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3ccccn3)cccc21		CHEMBL3112856	=	IC50	nM	66.0	CHEMBL3145	Homo sapiens	IC50	nM	66.0
	13917199	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3ccccc3)cccc21		CHEMBL3112855	=	IC50	nM	24.0	CHEMBL3145	Homo sapiens	IC50	nM	24.0
	13917200	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(OC(F)(F)F)cccc21		CHEMBL3112854	=	IC50	nM	54.0	CHEMBL3145	Homo sapiens	IC50	nM	54.0
	13917201	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c1cccc2C(F)(F)F		CHEMBL3112853	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	nM	9.0
	13917202	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	COc1cccc2c1CCN2C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112852	=	IC50	nM	60.0	CHEMBL3145	Homo sapiens	IC50	nM	60.0
	13917203	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	Cc1cccc2c1CCN2C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112851	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
	13917204	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(Br)cccc21		CHEMBL3112850	=	IC50	nM	1.0	CHEMBL3145	Homo sapiens	IC50	nM	1.0
	13917205	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(Cl)cccc21		CHEMBL3112849	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
	13917206	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(F)cccc21		CHEMBL3112848	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
	13917207	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2cc(Cl)ccc21		CHEMBL3112592	=	IC50	nM	124.0	CHEMBL3145	Homo sapiens	IC50	nM	124.0
	13917208	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2cc(F)ccc21		CHEMBL3112847	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	nM	7.0
	13917209	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2ccccc21		CHEMBL3112690	=	IC50	nM	15.0	CHEMBL3145	Homo sapiens	IC50	nM	15.0
	13917210	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccccc21		CHEMBL2064330	=	IC50	nM	76.0	CHEMBL3145	Homo sapiens	IC50	nM	76.0
	13917211	CHEMBL3119743	Inhibition of PI3Kbeta-mediated Akt phosphorylation at S473 in PTEN-deficient human PC3 cells after 0.5 to 2 hrs by Immunoblotting assay	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	13918208	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	C[C@@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112867	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
	13918209	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112866	=	IC50	nM	23.0	CHEMBL3145	Homo sapiens	IC50	nM	23.0
	13918210	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	CC1(C)CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2ccccc21		CHEMBL3112865	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	nM	17.0
	13918211	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	CC1CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2ccccc21		CHEMBL3112864	=	IC50	nM	22.0	CHEMBL3145	Homo sapiens	IC50	nM	22.0
	13918212	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	CC1(C)Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112863	=	IC50	nM	102.0	CHEMBL3145	Homo sapiens	IC50	nM	102.0
	13918213	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	CC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112862	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
	13918214	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	Cn1c(CC(=O)N2CCc3ccccc32)nc(N2CCOCC2)cc1=O		CHEMBL3112861	=	IC50	nM	48.0	CHEMBL3145	Homo sapiens	IC50	nM	48.0
	13918215	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	CN1CCN(Cc2cccc3c2CCN3C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)CC1		CHEMBL3112860	=	IC50	nM	332.0	CHEMBL3145	Homo sapiens	IC50	nM	332.0
	13918216	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	CN1CCN(c2cccc3c2CCN3C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)CC1		CHEMBL3112859	=	IC50	nM	407.0	CHEMBL3145	Homo sapiens	IC50	nM	407.0
	13918217	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3ccncc3)cccc21		CHEMBL3112858	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	13918218	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3cccnc3)cccc21		CHEMBL3112857	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	nM	17.0
	13918219	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3ccccn3)cccc21		CHEMBL3112856	=	IC50	nM	98.0	CHEMBL3145	Homo sapiens	IC50	nM	98.0
	13918220	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3ccccc3)cccc21		CHEMBL3112855	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	nM	8.0
	13918221	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(OC(F)(F)F)cccc21		CHEMBL3112854	=	IC50	nM	33.0	CHEMBL3145	Homo sapiens	IC50	nM	33.0
	13918222	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c1cccc2C(F)(F)F		CHEMBL3112853	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	13918223	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	COc1cccc2c1CCN2C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112852	=	IC50	nM	41.0	CHEMBL3145	Homo sapiens	IC50	nM	41.0
	13918224	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	Cc1cccc2c1CCN2C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112851	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
	13918225	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(Br)cccc21		CHEMBL3112850	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
	13918226	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(Cl)cccc21		CHEMBL3112849	=	IC50	nM	1.0	CHEMBL3145	Homo sapiens	IC50	nM	1.0
	13918227	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(F)cccc21		CHEMBL3112848	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
	13918228	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2cc(Cl)ccc21		CHEMBL3112592	=	IC50	nM	79.0	CHEMBL3145	Homo sapiens	IC50	nM	79.0
	13918229	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2cc(F)ccc21		CHEMBL3112847	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
	13918230	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2ccccc21		CHEMBL3112690	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
	13918231	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccccc21		CHEMBL2064330	=	IC50	nM	99.0	CHEMBL3145	Homo sapiens	IC50	nM	99.0
	13918232	CHEMBL3119746	Inhibition of N-terminal ploy-His-tagged human PI3Kbeta expressed in baculovirus-infected sf21 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	30.0	CHEMBL3145	Homo sapiens	IC50	nM	30.0
	13943736	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	CC1Cc2cc(F)ccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(N)=O		CHEMBL3125375	=	IC50	nM	14.0	CHEMBL3145	Homo sapiens	IC50	nM	14.0
	13943739	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	CC1Cc2cc(F)ccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(N)=O		CHEMBL3125375	=	IC50	nM	20.0	CHEMBL3145	Homo sapiens	IC50	nM	20.0
	13943861	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	O=C(O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2cc(Br)ccc21		CHEMBL3125382	=	IC50	nM	3000.0	CHEMBL3145	Homo sapiens	IC50	nM	3000.0
	13943863	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	CC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL3125377	=	IC50	nM	2305.0	CHEMBL3145	Homo sapiens	IC50	nM	2305.0
	13943866	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	O=C(O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2c(Cl)cccc21		CHEMBL3125378	=	IC50	nM	2000.0	CHEMBL3145	Homo sapiens	IC50	nM	2000.0
	13943868	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	O=C(O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2c(Br)cccc21		CHEMBL3125383	=	IC50	nM	1780.0	CHEMBL3145	Homo sapiens	IC50	nM	1780.0
	13943869	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	O=C(O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2cc(F)ccc21		CHEMBL3125380	=	IC50	nM	1730.0	CHEMBL3145	Homo sapiens	IC50	nM	1730.0
	13943871	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	O=C(O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2ccccc21		CHEMBL3125376	=	IC50	nM	1420.0	CHEMBL3145	Homo sapiens	IC50	nM	1420.0
	13943876	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	CC1Cc2c(Cl)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL3125379	=	IC50	nM	876.0	CHEMBL3145	Homo sapiens	IC50	nM	876.0
	13943878	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	CC1Cc2cc(F)ccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL3125381	=	IC50	nM	817.0	CHEMBL3145	Homo sapiens	IC50	nM	817.0
	13943884	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2cc(Br)ccc21		CHEMBL3125393	=	IC50	nM	420.0	CHEMBL3145	Homo sapiens	IC50	nM	420.0
	13943886	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	CC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL3125377	=	IC50	nM	340.0	CHEMBL3145	Homo sapiens	IC50	nM	340.0
	13943887	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	O=C(O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2cc(Br)ccc21		CHEMBL3125382	=	IC50	nM	308.0	CHEMBL3145	Homo sapiens	IC50	nM	308.0
	13943888	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL3125384	=	IC50	nM	307.0	CHEMBL3145	Homo sapiens	IC50	nM	307.0
	13943890	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	O=C(O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2ccccc21		CHEMBL3125376	=	IC50	nM	270.0	CHEMBL3145	Homo sapiens	IC50	nM	270.0
	13943892	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2cc(Br)ccc21		CHEMBL3125393	=	IC50	nM	240.0	CHEMBL3145	Homo sapiens	IC50	nM	240.0
	13943897	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	CC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(N)=O		CHEMBL3125386	=	IC50	nM	178.0	CHEMBL3145	Homo sapiens	IC50	nM	178.0
	13943898	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2cc(Cl)ccc21		CHEMBL3125392	=	IC50	nM	166.0	CHEMBL3145	Homo sapiens	IC50	nM	166.0
	13943900	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL3125384	=	IC50	nM	140.0	CHEMBL3145	Homo sapiens	IC50	nM	140.0
	13943901	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2c(F)cccc21		CHEMBL3125388	=	IC50	nM	138.0	CHEMBL3145	Homo sapiens	IC50	nM	138.0
	13943904	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	CC1CN(C(=O)Cc2nc(N3CCOCC3)sc2C(N)=O)c2ccccc21		CHEMBL3125387	=	IC50	nM	130.0	CHEMBL3145	Homo sapiens	IC50	nM	130.0
	13943905	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2c(Cl)cccc21		CHEMBL3125389	=	IC50	nM	122.0	CHEMBL3145	Homo sapiens	IC50	nM	122.0
	13943906	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2cc(Cl)ccc21		CHEMBL3125392	=	IC50	nM	110.0	CHEMBL3145	Homo sapiens	IC50	nM	110.0
	13943908	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL3125384	=	IC50	nM	84.0	CHEMBL3145	Homo sapiens	IC50	nM	84.0
	13943909	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	CC1CN(C(=O)Cc2nc(N3CCOCC3)sc2C(N)=O)c2ccccc21		CHEMBL3125387	=	IC50	nM	75.0	CHEMBL3145	Homo sapiens	IC50	nM	75.0
	13943910	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2ccccc21		CHEMBL3125385	=	IC50	nM	71.0	CHEMBL3145	Homo sapiens	IC50	nM	71.0
	13943914	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(N)=O		CHEMBL3125395	=	IC50	nM	58.0	CHEMBL3145	Homo sapiens	IC50	nM	58.0
	13943915	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2c(Cl)cccc21		CHEMBL3125389	=	IC50	nM	49.0	CHEMBL3145	Homo sapiens	IC50	nM	49.0
	13943916	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)Nc1ccc(F)c(Cl)c1		CHEMBL3125541	=	IC50	nM	45.0	CHEMBL3145	Homo sapiens	IC50	nM	45.0
	13943917	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	CC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(N)=O		CHEMBL3125386	=	IC50	nM	40.0	CHEMBL3145	Homo sapiens	IC50	nM	40.0
	13943918	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2c(F)cccc21		CHEMBL3125388	=	IC50	nM	38.0	CHEMBL3145	Homo sapiens	IC50	nM	38.0
	13943919	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2ccccc21		CHEMBL3125385	=	IC50	nM	25.0	CHEMBL3145	Homo sapiens	IC50	nM	25.0
	13943920	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	O=C(O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2cc(F)ccc21		CHEMBL3125380	=	IC50	nM	25.0	CHEMBL3145	Homo sapiens	IC50	nM	25.0
	13943921	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	O=C(O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2c(Cl)cccc21		CHEMBL3125378	=	IC50	nM	23.0	CHEMBL3145	Homo sapiens	IC50	nM	23.0
	13943922	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2c(Br)cccc21		CHEMBL3125390	=	IC50	nM	22.0	CHEMBL3145	Homo sapiens	IC50	nM	22.0
	13943923	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2cc(F)ccc21		CHEMBL3125391	=	IC50	nM	22.0	CHEMBL3145	Homo sapiens	IC50	nM	22.0
	13943924	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(N)=O		CHEMBL3125395	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	nM	17.0
	13943925	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2cc(F)ccc21		CHEMBL3125391	=	IC50	nM	15.0	CHEMBL3145	Homo sapiens	IC50	nM	15.0
	13943926	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	CC1Cc2cc(F)ccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL3125381	=	IC50	nM	15.0	CHEMBL3145	Homo sapiens	IC50	nM	15.0
	13943927	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	CC1Cc2c(Cl)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(N)=O		CHEMBL3125394	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	nM	13.0
	13943928	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(N)=O		CHEMBL3125395	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	nM	13.0
	13943929	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2c(Br)cccc21		CHEMBL3125390	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
	13943930	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	O=C(O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2c(Br)cccc21		CHEMBL3125383	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
	13943931	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	CC1Cc2c(Cl)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(N)=O		CHEMBL3125394	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	13943932	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL3125384	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	13943933	CHEMBL3129534	Inhibition of human PI3Kbeta after 15 mins	B	CC1Cc2c(Cl)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL3125379	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	nM	8.0
	13943934	CHEMBL3129531	Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473	B	CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(N)=O		CHEMBL3125395	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
	13967130	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	N#Cc1cc(S(=O)(=O)c2nc(-c3cnn4ccc(Br)cc34)cs2)ccc1NCCN1CCOCC1		CHEMBL3134265	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967131	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	CN(C)CCN(C)c1ccc(S(=O)(=O)c2nc(-c3cnn4ccc(Br)cc34)cs2)cc1C#N		CHEMBL3134282	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967132	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	CN(C)CCN(C)c1ccc(C#N)cc1S(=O)(=O)c1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134281	=	IC50	nM	3560.0	CHEMBL3145	Homo sapiens	IC50	uM	3.56
	13967133	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	CN(C)CCN(C)c1ccc(C#N)cc1[S+]([O-])c1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134280	=	IC50	nM	4340.0	CHEMBL3145	Homo sapiens	IC50	uM	4.34
	13967134	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	N#Cc1cc(S(=O)(=O)c2nc(-c3cnn4ccc(Br)cc34)cs2)ccc1F		CHEMBL3134279	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967135	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	N#Cc1ccc(F)c(S(=O)(=O)c2nc(-c3cnn4ccc(Br)cc34)cs2)c1		CHEMBL3134278	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967136	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	N#Cc1ccc(F)c([S+]([O-])c2nc(-c3cnn4ccc(Br)cc34)cs2)c1		CHEMBL3134277	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967137	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccccc1[S+]([O-])c1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134276	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967138	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	O=[N+]([O-])c1cccc(S(=O)(=O)c2nc(-c3cnn4ccc(Br)cc34)cs2)c1		CHEMBL3134275	=	IC50	nM	5450.0	CHEMBL3145	Homo sapiens	IC50	uM	5.45
	13967139	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	O=[N+]([O-])c1cccc([S+]([O-])c2nc(-c3cnn4ccc(Br)cc34)cs2)c1		CHEMBL3134274	=	IC50	nM	4420.0	CHEMBL3145	Homo sapiens	IC50	uM	4.42
	13967140	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	O=[N+]([O-])c1cccc(Sc2nc(-c3cnn4ccc(Br)cc34)cs2)c1		CHEMBL3134273	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967141	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)/N=c1/scc(-c2cnn3ccc(Br)cc23)n1C		CHEMBL3134272	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967142	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)c1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134271	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967143	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1CS(=O)(=O)c1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134270	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967144	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1Nc1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134269	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967145	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)Cc1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134268	=	IC50	nM	140.0	CHEMBL3145	Homo sapiens	IC50	uM	0.14
	13967146	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)Nc1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134267	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967147	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1CSc1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134266	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967148	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1Cc1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134297	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967149	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1-c1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134296	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967150	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)N1CCN(Cc2cnn3ccc(C#N)cc23)CC1		CHEMBL3134295	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967151	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)NC1CCN(Cc2cnn3ccc(C#N)cc23)CC1		CHEMBL3134294	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967152	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)N[C@@H]1CCCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134293	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967153	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)N[C@H]1CCCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134292	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967154	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)N[C@@H]1CCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134291	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967155	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)N[C@H]1CCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134290	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967156	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)NC1CN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134289	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967157	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N1CCCN(Cc2cnn3ccc(C#N)cc23)CC1		CHEMBL3134288	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967158	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N1CCN(Cc2cnn3ccc(C#N)cc23)CC1		CHEMBL3134287	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967159	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC1CCN(Cc2cnn3ccc(C#N)cc23)CC1		CHEMBL3134286	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967160	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@@H]1CCCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134285	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967161	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CCCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134284	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967162	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@@H]1CCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134283	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967163	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134303	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967164	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC1CN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134302	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967165	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)N1CCC(c2cnn3ccc(Br)cc23)CC1		CHEMBL3134301	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967166	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N1CCC(c2cnn3ccc(Br)cc23)CC1		CHEMBL3134300	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967167	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N1CCCC(c2cnn3ccc(Br)cc23)C1		CHEMBL3134299	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967168	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N1CCC(c2cnn3ccc(Br)cc23)C1		CHEMBL3134298	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13967169	CHEMBL3134981	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)C/C=C/c1cnn2ccc(Br)cc12		CHEMBL3132876	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	13973202	CHEMBL3136754	Inhibition of human PI3Kbeta	B	Nc1nc(N)c2nc(-c3cccc(O)c3)cnc2n1		CHEMBL244559	=	IC50	nM	215.0	CHEMBL3145	Homo sapiens	IC50	nM	215.0
	13973203	CHEMBL3136754	Inhibition of human PI3Kbeta	B	Clc1ccc(Nc2nccc(-c3ccc(Cl)cc3Cl)n2)c(Cl)c1		CHEMBL3134604	=	IC50	nM	799.0	CHEMBL3145	Homo sapiens	IC50	nM	799.0
	13973204	CHEMBL3136754	Inhibition of human PI3Kbeta	B	O=[N+]([O-])c1ccc(Nc2nccc(-c3ccc(Cl)cc3Cl)n2)cc1		CHEMBL3134603	=	IC50	nM	938.0	CHEMBL3145	Homo sapiens	IC50	nM	938.0
	13973205	CHEMBL3136754	Inhibition of human PI3Kbeta	B	COc1cccc(Nc2nccc(-c3ccc(Cl)cc3Cl)n2)c1		CHEMBL3134602	=	IC50	nM	893.0	CHEMBL3145	Homo sapiens	IC50	nM	893.0
	13973206	CHEMBL3136754	Inhibition of human PI3Kbeta	B	Cc1cccc(Nc2nccc(-c3ccc(Cl)cc3Cl)n2)c1		CHEMBL3134601	=	IC50	nM	851.0	CHEMBL3145	Homo sapiens	IC50	nM	851.0
	13973207	CHEMBL3136754	Inhibition of human PI3Kbeta	B	Clc1ccc(Nc2nccc(-c3ccc(Cl)c(Cl)c3)n2)c(Cl)c1		CHEMBL3134621	=	IC50	nM	926.0	CHEMBL3145	Homo sapiens	IC50	nM	926.0
	13973208	CHEMBL3136754	Inhibition of human PI3Kbeta	B	O=[N+]([O-])c1ccc(Nc2nccc(-c3ccc(Cl)c(Cl)c3)n2)cc1		CHEMBL3134620	=	IC50	nM	573.0	CHEMBL3145	Homo sapiens	IC50	nM	573.0
	13973209	CHEMBL3136754	Inhibition of human PI3Kbeta	B	COc1cccc(Nc2nccc(-c3ccc(Cl)c(Cl)c3)n2)c1		CHEMBL3134619	=	IC50	nM	741.0	CHEMBL3145	Homo sapiens	IC50	nM	741.0
	13973210	CHEMBL3136754	Inhibition of human PI3Kbeta	B	Clc1ccc(Nc2nccc(-c3ccc(Br)cc3)n2)c(Cl)c1		CHEMBL3134618	=	IC50	nM	673.0	CHEMBL3145	Homo sapiens	IC50	nM	673.0
	13973211	CHEMBL3136754	Inhibition of human PI3Kbeta	B	O=[N+]([O-])c1ccc(Nc2nccc(-c3ccc(Br)cc3)n2)cc1		CHEMBL3134617	=	IC50	nM	961.0	CHEMBL3145	Homo sapiens	IC50	nM	961.0
	13973236	CHEMBL3136754	Inhibition of human PI3Kbeta	B	COc1ccc(-c2ccnc(Nc3cccc(OC)c3)n2)cc1		CHEMBL3134605	=	IC50	nM	729.0	CHEMBL3145	Homo sapiens	IC50	nM	729.0
	13973240	CHEMBL3136754	Inhibition of human PI3Kbeta	B	COc1ccc(-c2ccnc(Nc3ccc(Cl)cc3Cl)n2)cc1		CHEMBL3134608	=	IC50	nM	839.0	CHEMBL3145	Homo sapiens	IC50	nM	839.0
	13973241	CHEMBL3136754	Inhibition of human PI3Kbeta	B	Cc1ccc(-c2ccnc(Nc3ccc(Cl)cc3Cl)n2)cc1		CHEMBL3134609	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	13973242	CHEMBL3136754	Inhibition of human PI3Kbeta	B	COc1ccc(-c2ccnc(Nc3ccc(Cl)cc3)n2)cc1		CHEMBL3134606	=	IC50	nM	603.0	CHEMBL3145	Homo sapiens	IC50	nM	603.0
	13973243	CHEMBL3136754	Inhibition of human PI3Kbeta	B	COc1ccc(-c2ccnc(Nc3ccc([N+](=O)[O-])cc3)n2)cc1		CHEMBL3134607	=	IC50	nM	537.0	CHEMBL3145	Homo sapiens	IC50	nM	537.0
	13973261	CHEMBL3136754	Inhibition of human PI3Kbeta	B	COc1cc(Nc2nccc(-c3ccc(Cl)cc3)n2)cc(OC)c1OC		CHEMBL3134612	=	IC50	nM	373.0	CHEMBL3145	Homo sapiens	IC50	nM	373.0
	13973262	CHEMBL3136754	Inhibition of human PI3Kbeta	B	Cc1cccc(Nc2nccc(-c3ccc(Br)cc3)n2)c1		CHEMBL3134613	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	13973263	CHEMBL3136754	Inhibition of human PI3Kbeta	B	COc1cccc(Nc2nccc(-c3ccc(F)cc3)n2)c1		CHEMBL3134610	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	13973264	CHEMBL3136754	Inhibition of human PI3Kbeta	B	O=[N+]([O-])c1ccc(Nc2nccc(-c3ccc(F)cc3)n2)cc1		CHEMBL3134611	=	IC50	nM	863.0	CHEMBL3145	Homo sapiens	IC50	nM	863.0
	13973265	CHEMBL3136754	Inhibition of human PI3Kbeta	B	COc1cccc(Nc2nccc(-c3ccc(Br)cc3)n2)c1		CHEMBL3134614	=	IC50	nM	977.0	CHEMBL3145	Homo sapiens	IC50	nM	977.0
	13973266	CHEMBL3136754	Inhibition of human PI3Kbeta	B	CC(C)c1ccccc1Nc1nccc(-c2ccc(Br)cc2)n1		CHEMBL3134615	=	IC50	nM	874.0	CHEMBL3145	Homo sapiens	IC50	nM	874.0
	13973267	CHEMBL3136754	Inhibition of human PI3Kbeta	B	Clc1ccc(Nc2nccc(-c3ccc(Br)cc3)n2)cc1		CHEMBL3134616	=	IC50	nM	946.0	CHEMBL3145	Homo sapiens	IC50	nM	946.0
	14553186	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	=	IC50	nM	27.0	CHEMBL3145	Homo sapiens	IC50	uM	0.027
	14553193	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	Cc1cc(C(C)Nc2ccccc2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL2064328	=	IC50	nM	57.0	CHEMBL3145	Homo sapiens	IC50	uM	0.057
	14553201	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	Cc1cc(NCc2ccccc2C)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3218574	=	IC50	nM	110.0	CHEMBL3145	Homo sapiens	IC50	uM	0.11
	14553202	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	Cc1cc(C(C)Nc2ccccc2)c2oc(-c3ccncc3)cc(=O)c2c1		CHEMBL3218573	=	IC50	nM	120.0	CHEMBL3145	Homo sapiens	IC50	uM	0.12
	14553204	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	Cc1cc(Oc2ccccc2C)c2[nH]c(N3CCOCC3)cc(=O)c2c1		CHEMBL3218572	=	IC50	nM	130.0	CHEMBL3145	Homo sapiens	IC50	uM	0.13
	14553205	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	IC50	nM	130.0	CHEMBL3145	Homo sapiens	IC50	uM	0.13
	14553213	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	IC50	nM	240.0	CHEMBL3145	Homo sapiens	IC50	uM	0.24
	14553220	CHEMBL3223606	Inhibition of PI3Kbeta (unknown origin) by lipid kinase assay	B	O=C1NC(=O)/C(=C/c2ccc3nccnc3c2)S1		CHEMBL568150	=	IC50	nM	270.0	CHEMBL3145	Homo sapiens	IC50	uM	0.27
	14553225	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc2c(c1OC)N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL1241857	=	IC50	nM	350.0	CHEMBL3145	Homo sapiens	IC50	uM	0.35
	14553232	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	565.0	CHEMBL3145	Homo sapiens	IC50	uM	0.565
	14553234	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	CC(=O)/N=c1/[nH]c(C)c(-c2ccc(Cl)c(S(=O)(=O)NCCO)c2)s1		CHEMBL1229535	=	IC50	nM	590.0	CHEMBL3145	Homo sapiens	IC50	uM	0.59
	14553237	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	N=C(N)NCCCC(NC(=O)CCC(=O)OC[N+]1(c2cc(=O)c3cccc(-c4ccccc4)c3o2)CCOCC1)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)[O-]		CHEMBL3218580	=	IC50	nM	736.0	CHEMBL3145	Homo sapiens	IC50	uM	0.736
	14553248	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	O=C1NC(=S)S/C1=C/c1ccc2c(c1)N(Cc1ccc(F)c(Cl)c1)C(=O)CO2		CHEMBL3218571	=	IC50	nM	1100.0	CHEMBL3145	Homo sapiens	IC50	uM	1.1
	14553254	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	IC50	nM	1400.0	CHEMBL3145	Homo sapiens	IC50	uM	1.4
	14553261	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	O=Cc1ccc(N2CCOCC2)cc1O		CHEMBL2181110	=	IC50	nM	2800.0	CHEMBL3145	Homo sapiens	IC50	uM	2.8
	14553263	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	IC50	nM	3700.0	CHEMBL3145	Homo sapiens	IC50	uM	3.7
	14553276	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	IC50	nM	8600.0	CHEMBL3145	Homo sapiens	IC50	uM	8.6
	14553286	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	IC50	nM	16000.0	CHEMBL3145	Homo sapiens	IC50	uM	16.0
	14553287	CHEMBL3223606	Inhibition of PI3Kbeta (unknown origin) by lipid kinase assay	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	IC50	nM	20000.0	CHEMBL3145	Homo sapiens	IC50	uM	20.0
	14553299	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	44.0	CHEMBL3145	Homo sapiens	IC50	nM	44.0
	14553302	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213082	=	IC50	nM	75000.0	CHEMBL3145	Homo sapiens	IC50	uM	75.0
	14553303	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	75.0	CHEMBL3145	Homo sapiens	IC50	nM	75.0
	14553312	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)c(OC)c3)cc2)cc(OC)c1		CHEMBL3349370	=	IC50	nM	113.0	CHEMBL3145	Homo sapiens	IC50	nM	113.0
	14553317	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	=	IC50	nM	383.0	CHEMBL3145	Homo sapiens	IC50	nM	383.0
	14553319	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	Cn1c(=O)c2c(ncn2C)n(C)c1=O	Outside typical range	CHEMBL113	=	IC50	nM	400000.0	CHEMBL3145	Homo sapiens	IC50	uM	400.0
	14553320	CHEMBL3223624	Displacement of ATP in PI3Kbeta (unknown origin) by cell based assay	B	Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1		CHEMBL165	=	IC50	nM	500.0	CHEMBL3145	Homo sapiens	IC50	nM	500.0
	14553322	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	Cn1c(=O)c2nc[nH]c2n(C)c1=O	Outside typical range	CHEMBL190	=	IC50	nM	800000.0	CHEMBL3145	Homo sapiens	IC50	uM	800.0
	14553336	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	33.0	CHEMBL3145	Homo sapiens	IC50	uM	0.033
	14553340	CHEMBL3223602	Inhibition of PI3Kbeta (unknown origin)	B	CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21		CHEMBL1684984	=	IC50	nM	120.0	CHEMBL3145	Homo sapiens	IC50	uM	0.12
	14666346	CHEMBL3270465	Inhibition of PI3K beta (unknown origin) assessed as [33P] incorporation in substrate by TopCount microplate scintillation counting analysis	B	COc1ccc(Oc2cc(C)c(-c3csc(NC(=O)c4ccnc(F)c4)n3)c(C)c2)cc1		CHEMBL3263869	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	14743605	CHEMBL3293769	Inhibition of human PI3K-beta assessed as inhibition of Ptdlns(3,4,5)P3 phosphorylation after 1 hr by TR-FRET analysis	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	316.0	CHEMBL3145	Homo sapiens	IC50	uM	0.316
	14743606	CHEMBL3293769	Inhibition of human PI3K-beta assessed as inhibition of Ptdlns(3,4,5)P3 phosphorylation after 1 hr by TR-FRET analysis	B	Cn1cc(-c2ccc3ncc4c(c3c2)n(-c2ccc(C(C)(C)C#N)cc2)c(=O)n4C)cn1		CHEMBL3290293	=	IC50	nM	7943.0	CHEMBL3145	Homo sapiens	IC50	uM	7.943
	14743607	CHEMBL3293769	Inhibition of human PI3K-beta assessed as inhibition of Ptdlns(3,4,5)P3 phosphorylation after 1 hr by TR-FRET analysis	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3ccccc3ncc21		CHEMBL3290300	>	IC50	nM	30000.0	CHEMBL3145	Homo sapiens	IC50	uM	30.0
	14743608	CHEMBL3293769	Inhibition of human PI3K-beta assessed as inhibition of Ptdlns(3,4,5)P3 phosphorylation after 1 hr by TR-FRET analysis	B	Cc1ccc(-n2c(=O)n(C)c3cnc4ccc(-c5ccncc5)cc4c32)cc1		CHEMBL3290305	=	IC50	nM	31623.0	CHEMBL3145	Homo sapiens	IC50	uM	31.623
	14743609	CHEMBL3293769	Inhibition of human PI3K-beta assessed as inhibition of Ptdlns(3,4,5)P3 phosphorylation after 1 hr by TR-FRET analysis	B	COc1ccc(-n2c(=O)n(C)c3cnc4ccc(-c5ccncc5)cc4c32)cc1		CHEMBL3290307	=	IC50	nM	7943.0	CHEMBL3145	Homo sapiens	IC50	uM	7.943
Not Active	14979381	CHEMBL3372412	Inhibition of PI3Kbeta (unknown origin) at <8 uM	B	C[C@@H]1COCCN1c1nc(-c2cncc3[nH]ccc23)cc2c1ncn2[C@@H](C)S(C)(=O)=O		CHEMBL3355474		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	15002505	CHEMBL3366581	Inhibition of PIK3CB (unknown origin) assessed as residual activity at 10 uM relative to control	B	Cc1cc(O)cc(-c2nn(C)cc2-c2cc(N3CCOCC3)nc(-c3cccnc3)n2)c1		CHEMBL3310332	=	Activity	%	7.2	CHEMBL3145	Homo sapiens	Activity	%	7.2
	15037328	CHEMBL3368575	Inhibition of PI3Kbeta (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1OC		CHEMBL3102948	=	Inhibition	%	100.0	CHEMBL3145	Homo sapiens	INH	%	100.0
	15037329	CHEMBL3368575	Inhibition of PI3Kbeta (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1cc(-c2c[nH]c3ncc(-c4cccc(N)c4)cc23)cc(OC)c1OC		CHEMBL3319457	=	Inhibition	%	87.0	CHEMBL3145	Homo sapiens	INH	%	87.0
	15037330	CHEMBL3368575	Inhibition of PI3Kbeta (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4ccc(C(=O)N5CCOCC5)c(N)c4)cc23)cc1OC		CHEMBL3319467	=	Inhibition	%	95.0	CHEMBL3145	Homo sapiens	INH	%	95.0
	15037331	CHEMBL3368575	Inhibition of PI3Kbeta (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4cc(OC)c(OC)c(OC)c4)cc23)cc1OC		CHEMBL3319468	=	Inhibition	%	94.0	CHEMBL3145	Homo sapiens	INH	%	94.0
	15041755	CHEMBL3368575	Inhibition of PI3Kbeta (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N		CHEMBL3319470	=	Inhibition	%	93.0	CHEMBL3145	Homo sapiens	INH	%	93.0
	15063308	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	=	IC50	nM	40.0	CHEMBL3145	Homo sapiens	IC50	uM	0.04
	15063309	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	22.0	CHEMBL3145	Homo sapiens	IC50	uM	0.022
	15063310	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	Cc1cccc(NC(C)c2cc(C)cn3c(=O)cc(N4CCOCC4)nc23)c1		CHEMBL3319639	=	IC50	nM	81.0	CHEMBL3145	Homo sapiens	IC50	uM	0.081
	15063311	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	Cc1cc(C(C)Nc2ccc(F)cc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3319640	=	IC50	nM	190.0	CHEMBL3145	Homo sapiens	IC50	uM	0.19
	15063312	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	Cc1cc(C(C)Nc2cccc(Cl)c2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3319641	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	uM	0.017
	15063313	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	Cc1cc(C(C)Nc2cc(F)cc(F)c2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3319642	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	uM	0.009
	15063314	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1ccccc1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318711	=	IC50	nM	156.0	CHEMBL3145	Homo sapiens	IC50	uM	0.156
	15063315	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1ccccc1)c1cc(C(=O)NCCN(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318715	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	uM	0.008
	15063316	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1ccc(Cl)cc1)c1cc(C(=O)NCCN(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3317473	=	IC50	nM	75.0	CHEMBL3145	Homo sapiens	IC50	uM	0.075
	15063317	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1cccc(Cl)c1)c1cc(C(=O)NCCN(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319643	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	uM	0.01
	15063318	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1ccccc1Cl)c1cc(C(=O)NCCN(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319644	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	uM	0.007
	15063319	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1ccc(F)cc1)c1cc(C(=O)NCCN(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319645	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	uM	0.012
	15063320	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1cccc(F)c1)c1cc(C(=O)NCCN(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319646	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	uM	0.002
	15063321	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1ccccc1F)c1cc(C(=O)NCCN(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319647	=	IC50	nM	23.0	CHEMBL3145	Homo sapiens	IC50	uM	0.023
	15063322	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1cccc(C(F)(F)F)c1)c1cc(C(=O)NCCN(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319648	=	IC50	nM	74.0	CHEMBL3145	Homo sapiens	IC50	uM	0.074
	15063323	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	Cc1ccc(NC(C)c2cc(C(=O)NCCN(C)C)cn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3319649	=	IC50	nM	530.0	CHEMBL3145	Homo sapiens	IC50	uM	0.53
	15063324	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1cccc(Cl)c1F)c1cc(C(=O)NCCN(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319485	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	uM	0.004
	15063325	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1ccc(F)cc1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319486	=	IC50	nM	62.0	CHEMBL3145	Homo sapiens	IC50	uM	0.062
	15063326	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1cccc(F)c1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319487	=	IC50	nM	39.0	CHEMBL3145	Homo sapiens	IC50	uM	0.039
	15063327	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1cccc(F)c1F)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319488	=	IC50	nM	73.0	CHEMBL3145	Homo sapiens	IC50	uM	0.073
	15063328	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1ccc(F)c(F)c1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319489	=	IC50	nM	34.0	CHEMBL3145	Homo sapiens	IC50	uM	0.034
	15063329	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319490	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	uM	0.003
	15063330	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1cc(F)cc(Cl)c1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319491	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	uM	0.011
	15063331	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1cc(F)c(F)c(F)c1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319492	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	uM	0.011
	15063332	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1cc(F)cc(F)c1F)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319493	=	IC50	nM	25.0	CHEMBL3145	Homo sapiens	IC50	uM	0.025
	15063333	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)CCO)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319494	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	uM	0.008
	15063334	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCOCC2)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319495	=	IC50	nM	25.0	CHEMBL3145	Homo sapiens	IC50	uM	0.025
	15063335	CHEMBL3366862	Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCN(C)CC2)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319496	=	IC50	nM	29.0	CHEMBL3145	Homo sapiens	IC50	uM	0.029
	15063389	CHEMBL3366868	Inhibition of human recombinant PI3Kbeta assessed as depletion of ATP substrate by Ultra Glo luciferase assay	B	CC(Nc1ccccc1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318711	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	uM	0.011
	15063390	CHEMBL3366868	Inhibition of human recombinant PI3Kbeta assessed as depletion of ATP substrate by Ultra Glo luciferase assay	B	CC(Nc1ccccc1)c1cc(C(=O)NCCN(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318715	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	uM	0.008
	15063391	CHEMBL3366868	Inhibition of human recombinant PI3Kbeta assessed as depletion of ATP substrate by Ultra Glo luciferase assay	B	CC(Nc1cccc(Cl)c1F)c1cc(C(=O)NCCN(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319485	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	uM	0.007
	15063392	CHEMBL3366868	Inhibition of human recombinant PI3Kbeta assessed as depletion of ATP substrate by Ultra Glo luciferase assay	B	CC(Nc1ccc(F)cc1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319486	=	IC50	nM	37.0	CHEMBL3145	Homo sapiens	IC50	uM	0.037
	15063393	CHEMBL3366868	Inhibition of human recombinant PI3Kbeta assessed as depletion of ATP substrate by Ultra Glo luciferase assay	B	CC(Nc1ccc(F)c(F)c1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319489	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	uM	0.007
	15063394	CHEMBL3366868	Inhibition of human recombinant PI3Kbeta assessed as depletion of ATP substrate by Ultra Glo luciferase assay	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319490	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	uM	0.005
	15064281	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	Cc1cc(C(C)Nc2ccccc2-c2nnn[nH]2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3318709	=	IC50	nM	51.0	CHEMBL3145	Homo sapiens	IC50	uM	0.051
	15064282	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)NS(C)(=O)=O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3318708	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	uM	0.012
	15064283	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	Cc1cc(C(C)Nc2ccccc2S(=O)(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3318707	=	IC50	nM	30.0	CHEMBL3145	Homo sapiens	IC50	uM	0.03
	15064284	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)NO)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3318706	=	IC50	nM	84.0	CHEMBL3145	Homo sapiens	IC50	uM	0.084
	15064285	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	Cc1cc(C(C)Nc2cc(Cl)ccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3318705	=	IC50	nM	31.0	CHEMBL3145	Homo sapiens	IC50	uM	0.031
	15064286	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	Cc1cc(C(C)Nc2cccc(C(=O)O)c2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3318704	=	IC50	nM	4800.0	CHEMBL3145	Homo sapiens	IC50	uM	4.8
	15064287	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	uM	0.01
	15064288	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	49.0	CHEMBL3145	Homo sapiens	IC50	uM	0.049
	15064296	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	Cc1c(F)cccc1OC(C)c1cc(C(=O)N(C)CCO)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318727	=	IC50	nM	46.0	CHEMBL3145	Homo sapiens	IC50	uM	0.046
	15064297	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	Cc1cc(OC(C)c2cc(C(=O)N(C)CCO)cn3c(=O)cc(N4CCOCC4)nc23)ccc1F		CHEMBL3318726	=	IC50	nM	200.0	CHEMBL3145	Homo sapiens	IC50	uM	0.2
	15064298	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	COc1cccc(OC(C)c2cc(C(=O)N(C)CCO)cn3c(=O)cc(N4CCOCC4)nc23)c1		CHEMBL3318725	=	IC50	nM	47.0	CHEMBL3145	Homo sapiens	IC50	uM	0.047
	15064299	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	COc1ccccc1OC(C)c1cc(C(=O)N(C)CCO)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318724	=	IC50	nM	400.0	CHEMBL3145	Homo sapiens	IC50	uM	0.4
	15064300	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	CC(Oc1cccc(C#N)c1)c1cc(C(=O)N(C)CCO)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318723	=	IC50	nM	1700.0	CHEMBL3145	Homo sapiens	IC50	uM	1.7
	15064301	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	CC(Oc1ccccc1F)c1cc(C(=O)N(C)CCO)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318722	=	IC50	nM	660.0	CHEMBL3145	Homo sapiens	IC50	uM	0.66
	15064302	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	Cc1cccc(OC(C)c2cc(C(=O)N(C)CCO)cn3c(=O)cc(N4CCOCC4)nc23)c1		CHEMBL3318721	=	IC50	nM	180.0	CHEMBL3145	Homo sapiens	IC50	uM	0.18
	15064303	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	Cc1ccccc1OC(C)c1cc(C(=O)N(C)CCO)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318718	=	IC50	nM	110.0	CHEMBL3145	Homo sapiens	IC50	uM	0.11
	15064304	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	CC(Oc1ccccc1)c1cc(C(=O)N(C)CCO)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318717	=	IC50	nM	190.0	CHEMBL3145	Homo sapiens	IC50	uM	0.19
	15064305	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	CC(Nc1ccccc1)c1cc(C(=O)NCCN2CCNCC2)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318716	=	IC50	nM	76.0	CHEMBL3145	Homo sapiens	IC50	uM	0.076
	15064306	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	CC(Nc1ccccc1)c1cc(C(=O)NCCN(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318715	=	IC50	nM	35.0	CHEMBL3145	Homo sapiens	IC50	uM	0.035
	15064307	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	CC(Nc1ccccc1)c1cc(C(=O)N(C)CC(=O)O)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318714	=	IC50	nM	340.0	CHEMBL3145	Homo sapiens	IC50	uM	0.34
	15064308	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	CC(Nc1ccccc1)c1cc(C(=O)N2CCOCC2)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318713	=	IC50	nM	140.0	CHEMBL3145	Homo sapiens	IC50	uM	0.14
	15064309	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	CC(Nc1ccccc1)c1cc(C(=O)N(C)CCO)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318712	=	IC50	nM	58.0	CHEMBL3145	Homo sapiens	IC50	uM	0.058
	15064310	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	CC(Nc1ccccc1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318711	=	IC50	nM	68.0	CHEMBL3145	Homo sapiens	IC50	uM	0.068
	15064311	CHEMBL3368174	Inhibition of human recombinant PI3Kbeta assessed as PIP3 production by AlphaScreen assay	B	CC(Nc1ccccc1)c1cc(C(=O)O)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318710	=	IC50	nM	59.0	CHEMBL3145	Homo sapiens	IC50	uM	0.059
	15152458	CHEMBL3395876	Inhibition of PI3K p110beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	16000.0	CHEMBL3145	Homo sapiens	IC50	uM	16.0
	15152459	CHEMBL3395876	Inhibition of PI3K p110beta (unknown origin)	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	IC50	nM	3700.0	CHEMBL3145	Homo sapiens	IC50	uM	3.7
	15152460	CHEMBL3395876	Inhibition of PI3K p110beta (unknown origin)	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	2000.0	CHEMBL3145	Homo sapiens	IC50	uM	2.0
	15152461	CHEMBL3395876	Inhibition of PI3K p110beta (unknown origin)	B	Cc1cc(C(C)Nc2ccccc2)c2oc(-c3ccncc3)cc(=O)c2c1		CHEMBL3218573	=	IC50	nM	5000.0	CHEMBL3145	Homo sapiens	IC50	uM	5.0
	15152462	CHEMBL3395876	Inhibition of PI3K p110beta (unknown origin)	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	=	IC50	nM	0.89	CHEMBL3145	Homo sapiens	IC50	nM	0.89
	15152463	CHEMBL3395876	Inhibition of PI3K p110beta (unknown origin)	B	Cc1c(CN2CCN(C(=O)[C@@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1921986	=	IC50	nM	27.0	CHEMBL3145	Homo sapiens	IC50	nM	27.0
	15152464	CHEMBL3395876	Inhibition of PI3K p110beta (unknown origin)	B	CCn1nnc2c(N3CCOCC3)nc(-c3ccc(NC(=O)Nc4ccc(C(=O)N5CCN(C)CC5)cc4)cc3)nc21		CHEMBL589258	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	nM	7.0
	15152465	CHEMBL3395876	Inhibition of PI3K p110beta (unknown origin)	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	44.0	CHEMBL3145	Homo sapiens	IC50	nM	44.0
	15152466	CHEMBL3395876	Inhibition of PI3K p110beta (unknown origin)	B	Cc1nc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2n1C(C)C		CHEMBL3393066	=	IC50	nM	68.0	CHEMBL3145	Homo sapiens	IC50	nM	68.0
	15165812	CHEMBL3405879	Inhibition of recombinant PI3Kbeta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	983.0	CHEMBL3145	Homo sapiens	IC50	uM	0.983
	15165813	CHEMBL3405879	Inhibition of recombinant PI3Kbeta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Cc1ccc2c(c1)-c1nc3cc(C(F)(F)F)ccc3n1CCO2		CHEMBL3401259	=	IC50	nM	1213.0	CHEMBL3145	Homo sapiens	IC50	uM	1.213
	15165814	CHEMBL3405879	Inhibition of recombinant PI3Kbeta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Cc1ccc2c(c1)-c1nc3cc([N+](=O)[O-])ccc3n1CCO2		CHEMBL3401255	=	IC50	nM	184.0	CHEMBL3145	Homo sapiens	IC50	uM	0.184
	15165815	CHEMBL3405879	Inhibition of recombinant PI3Kbeta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Brc1ccc2c(c1)-c1nc3cc(Br)ccc3n1CCO2		CHEMBL3401253	=	IC50	nM	284.0	CHEMBL3145	Homo sapiens	IC50	uM	0.284
	15165816	CHEMBL3405879	Inhibition of recombinant PI3Kbeta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Cc1ccc2c(c1)-c1nc3cc(Br)ccc3n1CCO2		CHEMBL3401251	=	IC50	nM	1032.0	CHEMBL3145	Homo sapiens	IC50	uM	1.032
	15165817	CHEMBL3405879	Inhibition of recombinant PI3Kbeta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Clc1ccc2c(c1)nc1n2CCOc2ccc(Br)cc2-1		CHEMBL3401249	=	IC50	nM	188.0	CHEMBL3145	Homo sapiens	IC50	uM	0.188
	15165818	CHEMBL3405879	Inhibition of recombinant PI3Kbeta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Clc1ccc2c(c1)-c1nc3cc(Cl)ccc3n1CCO2		CHEMBL3401248	=	IC50	nM	363.0	CHEMBL3145	Homo sapiens	IC50	uM	0.363
	15165819	CHEMBL3405879	Inhibition of recombinant PI3Kbeta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Fc1ccc2c(c1)nc1n2CCOc2ccc(Br)cc2-1		CHEMBL3401245	=	IC50	nM	473.0	CHEMBL3145	Homo sapiens	IC50	uM	0.473
	15165820	CHEMBL3405879	Inhibition of recombinant PI3Kbeta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Fc1ccc2c(c1)nc1n2CCOc2ccc(Cl)cc2-1		CHEMBL3401244	=	IC50	nM	488.0	CHEMBL3145	Homo sapiens	IC50	uM	0.488
	15165821	CHEMBL3405879	Inhibition of recombinant PI3Kbeta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Cc1ccc2c(c1)-c1nc3cc(F)ccc3n1CCO2		CHEMBL3401243	=	IC50	nM	907.0	CHEMBL3145	Homo sapiens	IC50	uM	0.907
	15165822	CHEMBL3405879	Inhibition of recombinant PI3Kbeta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Cc1ccc2c(c1)-c1nc3cc(C)ccc3n1CCO2		CHEMBL3403813	=	IC50	nM	394.0	CHEMBL3145	Homo sapiens	IC50	uM	0.394
	15168846	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(S(C)(=O)=O)c1-c1ccccc1		CHEMBL3403664	=	IC50	nM	510.0	CHEMBL3145	Homo sapiens	IC50	uM	0.51
	15168847	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	COc1c(-c2ccccc2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL3403665	=	IC50	nM	8.2	CHEMBL3145	Homo sapiens	IC50	uM	0.0082
	15168848	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(O)c1-c1ccccc1		CHEMBL3403666	>	IC50	nM	20000.0	CHEMBL3145	Homo sapiens	IC50	uM	20.0
	15168849	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c([S+]([O-])CCO)c1-c1ccccc1		CHEMBL3403667	=	IC50	nM	160.0	CHEMBL3145	Homo sapiens	IC50	uM	0.16
	15168850	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C#N)c1-c1ccccc1		CHEMBL3403668	=	IC50	nM	280.0	CHEMBL3145	Homo sapiens	IC50	uM	0.28
	15168851	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(NCCO)c1-c1ccccc1		CHEMBL3403669	=	IC50	nM	460.0	CHEMBL3145	Homo sapiens	IC50	uM	0.46
	15168852	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	COCCNc1c(-c2ccccc2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL3403670	=	IC50	nM	420.0	CHEMBL3145	Homo sapiens	IC50	uM	0.42
	15168853	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(NCCN(C)C)c1-c1ccccc1		CHEMBL3403671	=	IC50	nM	5000.0	CHEMBL3145	Homo sapiens	IC50	uM	5.0
	15168854	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(NCCS(C)(=O)=O)c1-c1ccccc1		CHEMBL2216892	=	IC50	nM	500.0	CHEMBL3145	Homo sapiens	IC50	uM	0.5
	15168855	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2cc1-c1ccccn1		CHEMBL3403672	>	IC50	nM	20000.0	CHEMBL3145	Homo sapiens	IC50	uM	20.0
	15168856	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(Cl)c1-c1ccccn1		CHEMBL3403673	=	IC50	nM	230.0	CHEMBL3145	Homo sapiens	IC50	uM	0.23
	15168857	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(N(C)C)c1-c1ccccn1		CHEMBL3403674	=	IC50	nM	710.0	CHEMBL3145	Homo sapiens	IC50	uM	0.71
	15168858	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(N2CC(O)C2)c1-c1ccccn1		CHEMBL3403675	=	IC50	nM	280.0	CHEMBL3145	Homo sapiens	IC50	uM	0.28
	15168859	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(N2CCOCC2)c1-c1ccccn1		CHEMBL3403676	=	IC50	nM	80.0	CHEMBL3145	Homo sapiens	IC50	uM	0.08
	15168860	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	COCc1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL3400185	=	IC50	nM	4030.0	CHEMBL3145	Homo sapiens	IC50	uM	4.03
	15168861	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C#N)c1-c1ccccn1		CHEMBL3403677	=	IC50	nM	240.0	CHEMBL3145	Homo sapiens	IC50	uM	0.24
	15168862	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(-c2ccccn2)c1-c1ccccn1		CHEMBL3403678	=	IC50	nM	2800.0	CHEMBL3145	Homo sapiens	IC50	uM	2.8
	15168863	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	Cc1cccnc1-c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL3403679	>	IC50	nM	20000.0	CHEMBL3145	Homo sapiens	IC50	uM	20.0
	15168864	CHEMBL3404163	Inhibition of PI3Kbeta (unknown origin) by biochemical Alphascreen assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	1400.0	CHEMBL3145	Homo sapiens	IC50	uM	1.4
	15174767	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	Fc1cnc2[nH]cc(-c3ncc(F)c(N[C@H]4C5CCC(CC5)[C@@H]4c4nnn[nH]4)n3)c2c1		CHEMBL3401975	>	Ki	nM	4000.0	CHEMBL3145	Homo sapiens	Ki	uM	4.0
	15174768	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	O=P(O)(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401976	>	Ki	nM	4000.0	CHEMBL3145	Homo sapiens	Ki	uM	4.0
	15174769	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	O=P(O)(O)CC[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401977	>	Ki	nM	4000.0	CHEMBL3145	Homo sapiens	Ki	uM	4.0
	15174770	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	O=c1[nH]c(=O)n(C[C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)o1		CHEMBL3401978	=	Ki	nM	2000.0	CHEMBL3145	Homo sapiens	Ki	uM	2.0
	15174771	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)no1		CHEMBL3401979	>	Ki	nM	4000.0	CHEMBL3145	Homo sapiens	Ki	uM	4.0
	15174772	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	CC(=O)NS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401980	>	Ki	nM	4000.0	CHEMBL3145	Homo sapiens	Ki	uM	4.0
	15174773	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)on1		CHEMBL3401981	>	Ki	nM	4000.0	CHEMBL3145	Homo sapiens	Ki	uM	4.0
	15174774	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	O=c1nc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)[nH]o1		CHEMBL3401982	>	Ki	nM	4000.0	CHEMBL3145	Homo sapiens	Ki	uM	4.0
	15174775	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	NS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401983	>	Ki	nM	4000.0	CHEMBL3145	Homo sapiens	Ki	uM	4.0
	15174776	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	OCC(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401984	=	Ki	nM	2500.0	CHEMBL3145	Homo sapiens	Ki	uM	2.5
	15174777	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)[nH]n1		CHEMBL3401985	>	Ki	nM	4000.0	CHEMBL3145	Homo sapiens	Ki	uM	4.0
	15174778	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	CNC(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401986	>	Ki	nM	4000.0	CHEMBL3145	Homo sapiens	Ki	uM	4.0
	15174779	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	CC(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401987	>	Ki	nM	4000.0	CHEMBL3145	Homo sapiens	Ki	uM	4.0
	15174780	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	Cc1noc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)n1		CHEMBL3401988	=	Ki	nM	2300.0	CHEMBL3145	Homo sapiens	Ki	uM	2.3
	15174781	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nnc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)o1		CHEMBL3401989	>	Ki	nM	4000.0	CHEMBL3145	Homo sapiens	Ki	uM	4.0
	15174782	CHEMBL3406127	Inhibition of PI3Kbeta (unknown origin)	B	CS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401990	>	Ki	nM	4000.0	CHEMBL3145	Homo sapiens	Ki	uM	4.0
	15196216	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1ccc(F)cc1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408244	=	IC50	nM	18.0	CHEMBL3145	Homo sapiens	IC50	uM	0.018
	15196217	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cccc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3407508	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	uM	0.012
	15196218	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cccc(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408245	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	uM	0.01
	15196219	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cccc(F)c1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408246	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	uM	0.013
	15196220	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Nc1ccc(F)c(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408247	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	uM	0.007
	15196221	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	uM	0.004
	15196222	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cc(F)ccc1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408249	=	IC50	nM	19.0	CHEMBL3145	Homo sapiens	IC50	uM	0.019
	15196223	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Nc1cccc(Cl)c1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408250	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	uM	0.005
	15196224	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1ccc(F)c(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408251	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	uM	0.012
	15196225	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Nc1cc(F)cc(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408252	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	uM	0.005
	15196226	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	Cc1cc(F)cc(NC(C)c2cc(C(=O)N(C)C)cc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL3408253	=	IC50	nM	15.0	CHEMBL3145	Homo sapiens	IC50	uM	0.015
	15196227	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	COc1cc(F)cc(NC(C)c2cc(C(=O)N(C)C)cc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL3408254	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	uM	0.01
	15196228	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cc(Cl)cc(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408255	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	uM	0.01
	15196229	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Nc1cc(F)c(F)c(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408256	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	uM	0.005
	15196230	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Nc1cc(F)cc(F)c1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408257	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	uM	0.008
	15196231	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CCN(C)C(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408258	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	uM	0.008
	15196250	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	COCCN(C)C(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408259	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	uM	0.011
	15196251	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)CCO)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408260	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	uM	0.01
	15196252	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CCN(CC)C(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408261	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	uM	0.01
	15196253	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408262	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	uM	0.004
	15196254	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408263	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	uM	0.009
	15196255	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCCCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408264	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	uM	0.012
	15196256	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCOCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408265	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	uM	0.011
	15196257	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCC(O)CC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408266	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	uM	0.011
	15196258	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CNC(=O)c1cc([C@@H](C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408267	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	uM	0.006
	15196259	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CCNC(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408268	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	uM	0.009
	15196260	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	COCCNC(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408269	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	uM	0.009
	15196261	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	C[C@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc([C@@H](C)Nc4cc(F)cc(F)c4)c3o2)CCO1		CHEMBL3408270	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	uM	0.004
	15196262	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	C[C@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc([C@H](C)Nc4cc(F)cc(F)c4)c3o2)CCO1		CHEMBL3408271	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	uM	0.009
	15196263	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CN(C)C(=O)c1cc(CNc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408272	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	uM	0.008
	15196264	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CN(C)C(=O)c1cc(CN(C)c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408273	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	uM	0.007
	15196265	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	C[C@H](c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3408274	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	uM	0.007
	15196266	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Oc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408275	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	uM	0.017
	15196267	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	CC(c1cc(C(=O)N2CCCC2)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3408276	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	uM	0.013
	15196268	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	C[C@H](c1cc(C(=O)N(C)CCO)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3408277	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	uM	0.006
	15196269	CHEMBL3411216	Inhibition of human recombinant PI3Kbeta using PIP2 by Kinase-Glo Plus assay	B	C[C@H](c1cc(C(=O)N2CCC(O)CC2)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3408278	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	uM	0.007
	15196378	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CC(Nc1ccc(F)cc1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408244	=	IC50	nM	128.0	CHEMBL3145	Homo sapiens	IC50	uM	0.128
	15196379	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CC(Nc1cccc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3407508	=	IC50	nM	32.0	CHEMBL3145	Homo sapiens	IC50	uM	0.032
	15196380	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CC(Nc1cccc(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408245	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	uM	0.009
	15196381	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CC(Nc1cccc(F)c1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408246	=	IC50	nM	24.0	CHEMBL3145	Homo sapiens	IC50	uM	0.024
	15196382	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	C[C@@H](Nc1ccc(F)c(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408247	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	uM	0.017
	15196383	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	uM	0.003
	15196384	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CC(Nc1cc(F)ccc1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408249	=	IC50	nM	60.0	CHEMBL3145	Homo sapiens	IC50	uM	0.06
	15196385	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	C[C@@H](Nc1cccc(Cl)c1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408250	=	IC50	nM	20.0	CHEMBL3145	Homo sapiens	IC50	uM	0.02
	15196386	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CC(Nc1ccc(F)c(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408251	=	IC50	nM	16.0	CHEMBL3145	Homo sapiens	IC50	uM	0.016
	15196387	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	C[C@@H](Nc1cc(F)cc(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408252	=	IC50	nM	1.0	CHEMBL3145	Homo sapiens	IC50	uM	0.001
	15196388	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	Cc1cc(F)cc(NC(C)c2cc(C(=O)N(C)C)cc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL3408253	=	IC50	nM	49.0	CHEMBL3145	Homo sapiens	IC50	uM	0.049
	15196389	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	COc1cc(F)cc(NC(C)c2cc(C(=O)N(C)C)cc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL3408254	=	IC50	nM	15.0	CHEMBL3145	Homo sapiens	IC50	uM	0.015
	15196390	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CC(Nc1cc(Cl)cc(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408255	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	uM	0.017
	15196391	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	C[C@@H](Nc1cc(F)c(F)c(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408256	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	uM	0.013
	15196392	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	C[C@@H](Nc1cc(F)cc(F)c1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408257	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	uM	0.006
	15196393	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CCN(C)C(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408258	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	uM	0.007
	15196394	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	COCCN(C)C(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408259	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	uM	0.017
	15196395	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)CCO)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408260	=	IC50	nM	15.0	CHEMBL3145	Homo sapiens	IC50	uM	0.015
	15196396	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CCN(CC)C(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408261	=	IC50	nM	16.0	CHEMBL3145	Homo sapiens	IC50	uM	0.016
	15196397	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408262	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	uM	0.002
	15196398	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408263	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	uM	0.002
	15196399	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCCCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408264	=	IC50	nM	14.0	CHEMBL3145	Homo sapiens	IC50	uM	0.014
	15196400	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCOCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408265	=	IC50	nM	33.0	CHEMBL3145	Homo sapiens	IC50	uM	0.033
	15196401	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCC(O)CC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408266	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	uM	0.017
	15196402	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CNC(=O)c1cc([C@@H](C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408267	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	uM	0.003
	15196403	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CCNC(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408268	=	IC50	nM	14.0	CHEMBL3145	Homo sapiens	IC50	uM	0.014
	15196404	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	COCCNC(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408269	=	IC50	nM	31.0	CHEMBL3145	Homo sapiens	IC50	uM	0.031
	15196405	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	C[C@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc([C@@H](C)Nc4cc(F)cc(F)c4)c3o2)CCO1		CHEMBL3408270	=	IC50	nM	0.4	CHEMBL3145	Homo sapiens	IC50	uM	0.0004
	15196406	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	C[C@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc([C@H](C)Nc4cc(F)cc(F)c4)c3o2)CCO1		CHEMBL3408271	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	uM	0.012
	15196407	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CN(C)C(=O)c1cc(CNc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408272	=	IC50	nM	35.0	CHEMBL3145	Homo sapiens	IC50	uM	0.035
	15196408	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CN(C)C(=O)c1cc(CN(C)c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408273	=	IC50	nM	35.0	CHEMBL3145	Homo sapiens	IC50	uM	0.035
	15196409	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	C[C@H](c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3408274	=	IC50	nM	15.0	CHEMBL3145	Homo sapiens	IC50	uM	0.015
	15196410	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	C[C@@H](Oc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408275	=	IC50	nM	132.0	CHEMBL3145	Homo sapiens	IC50	uM	0.132
	15196411	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	CC(c1cc(C(=O)N2CCCC2)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3408276	=	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	uM	0.1
	15196412	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	C[C@H](c1cc(C(=O)N(C)CCO)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3408277	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	uM	0.01
	15196413	CHEMBL3411220	Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	C[C@H](c1cc(C(=O)N2CCC(O)CC2)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3408278	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	uM	0.012
	15197142	CHEMBL3413523	Inhibition of recombinant PI3Kbeta (unknown origin) using biotinylated PIP2 as substrate	B	C[C@H]1COCCN1c1cc(C2(S(=O)(=O)C3CC3)CC2)nc(-c2ccc(NC(=S)NCCO)cc2)n1		CHEMBL3410672	=	IC50	nM	5495.41	CHEMBL3145	Homo sapiens	pIC50		5.26
	15245295	CHEMBL3429707	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2c(C)nn3c(NCCNC(C)=O)cc(C)nc23)cc1OC		CHEMBL3426594	<=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15245296	CHEMBL3429707	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2c(C)nn3c(NCCNC(=O)C(C)C)cc(C)nc23)cc1OC		CHEMBL3426595	<=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15245297	CHEMBL3429707	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2c(C)nn3c(NCCNS(C)(=O)=O)cc(C)nc23)cc1OC		CHEMBL3426596	<=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15245298	CHEMBL3429707	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2c(C)nn3c(NCCOC(C)=O)cc(C)nc23)cc1OC		CHEMBL3426597	<=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15245299	CHEMBL3429707	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2c(C)nc3c(NCCN4CCOCC4)ccnn23)cc1OC		CHEMBL3426598	<=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15245300	CHEMBL3429707	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2c(C)nc3c(NCCNC(C)=O)cc(Cl)nn23)cc1OC		CHEMBL3426599	<=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15245301	CHEMBL3429707	Inhibition of PI3Kbeta (unknown origin)	B	CC(=O)NCCNc1cc(Cl)nn2c(-c3ccc(F)c(C=O)c3)c(C)nc12		CHEMBL3426600	<=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15245302	CHEMBL3429707	Inhibition of PI3Kbeta (unknown origin)	B	CC(=O)NCCNc1cc(Cl)nn2c(-c3cccc(S(=O)(=O)NC(C)C)c3)c(C)nc12		CHEMBL3426601	<=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15245303	CHEMBL3429707	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2c(C)nc3c(NCCNC(C)=O)ccnn23)cc1OC		CHEMBL3426602	<=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15245304	CHEMBL3429707	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2c(C)nc3c(N)cc(Cl)nn23)cc1OC		CHEMBL3426603	<=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15245305	CHEMBL3429707	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2c(C)nn3c(NCCN4CCOCC4)cc(C)nc23)cc1OC		CHEMBL2397317	<=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15608380	CHEMBL3579764	Inhibition of PI3Kbeta (unknown origin) using PIP2/PS as substrate after 1 hr by luciferase-based luminescence assay	B	COc1ncc(-c2cc3c(-c4ccncc4)ncnc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3577921	=	IC50	nM	22.5	CHEMBL3145	Homo sapiens	IC50	nM	22.5
	15608381	CHEMBL3579764	Inhibition of PI3Kbeta (unknown origin) using PIP2/PS as substrate after 1 hr by luciferase-based luminescence assay	B	O=S(=O)(Nc1cc(-c2cc3c(-c4ccncc4)ncnc3s2)cnc1Cl)c1ccc(F)cc1F		CHEMBL3577925	=	IC50	nM	3.6	CHEMBL3145	Homo sapiens	IC50	nM	3.6
	15615244	CHEMBL3584207	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2cc(CNc3ccc(S(=O)(=O)Nc4nnc(C)s4)cc3)cc(C(=O)NCCc3ccccc3F)c2)cn1		CHEMBL3582350	=	IC50	nM	700.0	CHEMBL3145	Homo sapiens	IC50	nM	700.0
	15615245	CHEMBL3584207	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2cc(CNc3ccc(S(=O)(=O)Nc4nnc(C)s4)cc3)cc(C(=O)NCCC(C)C)c2)cn1		CHEMBL3582351	=	IC50	nM	398.0	CHEMBL3145	Homo sapiens	IC50	nM	398.0
Not Determined	15615246	CHEMBL3584207	Inhibition of PI3Kbeta (unknown origin)	B	COC(=O)c1cc(I)cc(CNc2ccc(S(=O)(=O)Nc3nnc(C)s3)cc2)c1		CHEMBL3582352		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	15615247	CHEMBL3584207	Inhibition of PI3Kbeta (unknown origin)	B	COC(=O)c1cc(CNc2ccc(S(=O)(=O)Nc3nnc(C)s3)cc2)cc(-c2ccc(OC)nc2)c1		CHEMBL3582353		IC50			CHEMBL3145	Homo sapiens	IC50		
	15615248	CHEMBL3584207	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2cc(CNc3ccc(S(=O)(=O)Nc4nnc(C)s4)cc3)cc(C(=O)O)c2)cn1		CHEMBL3582354	=	IC50	nM	149.0	CHEMBL3145	Homo sapiens	IC50	nM	149.0
	15615249	CHEMBL3584207	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2cccc(CNc3ccc(S(=O)(=O)Nc4nnc(C)s4)cc3)c2)cn1		CHEMBL3582355	=	IC50	nM	765.0	CHEMBL3145	Homo sapiens	IC50	nM	765.0
	15615250	CHEMBL3584207	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nnc(NS(=O)(=O)c2ccc(NCc3cc(C(=O)O)cc(-c4ccc5c(c4)OCCO5)c3)cc2)s1		CHEMBL3582356	=	IC50	nM	125.9	CHEMBL3145	Homo sapiens	IC50	nM	125.9
	15615251	CHEMBL3584207	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nnc(NS(=O)(=O)c2ccc(NCc3cc(C(=O)O)cc(-c4ccc5c(c4)OCO5)c3)cc2)s1		CHEMBL3582357	=	IC50	nM	501.0	CHEMBL3145	Homo sapiens	IC50	nM	501.0
	15615252	CHEMBL3584207	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2cc(CNc3ccc(S(=O)(=O)N(C)c4nnc(C)s4)cc3)cc(C(=O)NCCc3ccccc3F)c2)cn1		CHEMBL3582358	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	15615253	CHEMBL3584207	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2cc(CNc3ccc(S(=O)(=O)Nc4nnc(C)s4)cc3)cc(C(=O)NC(CO)CO)c2)cn1		CHEMBL3582359	=	IC50	nM	790.0	CHEMBL3145	Homo sapiens	IC50	nM	790.0
	15627181	CHEMBL3587145	Inhibition of PI3Kbeta in human THP1 cells assessed as inhibition of CSF1-stimulated chemotaxis pre-incubated for 1 hr before MCP1 stimulation	B	COc1cc(N2CCc3nc(NC(=O)NCCc4cn(CC(F)F)cn4)sc3C2)cnc1Cl		CHEMBL3585362	>	IC50	nM	20000.0	CHEMBL3145	Homo sapiens	IC50	uM	20.0
	15628751	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	uM	0.004
	15628752	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(C(C)N(C)c2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585581	=	IC50	nM	20.0	CHEMBL3145	Homo sapiens	IC50	uM	0.02
	15628753	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=c1cc(N2CCOCC2)nc2c(CNc3ccccc3)cccn12		CHEMBL3585582	=	IC50	nM	30.0	CHEMBL3145	Homo sapiens	IC50	uM	0.03
	15628754	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	CN(Cc1cccn2c(=O)cc(N3CCOCC3)nc12)c1ccccc1		CHEMBL3585583	=	IC50	nM	30.0	CHEMBL3145	Homo sapiens	IC50	uM	0.03
	15628755	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccccc1NCc1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585584	=	IC50	nM	20.0	CHEMBL3145	Homo sapiens	IC50	uM	0.02
	15628756	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cccc(NCc2cccn3c(=O)cc(N4CCOCC4)nc23)c1		CHEMBL3585585	=	IC50	nM	240.0	CHEMBL3145	Homo sapiens	IC50	uM	0.24
	15628757	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccc(NCc2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585586	=	IC50	nM	4600.0	CHEMBL3145	Homo sapiens	IC50	uM	4.6
	15628758	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=c1cc(N2CCOCC2)nc2c(CNc3ccc(Cl)cc3)cccn12		CHEMBL3585587	=	IC50	nM	310.0	CHEMBL3145	Homo sapiens	IC50	uM	0.31
	15628759	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	COc1ccc(NCc2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585588	=	IC50	nM	2100.0	CHEMBL3145	Homo sapiens	IC50	uM	2.1
	15628760	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccc(S(=O)(=O)NCc2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585589	=	IC50	nM	7400.0	CHEMBL3145	Homo sapiens	IC50	uM	7.4
	15628761	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=c1cc(N2CCOCC2)nc2c(CS(=O)(=O)c3ccccc3)cccn12		CHEMBL3585351	=	IC50	nM	4800.0	CHEMBL3145	Homo sapiens	IC50	uM	4.8
	15628762	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=c1cc(N2CCOCC2)nc2c(CSc3ccccc3)cccn12		CHEMBL3585590	=	IC50	nM	570.0	CHEMBL3145	Homo sapiens	IC50	uM	0.57
	15628763	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=c1cc(N2CCOCC2)nc2c(COc3ccccc3)cccn12		CHEMBL3585591	=	IC50	nM	230.0	CHEMBL3145	Homo sapiens	IC50	uM	0.23
	15628764	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccc(OCc2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585592	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	15628765	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	COc1ccc(OCc2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585593	=	IC50	nM	1400.0	CHEMBL3145	Homo sapiens	IC50	uM	1.4
	15628766	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	N#Cc1ccc(OCc2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585594	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	15628767	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585595	=	IC50	nM	450.0	CHEMBL3145	Homo sapiens	IC50	uM	0.45
	15628768	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(N(C)c2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585596	=	IC50	nM	670.0	CHEMBL3145	Homo sapiens	IC50	uM	0.67
	15628769	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(Nc2ccccc2C)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585597	=	IC50	nM	1100.0	CHEMBL3145	Homo sapiens	IC50	uM	1.1
	15628770	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cccc(Nc2cc(C)cn3c(=O)cc(N4CCOCC4)nc23)c1		CHEMBL3585598	=	IC50	nM	1200.0	CHEMBL3145	Homo sapiens	IC50	uM	1.2
	15628771	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccc(Nc2cc(C)cn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585599	=	IC50	nM	3200.0	CHEMBL3145	Homo sapiens	IC50	uM	3.2
	15628772	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(Nc2c(C)cccc2C)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585600	=	IC50	nM	2100.0	CHEMBL3145	Homo sapiens	IC50	uM	2.1
	15628773	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(NCc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585601	=	IC50	nM	150.0	CHEMBL3145	Homo sapiens	IC50	uM	0.15
	15628774	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(NCc2ccccc2C)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3218574	=	IC50	nM	20.0	CHEMBL3145	Homo sapiens	IC50	uM	0.02
	15628775	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cccc(CNc2cc(C)cn3c(=O)cc(N4CCOCC4)nc23)c1		CHEMBL3585602	=	IC50	nM	130.0	CHEMBL3145	Homo sapiens	IC50	uM	0.13
	15628776	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccc(CNc2cc(C)cn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585603	=	IC50	nM	1800.0	CHEMBL3145	Homo sapiens	IC50	uM	1.8
	15628777	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(NCc2ccccn2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585604	=	IC50	nM	420.0	CHEMBL3145	Homo sapiens	IC50	uM	0.42
	15628778	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(NCc2cccnc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585605	=	IC50	nM	590.0	CHEMBL3145	Homo sapiens	IC50	uM	0.59
	15628779	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(NCc2ccncc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585606	=	IC50	nM	4200.0	CHEMBL3145	Homo sapiens	IC50	uM	4.2
	15628780	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(N[C@@H](C)c2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585607	=	IC50	nM	210.0	CHEMBL3145	Homo sapiens	IC50	uM	0.21
	15628781	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(N[C@H](C)c2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585608	=	IC50	nM	2300.0	CHEMBL3145	Homo sapiens	IC50	uM	2.3
	15628782	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=C(Nc1ccccc1)c1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585609	=	IC50	nM	3600.0	CHEMBL3145	Homo sapiens	IC50	uM	3.6
	15628783	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccccc1NC(=O)c1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585610	=	IC50	nM	1500.0	CHEMBL3145	Homo sapiens	IC50	uM	1.5
	15628784	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cccc(NC(=O)c2cccn3c(=O)cc(N4CCOCC4)nc23)c1		CHEMBL3585611	=	IC50	nM	3900.0	CHEMBL3145	Homo sapiens	IC50	uM	3.9
	15628785	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccc(NC(=O)c2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585612	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15628786	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=C(NCc1ccccn1)c1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585613	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15628787	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=C(NCc1cccnc1)c1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585614	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15628788	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=C(NCc1ccncc1)c1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585615	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15628789	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=C(Nc1cccn2c(=O)cc(N3CCOCC3)nc12)c1ccccc1		CHEMBL3585616	=	IC50	nM	1800.0	CHEMBL3145	Homo sapiens	IC50	uM	1.8
	15628790	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccccc1C(=O)Nc1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585617	=	IC50	nM	2400.0	CHEMBL3145	Homo sapiens	IC50	uM	2.4
	15628791	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cccc(C(=O)Nc2cccn3c(=O)cc(N4CCOCC4)nc23)c1		CHEMBL3585618	=	IC50	nM	1800.0	CHEMBL3145	Homo sapiens	IC50	uM	1.8
	15628792	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccc(C(=O)Nc2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585619	=	IC50	nM	1900.0	CHEMBL3145	Homo sapiens	IC50	uM	1.9
	15628793	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=c1cc(N2CCOCC2)nc2c(NS(=O)(=O)c3ccccc3)cccn12		CHEMBL3585620	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15628794	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=C(Nc1ccccc1)Nc1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585621	=	IC50	nM	630.0	CHEMBL3145	Homo sapiens	IC50	uM	0.63
	15628795	CHEMBL3587454	Inhibition of N-terminal His-tagged human p110beta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=C(Nc1cccn2c(=O)cc(N3CCOCC3)nc12)Oc1ccccc1		CHEMBL3585622	=	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	15633292	CHEMBL3591914	Inhibition of GST-tagged human p110beta expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c(N3CCOCC3)nc(-c3cccc(OC)c3)nc21		CHEMBL3589320	=	IC50	nM	26180.0	CHEMBL3145	Homo sapiens	IC50	uM	26.18
	15633293	CHEMBL3591914	Inhibition of GST-tagged human p110beta expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c(N3CCOCC3)nc(-c3ccc(OC)cc3)nc21		CHEMBL3589321	=	IC50	nM	58430.0	CHEMBL3145	Homo sapiens	IC50	uM	58.43
	15633294	CHEMBL3591914	Inhibition of GST-tagged human p110beta expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	COc1cccc(-c2nc(N3CCOCC3)c3c(n2)N(c2ccccc2)C(=S)N2CCCC32)c1	Outside typical range	CHEMBL3589322	=	IC50	nM	113450.0	CHEMBL3145	Homo sapiens	IC50	uM	113.45
	15633295	CHEMBL3591914	Inhibition of GST-tagged human p110beta expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	COc1ccc(-c2nc(N3CCOCC3)c3c(n2)N(c2ccccc2)C(=S)N2CCCC32)cc1		CHEMBL3589323	=	IC50	nM	78290.0	CHEMBL3145	Homo sapiens	IC50	uM	78.29
	15633296	CHEMBL3591914	Inhibition of GST-tagged human p110beta expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c1nc(CN1CCOCC1)[nH]c2=O		CHEMBL3589324	=	IC50	nM	93.0	CHEMBL3145	Homo sapiens	IC50	uM	0.093
	15633297	CHEMBL3591914	Inhibition of GST-tagged human p110beta expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c1nc(C(C)N1CCOCC1)[nH]c2=O		CHEMBL3589370	=	IC50	nM	67.0	CHEMBL3145	Homo sapiens	IC50	uM	0.067
	15633298	CHEMBL3591914	Inhibition of GST-tagged human p110beta expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	O=c1[nH]c(CN2CCOCC2)nc2c1C1CCCN1C(=S)N2c1ccccc1		CHEMBL3589371	=	IC50	nM	80.0	CHEMBL3145	Homo sapiens	IC50	uM	0.08
	15633299	CHEMBL3591914	Inhibition of GST-tagged human p110beta expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CC(c1nc2c(c(=O)[nH]1)C1CCCN1C(=S)N2c1ccccc1)N1CCOCC1		CHEMBL3589372	=	IC50	nM	56.0	CHEMBL3145	Homo sapiens	IC50	uM	0.056
	15633300	CHEMBL3591914	Inhibition of GST-tagged human p110beta expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	S=C1N(c2ccccc2)c2nc(CN3CCOCC3)nc(N3CCOCC3)c2C2CCCN12	Outside typical range	CHEMBL3589373	=	IC50	nM	323450.0	CHEMBL3145	Homo sapiens	IC50	uM	323.45
	15633301	CHEMBL3591914	Inhibition of GST-tagged human p110beta expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CC(c1nc(N2CCOCC2)c2c(n1)N(c1ccccc1)C(=S)N1CCCC21)N1CCOCC1	Outside typical range	CHEMBL3589374	=	IC50	nM	418160.0	CHEMBL3145	Homo sapiens	IC50	uM	418.16
	15633302	CHEMBL3591914	Inhibition of GST-tagged human p110beta expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c1nc(-c1cccc(O)c1)c(C#N)c2N1CCOCC1		CHEMBL3589375	=	IC50	nM	890.0	CHEMBL3145	Homo sapiens	IC50	uM	0.89
	15633303	CHEMBL3591914	Inhibition of GST-tagged human p110beta expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c1nc(-c1cccc(OC)c1)c(C#N)c2N1CCOCC1		CHEMBL3589376	=	IC50	nM	560.0	CHEMBL3145	Homo sapiens	IC50	uM	0.56
	15633304	CHEMBL3591914	Inhibition of GST-tagged human p110beta expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c1nc(-c1ccc(OC)cc1)c(C#N)c2N1CCOCC1		CHEMBL3589377	=	IC50	nM	340.0	CHEMBL3145	Homo sapiens	IC50	uM	0.34
	15633305	CHEMBL3591914	Inhibition of GST-tagged human p110beta expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c1nc(-c1ccc(OC)c(O)c1)c(C#N)c2N1CCOCC1		CHEMBL3589378	=	IC50	nM	780.0	CHEMBL3145	Homo sapiens	IC50	uM	0.78
	15633306	CHEMBL3591914	Inhibition of GST-tagged human p110beta expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c1nc(-c1ccc(OC)c(OC)c1)c(C#N)c2N1CCOCC1		CHEMBL3589379	=	IC50	nM	480.0	CHEMBL3145	Homo sapiens	IC50	uM	0.48
	15637759	CHEMBL3591469	Inhibition of recombinant human PI3Kbeta using PIP2/ATP as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by Kinase-Glo plus assay	B	CN(C)CC(=O)N1CCC(n2cc(-c3cnc(N)c(-n4nnc5ccccc54)n3)cn2)CC1		CHEMBL3590219	=	IC50	nM	900.0	CHEMBL3145	Homo sapiens	IC50	uM	0.9
	15637760	CHEMBL3591469	Inhibition of recombinant human PI3Kbeta using PIP2/ATP as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by Kinase-Glo plus assay	B	CN(C)CC(=O)N1CCC(n2ccc(-c3cnc(N)c(-n4nnc5ccccc54)n3)n2)CC1		CHEMBL3590220	=	IC50	nM	1700.0	CHEMBL3145	Homo sapiens	IC50	uM	1.7
	15637761	CHEMBL3591469	Inhibition of recombinant human PI3Kbeta using PIP2/ATP as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by Kinase-Glo plus assay	B	CN(C)CC(=O)N1CCC(n2ncc(-c3cnc(N)c(-n4nnc5ccccc54)n3)n2)CC1		CHEMBL3590221	=	IC50	nM	650.0	CHEMBL3145	Homo sapiens	IC50	uM	0.65
	15637776	CHEMBL3591469	Inhibition of recombinant human PI3Kbeta using PIP2/ATP as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by Kinase-Glo plus assay	B	CN(C)CC(=O)N1CCC(c2cc(-c3cnc(N)c(-n4nnc5ccccc54)n3)n(C)n2)CC1		CHEMBL3590225	=	IC50	nM	380.0	CHEMBL3145	Homo sapiens	IC50	uM	0.38
	15637777	CHEMBL3591469	Inhibition of recombinant human PI3Kbeta using PIP2/ATP as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by Kinase-Glo plus assay	B	CN(C)CC(=O)N1CCC(c2cn(C)c(-c3cnc(N)c(-n4nnc5ccccc54)n3)n2)CC1		CHEMBL3590224	=	IC50	nM	1300.0	CHEMBL3145	Homo sapiens	IC50	uM	1.3
	15637778	CHEMBL3591469	Inhibition of recombinant human PI3Kbeta using PIP2/ATP as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by Kinase-Glo plus assay	B	CN(C)CC(=O)N1CCC(c2nc(-c3cnc(N)c(-n4nnc5ccccc54)n3)nn2C)CC1		CHEMBL3590223	=	IC50	nM	2400.0	CHEMBL3145	Homo sapiens	IC50	uM	2.4
	15637779	CHEMBL3591469	Inhibition of recombinant human PI3Kbeta using PIP2/ATP as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by Kinase-Glo plus assay	B	CN(C)CC(=O)N1CCC(c2nc(-c3cnc(N)c(-n4nnc5ccccc54)n3)n(C)n2)CC1		CHEMBL3590222	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	15637780	CHEMBL3591472	Inhibition of PI3Kbeta in human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation at Ser-473 after 2 hrs by ELISA	B	CN(C)CC(=O)N1CCC(n2cc(-c3cnc(N)c(-n4nnc5ccccc54)n3)cn2)CC1		CHEMBL3590219	=	IC50	nM	13000.0	CHEMBL3145	Homo sapiens	IC50	uM	13.0
	15637781	CHEMBL3591472	Inhibition of PI3Kbeta in human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation at Ser-473 after 2 hrs by ELISA	B	CN(C)CC(=O)N1CCC(n2ccc(-c3cnc(N)c(-n4nnc5ccccc54)n3)n2)CC1		CHEMBL3590220	=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15637782	CHEMBL3591472	Inhibition of PI3Kbeta in human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation at Ser-473 after 2 hrs by ELISA	B	CN(C)CC(=O)N1CCC(n2ncc(-c3cnc(N)c(-n4nnc5ccccc54)n3)n2)CC1		CHEMBL3590221	=	IC50	nM	7800.0	CHEMBL3145	Homo sapiens	IC50	uM	7.8
	15637783	CHEMBL3591472	Inhibition of PI3Kbeta in human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation at Ser-473 after 2 hrs by ELISA	B	CN(C)CC(=O)N1CCC(c2nc(-c3cnc(N)c(-n4nnc5ccccc54)n3)n(C)n2)CC1		CHEMBL3590222	=	IC50	nM	6900.0	CHEMBL3145	Homo sapiens	IC50	uM	6.9
	15637784	CHEMBL3591472	Inhibition of PI3Kbeta in human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation at Ser-473 after 2 hrs by ELISA	B	CN(C)CC(=O)N1CCC(c2nc(-c3cnc(N)c(-n4nnc5ccccc54)n3)nn2C)CC1		CHEMBL3590223	=	IC50	nM	12000.0	CHEMBL3145	Homo sapiens	IC50	uM	12.0
	15637785	CHEMBL3591472	Inhibition of PI3Kbeta in human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation at Ser-473 after 2 hrs by ELISA	B	CN(C)CC(=O)N1CCC(c2cn(C)c(-c3cnc(N)c(-n4nnc5ccccc54)n3)n2)CC1		CHEMBL3590224	=	IC50	nM	7900.0	CHEMBL3145	Homo sapiens	IC50	uM	7.9
	15637786	CHEMBL3591472	Inhibition of PI3Kbeta in human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation at Ser-473 after 2 hrs by ELISA	B	CN(C)CC(=O)N1CCC(c2cc(-c3cnc(N)c(-n4nnc5ccccc54)n3)n(C)n2)CC1		CHEMBL3590225	=	IC50	nM	4300.0	CHEMBL3145	Homo sapiens	IC50	uM	4.3
	15665862	CHEMBL3602858	Inhibition of recombinant PI3Kb (unknown origin) at 1 uM after 3 hrs	B	CS(=O)(=O)NCc1ccc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nn12		CHEMBL3601472	=	Inhibition	%	54.0	CHEMBL3145	Homo sapiens	INH	%	54.0
	15669863	CHEMBL3602202	Inhibition of PI3Kbeta (unknown origin) assessed as reduction of ATP level after 40 mins by luciferase based luminescence assay	B	COc1ncc(-c2ccc3nc(NC(=O)NC4CC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1		CHEMBL3601923	=	IC50	nM	47.0	CHEMBL3145	Homo sapiens	IC50	nM	47.0
	15669864	CHEMBL3602202	Inhibition of PI3Kbeta (unknown origin) assessed as reduction of ATP level after 40 mins by luciferase based luminescence assay	B	CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1		CHEMBL3601925	=	IC50	nM	41.0	CHEMBL3145	Homo sapiens	IC50	nM	41.0
	15669865	CHEMBL3602202	Inhibition of PI3Kbeta (unknown origin) assessed as reduction of ATP level after 40 mins by luciferase based luminescence assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	399.0	CHEMBL3145	Homo sapiens	IC50	nM	399.0
	15673059	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CCOc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600683	=	IC50	nM	6309.57	CHEMBL3145	Homo sapiens	pIC50		5.2
	15673060	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	COc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL1645105	=	IC50	nM	1584.89	CHEMBL3145	Homo sapiens	pIC50		5.8
	15673061	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CCSc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600684	=	IC50	nM	5011.87	CHEMBL3145	Homo sapiens	pIC50		5.3
	15673062	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	COCc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600685	=	IC50	nM	15848.93	CHEMBL3145	Homo sapiens	pIC50		4.8
	15673063	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CNCc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600686	=	IC50	nM	79432.82	CHEMBL3145	Homo sapiens	pIC50		4.1
	15673064	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CC(C)Oc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600687	=	IC50	nM	31622.78	CHEMBL3145	Homo sapiens	pIC50		4.5
	15673065	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CCNc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600688	=	IC50	nM	12589.25	CHEMBL3145	Homo sapiens	pIC50		4.9
	15673066	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CCN(C)c1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600689	=	IC50	nM	39810.72	CHEMBL3145	Homo sapiens	pIC50		4.4
Not Determined	15673067	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccc(CO)nc3)cc2s1		CHEMBL3600690		pIC50			CHEMBL3145	Homo sapiens	pIC50		
	15673068	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Cc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600691	=	IC50	nM	2511.89	CHEMBL3145	Homo sapiens	pIC50		5.6
	15673069	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccc(C(F)(F)F)nc3)cc2s1		CHEMBL3600692	=	IC50	nM	3981.07	CHEMBL3145	Homo sapiens	pIC50		5.4
	15673070	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CS(=O)(=O)c1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600693	=	IC50	nM	39810.72	CHEMBL3145	Homo sapiens	pIC50		4.4
	15673071	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccc(OCCO)nc3)cc2s1		CHEMBL3600694	=	IC50	nM	6309.57	CHEMBL3145	Homo sapiens	pIC50		5.2
	15673072	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	COCCOc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600695	=	IC50	nM	7943.28	CHEMBL3145	Homo sapiens	pIC50		5.1
Not Determined	15673073	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CNC(=O)c1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600696		pIC50			CHEMBL3145	Homo sapiens	pIC50		
	15673074	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CN(C)C(=O)c1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600697	=	IC50	nM	79432.82	CHEMBL3145	Homo sapiens	pIC50		4.1
	15673075	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CC(C)Oc1cncc(-c2ccc3nc(N)sc3c2)c1		CHEMBL3600698	=	IC50	nM	1258.93	CHEMBL3145	Homo sapiens	pIC50		5.9
	15673076	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CS(=O)(=O)c1cncc(-c2ccc3nc(N)sc3c2)c1		CHEMBL3600699	=	IC50	nM	251.19	CHEMBL3145	Homo sapiens	pIC50		6.6
Not Determined	15673077	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccccc3)cc2s1		CHEMBL97245		pIC50			CHEMBL3145	Homo sapiens	pIC50		
Not Determined	15673078	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccccn3)cc2s1		CHEMBL3600700		pIC50			CHEMBL3145	Homo sapiens	pIC50		
Not Determined	15673079	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3cccnc3)cc2s1		CHEMBL3600701		pIC50			CHEMBL3145	Homo sapiens	pIC50		
Not Determined	15673080	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccncc3)cc2s1		CHEMBL1645107		pIC50			CHEMBL3145	Homo sapiens	pIC50		
Not Determined	15673081	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ncccn3)cc2s1		CHEMBL3600702		pIC50			CHEMBL3145	Homo sapiens	pIC50		
	15673082	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3cnccn3)cc2s1		CHEMBL3600765	=	IC50	nM	6309.57	CHEMBL3145	Homo sapiens	pIC50		5.2
	15673083	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccc(=O)[nH]c3)cc2s1		CHEMBL3600766	=	IC50	nM	50118.72	CHEMBL3145	Homo sapiens	pIC50		4.3
	15673084	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3cc[nH]c(=O)c3)cc2s1		CHEMBL3600767	=	IC50	nM	6309.57	CHEMBL3145	Homo sapiens	pIC50		5.2
	15673085	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Cn1ccc(-c2ccc3nc(N)sc3c2)n1		CHEMBL3600768	=	IC50	nM	15848.93	CHEMBL3145	Homo sapiens	pIC50		4.8
	15673086	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Cn1nccc1-c1ccc2nc(N)sc2c1		CHEMBL3600769	=	IC50	nM	31622.78	CHEMBL3145	Homo sapiens	pIC50		4.5
	15673087	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Cn1cc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600770	=	IC50	nM	15848.93	CHEMBL3145	Homo sapiens	pIC50		4.8
	15673088	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CCn1cc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600771	=	IC50	nM	31622.78	CHEMBL3145	Homo sapiens	pIC50		4.5
	15673089	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CCCn1cc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600772	=	IC50	nM	12589.25	CHEMBL3145	Homo sapiens	pIC50		4.9
Not Determined	15673090	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CC(C)n1cc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600773		pIC50			CHEMBL3145	Homo sapiens	pIC50		
	15673091	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3cnn(C4CC4)c3)cc2s1		CHEMBL3600774	=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	15673092	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3cnn(CC4CC4)c3)cc2s1		CHEMBL3600775	=	IC50	nM	15848.93	CHEMBL3145	Homo sapiens	pIC50		4.8
	15673093	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3cnn(Cc4ccccc4)c3)cc2s1		CHEMBL3600776	=	IC50	nM	25118.86	CHEMBL3145	Homo sapiens	pIC50		4.6
	15673094	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Cn1ccc(-c2ccc3nc(N)sc3c2)cc1=O		CHEMBL3600777	=	IC50	nM	63095.73	CHEMBL3145	Homo sapiens	pIC50		4.2
	15673095	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CCn1ccc(-c2ccc3nc(N)sc3c2)cc1=O		CHEMBL3600778	=	IC50	nM	50118.72	CHEMBL3145	Homo sapiens	pIC50		4.3
	15673096	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccn(CC4CC4)c(=O)c3)cc2s1	Outside typical range	CHEMBL3600779	<	IC50	nM	125892.54	CHEMBL3145	Homo sapiens	pIC50		3.9
	15673097	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	COCCOn1ccc(-c2ccc3nc(N)sc3c2)cc1=O	Outside typical range	CHEMBL3600780	<	IC50	nM	199526.23	CHEMBL3145	Homo sapiens	pIC50		3.7
	15673098	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	O=c1cc(-c2ccc3nc(NCC4CCOCC4)sc3c2)ccn1CC1CC1	Outside typical range	CHEMBL3600781	<	IC50	nM	199526.23	CHEMBL3145	Homo sapiens	pIC50		3.7
	15673099	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	C[C@@H](Nc1nc2ccc(-c3ccn(CC4CC4)c(=O)c3)cc2s1)C1CCOCC1	Outside typical range	CHEMBL3600782	<	IC50	nM	199526.23	CHEMBL3145	Homo sapiens	pIC50		3.7
	15673100	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	C[C@H](Nc1nc2ccc(-c3ccn(CC4CC4)c(=O)c3)cc2s1)C1CCOCC1	Outside typical range	CHEMBL3600783	<	IC50	nM	199526.23	CHEMBL3145	Homo sapiens	pIC50		3.7
	15673101	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	O=c1cc(-c2ccc3nc(NCC4CCS(=O)(=O)CC4)sc3c2)ccn1CC1CC1	Outside typical range	CHEMBL3600784	<	IC50	nM	199526.23	CHEMBL3145	Homo sapiens	pIC50		3.7
	15673102	CHEMBL3603392	Inhibition of PI3Kbeta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	O=c1cc(-c2ccc3nc(NC[C@H]4CC[C@H](C(=O)O)CC4)sc3c2)ccn1CC1CC1	Outside typical range	CHEMBL3600785	<	IC50	nM	199526.23	CHEMBL3145	Homo sapiens	pIC50		3.7
Active	15679174	CHEMBL3607629	Inhibition of N-terminal poly-His tagged human p110-beta expressed in Sf9 cells incubated for 20 mins by alpha screen assay	B	CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1		CHEMBL1615189		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	15686585	CHEMBL3606205	Inhibition of myristoylated human P110beta expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analysis	B	Cc1nc(NC(=O)N2CC[C@@H](C)[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL3605178	=	IC50	nM	2000.0	CHEMBL3145	Homo sapiens	IC50	uM	2.0
	15687180	CHEMBL3606199	Inhibition of P110beta (unknown origin) by Kinase-Glo assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	=	IC50	nM	1200.0	CHEMBL3145	Homo sapiens	IC50	uM	1.2
	15687181	CHEMBL3606199	Inhibition of P110beta (unknown origin) by Kinase-Glo assay	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2cc(C(C)(C)C(F)(F)F)ncc2OC3)[C@@H]1C(N)=O		CHEMBL3605177	=	IC50	nM	670.0	CHEMBL3145	Homo sapiens	IC50	uM	0.67
	15687182	CHEMBL3606199	Inhibition of P110beta (unknown origin) by Kinase-Glo assay	B	Cc1nc(NC(=O)N2CC[C@@H](C)[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL3605178	=	IC50	nM	1040.0	CHEMBL3145	Homo sapiens	IC50	uM	1.04
	15687186	CHEMBL3606205	Inhibition of myristoylated human P110beta expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analysis	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2cc(C(C)(C)C(F)(F)F)ncc2OC3)[C@@H]1C(N)=O		CHEMBL3605177	=	IC50	nM	1110.0	CHEMBL3145	Homo sapiens	IC50	uM	1.11
	15687187	CHEMBL3606205	Inhibition of myristoylated human P110beta expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analysis	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	=	IC50	nM	2200.0	CHEMBL3145	Homo sapiens	IC50	uM	2.2
	15693414	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3218581	=	IC50	nM	6500.0	CHEMBL3145	Homo sapiens	IC50	uM	6.5
	15693415	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	CC(C)(C)c1nc2c(s1)CCc1nc(NC(=O)N3CCC[C@H]3C(N)=O)sc1-2		CHEMBL3609514	=	IC50	nM	2500.0	CHEMBL3145	Homo sapiens	IC50	uM	2.5
	15693416	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	NC(=O)[C@@H]1CCCN1C(=O)Nc1nc2c(s1)-c1nc(CC3CC3)sc1CC2		CHEMBL3609515	=	IC50	nM	5100.0	CHEMBL3145	Homo sapiens	IC50	uM	5.1
	15693417	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	CC(C)(C)c1nc2c(s1)CCc1nc(NC(=O)N3CCC[C@@]3(C)C(N)=O)sc1-2		CHEMBL3609516	=	IC50	nM	720.0	CHEMBL3145	Homo sapiens	IC50	uM	0.72
	15693418	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	CC(C)(C)c1nc2c(s1)CCc1nc(NC(=O)N3CC[C@@H]4C[C@@]43C(N)=O)sc1-2		CHEMBL3609517	=	IC50	nM	4500.0	CHEMBL3145	Homo sapiens	IC50	uM	4.5
	15693419	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	C[C@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)sc2CC3)[C@@H]1C(N)=O		CHEMBL3609518	=	IC50	nM	1800.0	CHEMBL3145	Homo sapiens	IC50	uM	1.8
	15693420	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)sc2CC3)[C@@H]1C(N)=O		CHEMBL3609519	=	IC50	nM	2300.0	CHEMBL3145	Homo sapiens	IC50	uM	2.3
	15693421	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C(F)(F)F)sc2CC3)[C@@H]1C(N)=O		CHEMBL3609520	=	IC50	nM	930.0	CHEMBL3145	Homo sapiens	IC50	uM	0.93
	15693422	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	CN(C)C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)sc2CC3)[C@@H]1C(N)=O		CHEMBL3609521	=	IC50	nM	5500.0	CHEMBL3145	Homo sapiens	IC50	uM	5.5
	15693423	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397186	=	IC50	nM	1900.0	CHEMBL3145	Homo sapiens	IC50	uM	1.9
	15693424	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	CC(C)(C)c1ncc2c(n1)-c1sc(NC(=O)N3CCC[C@H]3C(N)=O)nc1CC2		CHEMBL3609522	=	IC50	nM	220.0	CHEMBL3145	Homo sapiens	IC50	uM	0.22
	15693425	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	CC(C)(C)c1ncc2c(n1)-c1sc(NC(=O)N3CCC[C@@]3(C)C(N)=O)nc1CC2		CHEMBL3609523	=	IC50	nM	75.0	CHEMBL3145	Homo sapiens	IC50	uM	0.075
	15693426	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	CC(C)(C)c1ncc2c(n1)-c1sc(NC(=O)N3CC[C@@H]4C[C@@]43C(N)=O)nc1CC2		CHEMBL3609524	=	IC50	nM	290.0	CHEMBL3145	Homo sapiens	IC50	uM	0.29
	15693427	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)ncc2CC3)[C@@H]1C(N)=O		CHEMBL3609525	=	IC50	nM	320.0	CHEMBL3145	Homo sapiens	IC50	uM	0.32
	15693428	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C(F)(F)F)ncc2CC3)[C@@H]1C(N)=O		CHEMBL3609526	=	IC50	nM	81.0	CHEMBL3145	Homo sapiens	IC50	uM	0.081
	15693429	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	CN(C)C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)ncc2CC3)[C@@H]1C(N)=O		CHEMBL3609527	=	IC50	nM	770.0	CHEMBL3145	Homo sapiens	IC50	uM	0.77
	15693430	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	CN(C)C[C@@]1(C(N)=O)CCCN1C(=O)Nc1nc2c(s1)-c1nc(C(C)(C)C)ncc1CC2		CHEMBL3609528	=	IC50	nM	1400.0	CHEMBL3145	Homo sapiens	IC50	uM	1.4
	15693431	CHEMBL3610610	Inhibition of PI3Kbeta (unknown origin) using phosphatidylinositol as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by KinaseGlo luminescence assay	B	CN(C)[C@@H]1C[C@@H](C(N)=O)N(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)ncc2CC3)C1		CHEMBL3609529	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	15693486	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3218581	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15693487	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	CC(C)(C)c1nc2c(s1)CCc1nc(NC(=O)N3CCC[C@H]3C(N)=O)sc1-2		CHEMBL3609514	=	IC50	nM	3600.0	CHEMBL3145	Homo sapiens	IC50	uM	3.6
	15694065	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	NC(=O)[C@@H]1CCCN1C(=O)Nc1nc2c(s1)-c1nc(CC3CC3)sc1CC2		CHEMBL3609515	=	IC50	nM	1300.0	CHEMBL3145	Homo sapiens	IC50	uM	1.3
	15694066	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	CC(C)(C)c1nc2c(s1)CCc1nc(NC(=O)N3CCC[C@@]3(C)C(N)=O)sc1-2		CHEMBL3609516	=	IC50	nM	1200.0	CHEMBL3145	Homo sapiens	IC50	uM	1.2
	15694067	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	CC(C)(C)c1nc2c(s1)CCc1nc(NC(=O)N3CC[C@@H]4C[C@@]43C(N)=O)sc1-2		CHEMBL3609517	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15694068	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	C[C@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)sc2CC3)[C@@H]1C(N)=O		CHEMBL3609518	=	IC50	nM	450.0	CHEMBL3145	Homo sapiens	IC50	uM	0.45
	15694069	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)sc2CC3)[C@@H]1C(N)=O		CHEMBL3609519	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	15694070	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C(F)(F)F)sc2CC3)[C@@H]1C(N)=O		CHEMBL3609520	=	IC50	nM	980.0	CHEMBL3145	Homo sapiens	IC50	uM	0.98
	15694071	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	CN(C)C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)sc2CC3)[C@@H]1C(N)=O		CHEMBL3609521	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15694072	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397186	=	IC50	nM	3100.0	CHEMBL3145	Homo sapiens	IC50	uM	3.1
	15694073	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	CC(C)(C)c1ncc2c(n1)-c1sc(NC(=O)N3CCC[C@H]3C(N)=O)nc1CC2		CHEMBL3609522	=	IC50	nM	220.0	CHEMBL3145	Homo sapiens	IC50	uM	0.22
	15694074	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	CC(C)(C)c1ncc2c(n1)-c1sc(NC(=O)N3CCC[C@@]3(C)C(N)=O)nc1CC2		CHEMBL3609523	=	IC50	nM	470.0	CHEMBL3145	Homo sapiens	IC50	uM	0.47
	15694075	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	CC(C)(C)c1ncc2c(n1)-c1sc(NC(=O)N3CC[C@@H]4C[C@@]43C(N)=O)nc1CC2		CHEMBL3609524	=	IC50	nM	730.0	CHEMBL3145	Homo sapiens	IC50	uM	0.73
	15694076	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)ncc2CC3)[C@@H]1C(N)=O		CHEMBL3609525	=	IC50	nM	280.0	CHEMBL3145	Homo sapiens	IC50	uM	0.28
	15694077	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C(F)(F)F)ncc2CC3)[C@@H]1C(N)=O		CHEMBL3609526	=	IC50	nM	220.0	CHEMBL3145	Homo sapiens	IC50	uM	0.22
	15694078	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	CN(C)C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)ncc2CC3)[C@@H]1C(N)=O		CHEMBL3609527	=	IC50	nM	3700.0	CHEMBL3145	Homo sapiens	IC50	uM	3.7
	15694079	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	CN(C)C[C@@]1(C(N)=O)CCCN1C(=O)Nc1nc2c(s1)-c1nc(C(C)(C)C)ncc1CC2		CHEMBL3609528	=	IC50	nM	2300.0	CHEMBL3145	Homo sapiens	IC50	uM	2.3
	15694080	CHEMBL3610614	Inhibition of N-terminal myristoylated human PI3Kbeta expressed in Rat1 cells assessed as inhibition of Akt phosphorylatuion at Ser473 by ELISA	B	CN(C)[C@@H]1C[C@@H](C(N)=O)N(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)ncc2CC3)C1		CHEMBL3609529	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	15694325	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CC[C@@H]3C[C@@]32C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608936	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	15694326	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2C[C@@H](N(C)C)C[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608935	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	15694327	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2C[C@H](N(C)C)C[C@H]2C(N)=O)sc1-c1csc(C2(C)CC2)n1		CHEMBL3608934	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	15694328	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2C[C@H](N(C)C)C[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608933	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	15694329	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2C[C@@H](O)C[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608932	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	15694330	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2C[C@H](O)C[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608931	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	15694331	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2C[C@H](F)C[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608930	=	IC50	nM	8000.0	CHEMBL3145	Homo sapiens	IC50	uM	8.0
	15694332	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CC[C@@H](O)[C@H]2C(N)=O)sc1-c1csc(C2(C(F)(F)F)CC2)n1		CHEMBL3608929	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	15694333	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CC[C@H](O)[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608928	=	IC50	nM	7100.0	CHEMBL3145	Homo sapiens	IC50	uM	7.1
	15694334	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CC[C@@H](C)[C@H]2C(N)=O)sc1-c1csc(C2(C(F)(F)F)CC2)n1		CHEMBL3608927	=	IC50	nM	4600.0	CHEMBL3145	Homo sapiens	IC50	uM	4.6
	15694335	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CC[C@H](C)[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608926	=	IC50	nM	8100.0	CHEMBL3145	Homo sapiens	IC50	uM	8.1
	15694336	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@@]2(C)C(N)=O)sc1-c1csc(C2(C(F)(F)F)CC2)n1		CHEMBL3608925	=	IC50	nM	2100.0	CHEMBL3145	Homo sapiens	IC50	uM	2.1
	15694337	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@@]2(C)C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608924	=	IC50	nM	5000.0	CHEMBL3145	Homo sapiens	IC50	uM	5.0
	15694338	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(C2(C(F)(F)F)CC2)n1		CHEMBL3609545	=	IC50	nM	5500.0	CHEMBL3145	Homo sapiens	IC50	uM	5.5
	15694339	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(CN(C)C)n1		CHEMBL3609544	=	IC50	nM	8900.0	CHEMBL3145	Homo sapiens	IC50	uM	8.9
	15694340	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(-c2ccccc2F)n1		CHEMBL3609543	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	15694341	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(-c2cccnc2)n1		CHEMBL3609542	=	IC50	nM	8600.0	CHEMBL3145	Homo sapiens	IC50	uM	8.6
	15694342	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(N(C)C)n1		CHEMBL3609541	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	15694343	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(C2(C)CC2)n1		CHEMBL3609540	=	IC50	nM	4900.0	CHEMBL3145	Homo sapiens	IC50	uM	4.9
	15694344	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3218581	=	IC50	nM	6500.0	CHEMBL3145	Homo sapiens	IC50	uM	6.5
	15694345	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	CCC(CC)c1nc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2C)cs1		CHEMBL3609539	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	15694346	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(C2CCC2)n1		CHEMBL3609538	=	IC50	nM	7000.0	CHEMBL3145	Homo sapiens	IC50	uM	7.0
	15694347	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(CC2CC2)n1		CHEMBL3609537	=	IC50	nM	8500.0	CHEMBL3145	Homo sapiens	IC50	uM	8.5
	15694348	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(C(C)C)n1		CHEMBL3609536	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	15694349	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	CC(=O)Nc1nc(C)c(-c2csc(C(C)C)n2)s1		CHEMBL3608321	=	IC50	nM	1800.0	CHEMBL3145	Homo sapiens	IC50	uM	1.8
	15694350	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	=	IC50	nM	1200.0	CHEMBL3145	Homo sapiens	IC50	uM	1.2
	15694351	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397186	=	IC50	nM	1900.0	CHEMBL3145	Homo sapiens	IC50	uM	1.9
	15694352	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccc(S(C)(=O)=O)c(F)c1		CHEMBL2071336	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	15694353	CHEMBL3611487	Inhibition of PI3Kbeta (unknown origin)	B	CC(=O)Nc1nc(C)c(-c2ccc(S(C)(=O)=O)c(F)c2)s1		CHEMBL2071330	=	IC50	nM	1600.0	CHEMBL3145	Homo sapiens	IC50	uM	1.6
	15719250	CHEMBL3620386	Inhibition of PI3Kbeta (unknown origin) by alpha screen assay	B	COc1ncc(Nc2nc3ccc(C(C)(C)O)cn3c2-c2nc(C)nc(N)n2)cc1F		CHEMBL3618245	=	Ki	nM	17.0	CHEMBL3145	Homo sapiens	Ki	nM	17.0
	15743082	CHEMBL3626572	Inhibition of recombinant human PI3Kbeta by TR-FRET analysis	B	C[C@@H]1COCCN1c1cc(=O)n2c(n1)N(Cc1cncc(Cl)c1)[C@H](C(F)(F)F)CC2		CHEMBL3622372	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16391018	CHEMBL3738868	Inhibition of PI3Kbeta (unknown origin) at 1 uM after 1 hr by ADP-Glo Luminescent assay	B	CC(C)(C#N)c1ccc(Nc2c(C(N)=O)cnc3ccc(-c4cnc5ccccc5c4)cc23)cc1		CHEMBL3736298	=	Inhibition	%	10.3	CHEMBL3145	Homo sapiens	INH	%	10.3
	16391019	CHEMBL3738868	Inhibition of PI3Kbeta (unknown origin) at 1 uM after 1 hr by ADP-Glo Luminescent assay	B	Cl.NC(=O)c1cnc2ccc(-c3cnc4ccccc4c3)cc2c1Nc1ccc(N2CCNCC2)c(C(F)(F)F)c1		CHEMBL3735194	=	Inhibition	%	1.0	CHEMBL3145	Homo sapiens	INH	%	1.0
	16391020	CHEMBL3738869	Inhibition of PI3Kbeta (unknown origin) after 1 hr by ADP-Glo Luminescent assay	B	CC(=O)N1CCN(c2ccc(Nc3c(C(N)=O)cnc4ccc(-c5cnc6ccccc6c5)cc34)cc2C(F)(F)F)CC1		CHEMBL3735090	>	IC50	nM	5000.0	CHEMBL3145	Homo sapiens	IC50	nM	5000.0
	16391021	CHEMBL3738869	Inhibition of PI3Kbeta (unknown origin) after 1 hr by ADP-Glo Luminescent assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	nM	13.0
	16421954	CHEMBL3748471	Inhibition of PI3Kbeta (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	16442721	CHEMBL3756404	Inhibition of PI3Kbeta (unknown origin) using 1 alpha-phosphatidylinositol as substrate assessed as ATP depletion after 5 mins by KinaseGlo assay	B	CC(=O)Nc1cn2cc(-c3cnc(N)c(OC(C)C(F)(F)F)n3)ccc2n1		CHEMBL3753450	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	uM	0.007
	16467822	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccs3)cccc12		CHEMBL3764119	=	Inhibition	%	43.0	CHEMBL3145	Homo sapiens	INH	%	43.0
	16467827	CHEMBL3767082	Inhibition of PI3Kbeta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccnc3)cccc12		CHEMBL3765523	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16467890	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	NC(=O)c1ccc(-c2cccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL3763707	=	Inhibition	%	13.0	CHEMBL3145	Homo sapiens	INH	%	13.0
	16467895	CHEMBL3767082	Inhibition of PI3Kbeta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	Nc1cccc(-c2cccc3c(=O)nc(N4CCOCC4)oc23)c1		CHEMBL3765681	=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16467900	CHEMBL3767082	Inhibition of PI3Kbeta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(CO)cc3)cccc12		CHEMBL3763205	=	IC50	nM	3200.0	CHEMBL3145	Homo sapiens	IC50	uM	3.2
	16467905	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)cccc12		CHEMBL3763897	=	Inhibition	%	34.0	CHEMBL3145	Homo sapiens	INH	%	34.0
	16467968	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	COc1ccc(-c2cccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL3765105	=	Inhibition	%	22.0	CHEMBL3145	Homo sapiens	INH	%	22.0
	16467999	CHEMBL3767082	Inhibition of PI3Kbeta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccsc3)cccc12		CHEMBL3765574	=	IC50	nM	3400.0	CHEMBL3145	Homo sapiens	IC50	uM	3.4
	16468062	CHEMBL3767082	Inhibition of PI3Kbeta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4ccccc34)cccc12		CHEMBL3765457	=	IC50	nM	5000.0	CHEMBL3145	Homo sapiens	IC50	uM	5.0
	16468845	CHEMBL3768549	Inhibition of PI3K-beta (unknown origin) after 40 mins by ADP-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN4CCN(S(C)(=O)=O)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3763244	=	IC50	nM	9.4	CHEMBL3145	Homo sapiens	IC50	nM	9.4
	16468846	CHEMBL3768549	Inhibition of PI3K-beta (unknown origin) after 40 mins by ADP-Glo luminescent kinase assay	B	CCOC(=O)N1CCN(CC#Cc2ccnc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5F)c4)cc23)CC1		CHEMBL3765587	=	IC50	nM	23.0	CHEMBL3145	Homo sapiens	IC50	nM	23.0
	16468912	CHEMBL3768549	Inhibition of PI3K-beta (unknown origin) after 40 mins by ADP-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	=	IC50	nM	1.2	CHEMBL3145	Homo sapiens	IC50	nM	1.2
	16468913	CHEMBL3768549	Inhibition of PI3K-beta (unknown origin) after 40 mins by ADP-Glo luminescent kinase assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
	16468929	CHEMBL3768552	Inhibition of PI3K-beta (unknown origin) at 10 nM after 40 mins by ADP-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN(C)C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1		CHEMBL3763473	=	Inhibition	%	17.0	CHEMBL3145	Homo sapiens	INH	%	17.0
	16468930	CHEMBL3768552	Inhibition of PI3K-beta (unknown origin) at 10 nM after 40 mins by ADP-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN(C)C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3763397	=	Inhibition	%	41.0	CHEMBL3145	Homo sapiens	INH	%	41.0
	16468931	CHEMBL3768552	Inhibition of PI3K-beta (unknown origin) at 10 nM after 40 mins by ADP-Glo luminescent kinase assay	B	CCN(CC)CC#Cc1ccnc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc12		CHEMBL3765500	=	Inhibition	%	21.0	CHEMBL3145	Homo sapiens	INH	%	21.0
	16468932	CHEMBL3768552	Inhibition of PI3K-beta (unknown origin) at 10 nM after 40 mins by ADP-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN(C)CCO)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3764095	=	Inhibition	%	57.0	CHEMBL3145	Homo sapiens	INH	%	57.0
	16468933	CHEMBL3768552	Inhibition of PI3K-beta (unknown origin) at 10 nM after 40 mins by ADP-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN(C4CCCCC4)C4CCCCC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3765013	=	Inhibition	%	13.0	CHEMBL3145	Homo sapiens	INH	%	13.0
	16468934	CHEMBL3768552	Inhibition of PI3K-beta (unknown origin) at 10 nM after 40 mins by ADP-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN4CCCCC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3764069	=	Inhibition	%	1.4	CHEMBL3145	Homo sapiens	INH	%	1.4
	16468935	CHEMBL3768552	Inhibition of PI3K-beta (unknown origin) at 10 nM after 40 mins by ADP-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN4CCC(C)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3765065	=	Inhibition	%	5.8	CHEMBL3145	Homo sapiens	INH	%	5.8
	16468936	CHEMBL3768552	Inhibition of PI3K-beta (unknown origin) at 10 nM after 40 mins by ADP-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN4CCCCC4C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3765031	=	Inhibition	%	11.0	CHEMBL3145	Homo sapiens	INH	%	11.0
	16468937	CHEMBL3768552	Inhibition of PI3K-beta (unknown origin) at 10 nM after 40 mins by ADP-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN4CCOCC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3764625	=	Inhibition	%	70.0	CHEMBL3145	Homo sapiens	INH	%	70.0
	16468938	CHEMBL3768552	Inhibition of PI3K-beta (unknown origin) at 10 nM after 40 mins by ADP-Glo luminescent kinase assay	B	CCOC(=O)N1CCN(CC#Cc2ccnc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5F)c4)cc23)CC1		CHEMBL3765587	=	Inhibition	%	30.0	CHEMBL3145	Homo sapiens	INH	%	30.0
	16468939	CHEMBL3768552	Inhibition of PI3K-beta (unknown origin) at 10 nM after 40 mins by ADP-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN4CCN(S(C)(=O)=O)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3763244	=	Inhibition	%	69.0	CHEMBL3145	Homo sapiens	INH	%	69.0
	16468981	CHEMBL3767082	Inhibition of PI3Kbeta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4c3oc3ccccc34)cccc12		CHEMBL3763392	=	IC50	nM	6900.0	CHEMBL3145	Homo sapiens	IC50	uM	6.9
	16468986	CHEMBL3767082	Inhibition of PI3Kbeta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12		CHEMBL3764883	=	IC50	nM	5800.0	CHEMBL3145	Homo sapiens	IC50	uM	5.8
	16468992	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cc4ccccc4s3)cccc12		CHEMBL3763878	=	Inhibition	%	15.0	CHEMBL3145	Homo sapiens	INH	%	15.0
	16468997	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	COc1ccc(-c2cc(Cl)cc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL3764880	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	16469002	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccs3)cc(Cl)cc12		CHEMBL3763764	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	16469007	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cc4ccccc4s3)cc(Cl)cc12		CHEMBL3765110	=	Inhibition	%	15.0	CHEMBL3145	Homo sapiens	INH	%	15.0
	16469012	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cc(Cl)cc12		CHEMBL3763722	=	Inhibition	%	59.0	CHEMBL3145	Homo sapiens	INH	%	59.0
	16469017	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3ccccc3)cc12		CHEMBL3764490	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	16469022	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	COc1ccc(-c2ccc3oc(N4CCOCC4)nc(=O)c3c2)cc1		CHEMBL3765645	=	Inhibition	%	17.0	CHEMBL3145	Homo sapiens	INH	%	17.0
	16469027	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3ccc(Cl)cc3)cc12		CHEMBL3763662	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	16469032	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3ccc(CO)cc3)cc12		CHEMBL3763655	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
Not Determined	16469037	CHEMBL3767082	Inhibition of PI3Kbeta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	Nc1cccc(-c2ccc3oc(N4CCOCC4)nc(=O)c3c2)c1		CHEMBL3764800		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	16469042	CHEMBL3767082	Inhibition of PI3Kbeta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	NC(=O)c1ccc(-c2ccc3oc(N4CCOCC4)nc(=O)c3c2)cc1		CHEMBL3763440		IC50			CHEMBL3145	Homo sapiens	IC50		
	16469047	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cccnc3)cc12		CHEMBL3764517	=	Inhibition	%	36.0	CHEMBL3145	Homo sapiens	INH	%	36.0
Not Determined	16469052	CHEMBL3767082	Inhibition of PI3Kbeta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cccs3)cc12		CHEMBL3763957		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	16469057	CHEMBL3767082	Inhibition of PI3Kbeta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3ccsc3)cc12		CHEMBL3765350		IC50			CHEMBL3145	Homo sapiens	IC50		
	16469062	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cccc4ccccc34)cc12		CHEMBL3765284	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	16469067	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cccc4c3oc3ccccc34)cc12		CHEMBL3765235	=	Inhibition	%	6.0	CHEMBL3145	Homo sapiens	INH	%	6.0
	16469077	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cccc(-c4ccccc4)c3)cc12		CHEMBL3763994	=	Inhibition	%	13.0	CHEMBL3145	Homo sapiens	INH	%	13.0
	16469082	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(/C=C/c3ccccc3)cc12		CHEMBL3765722	=	Inhibition	%	29.0	CHEMBL3145	Homo sapiens	INH	%	29.0
	16469087	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cc4ccccc4s3)cc12		CHEMBL3764702	=	Inhibition	%	20.0	CHEMBL3145	Homo sapiens	INH	%	20.0
	16469092	CHEMBL3767082	Inhibition of PI3Kbeta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	3000.0	CHEMBL3145	Homo sapiens	IC50	uM	3.0
	16469218	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cccc4c3sc3ccccc34)cc12		CHEMBL3763170	=	Inhibition	%	21.0	CHEMBL3145	Homo sapiens	INH	%	21.0
Not Determined	16469254	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	Nc1cccc(-c2ccc3oc(N4CCOCC4)nc(=O)c3c2)c1		CHEMBL3764800		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Not Determined	16469255	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	NC(=O)c1ccc(-c2ccc3oc(N4CCOCC4)nc(=O)c3c2)cc1		CHEMBL3763440		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Not Determined	16469256	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cccs3)cc12		CHEMBL3763957		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Not Determined	16469257	CHEMBL3767081	Inhibition of PI3Kbeta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3ccsc3)cc12		CHEMBL3765350		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16484070	CHEMBL3772930	Inhibition of human recombinant PI3K beta by scintillation proximity radiometric assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
	16484078	CHEMBL3772925	Inhibition of PI3K beta (unknown origin) after 1 hr by ADP-Glo luminescent assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	21.0	CHEMBL3145	Homo sapiens	IC50	nM	21.0
	16484079	CHEMBL3772925	Inhibition of PI3K beta (unknown origin) after 1 hr by ADP-Glo luminescent assay	B	N#Cc1ncccc1Nc1ccc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc2c1		CHEMBL3769902	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	nM	13.0
	16495172	CHEMBL3777961	Inhibition of PI3Kbeta (unknown origin) assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-1.0	CHEMBL3145	Homo sapiens	Activity	%	-1.0
	16496091	CHEMBL3777961	Inhibition of PI3Kbeta (unknown origin) assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-3.0	CHEMBL3145	Homo sapiens	Activity	%	-3.0
	16508278	CHEMBL3777961	Inhibition of PI3Kbeta (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-2.0	CHEMBL3145	Homo sapiens	Activity	%	-2.0
	16513135	CHEMBL3784754	Inhibition of PI3Kbeta (unknown origin)	B	CNc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1		CHEMBL3780029	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	nM	9100.0
	16513136	CHEMBL3784754	Inhibition of PI3Kbeta (unknown origin)	B	CNc1ncc(-c2ccnc(N[C@H]3CC[C@H](O)CC3)n2)c(CC2CC2)n1		CHEMBL3781916	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	nM	9100.0
	16516425	CHEMBL3784496	Inhibition of PI3Kbeta (unknown origin) after 1 hr by ADP-Glo luminescent assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	nM	13.0
	16516426	CHEMBL3784496	Inhibition of PI3Kbeta (unknown origin) after 1 hr by ADP-Glo luminescent assay	B	CC(=O)Nc1cnc2ccc(-c3cnc4ccccc4c3)cc2c1Nc1ccc(N2CCN(C(C)=O)CC2)c(C(F)(F)F)c1		CHEMBL3781971	>	IC50	nM	5000.0	CHEMBL3145	Homo sapiens	IC50	nM	5000.0
	16517041	CHEMBL3784500	Inhibition of PI3Kbeta (unknown origin) at 1 uM after 1 hr by ADP-Glo luminescent assay	B	CC(=O)Nc1cnc2ccc(-c3cnc4ccccc4c3)cc2c1Nc1ccc(N2CCNCC2)c(C(F)(F)F)c1.Cl		CHEMBL3781549	=	Inhibition	%	1.0	CHEMBL3145	Homo sapiens	INH	%	1.0
	16525476	CHEMBL3789704	Inhibition of N-terminal histidine-tagged recombinant human full length PI3Kbeta expressed in baculovirus infected Sf9 insect cells upto 20 uM preincubated for 15 mins followed by addition of cold ATP/gamma32P-ATP measured after 15 mins	B	COc1ccc(-c2sc(NC(=O)C3CCCC3)nc2C)cc1S(=O)(=O)Nc1ccc(O)cc1		CHEMBL3785311	<	Inhibition	%	50.0	CHEMBL3145	Homo sapiens	INH	%	50.0
	16525477	CHEMBL3789704	Inhibition of N-terminal histidine-tagged recombinant human full length PI3Kbeta expressed in baculovirus infected Sf9 insect cells upto 20 uM preincubated for 15 mins followed by addition of cold ATP/gamma32P-ATP measured after 15 mins	B	COc1ccc(-c2sc(NC(=O)C(C)(C)C)nc2C)cc1S(=O)(=O)Nc1ccc(O)cc1		CHEMBL3786230	<	Inhibition	%	20.0	CHEMBL3145	Homo sapiens	INH	%	20.0
	16539483	CHEMBL3789408	Inhibition of PI3K-beta (unknown origin)	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	9000.0	CHEMBL3145	Homo sapiens	IC50	uM	9.0
	16539484	CHEMBL3789408	Inhibition of PI3K-beta (unknown origin)	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	230.0	CHEMBL3145	Homo sapiens	IC50	uM	0.23
	16539485	CHEMBL3789408	Inhibition of PI3K-beta (unknown origin)	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	>	IC50	nM	9000.0	CHEMBL3145	Homo sapiens	IC50	uM	9.0
	16539486	CHEMBL3789408	Inhibition of PI3K-beta (unknown origin)	B	CC1(C)CC[C@@H](COc2cccc(-c3cn([C@H]4C[C@@H](CN5CCC5)C4)c4ncnc(N)c34)c2)O1		CHEMBL3786567	>	IC50	nM	9000.0	CHEMBL3145	Homo sapiens	IC50	uM	9.0
	16540909	CHEMBL3790011	Inhibition of PI3Kbeta (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	16540910	CHEMBL3790011	Inhibition of PI3Kbeta (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	16540911	CHEMBL3790011	Inhibition of PI3Kbeta (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	230.0	CHEMBL3145	Homo sapiens	IC50	uM	0.23
	16540912	CHEMBL3790011	Inhibition of PI3Kbeta (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16564759	CHEMBL3802884	Inhibition of human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	CN(C)C(=O)c1cc(CN2CCOc3c(F)cccc32)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3799831	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	uM	0.008
	16564760	CHEMBL3802884	Inhibition of human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	CN(C)C(=O)c1cc(CN2CCOc3ccc(F)cc32)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3799187	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	uM	0.009
	16564761	CHEMBL3802884	Inhibition of human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN4CCOc5c(F)cccc54)c3o2)CCO1		CHEMBL3798914	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	uM	0.007
	16564762	CHEMBL3802884	Inhibition of human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN4CCOc5ccc(F)cc54)c3o2)CCO1		CHEMBL3799511	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	uM	0.007
	16564763	CHEMBL3802884	Inhibition of human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN4CCOc5c(F)cc(F)cc54)c3o2)CCO1		CHEMBL3797812	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	uM	0.006
	16564764	CHEMBL3802884	Inhibition of human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN(C)c4cc(F)cc(F)c4)c3o2)CCO1		CHEMBL3797698	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	uM	0.007
	16564765	CHEMBL3802884	Inhibition of human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	CN(C)C(=O)c1cc(CN2CCOc3c(F)cc(F)cc32)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3797750	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	uM	0.006
	16564766	CHEMBL3802884	Inhibition of human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	CN(C)C(=O)c1cc(CN(C)c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408273	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	uM	0.007
	16564796	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	CN(C)C(=O)c1cc(CN2CCOc3ccccc32)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3798108	=	IC50	nM	120.0	CHEMBL3145	Homo sapiens	IC50	uM	0.12
	16564797	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	CN(C)C(=O)c1cc(CN2CCOc3c(F)cccc32)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3799831	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	uM	0.012
	16564798	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	CN(C)C(=O)c1cc(CN2CCOc3ccc(F)cc32)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3799187	=	IC50	nM	37.0	CHEMBL3145	Homo sapiens	IC50	uM	0.037
	16564799	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N4CCOCC4)cc(CN4CCOc5c(F)cccc54)c3o2)CCO1		CHEMBL3799158	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	uM	0.004
	16564800	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN4CCOc5c(F)cccc54)c3o2)CCO1		CHEMBL3798914	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	uM	0.002
	16564801	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N4CCOCC4)cc(CN4CCOc5ccc(F)cc54)c3o2)CCO1		CHEMBL3799504	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	uM	0.012
	16564802	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN4CCOc5ccc(F)cc54)c3o2)CCO1		CHEMBL3799511	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	uM	0.003
	16564803	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N4CCOCC4)cc(CN4CCOc5c(F)cc(F)cc54)c3o2)CCO1		CHEMBL3799673	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	uM	0.006
	16564804	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN4CCOc5c(F)cc(F)cc54)c3o2)CCO1		CHEMBL3797812	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	uM	0.003
	16564805	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	COCCN(Cc1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCO[C@H](C)C3)oc12)c1cc(F)cc(F)c1		CHEMBL3800231	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	uM	0.005
	16564806	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN(C)c4cc(F)cc(F)c4)c3o2)CCO1		CHEMBL3797698	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	uM	0.002
	16564807	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	CC(c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12)N1CCOc2c(F)cc(F)cc21		CHEMBL3797528	=	IC50	nM	45.0	CHEMBL3145	Homo sapiens	IC50	uM	0.045
	16564808	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	CN(C)C(=O)c1cc(CN2CCOc3c(F)cc(F)cc32)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3797750	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	uM	0.009
	16564809	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	CN(C)C(=O)c1cc(CN(CC#N)c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3799515	=	IC50	nM	197.0	CHEMBL3145	Homo sapiens	IC50	uM	0.197
	16564810	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	CN(C)C(=O)c1cc(CN(CCC#N)c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3797821	=	IC50	nM	107.0	CHEMBL3145	Homo sapiens	IC50	uM	0.107
	16564811	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	COCCN(Cc1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12)c1cc(F)cc(F)c1		CHEMBL3800314	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	uM	0.017
	16564812	CHEMBL3802888	Inhibition of PI3Kbeta in PTEN deficient human MDA-MB-468 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 2 hrs by plate reader analysis	B	CN(C)C(=O)c1cc(CN(C)c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408273	=	IC50	nM	35.0	CHEMBL3145	Homo sapiens	IC50	uM	0.035
	16566105	CHEMBL3802915	Tight binding affinity to human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	CN(C)C(=O)c1cc(CN(C)c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408273	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	16566106	CHEMBL3802915	Tight binding affinity to human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	CN(C)C(=O)c1cc(CN2CCOc3c(F)cc(F)cc32)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3797750	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	16566107	CHEMBL3802915	Tight binding affinity to human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN(C)c4cc(F)cc(F)c4)c3o2)CCO1		CHEMBL3797698	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	16566108	CHEMBL3802915	Tight binding affinity to human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN4CCOc5c(F)cc(F)cc54)c3o2)CCO1		CHEMBL3797812	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	16566109	CHEMBL3802915	Tight binding affinity to human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN4CCOc5ccc(F)cc54)c3o2)CCO1		CHEMBL3799511	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	16566110	CHEMBL3802915	Tight binding affinity to human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN4CCOc5c(F)cccc54)c3o2)CCO1		CHEMBL3798914	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	16566111	CHEMBL3802915	Tight binding affinity to human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	CN(C)C(=O)c1cc(CN2CCOc3ccc(F)cc32)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3799187	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	16566112	CHEMBL3802915	Tight binding affinity to human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	CN(C)C(=O)c1cc(CN2CCOc3c(F)cccc32)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3799831	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
Not Determined	16566751	CHEMBL3803000	Inhibition of PI3Kbeta (unknown origin) using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	CCOC(Cn1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21)OCC		CHEMBL3799221		IC50			CHEMBL3145	Homo sapiens	IC50		
	16566768	CHEMBL3803000	Inhibition of PI3Kbeta (unknown origin) using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	CCOC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OCC		CHEMBL3800481	>	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	10'5nM	1.0
	16566772	CHEMBL3803004	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate by HTRF assay	B	CCOC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OCC		CHEMBL3800481	>	IC50	nM	100000.0	CHEMBL3145	Homo sapiens	IC50	10'5nM	1.0
	16566818	CHEMBL3803000	Inhibition of PI3Kbeta (unknown origin) using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	Nc1nc2cc(-c3nn(CC4OCCO4)c4ncnc(N)c34)ccc2o1		CHEMBL3797590	=	IC50	nM	3850.0	CHEMBL3145	Homo sapiens	IC50	nM	3850.0
	16566832	CHEMBL3803000	Inhibition of PI3Kbeta (unknown origin) using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	COC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OC		CHEMBL3800138	=	IC50	nM	5600.0	CHEMBL3145	Homo sapiens	IC50	nM	5600.0
	16566838	CHEMBL3803004	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate by HTRF assay	B	Nc1nc2cc(-c3nn(CC4CCCC4)c4ncnc(N)c34)ccc2o1		CHEMBL3797933	=	IC50	nM	89.0	CHEMBL3145	Homo sapiens	IC50	nM	89.0
	16566851	CHEMBL3803004	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate by HTRF assay	B	Nc1nc2cc(-c3nn(CC4CCCO4)c4ncnc(N)c34)ccc2o1		CHEMBL3797834	=	IC50	nM	1120.0	CHEMBL3145	Homo sapiens	IC50	nM	1120.0
	16566867	CHEMBL3803004	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate by HTRF assay	B	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2cncnc21		CHEMBL3798574	=	IC50	nM	5290.0	CHEMBL3145	Homo sapiens	IC50	nM	5290.0
Not Determined	16612857	CHEMBL3815758	Inhibition of PI3K beta (unknown origin)	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665		IC50			CHEMBL3145	Homo sapiens	IC50		
	16612858	CHEMBL3815758	Inhibition of PI3K beta (unknown origin)	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16612859	CHEMBL3815758	Inhibition of PI3K beta (unknown origin)	B	CCc1cc(-c2c[nH]c3ncc(-c4ccc(N)nc4)cc23)nc(N)n1		CHEMBL3814154	>	IC50	nM	30000.0	CHEMBL3145	Homo sapiens	IC50	uM	30.0
Not Determined	16612860	CHEMBL3815758	Inhibition of PI3K beta (unknown origin)	B	CCc1cc(-c2c[nH]c3ncc(-c4ccco4)cc23)nc(N)n1		CHEMBL3814317		IC50			CHEMBL3145	Homo sapiens	IC50		
	16612861	CHEMBL3815758	Inhibition of PI3K beta (unknown origin)	B	CCc1cc(-c2c[nH]c3ncc(-c4cn[nH]c4)cc23)nc(N)n1		CHEMBL3813865	>	IC50	nM	30000.0	CHEMBL3145	Homo sapiens	IC50	uM	30.0
	16612862	CHEMBL3815758	Inhibition of PI3K beta (unknown origin)	B	CCc1cc(-c2c[nH]c3ncc(-c4ccn[nH]4)cc23)nc(N)n1		CHEMBL3814539	>	IC50	nM	30000.0	CHEMBL3145	Homo sapiens	IC50	uM	30.0
Not Determined	16612863	CHEMBL3815758	Inhibition of PI3K beta (unknown origin)	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3814785		IC50			CHEMBL3145	Homo sapiens	IC50		
	16612864	CHEMBL3815758	Inhibition of PI3K beta (unknown origin)	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(CCN(C)C)c4)cc23)nc(N)n1		CHEMBL3814770	>	IC50	nM	30000.0	CHEMBL3145	Homo sapiens	IC50	uM	30.0
Not Determined	16612865	CHEMBL3815758	Inhibition of PI3K beta (unknown origin)	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140		IC50			CHEMBL3145	Homo sapiens	IC50		
	16612866	CHEMBL3815758	Inhibition of PI3K beta (unknown origin)	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(CC(C)C)c4)cc23)nc(N)n1		CHEMBL3813933	>	IC50	nM	30000.0	CHEMBL3145	Homo sapiens	IC50	uM	30.0
	16612867	CHEMBL3815758	Inhibition of PI3K beta (unknown origin)	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	>	IC50	nM	30000.0	CHEMBL3145	Homo sapiens	IC50	uM	30.0
	16647273	CHEMBL3829044	Inhibition of recombinant human p110beta expressed in baculovirus infected insect Sf9 cells incubated for 1 hr by ADP-gloreagen assay	B	COc1ccc(-c2nc(N3CCOCC3)c3nc(CN(C)c4ncc(C(=O)NO)cn4)n(C)c3n2)cc1		CHEMBL3828518	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	16647274	CHEMBL3829044	Inhibition of recombinant human p110beta expressed in baculovirus infected insect Sf9 cells incubated for 1 hr by ADP-gloreagen assay	B	CN(Cc1nc2c(N3CCOCC3)nc(-c3ccc(N)cc3)nc2n1C)c1ncc(C(=O)NO)cn1		CHEMBL3827814	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	16647275	CHEMBL3829044	Inhibition of recombinant human p110beta expressed in baculovirus infected insect Sf9 cells incubated for 1 hr by ADP-gloreagen assay	B	CN(Cc1nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc2n1C)c1ncc(C(=O)NO)cn1		CHEMBL3827894	=	IC50	nM	34.0	CHEMBL3145	Homo sapiens	IC50	nM	34.0
	16647276	CHEMBL3829044	Inhibition of recombinant human p110beta expressed in baculovirus infected insect Sf9 cells incubated for 1 hr by ADP-gloreagen assay	B	COc1ccc(-c2nc(N3CCOCC3)c3nc(CN(C)c4ncc(C(=O)NO)cn4)n(C)c3n2)cn1		CHEMBL3827281	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	16647277	CHEMBL3829044	Inhibition of recombinant human p110beta expressed in baculovirus infected insect Sf9 cells incubated for 1 hr by ADP-gloreagen assay	B	CN(Cc1nc2c(N3CCOCC3)nc(-c3ccncc3)nc2n1C)c1ncc(C(=O)NO)cn1		CHEMBL3827517	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	16647278	CHEMBL3829044	Inhibition of recombinant human p110beta expressed in baculovirus infected insect Sf9 cells incubated for 1 hr by ADP-gloreagen assay	B	COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1		CHEMBL3622533	=	IC50	nM	54.0	CHEMBL3145	Homo sapiens	IC50	nM	54.0
	16647279	CHEMBL3829044	Inhibition of recombinant human p110beta expressed in baculovirus infected insect Sf9 cells incubated for 1 hr by ADP-gloreagen assay	B	Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1		CHEMBL483254	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	16672504	CHEMBL3855728	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in AKT phosphorylation at S473 after 30 mins by ELISA	B	C[C@H](NC(=O)c1c(N)nn2cccnc12)c1cc2cccc(C#Cc3cnn(C)c3)c2c(=O)n1-c1ccccc1		CHEMBL3984425	=	IC50	nM	240.0	CHEMBL3145	Homo sapiens	IC50	nM	240.0
	16673491	CHEMBL3855893	Inhibition of human PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3cccc(S(=O)(=O)N4CCC(O)CC4)c3)nc1N2C		CHEMBL3959351	=	IC50	nM	4800.0	CHEMBL3145	Homo sapiens	IC50	nM	4800.0
	16673492	CHEMBL3855893	Inhibition of human PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	CCC(=O)N1CCN(S(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1		CHEMBL3942643	=	IC50	nM	610.0	CHEMBL3145	Homo sapiens	IC50	nM	610.0
	16673493	CHEMBL3855893	Inhibition of human PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	C=CC(=O)Nc1ccc(NS(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)cc1		CHEMBL3898901	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	16673494	CHEMBL3855893	Inhibition of human PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	C=CC(=O)N1CCN(S(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1		CHEMBL3979343	=	IC50	nM	540.0	CHEMBL3145	Homo sapiens	IC50	nM	540.0
Active	16673500	CHEMBL3855914	Inhibition of p110beta in HMEC assessed as reduction in S6RP phosphorylation at Ser-235/236 residue at 0.01 to 1 uM after 1 hr by Western blot analysis	B	C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3039502		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Active	16673501	CHEMBL3855913	Inhibition of p110beta in HMEC assessed as reduction in Akt phosphorylation at Thr-308 residue at 0.01 to 1 uM after 1 hr by Western blot analysis	B	C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3039502		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Active	16673502	CHEMBL3855912	Inhibition of p110beta in HMEC assessed as reduction in Akt phosphorylation at Ser-473 residue at 0.01 to 1 uM after 1 hr by Western blot analysis	B	C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3039502		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16673638	CHEMBL3855928	Inhibition of PI3Kbeta (unknown origin) preincubated prior addition of PIP2 as substrate and ATP measured after 30 mins by HTRF assay	B	COCCn1cnc2ccc(-c3cnc(COC4CC4)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc2c1=O		CHEMBL3902260	=	IC50	nM	1400.0	CHEMBL3145	Homo sapiens	IC50	nM	1400.0
	16754180	CHEMBL3860726	Inhibition of PI3Kbeta (unknown origin) up to 10 uM using L-a- phosphatidylinositol/OctylGlucoside as substrate after 10 mins by KinaseGlo luminescence assay	B	[2H]C([2H])([2H])C(c1nccc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2C)n1)(C([2H])([2H])[2H])C([2H])([2H])O		CHEMBL3948305		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16754181	CHEMBL3860726	Inhibition of PI3Kbeta (unknown origin) up to 10 uM using L-a- phosphatidylinositol/OctylGlucoside as substrate after 10 mins by KinaseGlo luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)CO)n1		CHEMBL3939525		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16754185	CHEMBL3860723	Inhibition of PI3Kbeta (unknown origin) expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser473 residue	B	[2H]C([2H])([2H])C(c1nccc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2C)n1)(C([2H])([2H])[2H])C([2H])([2H])[2H]		CHEMBL3975097	=	IC50	nM	1920.0	CHEMBL3145	Homo sapiens	IC50	uM	1.92
	16754186	CHEMBL3860723	Inhibition of PI3Kbeta (unknown origin) expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser473 residue	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397186	=	IC50	nM	3310.0	CHEMBL3145	Homo sapiens	IC50	uM	3.31
	16754191	CHEMBL3860720	Inhibition of PI3Kbeta (unknown origin) using L-a- phosphatidylinositol/OctylGlucoside as substrate after 10 mins by KinaseGlo luminescence assay	B	[2H]C([2H])([2H])C(c1nccc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2C)n1)(C([2H])([2H])[2H])C([2H])([2H])[2H]		CHEMBL3975097	=	IC50	nM	2070.0	CHEMBL3145	Homo sapiens	IC50	uM	2.07
	16754192	CHEMBL3860720	Inhibition of PI3Kbeta (unknown origin) using L-a- phosphatidylinositol/OctylGlucoside as substrate after 10 mins by KinaseGlo luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397186	=	IC50	nM	2010.0	CHEMBL3145	Homo sapiens	IC50	uM	2.01
	16754248	CHEMBL3860726	Inhibition of PI3Kbeta (unknown origin) up to 10 uM using L-a- phosphatidylinositol/OctylGlucoside as substrate after 10 mins by KinaseGlo luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(=O)O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL3911550		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16754251	CHEMBL3860726	Inhibition of PI3Kbeta (unknown origin) up to 10 uM using L-a- phosphatidylinositol/OctylGlucoside as substrate after 10 mins by KinaseGlo luminescence assay	B	[2H]C([2H])([2H])C(c1nccc(-c2sc(NC(=O)N3CCC[C@H]3C(=O)O)nc2C)n1)(C([2H])([2H])[2H])C([2H])([2H])[2H]		CHEMBL3920489		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16756847	CHEMBL3861245	ATP competitive inhibition of human recombinant PI3Kbeta assessed as PIP3 production by Alpha-screen assay	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	uM	0.01
	16772503	CHEMBL3864077	Inhibition of PI3Kbeta (unknown origin) by ADP-Glo kinase assay	B	CCc1cc(CNc2cc(Cl)nn3c(-c4ccc(OC)c(S(=O)(=O)NCCO)c4)c(C)nc23)ccn1		CHEMBL3976651	<	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16776647	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1cc(N2CCOCC2)oc2cc3ccccc3cc12		CHEMBL175883	=	Inhibition	%	-10.0	CHEMBL3145	Homo sapiens	INH	%	-10.0
	16776648	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)c3ccccc3cc12		CHEMBL3950259	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	16776649	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2ccc3ccccc3c12		CHEMBL1795742	=	Inhibition	%	23.0	CHEMBL3145	Homo sapiens	INH	%	23.0
	16776650	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2ccc3cc(-c4ccccc4)ccc3c12		CHEMBL3943031	=	Inhibition	%	-3.0	CHEMBL3145	Homo sapiens	INH	%	-3.0
	16776651	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3c(ccc4oc(N5CCOCC5)nc(=O)c43)c2)cc1		CHEMBL3945601	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	16776652	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2ccc3cc(-c4ccc(Cl)cc4)ccc3c12		CHEMBL3951788	=	Inhibition	%	-1.0	CHEMBL3145	Homo sapiens	INH	%	-1.0
	16776653	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL1795743	=	Inhibition	%	15.0	CHEMBL3145	Homo sapiens	INH	%	15.0
	16776654	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1ccccc1)c1ccccc12		CHEMBL3925185	=	Inhibition	%	10.0	CHEMBL3145	Homo sapiens	INH	%	10.0
	16776655	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccc(-c2cc3c(=O)nc(N4CCOCC4)oc3c3ccccc23)cc1		CHEMBL3897141	=	Inhibition	%	42.0	CHEMBL3145	Homo sapiens	INH	%	42.0
	16776656	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1cccc3c1oc1ccccc13)c1ccccc12		CHEMBL3934067	=	Inhibition	%	22.0	CHEMBL3145	Homo sapiens	INH	%	22.0
	16776657	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1cccc3c1sc1ccccc13)c1ccccc12		CHEMBL3906076	=	Inhibition	%	11.0	CHEMBL3145	Homo sapiens	INH	%	11.0
	16776708	CHEMBL3864784	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption after 60 mins by Kinase-Glo assay	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)c3ccccc3cc12		CHEMBL3945937	>	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
	16776709	CHEMBL3864784	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption after 60 mins by Kinase-Glo assay	B	COc1ccc(-c2c3ccccc3cc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL3915703	>	IC50	nM	50000.0	CHEMBL3145	Homo sapiens	IC50	uM	50.0
Not Determined	16776737	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2ccc3cc(-c4cccc5c4oc4ccccc45)ccc3c12		CHEMBL3979696		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Not Determined	16776738	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2ccc3cc(-c4cccc5c4sc4ccccc45)ccc3c12		CHEMBL3950725		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Not Determined	16776739	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1ccc(Cl)cc1)c1ccccc12		CHEMBL3910266		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Not Determined	16776740	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1ccc(CO)cc1)c1ccccc12		CHEMBL3972212		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Not Determined	16776741	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	Nc1cccc(-c2cc3c(=O)nc(N4CCOCC4)oc3c3ccccc23)c1		CHEMBL3919181		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Not Determined	16776742	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	NC(=O)c1ccc(-c2cc3c(=O)nc(N4CCOCC4)oc3c3ccccc23)cc1		CHEMBL3946978		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Not Determined	16776743	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(/C=C/c1ccccc1)c1ccccc12		CHEMBL3892236		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Not Determined	16776744	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1cccs1)c1ccccc12		CHEMBL3920237		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Not Determined	16776745	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1ccsc1)c1ccccc12		CHEMBL3901196		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Not Determined	16776746	CHEMBL3864777	Inhibition of p110beta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1cccc3ccccc13)c1ccccc12		CHEMBL3929149		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16779786	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	CS(=O)(=O)O.Cc1c(Cc2c(CO)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3894812	=	Kd	nM	1.2	CHEMBL3145	Homo sapiens	Kd	nM	1.2
	16779787	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(C(N)=O)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3941289	=	Kd	nM	20.0	CHEMBL3145	Homo sapiens	Kd	nM	20.0
	16779788	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(C(=O)O)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3970860	=	Kd	nM	1.4	CHEMBL3145	Homo sapiens	Kd	nM	1.4
	16779789	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3986383	=	Kd	nM	6.0	CHEMBL3145	Homo sapiens	Kd	nM	6.0
	16779790	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1c(Cc2c(CNCCS(C)(=O)=O)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3916621	=	Kd	nM	1.4	CHEMBL3145	Homo sapiens	Kd	nM	1.4
	16779791	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1c(Cc2c(CN(C)CCS(C)(=O)=O)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3897548	=	Kd	nM	2.4	CHEMBL3145	Homo sapiens	Kd	nM	2.4
Not Determined	16779808	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1c(Cc2c(CO)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F.O=S(=O)(O)O		CHEMBL3966155		Kd			CHEMBL3145	Homo sapiens	Kd		
	16779809	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(=O)NCc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3903747	=	Kd	nM	2.0	CHEMBL3145	Homo sapiens	Kd	nM	2.0
	16779810	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1c(Cc2c(CO)nc3c(C(=O)O)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3974658	=	Kd	nM	1.2	CHEMBL3145	Homo sapiens	Kd	nM	1.2
	16779811	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(N)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3975628	=	Kd	nM	6.0	CHEMBL3145	Homo sapiens	Kd	nM	6.0
	16779812	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1C		CHEMBL3946307	=	Kd	nM	2.6	CHEMBL3145	Homo sapiens	Kd	nM	2.6
	16779813	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CC(O)C1		CHEMBL3983623	=	Kd	nM	3.0	CHEMBL3145	Homo sapiens	Kd	nM	3.0
	16779814	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CC(O)C1		CHEMBL3955003	=	Kd	nM	1.9	CHEMBL3145	Homo sapiens	Kd	nM	1.9
	16779815	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CCN(C)CC1		CHEMBL3956037	=	Kd	nM	0.4	CHEMBL3145	Homo sapiens	Kd	nM	0.4
	16779816	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1c(Nc2c(CO)nc3c(N)cc(N4CCOC(CO)C4)nn23)cccc1C(F)(F)F		CHEMBL3928423	=	Kd	nM	1.3	CHEMBL3145	Homo sapiens	Kd	nM	1.3
	16779817	CHEMBL3865233	Binding affinity to human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1c(Nc2c(CO)nc3c(N)cc(N4CCOC(CO)C4)nn23)cccc1C(F)(F)F		CHEMBL3928423	=	Kd	nM	138.0	CHEMBL3145	Homo sapiens	Kd	nM	138.0
	16779866	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	Cc1c(Cc2c(CN(C)CCS(C)(=O)=O)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3897548	=	IC50	nM	34.0	CHEMBL3145	Homo sapiens	IC50	nM	34.0
	16779867	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	Cc1c(Cc2c(CNCCS(C)(=O)=O)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3916621	=	IC50	nM	138.0	CHEMBL3145	Homo sapiens	IC50	nM	138.0
	16779868	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3986383	=	IC50	nM	59.0	CHEMBL3145	Homo sapiens	IC50	nM	59.0
	16779869	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	Cc1nc2c(C(=O)O)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3970860	=	IC50	nM	513.0	CHEMBL3145	Homo sapiens	IC50	nM	513.0
	16779870	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	Cc1nc2c(C(N)=O)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3941289	=	IC50	nM	501.0	CHEMBL3145	Homo sapiens	IC50	nM	501.0
	16779871	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	CS(=O)(=O)O.Cc1c(Cc2c(CO)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3894812	=	IC50	nM	46.0	CHEMBL3145	Homo sapiens	IC50	nM	46.0
	16779872	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	Cc1c(Cc2c(CO)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F.O=S(=O)(O)O		CHEMBL3966155	=	IC50	nM	52.0	CHEMBL3145	Homo sapiens	IC50	nM	52.0
	16779873	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	CC(=O)NCc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3903747	=	IC50	nM	33.0	CHEMBL3145	Homo sapiens	IC50	nM	33.0
	16779874	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	Cc1c(Cc2c(CO)nc3c(C(=O)O)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3974658	>	IC50	nM	513.0	CHEMBL3145	Homo sapiens	IC50	nM	513.0
	16779875	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	Cc1nc2c(N)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3975628	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	nM	12.0
	16779876	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1C		CHEMBL3946307	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	nM	12.0
	16779877	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CC(O)C1		CHEMBL3983623	=	IC50	nM	174.0	CHEMBL3145	Homo sapiens	IC50	nM	174.0
	16779878	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CC(O)C1		CHEMBL3955003	=	IC50	nM	44.0	CHEMBL3145	Homo sapiens	IC50	nM	44.0
	16779879	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CCN(C)CC1		CHEMBL3956037	=	IC50	nM	21.0	CHEMBL3145	Homo sapiens	IC50	nM	21.0
	16779880	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	Cc1c(Nc2c(CO)nc3c(N)cc(N4CCOC(CO)C4)nn23)cccc1C(F)(F)F		CHEMBL3928423	=	IC50	nM	79.0	CHEMBL3145	Homo sapiens	IC50	nM	79.0
	16779881	CHEMBL3865237	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA	B	Cc1c(Nc2c(CO)nc3c(N)cc(N4CCOC(CO)C4)nn23)cccc1C(F)(F)F		CHEMBL3928423	>	IC50	nM	513.0	CHEMBL3145	Homo sapiens	IC50	nM	513.0
	16779882	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	Cc1c(Cc2c(CN(C)CCS(C)(=O)=O)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3897548	=	IC50	nM	41.0	CHEMBL3145	Homo sapiens	IC50	nM	41.0
	16779883	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	Cc1c(Cc2c(CNCCS(C)(=O)=O)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3916621	=	IC50	nM	186.0	CHEMBL3145	Homo sapiens	IC50	nM	186.0
	16779884	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3986383	=	IC50	nM	48.0	CHEMBL3145	Homo sapiens	IC50	nM	48.0
	16779885	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	Cc1nc2c(C(=O)O)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3970860	=	IC50	nM	316.0	CHEMBL3145	Homo sapiens	IC50	nM	316.0
	16779886	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	Cc1nc2c(C(N)=O)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3941289	>	IC50	nM	513.0	CHEMBL3145	Homo sapiens	IC50	nM	513.0
	16779887	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	CS(=O)(=O)O.Cc1c(Cc2c(CO)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3894812	=	IC50	nM	38.0	CHEMBL3145	Homo sapiens	IC50	nM	38.0
	16779888	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	Cc1c(Cc2c(CO)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F.O=S(=O)(O)O		CHEMBL3966155	=	IC50	nM	41.0	CHEMBL3145	Homo sapiens	IC50	nM	41.0
	16779889	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	CC(=O)NCc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3903747	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
	16779890	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	Cc1c(Cc2c(CO)nc3c(C(=O)O)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3974658	>	IC50	nM	513.0	CHEMBL3145	Homo sapiens	IC50	nM	513.0
	16779891	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	Cc1nc2c(N)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3975628	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	nM	17.0
	16779892	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1C		CHEMBL3946307	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	nM	8.0
	16779893	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CC(O)C1		CHEMBL3983623	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	nM	17.0
	16779894	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CC(O)C1		CHEMBL3955003	=	IC50	nM	33.0	CHEMBL3145	Homo sapiens	IC50	nM	33.0
	16779895	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CCN(C)CC1		CHEMBL3956037	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	nM	17.0
	16779896	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	Cc1c(Nc2c(CO)nc3c(N)cc(N4CCOC(CO)C4)nn23)cccc1C(F)(F)F		CHEMBL3928423	=	IC50	nM	43.0	CHEMBL3145	Homo sapiens	IC50	nM	43.0
	16779897	CHEMBL3865238	Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Thr308 after 60 mins by ELISA	B	Cc1c(Nc2c(CO)nc3c(N)cc(N4CCOC(CO)C4)nn23)cccc1C(F)(F)F		CHEMBL3928423	=	IC50	nM	513.0	CHEMBL3145	Homo sapiens	IC50	nM	513.0
	16786806	CHEMBL3866423	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced integrin alpha2bbeta3 activation preincubated for 5 mins followed by ADP stimulation after 10 mins by OG-FNG-based FACS analysis	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Imax	uM	25.0	CHEMBL3145	Homo sapiens	Imax	uM	25.0
	16786807	CHEMBL3866423	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced integrin alpha2bbeta3 activation preincubated for 5 mins followed by ADP stimulation after 10 mins by OG-FNG-based FACS analysis	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	Imax	uM	0.25	CHEMBL3145	Homo sapiens	Imax	uM	0.25
	16786808	CHEMBL3866423	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced integrin alpha2bbeta3 activation preincubated for 5 mins followed by ADP stimulation after 10 mins by OG-FNG-based FACS analysis	B	N[C@@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322664	=	Imax	uM	1.0	CHEMBL3145	Homo sapiens	Imax	uM	1.0
Dose-dependent effect	16786809	CHEMBL3866423	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced integrin alpha2bbeta3 activation preincubated for 5 mins followed by ADP stimulation after 10 mins by OG-FNG-based FACS analysis	B	N[C@@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322664		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16786810	CHEMBL3866422	Inhibition of PI3Kbeta in human platelet-rich plasma assessed as suppression of ADP-induced platelet aggregation preincubated for 5 mins followed by ADP stimulation after 10 mins by light transmission aggregometric analysis	B	N[C@@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322664	=	IC50	nM	2800.0	CHEMBL3145	Homo sapiens	IC50	uM	2.8
Active	16786811	CHEMBL3866420	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced platelet aggregation at 0.5 uM preincubated for 5 mins followed by 25 uM ADP stimulation after 10 mins by light transmission aggregometric analysis	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16786812	CHEMBL3866420	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced platelet aggregation at 0.5 uM preincubated for 5 mins followed by 25 uM ADP stimulation after 10 mins by light transmission aggregometric analysis	B	N[C@@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322664	=	Inhibition	%	15.0	CHEMBL3145	Homo sapiens	INH	%	15.0
Active	16786813	CHEMBL3866421	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced platelet aggregation at 0.5 uM preincubated for 5 mins followed by 5 to 10 uM ADP stimulation after 10 mins by light transmission aggregometric analysis	B	N[C@@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322664		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Dose-dependent effect	16786823	CHEMBL3866415	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced platelet aggregation preincubated for 5 mins followed by ADP stimulation after 10 mins by light transmission aggregometric analysis	B	O=C([C@@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322668		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16786824	CHEMBL3866415	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced platelet aggregation preincubated for 5 mins followed by ADP stimulation after 10 mins by light transmission aggregometric analysis	B	O=C([C@@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322668	=	IC50	nM	30.0	CHEMBL3145	Homo sapiens	IC50	nM	30.0
Dose-dependent effect	16786825	CHEMBL3866415	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced platelet aggregation preincubated for 5 mins followed by ADP stimulation after 10 mins by light transmission aggregometric analysis	B	N[C@@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322664		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16786826	CHEMBL3866415	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced platelet aggregation preincubated for 5 mins followed by ADP stimulation after 10 mins by light transmission aggregometric analysis	B	N[C@@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322664	=	IC50	nM	30.0	CHEMBL3145	Homo sapiens	IC50	nM	30.0
	16786827	CHEMBL3866415	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced platelet aggregation preincubated for 5 mins followed by ADP stimulation after 10 mins by light transmission aggregometric analysis	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Imax	uM	25.0	CHEMBL3145	Homo sapiens	Imax	uM	25.0
Dose-dependent effect	16786828	CHEMBL3866415	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced platelet aggregation preincubated for 5 mins followed by ADP stimulation after 10 mins by light transmission aggregometric analysis	B	O=C([C@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3982304		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16786829	CHEMBL3866415	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced platelet aggregation preincubated for 5 mins followed by ADP stimulation after 10 mins by light transmission aggregometric analysis	B	O=C([C@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3982304	=	IC50	nM	30.0	CHEMBL3145	Homo sapiens	IC50	nM	30.0
	16786830	CHEMBL3866414	Inhibition of PI3Kbeta Y778I mutant (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 at 200 nM by kinase-glo luminescence assay	B	NCC(=O)N1CCC(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3930788		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16786831	CHEMBL3866413	Inhibition of PI3Kbeta E858H mutant (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 at 200 nM by kinase-glo luminescence assay	B	NCC(=O)N1CCC(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3930788		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16786832	CHEMBL3866413	Inhibition of PI3Kbeta E858H mutant (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 at 200 nM by kinase-glo luminescence assay	B	NCCC1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3949883		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16786833	CHEMBL3866412	Inhibition of PI3Kbeta E858H mutant (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 at 70 nM by kinase-glo luminescence assay	B	NCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322660		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16786834	CHEMBL3866411	Inhibition of PI3Kbeta D862Q mutant (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 at 70 nM by kinase-glo luminescence assay	B	NCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322660		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16786854	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	52.0	CHEMBL3145	Homo sapiens	IC50	nM	52.0
	16786855	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
	16786856	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	O=C([C@@H]1CCCN1)N1CCC(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3908177	=	IC50	nM	2000.0	CHEMBL3145	Homo sapiens	IC50	nM	2000.0
	16786857	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	C[C@@H](N)C(=O)N1CCC(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3936124	=	IC50	nM	3200.0	CHEMBL3145	Homo sapiens	IC50	nM	3200.0
	16786858	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	C[C@H](N)C(=O)N1CCC(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3917147	=	IC50	nM	540.0	CHEMBL3145	Homo sapiens	IC50	nM	540.0
	16786859	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NCC(=O)N1CCC(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3930788	=	IC50	nM	360.0	CHEMBL3145	Homo sapiens	IC50	nM	360.0
	16786860	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NCC(=O)N1CCC(Nc2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3972268	=	IC50	nM	1060.0	CHEMBL3145	Homo sapiens	IC50	nM	1060.0
	16786861	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	FC(F)c1nc2ccccc2n1-c1nc(NC2CCNCC2)nc(N2CCOCC2)n1		CHEMBL3900274	=	IC50	nM	2114.0	CHEMBL3145	Homo sapiens	IC50	nM	2114.0
	16786862	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NCC(=O)NC1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL3978019	=	IC50	nM	1210.0	CHEMBL3145	Homo sapiens	IC50	nM	1210.0
	16786863	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NC1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL3948855	=	IC50	nM	554.0	CHEMBL3145	Homo sapiens	IC50	nM	554.0
	16786864	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NCCC1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3949883	=	IC50	nM	190.0	CHEMBL3145	Homo sapiens	IC50	nM	190.0
	16786865	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NCC(=O)NCC1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3922132	=	IC50	nM	428.0	CHEMBL3145	Homo sapiens	IC50	nM	428.0
	16786866	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NCC1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3958556	=	IC50	nM	811.0	CHEMBL3145	Homo sapiens	IC50	nM	811.0
	16786867	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	CC(=O)NC1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3963433	=	IC50	nM	521.0	CHEMBL3145	Homo sapiens	IC50	nM	521.0
	16786868	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	N[C@H](CC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)Cc1ccccc1		CHEMBL3935927	=	IC50	nM	7052.0	CHEMBL3145	Homo sapiens	IC50	nM	7052.0
	16786869	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	N[C@@H](CC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccccc1		CHEMBL3974302	=	IC50	nM	1797.0	CHEMBL3145	Homo sapiens	IC50	nM	1797.0
	16786870	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	O=C([C@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3982304	=	IC50	nM	36.0	CHEMBL3145	Homo sapiens	IC50	nM	36.0
	16786871	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NC1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3893326	=	IC50	nM	955.0	CHEMBL3145	Homo sapiens	IC50	nM	955.0
	16786872	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NCC(=O)NC1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3962354	=	IC50	nM	1328.0	CHEMBL3145	Homo sapiens	IC50	nM	1328.0
	16786873	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	CC(C)C[C@H](N)CC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3944869	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	16786874	CHEMBL3866409	Inhibition of PI3Kbeta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	O=C(C1CCNCC1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3953591	=	IC50	nM	3210.0	CHEMBL3145	Homo sapiens	IC50	nM	3210.0
	16786894	CHEMBL3866451	Inhibition of PI3Kbeta D862Q mutant (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 at 200 nM by kinase-glo luminescence assay	B	NCCC1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3949883		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16786895	CHEMBL3866451	Inhibition of PI3Kbeta D862Q mutant (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 at 200 nM by kinase-glo luminescence assay	B	NCC(=O)N1CCC(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3930788		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Active	16786896	CHEMBL3866452	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced platelet aggregation at 1 to 1000 nM preincubated for 5 mins followed by ADP stimulation after 10 mins by light transmission aggregometric analysis	B	NCCC1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3949883		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16786897	CHEMBL3866452	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced platelet aggregation at 1 to 1000 nM preincubated for 5 mins followed by ADP stimulation after 10 mins by light transmission aggregometric analysis	B	NCCCC[C@H](N)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322669		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Active	16786898	CHEMBL3866452	Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced platelet aggregation at 1 to 1000 nM preincubated for 5 mins followed by ADP stimulation after 10 mins by light transmission aggregometric analysis	B	C[C@H](N)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322662		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16786902	CHEMBL3866455	Ratio of IC50 for inhibition of PI3Kbeta in human platelet rich plasma assessed as suppression of ADP-induced platelet aggregation to IC50 for inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced platelet aggregation	B	N[C@@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322664	=	Ratio IC50		50.0	CHEMBL3145	Homo sapiens	Ratio IC50		50.0
Dose-dependent effect	16786905	CHEMBL3866422	Inhibition of PI3Kbeta in human platelet-rich plasma assessed as suppression of ADP-induced platelet aggregation preincubated for 5 mins followed by ADP stimulation after 10 mins by light transmission aggregometric analysis	B	N[C@@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322664		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	16790977	CHEMBL3867035	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate after 1 hr in presence of ATP by ADP-glo based luminescence assay	B	COc1ncc(-c2ccc3nccc(-c4ccc(CN(C)C)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3963018	=	IC50	nM	1.8	CHEMBL3145	Homo sapiens	IC50	nM	1.8
	16790978	CHEMBL3867035	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate after 1 hr in presence of ATP by ADP-glo based luminescence assay	B	COc1ncc(-c2ccc3nccc(-c4ccc(CN(C)CCO)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3905146	=	IC50	nM	1.1	CHEMBL3145	Homo sapiens	IC50	nM	1.1
	16790979	CHEMBL3867035	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate after 1 hr in presence of ATP by ADP-glo based luminescence assay	B	COc1ncc(-c2ccc3nccc(-c4ccc(Cn5cncn5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3968925	=	IC50	nM	1.7	CHEMBL3145	Homo sapiens	IC50	nM	1.7
	16790980	CHEMBL3867035	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate after 1 hr in presence of ATP by ADP-glo based luminescence assay	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	=	IC50	nM	1.2	CHEMBL3145	Homo sapiens	IC50	nM	1.2
	16790981	CHEMBL3867035	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate after 1 hr in presence of ATP by ADP-glo based luminescence assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	nM	12.0
	16798513	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCN(C(C)=O)C4)c3c2)cc1OC		CHEMBL3969716	=	IC50	nM	304.0	CHEMBL3145	Homo sapiens	IC50	uM	0.304
	16798514	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	CCC(=O)N1CC[C@H](Oc2ncnc3ccc(-c4cnc(OC)c(C#N)c4)cc23)C1		CHEMBL3960012	=	IC50	nM	360.0	CHEMBL3145	Homo sapiens	IC50	uM	0.36
	16798519	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCN(C(C)=O)C4)c3c2)cc1OC		CHEMBL3969716	=	IC50	nM	407.0	CHEMBL3145	Homo sapiens	IC50	uM	0.407
	16798528	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	CCC(=O)N1CC[C@H](Oc2ccnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL3905342	=	IC50	nM	655.0	CHEMBL3145	Homo sapiens	IC50	uM	0.655
	16798529	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	CCC(=O)N1CC[C@H](Oc2ncnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL3896413	=	IC50	nM	669.0	CHEMBL3145	Homo sapiens	IC50	uM	0.669
	16798536	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	CCC(=O)N1CC[C@@H](Oc2cnc3ccc(-c4ccc(OC)c(OC)c4)cc3n2)C1		CHEMBL3966263	=	IC50	nM	860.0	CHEMBL3145	Homo sapiens	IC50	uM	0.86
	16798537	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	CCC(=O)N1CC[C@H](Oc2ccnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL3905342	=	IC50	nM	877.0	CHEMBL3145	Homo sapiens	IC50	uM	0.877
	16798540	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cc1OC		CHEMBL3930000	=	IC50	nM	956.0	CHEMBL3145	Homo sapiens	IC50	uM	0.956
	16798549	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	CCC(=O)N1CC[C@H](Oc2ccnc3ccc(-c4ccc(OC)nc4)nc23)C1		CHEMBL3977135	=	IC50	nM	1030.0	CHEMBL3145	Homo sapiens	IC50	uM	1.03
	16798553	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	CCC(=O)N1CC[C@H](Oc2ncnc3ccc(-c4cnc(OC)c(C#N)c4)cc23)C1		CHEMBL3960012	=	IC50	nM	1280.0	CHEMBL3145	Homo sapiens	IC50	uM	1.28
	16798557	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCN(C)C4)c3c2)cc1OC		CHEMBL3921081	=	IC50	nM	1480.0	CHEMBL3145	Homo sapiens	IC50	uM	1.48
	16798559	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cc1OC		CHEMBL3930000	=	IC50	nM	1520.0	CHEMBL3145	Homo sapiens	IC50	uM	1.52
	16798560	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	IC50	nM	1650.0	CHEMBL3145	Homo sapiens	IC50	uM	1.65
	16798561	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	CCC(=O)N1CC[C@H](Oc2ncnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL3896413	=	IC50	nM	1780.0	CHEMBL3145	Homo sapiens	IC50	uM	1.78
	16798562	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(O[C@@H]4CCN(C(C)=O)C4)c3c2)cc1OC		CHEMBL3914282	=	IC50	nM	1790.0	CHEMBL3145	Homo sapiens	IC50	uM	1.79
	16798565	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1OC		CHEMBL3944013	=	IC50	nM	1940.0	CHEMBL3145	Homo sapiens	IC50	uM	1.94
	16798566	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(O[C@@H]4CCN(C)C4)c3c2)cc1OC		CHEMBL3948901	=	IC50	nM	1940.0	CHEMBL3145	Homo sapiens	IC50	uM	1.94
	16798569	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	CCC(=O)N1CC[C@@H](Oc2cnc3ccc(-c4ccc(OC)c(OC)c4)cc3n2)C1		CHEMBL3966263	=	IC50	nM	2130.0	CHEMBL3145	Homo sapiens	IC50	uM	2.13
	16798585	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	CCC(=O)N1CC[C@H](Oc2ccnc3ccc(-c4ccc(OC)nc4)nc23)C1		CHEMBL3977135	=	IC50	nM	3210.0	CHEMBL3145	Homo sapiens	IC50	uM	3.21
	16798587	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1OC		CHEMBL3944013	=	IC50	nM	3380.0	CHEMBL3145	Homo sapiens	IC50	uM	3.38
	16798590	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cn1		CHEMBL3947814	=	IC50	nM	3570.0	CHEMBL3145	Homo sapiens	IC50	uM	3.57
	16798596	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(O[C@@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cc1OC		CHEMBL3910692	=	IC50	nM	3880.0	CHEMBL3145	Homo sapiens	IC50	uM	3.88
	16798601	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cn1		CHEMBL3947814	=	IC50	nM	4840.0	CHEMBL3145	Homo sapiens	IC50	uM	4.84
	16798607	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	IC50	nM	6530.0	CHEMBL3145	Homo sapiens	IC50	uM	6.53
	16798609	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	CCC(=O)N1CC[C@H](Oc2cnnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL3933360	=	IC50	nM	9010.0	CHEMBL3145	Homo sapiens	IC50	uM	9.01
	16798610	CHEMBL3868295	Inhibition of PI3K-beta (unknown origin) by KinaseGlo assay	B	CCC(=O)N1CC[C@H](Oc2cnc3ccc(-c4ccc(OC)c(OC)c4)cc3n2)C1		CHEMBL3939028	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	16798613	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	CCC(=O)N1CC[C@H](Oc2cnnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL3933360	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
Not Determined	16798624	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	CCC(=O)N1CC[C@H](Oc2cnc3ccc(-c4ccc(OC)c(OC)c4)cc3n2)C1		CHEMBL3939028		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	16798625	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(O[C@@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cc1OC		CHEMBL3910692		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	16798626	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCN(C)C4)c3c2)cc1OC		CHEMBL3921081		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	16798627	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(O[C@@H]4CCN(C)C4)c3c2)cc1OC		CHEMBL3948901		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	16798628	CHEMBL3868299	Inhibition of myristoylated PI3K-beta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(O[C@@H]4CCN(C(C)=O)C4)c3c2)cc1OC		CHEMBL3914282		IC50			CHEMBL3145	Homo sapiens	IC50		
	16801210	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	COc1cc2ncnc(Nc3ccc(CC#N)cc3)c2cc1OC		CHEMBL3944796	=	IC50	nM	19000.0	CHEMBL3145	Homo sapiens	IC50	uM	19.0
	16801211	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cncc5ccccc45)cc23)cc1		CHEMBL3974237	>	IC50	nM	20000.0	CHEMBL3145	Homo sapiens	IC50	uM	20.0
	16801212	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccncc4)cc23)cc1		CHEMBL3953521	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
Not Determined	16801213	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cnc5ccccc5c4)cc23)cc1		CHEMBL3982233		IC50			CHEMBL3145	Homo sapiens	IC50		
	16801214	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc5[nH]ccc5c4)cc23)cc1		CHEMBL3962279	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
Not Determined	16801215	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cccc5c4sc4ccccc45)cc23)cc1		CHEMBL3893253		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	16801216	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cccc5c4oc4ccccc45)cc23)cc1		CHEMBL3973256		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	16801217	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cc5ccccc5s4)cc23)cc1		CHEMBL3902235		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	16801218	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cc5ccccc5o4)cc23)cc1		CHEMBL3908424		IC50			CHEMBL3145	Homo sapiens	IC50		
	16801219	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)cc1		CHEMBL3978826	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16801220	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc5c(c4)OCCO5)cc23)cc1		CHEMBL3899361	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
Not Determined	16801221	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc5ccccc5c4)cc23)cc1		CHEMBL3970545		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	16801222	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc(-c5ccccc5)cc4F)cc23)cc1		CHEMBL3890403		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	16801223	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	CCOc1ccc(-c2ccc(-c3ccc4ncnc(Nc5ccc(CC#N)cc5)c4c3)cc2)cc1		CHEMBL3959481		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	16801224	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc(-c5ccccc5)cc4)cc23)cc1		CHEMBL3979727		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	16801225	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	CC(=O)Nc1cccc(-c2ccc3ncnc(Nc4ccc(CC#N)cc4)c3c2)c1		CHEMBL3950768		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	16801226	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc(OCc5ccc(F)cc5)cc4)cc23)cc1		CHEMBL3971633		IC50			CHEMBL3145	Homo sapiens	IC50		
	16801227	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	C=Cc1ccc(-c2ccc3ncnc(Nc4ccc(CC#N)cc4)c3c2)cc1		CHEMBL3942049	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
Not Determined	16801228	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	Cc1ccccc1-c1ccc2ncnc(Nc3ccc(CC#N)cc3)c2c1		CHEMBL3966044		IC50			CHEMBL3145	Homo sapiens	IC50		
	16801229	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cccc([N+](=O)[O-])c4)cc23)cc1		CHEMBL3894691	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16801230	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cccc(O)c4)cc23)cc1		CHEMBL3919405	=	IC50	nM	670.0	CHEMBL3145	Homo sapiens	IC50	uM	0.67
	16801231	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	CC(=O)c1ccc(-c2ccc3ncnc(Nc4ccc(CC#N)cc4)c3c2)cc1		CHEMBL3890572	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
Not Determined	16801232	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccccc4C=O)cc23)cc1		CHEMBL3910480		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	16801233	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc(F)cc4F)cc23)cc1		CHEMBL3938413		IC50			CHEMBL3145	Homo sapiens	IC50		
	16801234	CHEMBL3868773	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccccc4)cc23)cc1		CHEMBL3937311	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16801262	CHEMBL3868769	Inhibition of PI3Kbeta (unknown origin) using PI:PS as substrate after 2 hrs in presence of [33P]ATP by liquid scintillation counting method	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	=	IC50	nM	3.7	CHEMBL3145	Homo sapiens	IC50	nM	3.7
	16801266	CHEMBL3868765	Inhibition of human recombinant PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 20 mins by aplhascreen assay	B	Cc1cc([C@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3979323	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	16801270	CHEMBL3868761	Inhibition of PI3Kbeta (unknown origin)	B	Nc1nc2cc(-c3ccc4ncc(C(=O)N5CCOCC5)n4c3)ccc2o1		CHEMBL3935857	=	IC50	nM	4500.0	CHEMBL3145	Homo sapiens	IC50	nM	4500.0
	16801275	CHEMBL3868756	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus co-expressing p85 using l-alpha-phosphatidylinositol as substrate after 60 mins by kinase-glo assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	76.0	CHEMBL3145	Homo sapiens	IC50	uM	0.076
	16801429	CHEMBL3868781	Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate up to 20 uM after 60 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cncc5ccccc45)cc23)cc1		CHEMBL3974237	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	16830452	CHEMBL3875079	Inhibition of PI3Kbeta in HUVEC assessed as reduction in sphingosine-1-phosphate stimulated akt phosphorylation at Ser473 residue preincubated for 15 mins followed by sphingosine-1-phosphate stimulation for 5 mins by HTRF assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nn2ccc(C#N)c2c(=O)n1-c1ccccc1		CHEMBL3910904	=	IC50	nM	295.0	CHEMBL3145	Homo sapiens	IC50	nM	295.0
	16844175	CHEMBL3877205	Inhibition of immobilized N-LY294002 bead binding to PI3Kbeta (unknown origin) expressed in HEK293T cells incubated for 1 hr by LC-MS/MS analysis	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	420.0	CHEMBL3145	Homo sapiens	IC50	uM	0.42
	16896780	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	Nc1nc2cc(-c3nn(C4CC(O)C4)c4ncnc(N)c34)ccc2o1		CHEMBL3894734	<	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	uM	1.0
	16896781	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	CC(=O)Nc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3893037	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896782	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	CC(=O)Nc1nc2ccc(-c3nn(C(C)C)c4ncnc(N)c34)cc2o1		CHEMBL3958537	<	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896783	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	CC(C)n1nc(-c2ccc3nc(N)oc3c2)c2c(N)ncnc21		CHEMBL3962632	<	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896784	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	Nc1nc2cc(-c3nn(C4CCC(N5CCOCC5)CC4)c4ncnc(N)c34)ccc2o1		CHEMBL3925171	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896785	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	CC(=O)N1CCC(n2nc(-c3ccc4oc(N)nc4c3)c3c(N)ncnc32)CC1		CHEMBL3914396	<	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896786	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	COC(=O)Nc1noc2ccc(-c3nn(C(C)C)c4ncnc(N)c34)cc12		CHEMBL3946594	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896787	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	COC(=O)Nc1noc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc12		CHEMBL3975796	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896788	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	Cc1nc(N)c2c(-c3ccc4oc(N)nc4c3)nn(C(C)C)c2n1		CHEMBL3978294	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896789	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	[2H]C([2H])([2H])C([2H])(n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)C([2H])([2H])[2H]		CHEMBL3943182	<	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896790	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	CC(CO)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21		CHEMBL3945869	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896791	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	CCOC(=O)C(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21		CHEMBL3896957	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896792	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	Nc1nc2cc(-c3nn(C4CC(=O)C4)c4ncnc(N)c34)ccc2o1		CHEMBL3901250	<	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896793	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	CC(C)(CO)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21		CHEMBL3891983	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896843	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21		CHEMBL3545097	<	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896844	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	Nc1nc2cc(-c3nn(C4CCOCC4)c4ncnc(N)c34)ccc2o1		CHEMBL3965413	<	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896845	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	CC(C)n1cc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21		CHEMBL3890780	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16896846	CHEMBL3882341	Inhibition of human PI3Kbeta using PIP2 as substrate by HTRF assay	B	Nc1nc2cc(-c3cn(C4CCOCC4)c4ncnc(N)c34)ccc2o1		CHEMBL3961477	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	16897217	CHEMBL3882564	Inhibition of PI3K-beta (unknown origin)	B	COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1		CHEMBL3360203	=	IC50	nM	383.0	CHEMBL3145	Homo sapiens	IC50	nM	383.0
245967	17629342	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1ccc(F)cc1)c1cc(C(=O)NCCN(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656386	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	nM	2.0
245968	17629343	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cccc(F)c1)c1cc(C(=O)NCCN(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656387	=	IC50	nM	1.0	CHEMBL3145	Homo sapiens	IC50	nM	1.0
245969	17629344	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1ccccc1)c1cc(C(=O)NCCN(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656388	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	nM	2.0
245970	17629345	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cccc(Cl)c1F)c1cc(C(=O)NCCN(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656389	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	nM	9.0
245971	17629346	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1ccc(F)cc1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408244	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	nM	7.0
245972	17629347	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1ccc(F)cc1)c1cc(C(=O)N(C)CCN(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656390	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	nM	7.0
245973	17629348	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1ccc(F)c(Cl)c1)c1cc(C(=O)N2CCC(O)CC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656391	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
245974	17629349	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1ccc(F)c(Cl)c1)c1cc(C(=O)N(C)CCO)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656392	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
245975	17629350	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cccc(Cl)c1F)c1cc(C(=O)N(C)CCO)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656393	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
245976	17629351	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cccc(Cl)c1F)c1cc(C(=O)N2CCC(O)CC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656394	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
245977	17629352	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCOCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408265	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
245978	17629353	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CC[C@H](O)C2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656395	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	nM	7.0
245979	17629354	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1ccc(F)c(F)c1)C(C)c1cc(C(=O)NCCN(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656396	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
245980	17629355	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N(C)CCN(C)C)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1ccc(F)cc1		CHEMBL3656397	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
245981	17629356	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1ccc(F)c(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3916146	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	nM	9.0
245982	17629357	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cccc(Cl)c1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656398	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
245983	17629358	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1ccc(F)c(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408251	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
245984	17629359	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656399	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
245985	17629360	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12)C(C)[n+]1ccc(F)cc1		CHEMBL4114274	=	IC50	nM	29.0	CHEMBL3145	Homo sapiens	IC50	nM	29.0
245986	17629361	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1ccc(F)c(Cl)c1		CHEMBL3656401	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
245987	17629362	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cccc(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408245	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
245988	17629363	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cccc(F)c1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408246	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
245989	17629364	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)c(F)c(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656402	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
245990	17629365	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cccc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3407508	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	nM	7.0
245991	17629366	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cccc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3407508	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
245992	17629367	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656403	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
245993	17629368	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656404	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
245994	17629369	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)ccc1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408249	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
245995	17629370	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	Cc1cc(F)cc(NC(C)c2cc(C(=O)N(C)C)cc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL3408253	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
245996	17629371	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(C#N)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656405	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
245997	17629372	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cccc(C#N)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656406	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
245998	17629373	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cccc(Cl)c1Cl)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656407	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
245999	17629374	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	C#Cc1cccc(NC(C)c2cc(C(=O)N(C)C)cc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL3656408	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
246000	17629375	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	Cc1ccc(C#N)cc1NC(C)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656409	=	IC50	nM	114.0	CHEMBL3145	Homo sapiens	IC50	nM	114.0
246001	17629376	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	Cc1ccc(F)cc1NC(C)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656410	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246002	17629377	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	Cc1cc(C#N)cc(NC(C)c2cc(C(=O)N(C)C)cc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL3656411	=	IC50	nM	13.0	CHEMBL3145	Homo sapiens	IC50	nM	13.0
246003	17629378	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	COc1ccc(F)cc1NC(C)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656412	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
246004	17629379	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	COc1ccc(C#N)cc1NC(C)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656413	=	IC50	nM	212.0	CHEMBL3145	Homo sapiens	IC50	nM	212.0
246005	17629380	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)ccc1Cl)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656414	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246006	17629381	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1c(F)ccc(F)c1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656415	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	nM	9.0
246007	17629382	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	Cc1ccc(Cl)cc1NC(C)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656416	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246008	17629383	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	Cc1c(C#N)cccc1NC(C)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656417	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
246009	17629384	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	COc1cc(F)cc(NC(C)c2cc(C(=O)N(C)C)cc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL3408254	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246010	17629385	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	COc1c(F)cccc1NC(C)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656418	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
246011	17629386	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1c(F)ccc(Cl)c1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656419	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	nM	8.0
246012	17629387	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(Cl)cc(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408255	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
246013	17629388	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	C#Cc1cc(F)cc(NC(C)c2cc(C(=O)N(C)C)cc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL3656420	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246014	17629389	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)ccc1C#N)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656421	=	IC50	nM	31.0	CHEMBL3145	Homo sapiens	IC50	nM	31.0
246015	17629390	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cccc(F)c1C#N)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656422	=	IC50	nM	24.0	CHEMBL3145	Homo sapiens	IC50	nM	24.0
246016	17629391	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(Cl)c1		CHEMBL3656423	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	nM	12.0
246017	17629392	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)c(F)c(F)c1		CHEMBL3656424	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	nM	17.0
246018	17629393	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1F		CHEMBL3656425	=	IC50	nM	21.0	CHEMBL3145	Homo sapiens	IC50	nM	21.0
246019	17629394	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1ccccc1		CHEMBL3656426	=	IC50	nM	43.0	CHEMBL3145	Homo sapiens	IC50	nM	43.0
246020	17629395	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	C#Cc1cc(F)cc(N(C)C(C)c2cc(C(=O)N(C)C)cc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL3656427	=	IC50	nM	14.0	CHEMBL3145	Homo sapiens	IC50	nM	14.0
246021	17629396	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CCN(CC)C(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408261	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246022	17629397	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408263	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246023	17629398	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCN(C)CC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656428	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246024	17629399	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCNCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656429	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246025	17629400	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCSCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656430	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	nM	8.0
246026	17629401	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCCCCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656431	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246027	17629402	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)CCO)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408260	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246028	17629403	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656432	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
246029	17629404	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCC(O)CC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408266	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
246030	17629405	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCCCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408264	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
246031	17629406	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CCN(C)C(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408258	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	nM	2.0
246032	17629407	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CC(O)C2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656433	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246033	17629408	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CC(F)C2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656434	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	nM	9.0
246034	17629409	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)NCCO)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656435	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246035	17629410	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	COCCNC(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408269	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246036	17629411	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CCCNC(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3656436	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	nM	9.0
246037	17629412	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CCNC(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408268	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
246038	17629413	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)NCCF)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656437	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246039	17629414	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	COCCCNC(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3656438	=	IC50	nM	23.0	CHEMBL3145	Homo sapiens	IC50	nM	23.0
246040	17629415	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCC[C@@H]2CO)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656439	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
246041	17629416	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCC[C@H]2CO)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656440	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246042	17629417	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CNC(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3639553	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246043	17629418	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)NCC2CC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656441	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
246044	17629419	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	COCCN(C)C(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408259	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246045	17629420	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCCOCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656442	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
246046	17629421	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	COC1CCN(C(=O)c2cc(C(C)Nc3cc(F)cc(F)c3)c3oc(N4CCOCC4)cc(=O)c3c2)CC1		CHEMBL3656443	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246047	17629422	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N2CCC(O)CC2)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3656444	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	nM	8.0
246048	17629423	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N2CCC(O)C2)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3656445	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	nM	7.0
246049	17629424	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N2CCC[C@@H]2CO)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3656446	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	nM	7.0
246050	17629425	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N2CCCC2)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3408276	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
246051	17629426	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N(C)CCO)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3895589	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
246052	17629427	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N(C)CCO)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3895589	=	IC50	nM	3381.0	CHEMBL3145	Homo sapiens	IC50	nM	3381.0
246053	17629428	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N(C)CCO)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3895589	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
246054	17629429	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N2CCC(O)CC2)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3656444	=	IC50	nM	8.0	CHEMBL3145	Homo sapiens	IC50	nM	8.0
246055	17629430	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N2CCC(O)CC2)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3656444	=	IC50	nM	4315.0	CHEMBL3145	Homo sapiens	IC50	nM	4315.0
246056	17629431	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656432	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246057	17629432	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656404	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
246058	17629433	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(C#N)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656405	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
246059	17629434	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)c(F)c(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656402	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	nM	2.0
246060	17629435	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1ccc(F)cc1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCO[C@H](C)C3)oc12		CHEMBL3656447	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
246061	17629436	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCO[C@H](C)C3)oc12		CHEMBL3656448	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
246062	17629437	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCO[C@@H](C)C3)oc12		CHEMBL3656449	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
246063	17629438	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1ccc(F)cc1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCO[C@@H](C)C3)oc12		CHEMBL3656450	=	IC50	nM	64.0	CHEMBL3145	Homo sapiens	IC50	nM	64.0
246064	17629439	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCO[C@H](C)C3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3656451	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	nM	12.0
246065	17629440	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N(C)CCO)cc2c(=O)cc(N3CCO[C@H](C)C3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3656452	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
246066	17629441	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1cc(C(=O)N2CCC(O)CC2)cc2c(=O)cc(N3CCO[C@H](C)C3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3656453	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	nM	9.0
246067	17629442	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOC[C@@H]3C)oc12		CHEMBL3656454	=	IC50	nM	21.0	CHEMBL3145	Homo sapiens	IC50	nM	21.0
246068	17629443	CHEMBL3705076	Enzyme Inhibition Assay: The inhibition of PI3K, PI3K, PI3K and PI3K was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. The assay measures depletion of ATP after incubation with enzyme, PIP2 and ATP plus compound. ATP at the end of the reaction is detected by addition of Kinase Glo reagent, in this the Ultra Glo luciferase (Promega) uses the ATP as a substrate to catalyze the mono-oxygenation of luciferin and the generation of light. A direct relationship exists between the luminescence measured with the Kinase-Glo Plus Reagent and the amount of ATP remaining in a completed kinase reaction and luminescence is inversely related to kinase activity.	B	CC(c1ccc(F)cc1)C(C)c1cc(C(=O)NCCN(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3656455	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	nM	7.0
274123	17656423	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OCC(O)CN2CCOCC2)ccc2c1N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL3644646	=	IC50	nM	9.92	CHEMBL3145	Homo sapiens	IC50	nM	9.92
274124	17656424	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCOCC2)ccc2c1N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL3644648	=	IC50	nM	2.98	CHEMBL3145	Homo sapiens	IC50	nM	2.98
274125	17656425	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@@H](O)CN2CCOCC2)ccc2c1N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL3644650	=	IC50	nM	6.2	CHEMBL3145	Homo sapiens	IC50	nM	6.2
274126	17656426	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2C[C@H](C)O[C@H](C)C2)ccc2c1N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL3644651	=	IC50	nM	4.85	CHEMBL3145	Homo sapiens	IC50	nM	4.85
274127	17656427	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CC3CCC(C2)O3)ccc2c1N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL3644652	=	IC50	nM	3.68	CHEMBL3145	Homo sapiens	IC50	nM	3.68
274128	17656428	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OCC(O)CN2CCSCC2)ccc2c1N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL3644658	=	IC50	nM	9.96	CHEMBL3145	Homo sapiens	IC50	nM	9.96
274129	17656429	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCC2)ccc2c1N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL3644664	=	IC50	nM	2.22	CHEMBL3145	Homo sapiens	IC50	nM	2.22
274130	17656430	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCCC2)ccc2c1N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL3644665	=	IC50	nM	2.62	CHEMBL3145	Homo sapiens	IC50	nM	2.62
274131	17656431	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCCCC2)ccc2c1N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL3644671	=	IC50	nM	2.02	CHEMBL3145	Homo sapiens	IC50	nM	2.02
274132	17656432	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OCC(O)CN(C)C)ccc2c1N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL3644659	=	IC50	nM	5.47	CHEMBL3145	Homo sapiens	IC50	nM	5.47
274133	17656433	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN(C)C)ccc2c1N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL3639435	=	IC50	nM	1.6	CHEMBL3145	Homo sapiens	IC50	nM	1.6
274134	17656434	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN(C(C)C)C(C)C)ccc2c1N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL3644660	=	IC50	nM	4.74	CHEMBL3145	Homo sapiens	IC50	nM	4.74
274135	17656435	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCOCC2)ccc2c1N=C(NC(=O)c1cccnc1C)N1CCN=C21		CHEMBL3644672	=	IC50	nM	3.09	CHEMBL3145	Homo sapiens	IC50	nM	3.09
274136	17656436	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCC2)ccc2c1N=C(NC(=O)c1cccnc1C)N1CCN=C21		CHEMBL3644653	=	IC50	nM	3.94	CHEMBL3145	Homo sapiens	IC50	nM	3.94
274137	17656437	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2C[C@H](C)O[C@H](C)C2)ccc2c1N=C(NC(=O)c1cccnc1C)N1CCN=C21		CHEMBL3644654	=	IC50	nM	5.36	CHEMBL3145	Homo sapiens	IC50	nM	5.36
274138	17656438	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCCC2)ccc2c1N=C(NC(=O)c1cccnc1C)N1CCN=C21		CHEMBL3644666	=	IC50	nM	3.9	CHEMBL3145	Homo sapiens	IC50	nM	3.9
274139	17656439	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCCCC2)ccc2c1N=C(NC(=O)c1cccnc1C)N1CCN=C21		CHEMBL3644673	=	IC50	nM	2.78	CHEMBL3145	Homo sapiens	IC50	nM	2.78
274140	17656440	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN(C(C)C)C(C)C)ccc2c1N=C(NC(=O)c1cccnc1C)N1CCN=C21		CHEMBL3644661	=	IC50	nM	4.2	CHEMBL3145	Homo sapiens	IC50	nM	4.2
274141	17656441	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OCC(O)CN2CCOCC2)ccc2c1N=C(NC(=O)c1ccc(N)nc1)N1CCN=C21		CHEMBL3644647	=	IC50	nM	9.37	CHEMBL3145	Homo sapiens	IC50	nM	9.37
274142	17656442	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCOCC2)ccc2c1N=C(NC(=O)c1ccc(N)nc1C)N1CCN=C21		CHEMBL3644674	=	IC50	nM	7.3	CHEMBL3145	Homo sapiens	IC50	nM	7.3
274143	17656443	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCCC2)ccc2c1N=C(NC(=O)c1cncnc1)N1CCN=C21		CHEMBL3644667	=	IC50	nM	1.99	CHEMBL3145	Homo sapiens	IC50	nM	1.99
274144	17656444	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OCC(O)CN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3644675	=	IC50	nM	8.3	CHEMBL3145	Homo sapiens	IC50	nM	8.3
274145	17656445	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2C[C@H](C)O[C@H](C)C2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3644649	=	IC50	nM	5.52	CHEMBL3145	Homo sapiens	IC50	nM	5.52
274146	17656446	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CC3CCC(C2)O3)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3644655	=	IC50	nM	4.71	CHEMBL3145	Homo sapiens	IC50	nM	4.71
274147	17656447	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN(C)C)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3644662	=	IC50	nM	6.75	CHEMBL3145	Homo sapiens	IC50	nM	6.75
274148	17656448	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc3[nH]cnc3c1)N1CCN=C21		CHEMBL3644676	=	IC50	nM	8.83	CHEMBL3145	Homo sapiens	IC50	nM	8.83
274149	17656449	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCOCC2)ccc2c1N=C(NC(=O)c1cncs1)N1CCN=C21		CHEMBL3644677	=	IC50	nM	5.91	CHEMBL3145	Homo sapiens	IC50	nM	5.91
274150	17656450	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2C[C@H](C)O[C@H](C)C2)ccc2c1N=C(NC(=O)c1cncs1)N1CCN=C21		CHEMBL3644656	=	IC50	nM	7.21	CHEMBL3145	Homo sapiens	IC50	nM	7.21
274151	17656451	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCC2)ccc2c1N=C(NC(=O)c1cncs1)N1CCN=C21		CHEMBL3644657	=	IC50	nM	6.3	CHEMBL3145	Homo sapiens	IC50	nM	6.3
274152	17656452	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCCC2)ccc2c1N=C(NC(=O)c1cncs1)N1CCN=C21		CHEMBL3644668	=	IC50	nM	3.41	CHEMBL3145	Homo sapiens	IC50	nM	3.41
274153	17656453	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCCCC2)ccc2c1N=C(NC(=O)c1cncs1)N1CCN=C21		CHEMBL3644678	=	IC50	nM	2.98	CHEMBL3145	Homo sapiens	IC50	nM	2.98
274154	17656454	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCCC2)ccc2c1N=C(NC(=O)c1scnc1C)N1CCN=C21		CHEMBL3644669	=	IC50	nM	5.64	CHEMBL3145	Homo sapiens	IC50	nM	5.64
274155	17656455	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCOCC2)ccc2c1N=C(NC(=O)c1sc(N)nc1C)N1CCN=C21		CHEMBL3644679	=	IC50	nM	5.32	CHEMBL3145	Homo sapiens	IC50	nM	5.32
274156	17656456	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN2CCCC2)ccc2c1N=C(NC(=O)c1cnco1)N1CCN=C21		CHEMBL3644670	=	IC50	nM	3.09	CHEMBL3145	Homo sapiens	IC50	nM	3.09
274157	17656457	CHEMBL3705593	HTRF Assay: As reagents for the kinase reaction itself and the quantification of the reaction product, the PI3-Kinase HTRF Assay kit from Millipore (#33-017) was used. With this kit the phosphatidylinositol 3,4,5-trisphosphate (PIP3) generated in the kinase reaction is detected by displacement of a biotinylated ligand from an energy transfer complex consisting of a Europium-labeled anti-GST monoclonal antibody, a GST-tagged PH domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). As kinase a complex of N-terminal His6-tagged recombinant full-length human p110alpha and untagged, recombinant, full length, human p85alpha , coexpressed by baculovirus infected Sf21 insect cells and purified using Ni2+/NTA-agarose, was used (Millipore product #14-602).For the assay 50 nL of a 80-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 3 uL of a solution of PI3Kalpha .	B	COc1c(OC[C@H](O)CN(C(C)C)C(C)C)ccc2c1N=C(NC(=O)c1cncs1)N1CCN=C21		CHEMBL3644663	=	IC50	nM	5.83	CHEMBL3145	Homo sapiens	IC50	nM	5.83
334290	17712532	CHEMBL3887341	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	Cn1nc(C2CCN(C(=O)CCO)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1		CHEMBL3920043	=	IC50	nM	2240.0	CHEMBL3145	Homo sapiens	IC50	nM	2240.0
334291	17712533	CHEMBL3887341	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	CCn1nc(C2CCN(C(=O)CCO)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1		CHEMBL3894518	=	IC50	nM	570.0	CHEMBL3145	Homo sapiens	IC50	nM	570.0
334292	17712534	CHEMBL3887341	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	C[C@H](O)CC(=O)N1CCC(c2nc(-c3cnc(N)c(-c4nnc(C(C)(C)C)o4)n3)n(C)n2)CC1		CHEMBL3890694	=	IC50	nM	2910.0	CHEMBL3145	Homo sapiens	IC50	nM	2910.0
334293	17712535	CHEMBL3887341	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	C[C@H](O)CC(=O)N1CCC(c2nc(-c3cnc(N)c(-c4nnc(C(C)(C)C)o4)n3)n(C)n2)CC1		CHEMBL3890694	=	IC50	nM	3310.0	CHEMBL3145	Homo sapiens	IC50	nM	3310.0
334294	17712536	CHEMBL3887341	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	C[C@H](CO)C(=O)N1CCC(c2nc(-c3cnc(N)c(-c4nnc(C(C)(C)C)o4)n3)n(C)n2)CC1		CHEMBL4107650	=	IC50	nM	3420.0	CHEMBL3145	Homo sapiens	IC50	nM	3420.0
334295	17712537	CHEMBL3887341	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	Cn1nc(C2CCN(C(=O)C(C)(C)O)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1		CHEMBL3935719	=	IC50	nM	6260.0	CHEMBL3145	Homo sapiens	IC50	nM	6260.0
334296	17712538	CHEMBL3887341	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	Cn1nc(C2CCN(C(=O)CC(=O)O)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1		CHEMBL3926852	=	IC50	nM	1520.0	CHEMBL3145	Homo sapiens	IC50	nM	1520.0
334297	17712539	CHEMBL3887341	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	CCn1nc(C2CCN(C(=O)CC(=O)O)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1		CHEMBL3897192	=	IC50	nM	640.0	CHEMBL3145	Homo sapiens	IC50	nM	640.0
348890	17725267	CHEMBL3887695	PI3K Inhibition Assay: PI3K inhibition assay (PI3K Assay (Emmanuelle M, Huang Y, Yan H G et al. Targeting Protein Translation in Human Non-Small Cell Lung Cancer via Combined MEK and Mammalian Target of Rapamycin Suppression. Cancer Res 67:(23). (2007).) was carried out by PI3 Kinase activity/inhibitor assay kit, where PI3 kinase reaction was set up in Glutathione-coated strips/plate for inhibitor reaction. Kinase and inhibitors were pre-incubated for 10 minutes prior to the addition of PIP2 substrate. 5 uL of 5x kinase reaction buffer were added in each well followed by the further addition of 5 uL/well of PIP2 substrate. Then distilled H2O was added to each well so as to make up a final volume of 25 uL/well. Incubation was done at rt for 1 hour which was followed by washing the wells 3 times with 200 uL of 1xTBST per well and then 2 times with 200 uL of IX TBS per well. Then 100 uL of the Substrate TMB per well was added and then to keep for colour development in the dark.	B	CC1(C)CCCC2(C)c3c(oc4c(B(O)O)c(O)c(O)cc34)CCC12		CHEMBL3959396	=	IC50	nM	5700.0	CHEMBL3145	Homo sapiens	IC50	nM	5700.0
351127	17727296	CHEMBL3887745	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3K, PI3K, PI3K, and PI3K, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	O=c1c2c(F)cccc2nc([C@H](CC(F)(F)F)Nc2ncnc3[nH]cnc23)n1-c1ccccc1		CHEMBL3934646	=	IC50	nM	3900.0	CHEMBL3145	Homo sapiens	IC50	nM	3900.0
351128	17727297	CHEMBL3887745	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3K, PI3K, PI3K, and PI3K, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	CC[C@H](Nc1ncnc2[nH]ccc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL3927331	=	IC50	nM	650.0	CHEMBL3145	Homo sapiens	IC50	nM	650.0
351129	17727298	CHEMBL3887745	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3K, PI3K, PI3K, and PI3K, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1cccc(CC(F)(F)F)c1		CHEMBL3930489	=	IC50	nM	3100.0	CHEMBL3145	Homo sapiens	IC50	nM	3100.0
351130	17727299	CHEMBL3887745	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3K, PI3K, PI3K, and PI3K, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	CC[C@H](Nc1ncnc2[nH]ccc12)c1nc2cccc(F)c2c(=O)n1-c1cccc(CC(F)(F)F)c1		CHEMBL3896043	=	IC50	nM	5800.0	CHEMBL3145	Homo sapiens	IC50	nM	5800.0
351131	17727300	CHEMBL3887745	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3K, PI3K, PI3K, and PI3K, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	C[C@H](Nc1ncnc2[nH]ccc12)c1nc2cccc(F)c2c(=O)n1-c1ccc(OCC(F)(F)F)cc1		CHEMBL3965450	=	IC50	nM	7300.0	CHEMBL3145	Homo sapiens	IC50	nM	7300.0
351132	17727301	CHEMBL3887745	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3K, PI3K, PI3K, and PI3K, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	CC[C@H](Nc1ncnc2[nH]ccc12)c1nc2cccc(F)c2c(=O)n1-c1ccc(OCC(F)(F)F)cc1		CHEMBL3955875	=	IC50	nM	10500.0	CHEMBL3145	Homo sapiens	IC50	nM	10500.0
351133	17727302	CHEMBL3887745	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3K, PI3K, PI3K, and PI3K, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	C[C@H](Nc1ncnc2[nH]cc(F)c12)c1nc2cccc(F)c2c(=O)n1-c1cccc(OCC(F)(F)F)c1		CHEMBL3921325	=	IC50	nM	3400.0	CHEMBL3145	Homo sapiens	IC50	nM	3400.0
351134	17727303	CHEMBL3887745	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3K, PI3K, PI3K, and PI3K, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	C[C@H](Nc1ncnc2[nH]ccc12)c1nc2cccc(F)c2c(=O)n1-c1cccc(OCC(F)(F)C(F)(F)F)c1		CHEMBL3896805	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
351135	17727304	CHEMBL3887745	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3K, PI3K, PI3K, and PI3K, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	C[C@H](Nc1ncnc2[nH]ccc12)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(OCC(F)(F)F)c1		CHEMBL3946161	=	IC50	nM	1100.0	CHEMBL3145	Homo sapiens	IC50	nM	1100.0
351136	17727305	CHEMBL3887745	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3K, PI3K, PI3K, and PI3K, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	O=c1c2c(F)cccc2nc(CNc2ncnc3[nH]ccc23)n1-c1cccc(OCC(F)(F)F)c1		CHEMBL3903447	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
351599	17727768	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1ccc(N)nc1		CHEMBL3921336	=	IC50	nM	180.0	CHEMBL3145	Homo sapiens	IC50	nM	180.0
351600	17727769	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1ccc(N)nc1		CHEMBL3957788	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
351601	17727770	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3926774	=	IC50	nM	42.0	CHEMBL3145	Homo sapiens	IC50	nM	42.0
351602	17727771	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3899696	=	IC50	nM	1.0	CHEMBL3145	Homo sapiens	IC50	nM	1.0
351603	17727772	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2cccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3970845	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	nM	9.0
351604	17727773	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	CC[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2cccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3933314	=	IC50	nM	35.0	CHEMBL3145	Homo sapiens	IC50	nM	35.0
351605	17727774	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3957355	=	IC50	nM	0.8	CHEMBL3145	Homo sapiens	IC50	nM	0.8
351606	17727775	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3920883	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
351607	17727776	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	Nc1ccc(-n2c([C@@H](Nc3nc(N)nc(N)c3Cl)C3CC3)nc3cccc(Cl)c3c2=O)cn1		CHEMBL3948693	=	IC50	nM	27.0	CHEMBL3145	Homo sapiens	IC50	nM	27.0
351608	17727777	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2cccc(Cl)c2c(=O)n1-c1ccc(N)nc1)C1CC1		CHEMBL3911944	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	nM	2.0
351609	17727778	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cnc(N)cc1C		CHEMBL3943356	=	IC50	nM	99.0	CHEMBL3145	Homo sapiens	IC50	nM	99.0
351610	17727779	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cnc(N)cc1C		CHEMBL3943356	=	IC50	nM	1.0	CHEMBL3145	Homo sapiens	IC50	nM	1.0
351611	17727780	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	Cc1cc(N)ncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL3934385	=	IC50	nM	30.0	CHEMBL3145	Homo sapiens	IC50	nM	30.0
351612	17727781	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	Cc1cc(N)ncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL3934385	=	IC50	nM	1.0	CHEMBL3145	Homo sapiens	IC50	nM	1.0
351613	17727782	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	Cc1cc(N)ncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2c(Cl)ccc(Cl)c2c1=O		CHEMBL3921986	=	IC50	nM	28.0	CHEMBL3145	Homo sapiens	IC50	nM	28.0
351614	17727783	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	Cc1cc(N)ncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2c(Cl)ccc(Cl)c2c1=O		CHEMBL3921986	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
351615	17727784	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3962159	=	IC50	nM	0.7	CHEMBL3145	Homo sapiens	IC50	nM	0.7
351616	17727785	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	Cc1cc(N)ncc1-n1c([C@@H](Nc2nc(N)nc(N)c2C#N)C2CC2)nc2c(Cl)ccc(Cl)c2c1=O		CHEMBL3924661	=	IC50	nM	160.0	CHEMBL3145	Homo sapiens	IC50	nM	160.0
351617	17727786	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	Cc1cc(N)ncc1-n1c([C@@H](Nc2nc(N)nc(N)c2C#N)C2CC2)nc2c(Cl)ccc(Cl)c2c1=O		CHEMBL3924661	=	IC50	nM	3600.0	CHEMBL3145	Homo sapiens	IC50	nM	3600.0
351618	17727787	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2ccc(F)c(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3905431	=	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
351619	17727788	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2ccc(F)c(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3970492	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
351620	17727789	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	CCC[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2cccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3938252	=	IC50	nM	62.0	CHEMBL3145	Homo sapiens	IC50	nM	62.0
351621	17727790	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	CCC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3956754	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
351622	17727791	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	CCC[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2ccc(F)c(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3969816	=	IC50	nM	530.0	CHEMBL3145	Homo sapiens	IC50	nM	530.0
351623	17727792	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	CCC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2ccc(F)c(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3898636	=	IC50	nM	41.0	CHEMBL3145	Homo sapiens	IC50	nM	41.0
351624	17727793	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	Nc1ccc(-n2c([C@@H](Nc3nc(N)nc(N)c3Cl)C3CC3)nc3c(F)ccc(Cl)c3c2=O)cn1		CHEMBL3940119	=	IC50	nM	180.0	CHEMBL3145	Homo sapiens	IC50	nM	180.0
351625	17727794	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1ccc(N)nc1)C1CC1		CHEMBL3908617	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
351626	17727795	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(N)c1		CHEMBL3931089	=	IC50	nM	33.0	CHEMBL3145	Homo sapiens	IC50	nM	33.0
351627	17727796	CHEMBL3887755	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2 Km ATP (75-500 M), 2 M PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3K, PI3K, and PI3K between 25 and 50 pM, and PI3K at 2 nM. After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 s read window).	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(N)c1		CHEMBL3903107	=	IC50	nM	460.0	CHEMBL3145	Homo sapiens	IC50	nM	460.0
356698	17732361	CHEMBL3887828	Enzyme Inhibition Assay: The PI3K enzymes catalyse the phosphorylation of phosphatidylinositol 4,5-biphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate (PIP3) in the presence of ATP and Mg2+ ions. The PIP3 product can be detected by displacement of biotin-PIP3 from energy transfer complexes consisting of europium labelled anti-GST monoclonal antibody, a GST-tagged Pleckstrin homology (PH) domain, biotinylated PIP3 and streptavidin-allophycocyanin (APC) by the time-resolved fluorescence resonance energy transfer (TR-FRET) (HTRF PI3K enzyme assay, Millipore). Excitation, at 330 nm, of europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm although europium itself emits at its characteristic wavelength of 620 nm. The PIP3 product formed by PI3K activity displaces biotin-PIP3 from the complex and results in a loss of energy transfer (decreasing signal).The compound to be tested was added, at the desired final concentrations, to a mixture of PIP2 substrate.	B	COCCOCCOCC#Cc1cccc2nc(Cn3nc(-c4cc(O)cc(F)c4)c4c(N)ncnc43)n(Cc3ccccc3C(F)(F)F)c(=O)c12		CHEMBL3934989	=	IC50	nM	4890.0	CHEMBL3145	Homo sapiens	IC50	nM	4890.0
356708	17732371	CHEMBL3887834	Cell Based Assay: As a means of assessing PI3K alpha or beta; activation in response to stimuli, the phosphorylation status of the protein, Akt, a downstream product of PI3K alpha or beta, signaling was determined.	B	Nc1ncnc2c1c(-c1cc(O)cc(F)c1)nn2Cc1nc2cccc(C#CCOCCOCCO)c2c(=O)n1Cc1ccccc1C(F)(F)F		CHEMBL3963503	>	IC50	nM	14200.0	CHEMBL3145	Homo sapiens	IC50	nM	14200.0
368978	17743844	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(F)ccc(F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3922388	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
368979	17743845	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(F)cccc2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3890805	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
368980	17743846	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COC(=O)c1ccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)nc1		CHEMBL3906822	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
368981	17743847	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(F)ccc(F)c2c(=O)n1-c1ccccc1		CHEMBL3950633	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
368982	17743848	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(Cl)cccc2c(=O)n1-c1ccccc1		CHEMBL3928621	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
368983	17743849	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3956195	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
368984	17743850	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3919714	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
368985	17743851	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL3950928	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
368986	17743852	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3914201	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
368987	17743853	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1ccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3c(Cl)ccc(Cl)c3c(=O)n2-c2ccccc2)nc1		CHEMBL3963325	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
368988	17743854	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3964862	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
368989	17743855	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1ccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3c(F)cccc3c(=O)n2-c2ccccc2)nc1		CHEMBL3929687	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
368990	17743856	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(F)cccc2c(=O)n1-c1ccccc1		CHEMBL3967711	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
368991	17743857	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccnn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3806228	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
368992	17743858	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccc(N)n1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3976222	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
368993	17743859	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3804882	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
368994	17743860	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnc(N)cc1C(F)(F)F)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3951402	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
368995	17743861	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnc(N)cc1C(F)(F)F)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3923690	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
368996	17743862	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(O)C#Cc1c(N)ncnc1N[C@@H](C)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3960130	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
368997	17743863	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(O)C#Cc1c(N)ncnc1N[C@H](C)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL4106652	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
368998	17743864	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(O)C#Cc1c(N)ncnc1N[C@@H](C)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3908201	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
368999	17743865	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(O)C#Cc1c(N)ncnc1N[C@H](C)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL4111669	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369000	17743866	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#CC1CC1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3902091	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369001	17743867	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#CC1CC1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3973117	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369002	17743868	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#Cc1ccccc1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3935531	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369003	17743869	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(OC(F)(F)F)cc1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3907586	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369004	17743870	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(OC(F)(F)F)cc1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3944491	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369005	17743871	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#CC(C)(C)O)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3913035	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369006	17743872	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#CC(C)(C)O)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3949799	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369007	17743873	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3ccccn3)n(-c3ccccc3)c(=O)c12		CHEMBL3922036	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369008	17743874	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccc(N)n1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3930845	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369009	17743875	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnc(N)nc1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3906328	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369010	17743876	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnc(N)nc1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3943275	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369011	17743877	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(N)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3915305	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369012	17743878	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(N)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3943827	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369013	17743879	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Nc1ncnc(N2CCCC[C@H]2c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1C#Cc1ccccn1		CHEMBL3976500	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369014	17743880	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Nc1ncnc(N2CCC[C@H]2c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1C#Cc1ccccn1		CHEMBL3938430	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369015	17743881	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(C(N)=O)c1		CHEMBL3967978	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369016	17743882	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CCNS(=O)(=O)c1cccc(-n2c([C@H](C)Nc3ncnc(N)c3C#Cc3ccccn3)nc3cccc(Cl)c3c2=O)c1		CHEMBL3986194	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369017	17743883	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(S(N)(=O)=O)c1		CHEMBL3961122	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369018	17743884	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cncnc1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3952571	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369019	17743885	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cncnc1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3981331	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369020	17743886	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccnc1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3951359	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369021	17743887	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccnc1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3805337	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369022	17743888	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3970591	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369023	17743889	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc2nc(N)sc2c1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3937519	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369024	17743890	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cc(F)cc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1		CHEMBL3959531	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369025	17743891	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3805019	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369026	17743892	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cn[nH]c1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3806195	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369027	17743893	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3958476	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369028	17743894	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccc1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3805061	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369029	17743895	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(O)c2c(=O)n1-c1ccccc1		CHEMBL3946382	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369030	17743896	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(Cl)c2c(=O)n(-c3ccccc3)c([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)nc12		CHEMBL3960691	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369031	17743897	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)n(-c3ccccc3)c(=O)c12		CHEMBL3935980	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369032	17743898	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(C#N)c2c(=O)n1-c1ccccc1		CHEMBL3907068	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369033	17743899	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2c(=O)n(-c3ccccc3)c([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)nc12		CHEMBL3947550	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369034	17743900	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CCCCc1cccc(-n2c([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)nc3cccc(Cl)c3c2=O)c1		CHEMBL3891379	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369035	17743901	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(S(C)(=O)=O)c1		CHEMBL3915903	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369036	17743902	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(C(C)(C)C)c1		CHEMBL3892650	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369037	17743903	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(-c2ccccc2)c1		CHEMBL3920650	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369038	17743904	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CCc1cccc(-n2c([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)nc3cccc(Cl)c3c2=O)c1		CHEMBL3898042	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369039	17743905	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(F)c2nc([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)n(-c3ccccc3)c(=O)c12		CHEMBL3935121	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369040	17743906	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cc(F)cc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3c(F)ccc(F)c3c(=O)n2-c2ccccc2)c1		CHEMBL3914780	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369041	17743907	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cc(F)cc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3c(F)cccc3c(=O)n2-c2ccccc2)c1		CHEMBL3942778	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369042	17743908	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cc(F)cc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(F)c3c(=O)n2-c2ccccc2)c1		CHEMBL3901264	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369043	17743909	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(C(F)F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3959485	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369044	17743910	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(C(F)F)c2c(=O)n1-c1ccccc1		CHEMBL3910328	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369045	17743911	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(C(F)(F)F)c2c(=O)n1-c1ccccc1		CHEMBL3983551	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369046	17743912	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(F)c2c(=O)n(-c3ccccc3)c([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)nc12		CHEMBL3984593	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369047	17743913	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(C(F)F)c2c(=O)n1-c1cccc(C#N)c1		CHEMBL3900762	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369048	17743914	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(C(F)F)c2c(=O)n1-c1cccc(C#N)c1		CHEMBL3895810	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369049	17743915	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(F)c2nc([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)n(-c3cccc(C#N)c3)c(=O)c12		CHEMBL3961281	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369050	17743916	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(F)c2nc([C@H](C)Nc3ncnc(N)c3C#Cc3cnccn3)n(-c3cccc(C#N)c3)c(=O)c12		CHEMBL3893512	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369051	17743917	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(C(F)F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3962518	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369052	17743918	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(F)c2nc([C@H](C)Nc3ncnc(N)c3C#Cc3cnccn3)n(-c3ccccc3)c(=O)c12		CHEMBL3943986	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369053	17743919	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(C(F)F)c2c(=O)n1-c1ccccc1		CHEMBL3970101	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369054	17743920	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(C(F)F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3931513	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369055	17743921	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3959013	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369056	17743922	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncccc1F)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3922602	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369057	17743923	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cccnc1C#Cc1c(N)ncnc1N[C@@H](C)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3964884	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369058	17743924	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cccc(-n2c([C@H](C)Nc3ncnc(N)c3C#Cc3ncccc3F)nc3cccc(Cl)c3c2=O)c1C		CHEMBL3917126	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369059	17743925	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cccc(-n2c([C@H](C)Nc3ncnc(N)c3C#Cc3ncccc3F)nc3cccc(Cl)c3c2=O)c1C		CHEMBL3917126	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369060	17743926	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncc(F)cc1F)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3945040	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369061	17743927	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3908150	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369062	17743928	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3932612	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369063	17743929	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3972643	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369064	17743930	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL3946520	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369065	17743931	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3961581	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369066	17743932	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(Cl)c1		CHEMBL3934086	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369067	17743933	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2ccc(F)cc2c(=O)n1-c1ccccc1		CHEMBL3902512	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369068	17743934	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2ccc(F)cc2c(=O)n1-c1ccccc1		CHEMBL3925201	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369069	17743935	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(C#N)c1		CHEMBL3946133	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369070	17743936	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(C#N)c1		CHEMBL3919742	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369071	17743937	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2ccc(F)cc2c(=O)n1-c1cccc(C#N)c1		CHEMBL3979594	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369072	17743938	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2ccc(F)cc2c(=O)n1-c1cccc(C#N)c1		CHEMBL3954063	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369073	17743939	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2ccc(F)cc2c(=O)n1-c1cccc(Cl)c1		CHEMBL3919058	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369074	17743940	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2ccc(F)cc2c(=O)n1-c1cccc(Cl)c1		CHEMBL3946867	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369075	17743941	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3cnccn3)n(-c3ccccc3)c(=O)c12		CHEMBL3924491	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369076	17743942	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(F)c2c(=O)n1-c1cccc(F)c1		CHEMBL3955573	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369077	17743943	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2c(F)cccc2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3957723	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369078	17743944	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(F)c2c(=O)n1-c1cccc(F)c1		CHEMBL3960871	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369079	17743945	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3945844	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369080	17743946	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3985129	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369081	17743947	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3ncccn3)n(-c3ccccc3)c(=O)c12		CHEMBL3954547	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369082	17743948	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3ncccn3)n(-c3cc(F)cc(F)c3)c(=O)c12		CHEMBL3983189	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369083	17743949	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3cnccn3)n(-c3cccc(F)c3)c(=O)c12		CHEMBL3937838	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369084	17743950	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3909896	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369085	17743951	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(C)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3969032	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369086	17743952	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncccn1)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL3915257	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369087	17743953	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccc1)c1nc2cccc(F)c2c(=O)n1-c1cccc(C#N)c1		CHEMBL3924120	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369088	17743954	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccc1)c1nc2cccc(F)c2c(=O)n1-c1cccc(F)c1		CHEMBL3896111	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369089	17743955	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccc1)c1nc2cccc(S(C)(=O)=O)c2c(=O)n1-c1ccccc1		CHEMBL3955690	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369090	17743956	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(S(C)(=O)=O)c2c(=O)n1-c1ccccc1		CHEMBL3908658	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369091	17743957	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccc1)c1nc2cccc(C#N)c2c(=O)n1-c1ccccc1		CHEMBL3963832	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369092	17743958	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(F)c2c(=O)n1-c1cccnc1		CHEMBL3972988	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369093	17743959	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccc1)c1nc2cccc(F)c2c(=O)n1-c1cccnc1		CHEMBL3905764	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369094	17743960	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3909257	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369095	17743961	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3900390	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369096	17743962	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3cnccn3)n(-c3cccnc3)c(=O)c12		CHEMBL3944692	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369097	17743963	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3cnccn3)n(-c3cncc(F)c3)c(=O)c12		CHEMBL3899091	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369098	17743964	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1N1CCOCC1		CHEMBL3923649	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369099	17743965	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cc(F)cc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2N2CCOCC2)c1		CHEMBL3984444	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369100	17743966	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(CNS(C)(=O)=O)c1		CHEMBL3914621	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369101	17743967	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1C1C[C@@H]2CC[C@H](C1)N2C		CHEMBL3901439	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369102	17743968	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1C1C[C@@H]2CC[C@H](C1)N2C		CHEMBL3901439	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369103	17743969	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1N1CCCCCC1		CHEMBL3908091	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369104	17743970	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1N1CCNCC1		CHEMBL3936046	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369105	17743971	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)n(-c3cccc(CN(C)S(C)(=O)=O)c3)c(=O)c12		CHEMBL3936315	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369106	17743972	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@@H](c1nc2cccc(Cl)c2c(=O)n1-c1cccc(CN(C)S(C)(=O)=O)c1)N(C)c1ncnc(N)c1C#Cc1ccc(F)cn1		CHEMBL3916948	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369107	17743973	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(CNS(C)(=O)=O)c1		CHEMBL3894395	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369108	17743974	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(C)CS(=O)(=O)NCc1cccc(-n2c([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)nc3cccc(Cl)c3c2=O)c1		CHEMBL3922409	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369109	17743975	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(C(F)(F)F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3906875	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369110	17743976	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)nc1		CHEMBL3931327	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369111	17743977	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(C(F)(F)F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3971322	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369112	17743978	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(C(N)=O)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3953484	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369113	17743979	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(C(N)=O)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3940834	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369114	17743980	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(C)OC(=O)c1ccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)nc1		CHEMBL3952804	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369115	17743981	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(C(=O)O)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3948382	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369116	17743982	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Nc1ncnc(N[C@H](CO)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1C#Cc1ccc(F)cn1		CHEMBL4111963	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369117	17743983	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1nc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)ccc1F		CHEMBL3926413	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369118	17743984	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)n1		CHEMBL3923008	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369119	17743985	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncccc1C(F)(F)F)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3945447	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369120	17743986	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccnc1C#Cc1c(N)ncnc1N[C@@H](C)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3917559	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369121	17743987	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#CC1CCCC1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3965130	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369122	17743988	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#CC1CCCCC1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3908612	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369123	17743989	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COC[C@@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL4109343	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369124	17743990	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccnc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1		CHEMBL3911495	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369125	17743991	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cc(C(F)(F)F)ccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3973482	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369126	17743992	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cc(C(F)F)ccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3902489	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369127	17743993	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CCc1ccnc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1		CHEMBL3962520	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369128	17743994	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccc(C(F)(F)F)n1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3896991	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369129	17743995	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(=O)c1cccnc1C#Cc1c(N)ncnc1N[C@@H](C)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3908064	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369130	17743996	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(=O)c1cccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)n1		CHEMBL3985786	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369131	17743997	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cc(CO)ccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3894743	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369132	17743998	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccc(CO)n1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3919255	>	IC50	nM	1.0	CHEMBL3145	Homo sapiens	IC50	nM	1.0
369133	17743999	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cc(C(N)=O)ccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3907367	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369134	17744000	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(O)c1cccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)n1		CHEMBL3977922	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369135	17744001	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COC(=O)c1ccnc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1		CHEMBL3916345	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369136	17744002	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccc(CN)n1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3891821	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369137	17744003	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cc(C(=O)O)ccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3892931	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369138	17744004	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(=O)c1cccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1		CHEMBL3961942	<	IC50	nM	100.0	CHEMBL3145	Homo sapiens	IC50	nM	100.0
369139	17744005	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccc(CO)c1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3901914	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	nM	550.0
369140	17744006	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncccc1CO)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3969543	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
369141	17744007	CHEMBL3888035	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25 C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2cc(F)cc(F)c2)nc1		CHEMBL3915079	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
445460	17805168	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3929977	=	IC50	nM	54.0	CHEMBL3145	Homo sapiens	IC50	nM	54.0
445461	17805169	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3915208	=	IC50	nM	4.4	CHEMBL3145	Homo sapiens	IC50	nM	4.4
445462	17805170	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3919381	=	IC50	nM	74.0	CHEMBL3145	Homo sapiens	IC50	nM	74.0
445463	17805171	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1ncnc2[nH]nnc12)c1nc2c(F)cccc2c(=O)n1-c1cnc(N)cn1		CHEMBL3922845	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
445464	17805172	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1ncnc2occc12)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3943639	=	IC50	nM	5800.0	CHEMBL3145	Homo sapiens	IC50	nM	5800.0
445465	17805173	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3913858	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	nM	2.0
445466	17805174	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2cccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3983697	=	IC50	nM	47.0	CHEMBL3145	Homo sapiens	IC50	nM	47.0
445467	17805175	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	Nc1cnc(-n2c([C@@H](Nc3nc(N)nc(N)c3Cl)C3CC3)nc3cccc(Cl)c3c2=O)cn1		CHEMBL3937257	=	IC50	nM	190.0	CHEMBL3145	Homo sapiens	IC50	nM	190.0
445468	17805176	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2cccc(Cl)c2c(=O)n1-c1cnc(N)cn1)C1CC1		CHEMBL3912814	=	IC50	nM	4.2	CHEMBL3145	Homo sapiens	IC50	nM	4.2
445469	17805177	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1cnc(N)cn1)C1CC1		CHEMBL3928265	=	IC50	nM	3.6	CHEMBL3145	Homo sapiens	IC50	nM	3.6
445470	17805178	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3954098	=	IC50	nM	1.8	CHEMBL3145	Homo sapiens	IC50	nM	1.8
445471	17805179	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	Nc1cnc(-n2c([C@@H](Nc3nc(N)nc(N)c3Cl)C3CC3)nc3c(Cl)ccc(Cl)c3c2=O)cn1		CHEMBL3945462	=	IC50	nM	1200.0	CHEMBL3145	Homo sapiens	IC50	nM	1200.0
445472	17805180	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3981609	=	IC50	nM	170.0	CHEMBL3145	Homo sapiens	IC50	nM	170.0
445473	17805181	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(F)cc(F)cc2c(=O)n1-c1cnc(N)cn1		CHEMBL3963307	=	IC50	nM	200.0	CHEMBL3145	Homo sapiens	IC50	nM	200.0
445474	17805182	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)cc(F)cc2c(=O)n1-c1cnc(N)cn1		CHEMBL3906405	=	IC50	nM	9.8	CHEMBL3145	Homo sapiens	IC50	nM	9.8
445475	17805183	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cnc(N)cn1		CHEMBL3968564	=	IC50	nM	530.0	CHEMBL3145	Homo sapiens	IC50	nM	530.0
445476	17805184	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cnc(N)cn1		CHEMBL3937355	=	IC50	nM	14.0	CHEMBL3145	Homo sapiens	IC50	nM	14.0
445477	17805185	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1ncnc(N)c1Cl)c1nc2cccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3957550	=	IC50	nM	570.0	CHEMBL3145	Homo sapiens	IC50	nM	570.0
445478	17805186	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	Nc1cnc(-n2c([C@@H](Nc3ncnc(N)c3Cl)C3CC3)nc3c(Cl)ccc(Cl)c3c2=O)cn1		CHEMBL3937861	=	IC50	nM	360.0	CHEMBL3145	Homo sapiens	IC50	nM	360.0
445479	17805187	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	Nc1cnc(-n2c([C@@H](Nc3ncnc(N)c3Cl)C3CC3)nc3cccc(Cl)c3c2=O)cn1		CHEMBL3905253	=	IC50	nM	1100.0	CHEMBL3145	Homo sapiens	IC50	nM	1100.0
445480	17805188	CHEMBL3889293	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3K, PI3K, and PI3K between 25 and 50 uM, and PI3K at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25 C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K , ,  and  were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(C(F)F)c1C#N)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cnc(N)cn1		CHEMBL3981093	=	IC50	nM	720.0	CHEMBL3145	Homo sapiens	IC50	nM	720.0
	17973984	CHEMBL3996853	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate incubated for 30 mins by ADP-Glo assay	B	CC(=O)N1C[C@H](C)N(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)[C@H](C)C1		CHEMBL4061855	=	IC50	nM	795.0	CHEMBL3145	Homo sapiens	IC50	nM	795.0
	18018605	CHEMBL4005478	Inhibition of PI3K p110beta in PTEN-deficient human PC3 cells assessed as decrease in AKT phosphorylation at ser473 after 2 hrs by TR-FRET assay	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2cccc(Cl)c2c(=O)n1-c1cc[nH]n1		CHEMBL4074361	=	EC50	nM	4.2	CHEMBL3145	Homo sapiens	EC50	nM	4.2
	18018606	CHEMBL4005478	Inhibition of PI3K p110beta in PTEN-deficient human PC3 cells assessed as decrease in AKT phosphorylation at ser473 after 2 hrs by TR-FRET assay	B	Nc1nc(N)c(Cl)c(N[C@H](c2nc3cccc(Cl)c3c(=O)n2-c2cc[nH]n2)C2CC2)n1		CHEMBL4101102	=	EC50	nM	7.6	CHEMBL3145	Homo sapiens	EC50	nM	7.6
	18018607	CHEMBL4005478	Inhibition of PI3K p110beta in PTEN-deficient human PC3 cells assessed as decrease in AKT phosphorylation at ser473 after 2 hrs by TR-FRET assay	B	N#Cc1c(N[C@H](c2nc3cccc(Cl)c3c(=O)n2-c2cc[nH]n2)C2CC2)nc(N)nc1C(F)F		CHEMBL4079545	=	EC50	nM	45.0	CHEMBL3145	Homo sapiens	EC50	nM	45.0
	18018608	CHEMBL4005478	Inhibition of PI3K p110beta in PTEN-deficient human PC3 cells assessed as decrease in AKT phosphorylation at ser473 after 2 hrs by TR-FRET assay	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cc[nH]n1		CHEMBL4082978	=	EC50	nM	20.0	CHEMBL3145	Homo sapiens	EC50	nM	20.0
	18018609	CHEMBL4005478	Inhibition of PI3K p110beta in PTEN-deficient human PC3 cells assessed as decrease in AKT phosphorylation at ser473 after 2 hrs by TR-FRET assay	B	C[C@H](Nc1nc(N)nc(C(F)F)c1C#N)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cc[nH]n1		CHEMBL4085918	=	EC50	nM	15.0	CHEMBL3145	Homo sapiens	EC50	nM	15.0
	18018610	CHEMBL4005478	Inhibition of PI3K p110beta in PTEN-deficient human PC3 cells assessed as decrease in AKT phosphorylation at ser473 after 2 hrs by TR-FRET assay	B	N#Cc1c(N[C@H](c2nc3c(Cl)cc(F)cc3c(=O)n2-c2cc[nH]n2)C2CC2)nc(N)nc1C(F)F		CHEMBL4102306	=	EC50	nM	42.0	CHEMBL3145	Homo sapiens	EC50	nM	42.0
	18018611	CHEMBL4005478	Inhibition of PI3K p110beta in PTEN-deficient human PC3 cells assessed as decrease in AKT phosphorylation at ser473 after 2 hrs by TR-FRET assay	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cc[nH]n1)C1CC1		CHEMBL4081433	=	EC50	nM	3.7	CHEMBL3145	Homo sapiens	EC50	nM	3.7
	18018656	CHEMBL4005479	Inhibition of PI3Kbeta in PTEN-deficient human PC3 cells assessed as decrease in AKT1 phosphorylation at Ser473 after 2 hrs	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cc[nH]n1		CHEMBL4082978	=	EC50	nM	5.4	CHEMBL3145	Homo sapiens	EC50	nM	5.4
	18018657	CHEMBL4005480	Inhibition of PI3Kbeta in PTEN-deficient human LNCaP cells assessed as decrease in AKT1 phosphorylation at Ser473 after 2 hrs	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cc[nH]n1		CHEMBL4082978	=	EC50	nM	7.3	CHEMBL3145	Homo sapiens	EC50	nM	7.3
	18018658	CHEMBL4005481	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-415 cells assessed as decrease in AKT1 phosphorylation at Ser473 after 2 hrs	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cc[nH]n1		CHEMBL4082978	=	EC50	nM	5.7	CHEMBL3145	Homo sapiens	EC50	nM	5.7
	18018659	CHEMBL4005482	Inhibition of PI3Kbeta in PTEN-deficient human ZR-75-1 cells assessed as decrease in AKT1 phosphorylation at Ser473 after 2 hrs	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cc[nH]n1		CHEMBL4082978	=	EC50	nM	3.4	CHEMBL3145	Homo sapiens	EC50	nM	3.4
	18069781	CHEMBL4015043	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrs	B	O=C(c1cc([C@H]2CCCN2c2cccc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1)N1CCOCC1		CHEMBL4090811	=	IC50	nM	2.8	CHEMBL3145	Homo sapiens	IC50	uM	0.0028
	18069782	CHEMBL4015043	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrs	B	O=C(c1cc(C2CCCN2c2ccc(F)cc2)c2oc(N3CCOCC3)cc(=O)c2c1)N1CCOCC1		CHEMBL4062879	=	IC50	nM	4.5	CHEMBL3145	Homo sapiens	IC50	uM	0.0045
	18069783	CHEMBL4015043	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrs	B	O=C(c1cc(C2CCCN2c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1)N1CCC(O)CC1		CHEMBL4083021	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	uM	0.003
	18069784	CHEMBL4015043	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrs	B	O=C(c1cc([C@H]2CCCN2c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1)N1CC1		CHEMBL4101005	=	IC50	nM	1.4	CHEMBL3145	Homo sapiens	IC50	uM	0.0014
	18069785	CHEMBL4015043	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrs	B	CN1CCN(C(=O)c2cc([C@H]3CCCN3c3cc(F)cc(F)c3)c3oc(N4CCOCC4)cc(=O)c3c2)CC1		CHEMBL4082650	=	IC50	nM	2.3	CHEMBL3145	Homo sapiens	IC50	uM	0.0023
	18069786	CHEMBL4015043	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrs	B	O=C(c1cc([C@H]2CCCN2c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1)N1CCOCC1		CHEMBL4060768	=	IC50	nM	1.1	CHEMBL3145	Homo sapiens	IC50	uM	0.0011
	18069787	CHEMBL4015043	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrs	B	CN(CCO)C(=O)c1cc(C2CCCN2c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL4067312	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	uM	0.002
	18069788	CHEMBL4015043	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrs	B	CN(C)C(=O)c1cc(C2CCCN2c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL4094771	=	IC50	nM	1.2	CHEMBL3145	Homo sapiens	IC50	uM	0.0012
	18069789	CHEMBL4015043	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrs	B	CN(C)C(=O)c1cc([C@H]2CCCN2c2cccc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL4078233	=	IC50	nM	1.2	CHEMBL3145	Homo sapiens	IC50	uM	0.0012
	18069790	CHEMBL4015043	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrs	B	CN(C)C(=O)c1cc([C@H]2CCCN2c2ccc(F)cc2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL4102511	=	IC50	nM	3.4	CHEMBL3145	Homo sapiens	IC50	uM	0.0034
	18069791	CHEMBL4015043	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as decrease in AKT phosphorylation at Ser473 measured after 2 hrs	B	CN(C)C(=O)c1cc(C2CCCN2c2ccccc2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL4086125	=	IC50	nM	3.2	CHEMBL3145	Homo sapiens	IC50	uM	0.0032
	18069811	CHEMBL4015049	Inhibition of recombinant human PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in presence of ATP by Kinase Glo luminescence assay	B	CN(C)C(=O)c1cc([C@H]2CCCN2c2ccc(F)cc2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL4102511	=	IC50	nM	6.7	CHEMBL3145	Homo sapiens	IC50	uM	0.0067
	18069812	CHEMBL4015049	Inhibition of recombinant human PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in presence of ATP by Kinase Glo luminescence assay	B	O=C(c1cc([C@H]2CCCN2c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1)N1CCOCC1		CHEMBL4060768	=	IC50	nM	7.1	CHEMBL3145	Homo sapiens	IC50	uM	0.0071
	18069813	CHEMBL4015049	Inhibition of recombinant human PI3Kbeta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in presence of ATP by Kinase Glo luminescence assay	B	O=C(c1cc([C@H]2CCCN2c2cccc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1)N1CCOCC1		CHEMBL4090811	=	IC50	nM	6.1	CHEMBL3145	Homo sapiens	IC50	uM	0.0061
	18077894	CHEMBL4016572	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate after 30 mins by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4068514	=	IC50	nM	1200.0	CHEMBL3145	Homo sapiens	IC50	nM	1200.0
	18077895	CHEMBL4016572	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate after 30 mins by ADP-Glo assay	B	CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4064666	>	IC50	nM	5000.0	CHEMBL3145	Homo sapiens	IC50	nM	5000.0
	18077980	CHEMBL4016648	Inhibition of PI3Kbeta (unknown origin)	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	380.0	CHEMBL3145	Homo sapiens	IC50	nM	380.0
	18077981	CHEMBL4016648	Inhibition of PI3Kbeta (unknown origin)	B	C[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3805348	=	IC50	nM	77.0	CHEMBL3145	Homo sapiens	IC50	nM	77.0
	18088159	CHEMBL4019290	Inhibition of PI3Kbeta (unknown origin)	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	=	IC50	nM	607.0	CHEMBL3145	Homo sapiens	IC50	nM	607.0
	18088160	CHEMBL4019290	Inhibition of PI3Kbeta (unknown origin)	B	Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL4084907	=	IC50	nM	661.0	CHEMBL3145	Homo sapiens	IC50	nM	661.0
	18088190	CHEMBL4019280	Binding affinity to human PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system by Kinomescan assay	B	Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL4084907	=	Kd	nM	11.0	CHEMBL3145	Homo sapiens	Kd	nM	11.0
	18088191	CHEMBL4019280	Binding affinity to human PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system by Kinomescan assay	B	Nc1ncc(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)c(C(F)(F)F)n1		CHEMBL4102855	=	Kd	nM	3.5	CHEMBL3145	Homo sapiens	Kd	nM	3.5
	18088192	CHEMBL4019280	Binding affinity to human PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system by Kinomescan assay	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	=	Kd	nM	3.5	CHEMBL3145	Homo sapiens	Kd	nM	3.5
	18088193	CHEMBL4019280	Binding affinity to human PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system by Kinomescan assay	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	=	Kd	nM	36.0	CHEMBL3145	Homo sapiens	Kd	nM	36.0
	18088194	CHEMBL4019280	Binding affinity to human PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system by Kinomescan assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	Kd	nM	2.1	CHEMBL3145	Homo sapiens	Kd	nM	2.1
	18088195	CHEMBL4019280	Binding affinity to human PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system by Kinomescan assay	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	=	Kd	nM	3.8	CHEMBL3145	Homo sapiens	Kd	nM	3.8
	18114036	CHEMBL4024909	Inhibition of PI3Kbeta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	380.0	CHEMBL3145	Homo sapiens	IC50	nM	380.0
	18114037	CHEMBL4024909	Inhibition of PI3Kbeta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3805348	=	IC50	nM	77.0	CHEMBL3145	Homo sapiens	IC50	nM	77.0
	18114038	CHEMBL4024909	Inhibition of PI3Kbeta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	Nc1ncnn2c(-c3cccc(N4CCOCC4=O)c3)cc(-c3ccnn3CC(F)(F)F)c12		CHEMBL4086343	>	IC50	nM	15000.0	CHEMBL3145	Homo sapiens	IC50	nM	15000.0
	18114039	CHEMBL4024909	Inhibition of PI3Kbeta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	Nc1ncnn2c(-c3cccc(N4CCOCC4=O)c3)cc(Cl)c12		CHEMBL4080945	=	IC50	nM	1700.0	CHEMBL3145	Homo sapiens	IC50	nM	1700.0
	18114040	CHEMBL4024909	Inhibition of PI3Kbeta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	Nc1ncnn2c(-c3cccc(N4CCOCC4=O)c3)cc(C(F)(F)F)c12		CHEMBL4105190	>	IC50	nM	15000.0	CHEMBL3145	Homo sapiens	IC50	nM	15000.0
	18114041	CHEMBL4024909	Inhibition of PI3Kbeta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC1(C)OCCN(c2cccc(-c3cc(-c4ccnn4CC(F)(F)F)c4c(N)ncnn34)c2)C1=O		CHEMBL4088828	>	IC50	nM	15000.0	CHEMBL3145	Homo sapiens	IC50	nM	15000.0
Not Determined	18114042	CHEMBL4024909	Inhibition of PI3Kbeta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC1(C)OCCN(c2cccc(-c3cc(Cl)c4c(N)ncnn34)c2)C1=O		CHEMBL4067592		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	18114043	CHEMBL4024909	Inhibition of PI3Kbeta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC1(C)OCCN(c2cccc(-c3cc(C(F)(F)F)c4c(N)ncnn34)c2)C1=O		CHEMBL4061641		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	18114044	CHEMBL4024909	Inhibition of PI3Kbeta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	COc1ccc(-c2cc(-c3ccnn3CC(F)(F)F)c3c(N)ncnn23)cc1N1CCOC(C)(C)C1=O		CHEMBL4089756		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	18114045	CHEMBL4024909	Inhibition of PI3Kbeta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	COc1ccc(-c2cc(Cl)c3c(N)ncnn23)cc1N1CCOC(C)(C)C1=O		CHEMBL4063245		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	18114046	CHEMBL4024909	Inhibition of PI3Kbeta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	COc1ccc(-c2cc(C(F)(F)F)c3c(N)ncnn23)cc1N1CCOC(C)(C)C1=O		CHEMBL4084897		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	18114047	CHEMBL4024909	Inhibition of PI3Kbeta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC1(C)OCCN(c2cc(-c3cc(-c4ccnn4CC(F)(F)F)c4c(N)ncnn34)ccc2C#N)C1=O		CHEMBL4071877		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	18114048	CHEMBL4024909	Inhibition of PI3Kbeta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC1(C)OCCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C1=O		CHEMBL4092654		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	18114049	CHEMBL4024909	Inhibition of PI3Kbeta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC1(C)OCCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C1=O		CHEMBL4093593		IC50			CHEMBL3145	Homo sapiens	IC50		
	18114786	CHEMBL4025316	Inhibition of wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL3145	Homo sapiens	Activity	%	100.0
	18153240	CHEMBL4034458	Inhibition of PIK3CB ATP binding site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-4.6	CHEMBL3145	Homo sapiens	INH	%	-4.6
	18161815	CHEMBL4035971	Inhibition of PI3Kbeta (unknown origin)	B	CNC(=O)c1nc(-c2nc(-c3cnn4ccccc34)c(C)nc2N)n(C)n1		CHEMBL4078681	=	IC50	nM	24.0	CHEMBL3145	Homo sapiens	IC50	uM	0.024
	18161816	CHEMBL4035971	Inhibition of PI3Kbeta (unknown origin)	B	CNC(=O)c1nc(-c2nc(-c3cnc4ccccn34)cnc2N)n(C)n1		CHEMBL4102957	=	IC50	nM	1300.0	CHEMBL3145	Homo sapiens	IC50	uM	1.3
	18161817	CHEMBL4035971	Inhibition of PI3Kbeta (unknown origin)	B	CNC(=O)c1nc(-c2nc(-c3cnc4ccccn34)c(C)nc2N)n(C)n1		CHEMBL4072637	=	IC50	nM	87.0	CHEMBL3145	Homo sapiens	IC50	uM	0.087
	18161818	CHEMBL4035971	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(N)c(-c2nc(C3CCN(C)CC3)nn2C)nc1-c1cnc2ccccn12		CHEMBL4093351	=	IC50	nM	32.0	CHEMBL3145	Homo sapiens	IC50	uM	0.032
	18161819	CHEMBL4035971	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(N)c(-c2cnn(C3CCN(C)CC3)n2)nc1-c1cnc2ccccn12		CHEMBL4064039	=	IC50	nM	76.0	CHEMBL3145	Homo sapiens	IC50	uM	0.076
	18161820	CHEMBL4035971	Inhibition of PI3Kbeta (unknown origin)	B	CN(C)CC(=O)N1CCC(n2cc(-c3cnc(N)c(-n4nnc5ccccc54)n3)cn2)CC1		CHEMBL3590219	=	IC50	nM	900.0	CHEMBL3145	Homo sapiens	IC50	uM	0.9
	18161847	CHEMBL4035973	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as reduction in AKT phosphorylation at Ser473	B	CO[C@H]1CC[C@H](NC(=O)c2nc(-c3nc(-c4cnc5ccccn45)c(C)nc3N)n(C)n2)CC1		CHEMBL4086526	=	IC50	nM	16000.0	CHEMBL3145	Homo sapiens	IC50	uM	16.0
	18161848	CHEMBL4035973	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as reduction in AKT phosphorylation at Ser473	B	Cc1nc(N)c(-c2nc(C(=O)NCCN(C)C)nn2C)nc1-c1cnn2ccccc12		CHEMBL4065083	=	IC50	nM	1500.0	CHEMBL3145	Homo sapiens	IC50	uM	1.5
	18161849	CHEMBL4035973	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as reduction in AKT phosphorylation at Ser473	B	CNC(=O)c1nc(-c2nc(-c3cnn4ccccc34)c(C)nc2N)n(C)n1		CHEMBL4078681	=	IC50	nM	1500.0	CHEMBL3145	Homo sapiens	IC50	uM	1.5
	18161850	CHEMBL4035973	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as reduction in AKT phosphorylation at Ser473	B	CNC(=O)c1nc(-c2nc(-c3cnc4ccccn34)cnc2N)n(C)n1		CHEMBL4102957	=	IC50	nM	21000.0	CHEMBL3145	Homo sapiens	IC50	uM	21.0
	18161851	CHEMBL4035973	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as reduction in AKT phosphorylation at Ser473	B	CNC(=O)c1nc(-c2nc(-c3cnc4ccccn34)c(C)nc2N)n(C)n1		CHEMBL4072637	=	IC50	nM	8400.0	CHEMBL3145	Homo sapiens	IC50	uM	8.4
	18161852	CHEMBL4035973	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as reduction in AKT phosphorylation at Ser473	B	Cc1nc(N)c(-c2nc(C3CCN(C)CC3)nn2C)nc1-c1cnc2ccccn12		CHEMBL4093351	=	IC50	nM	200.0	CHEMBL3145	Homo sapiens	IC50	uM	0.2
	18161853	CHEMBL4035973	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as reduction in AKT phosphorylation at Ser473	B	Cc1nc(N)c(-c2cnn(C3CCN(C)CC3)n2)nc1-c1cnc2ccccn12		CHEMBL4064039	=	IC50	nM	550.0	CHEMBL3145	Homo sapiens	IC50	uM	0.55
	18161854	CHEMBL4035973	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-468 cells assessed as reduction in AKT phosphorylation at Ser473	B	CN(C)CC(=O)N1CCC(n2cc(-c3cnc(N)c(-n4nnc5ccccc54)n3)cn2)CC1		CHEMBL3590219	=	IC50	nM	13000.0	CHEMBL3145	Homo sapiens	IC50	uM	13.0
	18197042	CHEMBL4042391	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(C#CCCCC(=O)N3CCCC3)c2c(=O)n1-c1ccccc1		CHEMBL4060396	=	IC50	nM	530.0	CHEMBL3145	Homo sapiens	IC50	nM	530.0
	18197043	CHEMBL4042391	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(C#CCCCC(=O)N3CCOCC3)c2c(=O)n1-c1ccccc1		CHEMBL4073929	=	IC50	nM	509.0	CHEMBL3145	Homo sapiens	IC50	nM	509.0
	18197044	CHEMBL4042391	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	669.0	CHEMBL3145	Homo sapiens	IC50	nM	669.0
	18197045	CHEMBL4042391	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	Cc1nc(N)nc(N2CCC[C@H]2c2nc3cccc(C#CCCCC(=O)N4CCCC4)c3c(=O)n2-c2ccccc2)c1C#N		CHEMBL4098370	=	IC50	nM	2020.0	CHEMBL3145	Homo sapiens	IC50	nM	2020.0
	18197046	CHEMBL4042391	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C#CCCCC(=O)N3CCOCC3)c2c(=O)n1-c1ccccc1		CHEMBL4080347	=	IC50	nM	1650.0	CHEMBL3145	Homo sapiens	IC50	nM	1650.0
	18197124	CHEMBL4042421	Inhibition of recombinant human full length His-tagged PI3Kbeta expressed in insect cells	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	565.0	CHEMBL3145	Homo sapiens	IC50	nM	565.0
	18203840	CHEMBL4044127	Inhibition of wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL3145	Homo sapiens	Activity	%	100.0
	18211702	CHEMBL4045798	Inhibition of PIK3CB ATP binding site (VFGEDSVGVIFKNGDDLRQDMLTLQMLR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	21.2	CHEMBL3145	Homo sapiens	INH	%	21.2
	18211943	CHEMBL4046039	Inhibition of PIK3CB ATP binding site (VFGEDSVGVIFKNGDDLRQDMLTLQMLR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-65.5	CHEMBL3145	Homo sapiens	INH	%	-65.5
	18215108	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccccc3)c(OCc3ccccc3)ccc12		CHEMBL4064166	=	Inhibition	%	29.8	CHEMBL3145	Homo sapiens	INH	%	29.8
	18215109	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)c(OCc3ccccc3)ccc12		CHEMBL4085734	=	Inhibition	%	11.0	CHEMBL3145	Homo sapiens	INH	%	11.0
	18215110	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCc3ccccc3)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4077056	=	Inhibition	%	19.8	CHEMBL3145	Homo sapiens	INH	%	19.8
	18215111	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	Nc1cccc(-c2c(OCc3ccccc3)ccc3c(=O)nc(N4CCOCC4)oc23)c1		CHEMBL4075379	=	Inhibition	%	63.1	CHEMBL3145	Homo sapiens	INH	%	63.1
	18215112	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccs3)c(OCc3ccccc3)ccc12	Outside typical range	CHEMBL4089833	=	Inhibition	%	-10.5	CHEMBL3145	Homo sapiens	INH	%	-10.5
	18215113	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccsc3)c(OCc3ccccc3)ccc12		CHEMBL4075347	=	Inhibition	%	20.6	CHEMBL3145	Homo sapiens	INH	%	20.6
	18215114	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cc4ccccc4s3)c(OCc3ccccc3)ccc12		CHEMBL4097015	=	Inhibition	%	0.4	CHEMBL3145	Homo sapiens	INH	%	0.4
	18215115	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)c(OCc3ccccc3)ccc12		CHEMBL4076608	=	Inhibition	%	15.1	CHEMBL3145	Homo sapiens	INH	%	15.1
	18215116	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4c3oc3ccccc34)c(OCc3ccccc3)ccc12	Outside typical range	CHEMBL4061599	=	Inhibition	%	-27.4	CHEMBL3145	Homo sapiens	INH	%	-27.4
	18215117	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(CO)cc3)c(OCc3ccccc3)ccc12		CHEMBL4088661	=	Inhibition	%	54.2	CHEMBL3145	Homo sapiens	INH	%	54.2
	18215118	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccnc3)c(OCc3ccccc3)ccc12		CHEMBL4059469	=	Inhibition	%	21.0	CHEMBL3145	Homo sapiens	INH	%	21.0
	18215119	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4ccccc34)c(OCc3ccccc3)ccc12		CHEMBL4087811	=	Inhibition	%	4.67	CHEMBL3145	Homo sapiens	INH	%	4.67
	18215120	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4c3Sc3ccccc3S4)c(OCc3ccccc3)ccc12		CHEMBL4076848	=	Inhibition	%	0.6	CHEMBL3145	Homo sapiens	INH	%	0.6
	18215121	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccccc3)c(OCc3ccccn3)ccc12		CHEMBL4077367	=	Inhibition	%	66.4	CHEMBL3145	Homo sapiens	INH	%	66.4
	18215122	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)c(OCc3ccccn3)ccc12		CHEMBL4105146	=	Inhibition	%	48.8	CHEMBL3145	Homo sapiens	INH	%	48.8
	18215123	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCc3ccccn3)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4074385	=	Inhibition	%	42.9	CHEMBL3145	Homo sapiens	INH	%	42.9
	18215124	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	Nc1cccc(-c2c(OCc3ccccn3)ccc3c(=O)nc(N4CCOCC4)oc23)c1		CHEMBL4070804	=	Inhibition	%	65.5	CHEMBL3145	Homo sapiens	INH	%	65.5
	18215125	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccs3)c(OCc3ccccn3)ccc12		CHEMBL4091681	=	Inhibition	%	4.1	CHEMBL3145	Homo sapiens	INH	%	4.1
	18215126	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccsc3)c(OCc3ccccn3)ccc12		CHEMBL4062189	=	Inhibition	%	-3.0	CHEMBL3145	Homo sapiens	INH	%	-3.0
	18215127	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cc4ccccc4s3)c(OCc3ccccn3)ccc12	Outside typical range	CHEMBL4083912	=	Inhibition	%	-15.6	CHEMBL3145	Homo sapiens	INH	%	-15.6
	18215128	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccccc3)c(OCc3cccnc3)ccc12		CHEMBL4061587	=	Inhibition	%	64.4	CHEMBL3145	Homo sapiens	INH	%	64.4
	18215129	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)c(OCc3cccnc3)ccc12		CHEMBL4071051	=	Inhibition	%	53.2	CHEMBL3145	Homo sapiens	INH	%	53.2
	18215130	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCc3cccnc3)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4079378	=	Inhibition	%	39.3	CHEMBL3145	Homo sapiens	INH	%	39.3
	18215131	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	Nc1cccc(-c2c(OCc3cccnc3)ccc3c(=O)nc(N4CCOCC4)oc23)c1		CHEMBL4075461	=	Inhibition	%	28.2	CHEMBL3145	Homo sapiens	INH	%	28.2
	18215132	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccs3)c(OCc3cccnc3)ccc12		CHEMBL4077277	=	Inhibition	%	5.3	CHEMBL3145	Homo sapiens	INH	%	5.3
	18215133	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccsc3)c(OCc3cccnc3)ccc12		CHEMBL4076504	=	Inhibition	%	0.3	CHEMBL3145	Homo sapiens	INH	%	0.3
	18215134	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cc4ccccc4s3)c(OCc3cccnc3)ccc12		CHEMBL4103756	=	Inhibition	%	18.1	CHEMBL3145	Homo sapiens	INH	%	18.1
	18215135	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccccc3)c(OCc3ccncc3)ccc12		CHEMBL4084755	=	Inhibition	%	68.1	CHEMBL3145	Homo sapiens	INH	%	68.1
	18215136	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)c(OCc3ccncc3)ccc12		CHEMBL4094832	=	Inhibition	%	56.6	CHEMBL3145	Homo sapiens	INH	%	56.6
	18215137	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCc3ccncc3)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4104565	=	Inhibition	%	53.8	CHEMBL3145	Homo sapiens	INH	%	53.8
	18215138	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	Nc1cccc(-c2c(OCc3ccncc3)ccc3c(=O)nc(N4CCOCC4)oc23)c1		CHEMBL4069955	=	Inhibition	%	-5.5	CHEMBL3145	Homo sapiens	INH	%	-5.5
	18215139	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccs3)c(OCc3ccncc3)ccc12		CHEMBL4093073	=	Inhibition	%	5.4	CHEMBL3145	Homo sapiens	INH	%	5.4
	18215140	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccsc3)c(OCc3ccncc3)ccc12		CHEMBL4076512	=	Inhibition	%	53.6	CHEMBL3145	Homo sapiens	INH	%	53.6
	18215141	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cc4ccccc4s3)c(OCc3ccncc3)ccc12	Outside typical range	CHEMBL4072665	=	Inhibition	%	-13.3	CHEMBL3145	Homo sapiens	INH	%	-13.3
	18215142	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccccc3)c(OCCBr)ccc12		CHEMBL4061393	=	Inhibition	%	33.8	CHEMBL3145	Homo sapiens	INH	%	33.8
	18215143	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)c(OCCBr)ccc12		CHEMBL4095309	=	Inhibition	%	7.6	CHEMBL3145	Homo sapiens	INH	%	7.6
	18215144	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCCBr)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4071376	=	Inhibition	%	39.7	CHEMBL3145	Homo sapiens	INH	%	39.7
	18215145	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	CN1CCN(CCOc2ccc3c(=O)nc(N4CCOCC4)oc3c2-c2ccccc2)CC1		CHEMBL4076379	=	Inhibition	%	31.8	CHEMBL3145	Homo sapiens	INH	%	31.8
	18215146	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	CN1CCN(CCOc2ccc3c(=O)nc(N4CCOCC4)oc3c2-c2ccc(Cl)cc2)CC1		CHEMBL4083132	=	Inhibition	%	20.3	CHEMBL3145	Homo sapiens	INH	%	20.3
	18215147	CHEMBL4046828	Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCCN3CCN(C)CC3)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4075473	=	Inhibition	%	44.8	CHEMBL3145	Homo sapiens	INH	%	44.8
	18231652	CHEMBL4050203	Inhibition of PI3Kbeta (unknown origin)	B	COc1cc(N2CCOCC2)ccc1Nc1nc(NC2CCCCC2)c2cc[nH]c2n1		CHEMBL4076767	=	IC50	nM	40600.0	CHEMBL3145	Homo sapiens	IC50	10'-5M	4.06
Not Determined	18231711	CHEMBL4050203	Inhibition of PI3Kbeta (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50			CHEMBL3145	Homo sapiens	IC50		
	18231741	CHEMBL4050203	Inhibition of PI3Kbeta (unknown origin)	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	3.82	CHEMBL3145	Homo sapiens	IC50	10'-9M	3.82
	18238978	CHEMBL4051854	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate after 1 hr by kinase-glo luminescence assay	B	C[C@H]1CN(c2nc(N3CCOCC3)c3sc(-c4cnc(N)nc4)cc3n2)C[C@@H](C)O1		CHEMBL4060108	=	IC50	nM	317.0	CHEMBL3145	Homo sapiens	IC50	nM	317.0
	18238979	CHEMBL4051854	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate after 1 hr by kinase-glo luminescence assay	B	C[C@H]1CN(c2nc(N3CCOCC3)c3sc(-c4ccn[nH]4)cc3n2)C[C@@H](C)O1		CHEMBL4071083	=	IC50	nM	175.0	CHEMBL3145	Homo sapiens	IC50	nM	175.0
	18238980	CHEMBL4051854	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate after 1 hr by kinase-glo luminescence assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	33.0	CHEMBL3145	Homo sapiens	IC50	nM	33.0
	18245834	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	251.19	CHEMBL3145	Homo sapiens	pIC50		6.6
	18245835	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	IC50	nM	794.33	CHEMBL3145	Homo sapiens	pIC50		6.1
	18245836	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	Cc1nncn1C1CCN(Cc2cc3nc(-c4cccc(O)c4)nc(N4CCOCC4)c3s2)CC1		CHEMBL4068098	=	IC50	nM	158.49	CHEMBL3145	Homo sapiens	pIC50		6.8
	18245837	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	Cc1nncn1C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4089288	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
	18245838	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	Cc1nncn1C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4105669	=	IC50	nM	398.11	CHEMBL3145	Homo sapiens	pIC50		6.4
	18245839	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	Oc1cccc(-c2nc(N3CCOCC3)c3sc(CN4CCC(n5cnnc5C(F)(F)F)CC4)cc3n2)c1		CHEMBL4081413	=	IC50	nM	100.0	CHEMBL3145	Homo sapiens	pIC50		7.0
	18245840	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	FC(F)(F)c1nncn1C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4086820	=	IC50	nM	1258.93	CHEMBL3145	Homo sapiens	pIC50		5.9
	18245841	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	FC(F)(F)c1nncn1C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4104716	=	IC50	nM	794.33	CHEMBL3145	Homo sapiens	pIC50		6.1
	18245842	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	FC(F)(F)c1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ncc56)nc(N5CCOCC5)c4s3)C[C@H]1CC2		CHEMBL4078972	=	IC50	nM	398.11	CHEMBL3145	Homo sapiens	pIC50		6.4
	18245843	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	Oc1cccc(-c2nc(N3CCOCC3)c3sc(CN4CC[C@H]5[C@H](CCc6nnc(C(F)(F)F)n65)C4)cc3n2)c1		CHEMBL4096987	=	IC50	nM	50.12	CHEMBL3145	Homo sapiens	pIC50		7.3
	18245844	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	Cc1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ncc56)nc(N5CCOCC5)c4s3)C[C@H]1CC2		CHEMBL4100380	=	IC50	nM	1258.93	CHEMBL3145	Homo sapiens	pIC50		5.9
	18245845	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	FC(F)(F)c1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ccc56)nc(N5CCOCC5)c4s3)C[C@H]1CC2		CHEMBL4068538	=	IC50	nM	100.0	CHEMBL3145	Homo sapiens	pIC50		7.0
	18245846	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	Cc1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ccc56)nc(N5CCOCC5)c4s3)C[C@H]1CC2		CHEMBL4081998	=	IC50	nM	316.23	CHEMBL3145	Homo sapiens	pIC50		6.5
	18245847	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	FC(F)(F)c1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ncc56)nc(N5CCOCC5)c4s3)C[C@@H]1CC2		CHEMBL4092258	=	IC50	nM	630.96	CHEMBL3145	Homo sapiens	pIC50		6.2
	18245848	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	Oc1cccc(-c2nc(N3CCOCC3)c3sc(CN4CC[C@H]5[C@@H](CCc6nnc(C(F)(F)F)n65)C4)cc3n2)c1		CHEMBL4071462	=	IC50	nM	50.12	CHEMBL3145	Homo sapiens	pIC50		7.3
	18245849	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	Cc1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ncc56)nc(N5CCOCC5)c4s3)C[C@@H]1CC2		CHEMBL4070417	=	IC50	nM	501.19	CHEMBL3145	Homo sapiens	pIC50		6.3
	18245850	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	FC(F)(F)c1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ccc56)nc(N5CCOCC5)c4s3)C[C@@H]1CC2		CHEMBL4097593	=	IC50	nM	158.49	CHEMBL3145	Homo sapiens	pIC50		6.8
	18245851	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	Cc1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ccc56)nc(N5CCOCC5)c4s3)C[C@@H]1CC2		CHEMBL4061794	=	IC50	nM	316.23	CHEMBL3145	Homo sapiens	pIC50		6.5
	18245852	CHEMBL4053405	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	A	Cc1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc(O)c5)nc(N5CCOCC5)c4s3)C[C@@H]1CC2		CHEMBL4094734	=	IC50	nM	125.89	CHEMBL3145	Homo sapiens	pIC50		6.9
	18253913	CHEMBL4055241	Inhibition of wild-type human partial length PI3KCB (P118 to S1070 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL3145	Homo sapiens	Activity	%	100.0
	18253914	CHEMBL4055241	Inhibition of wild-type human partial length PI3KCB (P118 to S1070 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL3145	Homo sapiens	Activity	%	100.0
	18275217	CHEMBL4118451	Inhibition of PIK3CB in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VFGEDSVGVIFKNGDDLRQDMLTLQMLR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-79.2	CHEMBL3145	Homo sapiens	INH	%	-79.2
	18275218	CHEMBL4118451	Inhibition of PIK3CB in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VFGEDSVGVIFKNGDDLRQDMLTLQMLR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-42.4	CHEMBL3145	Homo sapiens	INH	%	-42.4
	18275219	CHEMBL4118451	Inhibition of PIK3CB in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VFGEDSVGVIFKNGDDLRQDMLTLQMLR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-21.6	CHEMBL3145	Homo sapiens	INH	%	-21.6
	18281186	CHEMBL4119781	Binding affinity to wild-type human PIK3Cbeta (P118 to S1070 residues) expressed in mammalian expression system by KINOMEScan assay	B	CN(C)C(=O)c1cc([C@H]2CCCN2c2cc(F)cc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4130282	=	Kd	nM	0.3	CHEMBL3145	Homo sapiens	Kd	nM	0.3
	18281187	CHEMBL4119781	Binding affinity to wild-type human PIK3Cbeta (P118 to S1070 residues) expressed in mammalian expression system by KINOMEScan assay	B	CN(C)C(=O)c1cc([C@@H]2CCCN2c2cc(F)cc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4127012	=	Kd	nM	1086.0	CHEMBL3145	Homo sapiens	Kd	nM	1086.0
	18281188	CHEMBL4119781	Binding affinity to wild-type human PIK3Cbeta (P118 to S1070 residues) expressed in mammalian expression system by KINOMEScan assay	B	CN(C)C(=O)c1cc(C2CCCN2c2cc(F)cc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4129062	=	Kd	nM	2.0	CHEMBL3145	Homo sapiens	Kd	nM	2.0
	18281189	CHEMBL4119781	Binding affinity to wild-type human PIK3Cbeta (P118 to S1070 residues) expressed in mammalian expression system by KINOMEScan assay	B	C[C@H]1CN(C(=O)c2cc(C3CCCN3c3cc(F)cc(F)c3)c3nc(N4CCOCC4)cnc3c2)C[C@@H](C)N1		CHEMBL4125781	=	Kd	nM	0.2	CHEMBL3145	Homo sapiens	Kd	nM	0.2
	18281190	CHEMBL4119781	Binding affinity to wild-type human PIK3Cbeta (P118 to S1070 residues) expressed in mammalian expression system by KINOMEScan assay	B	C[C@@H](Nc1cccc(F)c1)c1cc(C(=O)NCCO)cc2ncc(N3CCOCC3)nc12		CHEMBL4127822	=	Kd	nM	3.0	CHEMBL3145	Homo sapiens	Kd	nM	3.0
	18281191	CHEMBL4119781	Binding affinity to wild-type human PIK3Cbeta (P118 to S1070 residues) expressed in mammalian expression system by KINOMEScan assay	B	C[C@H](Nc1cccc(F)c1)c1cc(C(=O)NCCO)cc2ncc(N3CCOCC3)nc12		CHEMBL4129223	=	Kd	nM	204.0	CHEMBL3145	Homo sapiens	Kd	nM	204.0
	18281192	CHEMBL4119781	Binding affinity to wild-type human PIK3Cbeta (P118 to S1070 residues) expressed in mammalian expression system by KINOMEScan assay	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4127116	=	Kd	nM	0.1	CHEMBL3145	Homo sapiens	Kd	nM	0.1
	18281193	CHEMBL4119781	Binding affinity to wild-type human PIK3Cbeta (P118 to S1070 residues) expressed in mammalian expression system by KINOMEScan assay	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4128507	=	Kd	nM	0.2	CHEMBL3145	Homo sapiens	Kd	nM	0.2
	18281194	CHEMBL4119781	Binding affinity to wild-type human PIK3Cbeta (P118 to S1070 residues) expressed in mammalian expression system by KINOMEScan assay	B	C[C@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4128821	=	Kd	nM	29.0	CHEMBL3145	Homo sapiens	Kd	nM	29.0
	18281195	CHEMBL4119781	Binding affinity to wild-type human PIK3Cbeta (P118 to S1070 residues) expressed in mammalian expression system by KINOMEScan assay	B	CNCCNC(=O)c1cc(C(C)Nc2cccc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4127425	=	Kd	nM	0.2	CHEMBL3145	Homo sapiens	Kd	nM	0.2
	18281196	CHEMBL4119781	Binding affinity to wild-type human PIK3Cbeta (P118 to S1070 residues) expressed in mammalian expression system by KINOMEScan assay	B	Cc1c(F)cccc1NCc1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4127570	=	Kd	nM	0.2	CHEMBL3145	Homo sapiens	Kd	nM	0.2
	18281230	CHEMBL4119785	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at S473 residue measured after 60 mins by ELISA	B	CN(C)C(=O)c1cc([C@H]2CCCN2c2cc(F)cc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4130282	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	nM	2.0
	18281231	CHEMBL4119785	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at S473 residue measured after 60 mins by ELISA	B	CN(C)C(=O)c1cc([C@@H]2CCCN2c2cc(F)cc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4127012	>	IC50	nM	513.0	CHEMBL3145	Homo sapiens	IC50	nM	513.0
	18281232	CHEMBL4119785	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at S473 residue measured after 60 mins by ELISA	B	CN(C)C(=O)c1cc(C2CCCN2c2cc(F)cc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4129062	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
	18281233	CHEMBL4119785	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at S473 residue measured after 60 mins by ELISA	B	C[C@H]1CN(C(=O)c2cc(C3CCCN3c3cc(F)cc(F)c3)c3nc(N4CCOCC4)cnc3c2)C[C@@H](C)N1		CHEMBL4125781	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	nM	7.0
	18281234	CHEMBL4119785	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at S473 residue measured after 60 mins by ELISA	B	C[C@@H](Nc1cccc(F)c1)c1cc(C(=O)NCCO)cc2ncc(N3CCOCC3)nc12		CHEMBL4127822	=	IC50	nM	49.0	CHEMBL3145	Homo sapiens	IC50	nM	49.0
	18281235	CHEMBL4119785	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at S473 residue measured after 60 mins by ELISA	B	C[C@H](Nc1cccc(F)c1)c1cc(C(=O)NCCO)cc2ncc(N3CCOCC3)nc12		CHEMBL4129223	>	IC50	nM	513.0	CHEMBL3145	Homo sapiens	IC50	nM	513.0
	18281236	CHEMBL4119785	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at S473 residue measured after 60 mins by ELISA	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4127116	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
	18281237	CHEMBL4119785	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at S473 residue measured after 60 mins by ELISA	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4128507	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	nM	2.0
	18281238	CHEMBL4119785	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at S473 residue measured after 60 mins by ELISA	B	C[C@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4128821	=	IC50	nM	331.0	CHEMBL3145	Homo sapiens	IC50	nM	331.0
	18281239	CHEMBL4119785	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at S473 residue measured after 60 mins by ELISA	B	CNCCNC(=O)c1cc(C(C)Nc2cccc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4127425	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	nM	7.0
	18281240	CHEMBL4119785	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at S473 residue measured after 60 mins by ELISA	B	Cc1c(F)cccc1NCc1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4127570	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	nM	9.0
	18281241	CHEMBL4119786	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at Thr308 residue measured after 60 mins by ELISA	B	CN(C)C(=O)c1cc([C@H]2CCCN2c2cc(F)cc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4130282	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
	18281242	CHEMBL4119786	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at Thr308 residue measured after 60 mins by ELISA	B	CN(C)C(=O)c1cc([C@@H]2CCCN2c2cc(F)cc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4127012	>	IC50	nM	513.0	CHEMBL3145	Homo sapiens	IC50	nM	513.0
	18281243	CHEMBL4119786	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at Thr308 residue measured after 60 mins by ELISA	B	CN(C)C(=O)c1cc(C2CCCN2c2cc(F)cc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4129062	=	IC50	nM	1.35	CHEMBL3145	Homo sapiens	IC50	nM	1.35
	18281244	CHEMBL4119786	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at Thr308 residue measured after 60 mins by ELISA	B	C[C@H]1CN(C(=O)c2cc(C3CCCN3c3cc(F)cc(F)c3)c3nc(N4CCOCC4)cnc3c2)C[C@@H](C)N1		CHEMBL4125781	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
	18281245	CHEMBL4119786	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at Thr308 residue measured after 60 mins by ELISA	B	C[C@@H](Nc1cccc(F)c1)c1cc(C(=O)NCCO)cc2ncc(N3CCOCC3)nc12		CHEMBL4127822	=	IC50	nM	44.0	CHEMBL3145	Homo sapiens	IC50	nM	44.0
	18281246	CHEMBL4119786	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at Thr308 residue measured after 60 mins by ELISA	B	C[C@H](Nc1cccc(F)c1)c1cc(C(=O)NCCO)cc2ncc(N3CCOCC3)nc12		CHEMBL4129223	>	IC50	nM	513.0	CHEMBL3145	Homo sapiens	IC50	nM	513.0
	18281247	CHEMBL4119786	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at Thr308 residue measured after 60 mins by ELISA	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4127116	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
	18281248	CHEMBL4119786	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at Thr308 residue measured after 60 mins by ELISA	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4128507	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	nM	2.0
	18281249	CHEMBL4119786	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at Thr308 residue measured after 60 mins by ELISA	B	C[C@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4128821	=	IC50	nM	148.0	CHEMBL3145	Homo sapiens	IC50	nM	148.0
	18281250	CHEMBL4119786	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at Thr308 residue measured after 60 mins by ELISA	B	CNCCNC(=O)c1cc(C(C)Nc2cccc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4127425	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
	18281251	CHEMBL4119786	Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at Thr308 residue measured after 60 mins by ELISA	B	Cc1c(F)cccc1NCc1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4127570	=	IC50	nM	9.0	CHEMBL3145	Homo sapiens	IC50	nM	9.0
	18281699	CHEMBL4119811	Inhibition of PI3Kbeta (unknown origin) by TR-FRET assay	B	O=C(NOCCOCCOCCOCCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL4127114	=	IC50	nM	1482.0	CHEMBL3145	Homo sapiens	IC50	nM	1482.0
	18281700	CHEMBL4119811	Inhibition of PI3Kbeta (unknown origin) by TR-FRET assay	B	NOCCOCCOCCOCCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4127267	=	IC50	nM	214.0	CHEMBL3145	Homo sapiens	IC50	nM	214.0
	18281701	CHEMBL4119811	Inhibition of PI3Kbeta (unknown origin) by TR-FRET assay	B	CC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4125884	=	IC50	nM	14.3	CHEMBL3145	Homo sapiens	IC50	nM	14.3
	18281702	CHEMBL4119811	Inhibition of PI3Kbeta (unknown origin) by TR-FRET assay	B	O=C(NOCCOCCOCCOCCN1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3819302	=	IC50	nM	4073.0	CHEMBL3145	Homo sapiens	IC50	nM	4073.0
	18281703	CHEMBL4119811	Inhibition of PI3Kbeta (unknown origin) by TR-FRET assay	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCNCC2)nc(N2CCOCC2)n1		CHEMBL3400288	=	IC50	nM	1093.0	CHEMBL3145	Homo sapiens	IC50	nM	1093.0
	18281704	CHEMBL4119811	Inhibition of PI3Kbeta (unknown origin) by TR-FRET assay	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	15.2	CHEMBL3145	Homo sapiens	IC50	nM	15.2
	18298596	CHEMBL4124218	Inhibition of PI3Kbeta in human MDA-MB-468 cells assessed as reduction in Akt phosphorylation at Tyr308 residue after 2 hrs	A	CNS(=O)(=O)c1cc(-c2sc(NC(C)=O)nc2C)cc2c1C(=O)N([C@@H](C)C1CC1)C2		CHEMBL4129600	<	IC50	nM	31622.78	CHEMBL3145	Homo sapiens	pIC50		4.5
	18298597	CHEMBL4124218	Inhibition of PI3Kbeta in human MDA-MB-468 cells assessed as reduction in Akt phosphorylation at Tyr308 residue after 2 hrs	A	CC(=O)Nc1nc(C)c(-c2cc3c(c(S(C)(=O)=O)c2)C(=O)N([C@@H](C)C2CC2)C3)s1		CHEMBL4126156	<	IC50	nM	31622.78	CHEMBL3145	Homo sapiens	pIC50		4.5
	18298598	CHEMBL4124218	Inhibition of PI3Kbeta in human MDA-MB-468 cells assessed as reduction in Akt phosphorylation at Tyr308 residue after 2 hrs	A	CC(=O)Nc1nc(C)c(-c2cc3c(c(NS(C)(=O)=O)c2)C(=O)N([C@@H](C)C2CC2)C3)s1		CHEMBL4127396	<	IC50	nM	31622.78	CHEMBL3145	Homo sapiens	pIC50		4.5
	18320179	CHEMBL4134209	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol/n-Octyl-glucoside as substrate measured after 60 mins by KinaseGlo assay	A	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	IC50	nM	1650.0	CHEMBL3145	Homo sapiens	IC50	uM	1.65
	18320180	CHEMBL4134209	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol/n-Octyl-glucoside as substrate measured after 60 mins by KinaseGlo assay	A	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cn1		CHEMBL3947814	=	IC50	nM	4840.0	CHEMBL3145	Homo sapiens	IC50	uM	4.84
	18320181	CHEMBL4134209	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol/n-Octyl-glucoside as substrate measured after 60 mins by KinaseGlo assay	A	COc1ccc(N2CCc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3C2)cn1		CHEMBL4164149	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	18320182	CHEMBL4134209	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol/n-Octyl-glucoside as substrate measured after 60 mins by KinaseGlo assay	A	COc1ccc(N2CCc3ncnc(-c4cccc(OC5CCN(C(C)=O)CC5)c4)c3C2)cn1		CHEMBL4163245	>	IC50	nM	9100.0	CHEMBL3145	Homo sapiens	IC50	uM	9.1
	18320183	CHEMBL4134209	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol/n-Octyl-glucoside as substrate measured after 60 mins by KinaseGlo assay	A	CCC(=O)N1CC[C@H](Oc2ncnc3c2CN(c2ccc(OC)nc2)CC3)C1		CHEMBL4171158	=	IC50	nM	8940.0	CHEMBL3145	Homo sapiens	IC50	uM	8.94
	18320184	CHEMBL4134209	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol/n-Octyl-glucoside as substrate measured after 60 mins by KinaseGlo assay	A	CCC(=O)N1CC[C@H](Oc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643409	=	IC50	nM	1710.0	CHEMBL3145	Homo sapiens	IC50	uM	1.71
	18320185	CHEMBL4134209	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol/n-Octyl-glucoside as substrate measured after 60 mins by KinaseGlo assay	A	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C		CHEMBL3643349	=	IC50	nM	4150.0	CHEMBL3145	Homo sapiens	IC50	uM	4.15
	18320186	CHEMBL4134209	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol/n-Octyl-glucoside as substrate measured after 60 mins by KinaseGlo assay	A	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643407	=	IC50	nM	1330.0	CHEMBL3145	Homo sapiens	IC50	uM	1.33
	18320187	CHEMBL4134209	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol/n-Octyl-glucoside as substrate measured after 60 mins by KinaseGlo assay	A	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C		CHEMBL3643429	=	IC50	nM	2020.0	CHEMBL3145	Homo sapiens	IC50	uM	2.02
	18320188	CHEMBL4134209	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol/n-Octyl-glucoside as substrate measured after 60 mins by KinaseGlo assay	A	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643414	=	IC50	nM	300.0	CHEMBL3145	Homo sapiens	IC50	uM	0.3
	18320189	CHEMBL4134209	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol/n-Octyl-glucoside as substrate measured after 60 mins by KinaseGlo assay	A	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C)c2)CC3)C1		CHEMBL3643427	=	IC50	nM	951.0	CHEMBL3145	Homo sapiens	IC50	uM	0.951
	18320190	CHEMBL4134209	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol/n-Octyl-glucoside as substrate measured after 60 mins by KinaseGlo assay	A	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643413	=	IC50	nM	424.0	CHEMBL3145	Homo sapiens	IC50	uM	0.424
	18320227	CHEMBL4134213	Inhibition of recombinant human myristoylated PI3Kbeta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	A	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	IC50	nM	6530.0	CHEMBL3145	Homo sapiens	IC50	uM	6.53
	18320228	CHEMBL4134213	Inhibition of recombinant human myristoylated PI3Kbeta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	A	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cn1		CHEMBL3947814	=	IC50	nM	3570.0	CHEMBL3145	Homo sapiens	IC50	uM	3.57
	18320229	CHEMBL4134213	Inhibition of recombinant human myristoylated PI3Kbeta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	A	COc1ccc(N2CCc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3C2)cn1		CHEMBL4164149	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	18320230	CHEMBL4134213	Inhibition of recombinant human myristoylated PI3Kbeta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	A	COc1ccc(N2CCc3ncnc(-c4cccc(OC5CCN(C(C)=O)CC5)c4)c3C2)cn1		CHEMBL4163245	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	18320231	CHEMBL4134213	Inhibition of recombinant human myristoylated PI3Kbeta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	A	CCC(=O)N1CC[C@H](Oc2ncnc3c2CN(c2ccc(OC)nc2)CC3)C1		CHEMBL4171158	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	18320232	CHEMBL4134213	Inhibition of recombinant human myristoylated PI3Kbeta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	A	CCC(=O)N1CC[C@H](Oc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643409	=	IC50	nM	3110.0	CHEMBL3145	Homo sapiens	IC50	uM	3.11
	18320233	CHEMBL4134213	Inhibition of recombinant human myristoylated PI3Kbeta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	A	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C		CHEMBL3643349	=	IC50	nM	6790.0	CHEMBL3145	Homo sapiens	IC50	uM	6.79
	18320234	CHEMBL4134213	Inhibition of recombinant human myristoylated PI3Kbeta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	A	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643407	=	IC50	nM	3580.0	CHEMBL3145	Homo sapiens	IC50	uM	3.58
	18320235	CHEMBL4134213	Inhibition of recombinant human myristoylated PI3Kbeta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	A	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C		CHEMBL3643429	=	IC50	nM	9870.0	CHEMBL3145	Homo sapiens	IC50	uM	9.87
	18320236	CHEMBL4134213	Inhibition of recombinant human myristoylated PI3Kbeta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	A	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643414	=	IC50	nM	3990.0	CHEMBL3145	Homo sapiens	IC50	uM	3.99
	18320237	CHEMBL4134213	Inhibition of recombinant human myristoylated PI3Kbeta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	A	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C)c2)CC3)C1		CHEMBL3643427	=	IC50	nM	7910.0	CHEMBL3145	Homo sapiens	IC50	uM	7.91
	18320238	CHEMBL4134213	Inhibition of recombinant human myristoylated PI3Kbeta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	A	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643413	=	IC50	nM	2250.0	CHEMBL3145	Homo sapiens	IC50	uM	2.25
	18327935	CHEMBL4135741	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1n[nH]c2cc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL260163	<	IC50	nM	25118.86	CHEMBL3145	Homo sapiens	pIC50		4.6
	18327936	CHEMBL4135741	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2ccc(O)cc2)cc2[nH]ncc12)C1CC1		CHEMBL4172211	=	IC50	nM	25118.86	CHEMBL3145	Homo sapiens	pIC50		4.6
	18327937	CHEMBL4135741	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2ccc(O)cc2)cc2[nH]ncc12)c1ccccn1		CHEMBL4161596	<	IC50	nM	25118.86	CHEMBL3145	Homo sapiens	pIC50		4.6
	18327938	CHEMBL4135741	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2ccccc2)cc2[nH]ncc12)C1CC1		CHEMBL4168859	<	IC50	nM	25118.86	CHEMBL3145	Homo sapiens	pIC50		4.6
	18327939	CHEMBL4135741	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2cccc(O)c2)cc2[nH]ncc12)C1CC1		CHEMBL4176717	=	IC50	nM	19952.62	CHEMBL3145	Homo sapiens	pIC50		4.7
	18327940	CHEMBL4135741	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2cccc(O)c2)cc2[nH]ncc12)c1ccccn1		CHEMBL4174177	=	IC50	nM	31622.78	CHEMBL3145	Homo sapiens	pIC50		4.5
	18327941	CHEMBL4135741	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2cccc3[nH]ccc23)cc2[nH]ncc12)C1CC1		CHEMBL4163479	=	IC50	nM	25118.86	CHEMBL3145	Homo sapiens	pIC50		4.6
	18327942	CHEMBL4135741	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2cccc3[nH]ccc23)cc2[nH]ncc12)c1ccccn1		CHEMBL4165288	=	IC50	nM	6309.57	CHEMBL3145	Homo sapiens	pIC50		5.2
	18327943	CHEMBL4135741	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2ccc3cc[nH]c3c2)cc2[nH]ncc12)c1ccccn1		CHEMBL4175904	=	IC50	nM	12589.25	CHEMBL3145	Homo sapiens	pIC50		4.9
	18333063	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	CCOc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3C[C@H](C)O[C@H](C)C3)cc2F)c1		CHEMBL4164450	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333064	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3C[C@H](C)O[C@H](C)C3)cc2F)c1		CHEMBL4175737	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333065	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2cc(Cl)c(CN3CCN(C(C)C)CC3)cc2F)c1		CHEMBL4167878	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333066	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)N(COC(=O)C(C)(C)C)c1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1		CHEMBL4174937	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333067	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	CCOC(=O)CN(c1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1)S(=O)(=O)c1cc(N2CCOCC2)cnc1OC		CHEMBL4164289	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333068	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)N(c1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1)C(C)C		CHEMBL4164720	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333069	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	CCCN(c1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1)S(=O)(=O)c1cc(N2CCOCC2)cnc1OC		CHEMBL4172619	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333070	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	CCN(c1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1)S(=O)(=O)c1cc(N2CCOCC2)cnc1OC		CHEMBL4168162	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333071	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)N(C)c1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1		CHEMBL4176011	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333072	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)N(C)c1ccnc(-c2ccc(CN3CCN(C(C)(C)C)CC3)cc2F)c1		CHEMBL4176410	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333073	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	CN(C)c1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)(C)C)CC3)cc2F)c1		CHEMBL4165802	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333074	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	CC(C)N1CCN(Cc2ccc(-c3cc(NS(=O)(=O)c4cc(N5CCOCC5)cnc4N(C)C)ccn3)c(F)c2)CC1		CHEMBL4161306	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333075	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCNCC3)cc2F)c1		CHEMBL4169235	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333076	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCOCC3)cc2)c1		CHEMBL4173426	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333077	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3C[C@H](C)O[C@H](C)C3)cc2)c1		CHEMBL4165501	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333078	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCC(C(C)(C)O)CC3)cc2F)c1		CHEMBL4174874	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333079	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCCCC3)cc2F)c1.O=CO		CHEMBL4166983	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333080	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCCC3C)cc2F)c1		CHEMBL4171432	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333081	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCC(C)C3)cc2F)c1		CHEMBL4163532	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333082	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COCCN1CCN(Cc2ccc(-c3cc(NS(=O)(=O)c4cc(N5CCOCC5)cnc4OC)ccn3)c(F)c2)CC1.O=CO		CHEMBL4163118	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333083	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2cc(F)c(CN3CCN(C(C)C)CC3)cc2F)c1		CHEMBL4173828	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333084	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C4CCC4)CC3)cc2F)c1.O=CO		CHEMBL4159756	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333085	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C4COC4)CC3)cc2F)c1.O=CO.O=CO.O=CO		CHEMBL4170389	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333086	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)c(F)c2F)c1		CHEMBL4170075	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333087	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C4COC4)CC3)cc2)c1		CHEMBL4159454	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333088	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2cc(F)c(CN3CCN(C(C)C)CC3)c(F)c2)c1		CHEMBL4175405	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333089	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCCC3)c(F)c2)c1		CHEMBL4164780	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333090	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCCC3)cc2F)c1		CHEMBL4171961	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333091	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	CCC(C)N1CCN(Cc2ccc(-c3cc(NS(=O)(=O)c4cc(N5CCOCC5)cnc4OC)ccn3)cc2)CC1		CHEMBL4161366	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333092	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2c(F)cc(CN3CCN(C(C)C)CC3)cc2F)c1		CHEMBL4168604	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333093	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C4CCC4)CC3)cc2)c1		CHEMBL4176468	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333094	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)(C)C)CC3)cc2)c1		CHEMBL4165185	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333095	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)c(F)c2)c1		CHEMBL4173087	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333096	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN(C)C)cc2)c1		CHEMBL4177053	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333097	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2)c1		CHEMBL4169192	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333098	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)(C)C)CC3)cc2F)c1		CHEMBL4175571	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18333099	CHEMBL4136594	Inhibition of GST-tagged PI3Kbeta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1		CHEMBL4167702	>=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	18402504	CHEMBL4150388	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate by ADP-Glo assay	B	COc1ncc(-c2cc(OC3CCOCC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4166144	=	IC50	nM	0.53	CHEMBL3145	Homo sapiens	IC50	nM	0.53
	18402539	CHEMBL4150411	Inhibition of wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	COc1ncc(-c2cc(OC3CCOCC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4166144	=	Activity	%	1.6	CHEMBL3145	Homo sapiens	Activity	%	1.6
	18402605	CHEMBL4150388	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate by ADP-Glo assay	B	COc1ncc(-c2cc(O[C@@H]3CCOC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4176771	=	IC50	nM	0.4	CHEMBL3145	Homo sapiens	IC50	nM	0.4
	18402698	CHEMBL4150388	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate by ADP-Glo assay	B	CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc(OC3CCOCC3)c2n1		CHEMBL4166594	=	IC50	nM	1.2	CHEMBL3145	Homo sapiens	IC50	nM	1.2
	18402779	CHEMBL4150388	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate by ADP-Glo assay	B	CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc(O[C@@H]3CCOC3)c2n1		CHEMBL4174909	=	IC50	nM	1.1	CHEMBL3145	Homo sapiens	IC50	nM	1.1
	18420340	CHEMBL4153806	Inhibition of human PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCOCC2)c(=O)n4C)cn1		CHEMBL3960662	=	IC50	nM	1800.0	CHEMBL3145	Homo sapiens	IC50	uM	1.8
	18439853	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	CC(=O)Nc1nc(C)c(-c2cnc(Cl)c(NS(=O)(=O)c3ccccc3)c2)s1		CHEMBL4174132	=	IC50	nM	1.28	CHEMBL3145	Homo sapiens	IC50	nM	1.28
	18439854	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	CCC(=O)Nc1nc(C)c(-c2cnc(Cl)c(NS(=O)(=O)c3ccccc3)c2)s1		CHEMBL4166220	=	IC50	nM	6.6	CHEMBL3145	Homo sapiens	IC50	nM	6.6
	18439855	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)CN)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4170707	=	IC50	nM	17.0	CHEMBL3145	Homo sapiens	IC50	nM	17.0
	18439856	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	COc1ncc(-c2sc(NC(=O)CN)nc2C)cc1NS(=O)(=O)c1ccccc1		CHEMBL4162773	=	IC50	nM	290.0	CHEMBL3145	Homo sapiens	IC50	nM	290.0
	18439857	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)CN)sc1-c1cnc(O)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4162361	=	IC50	nM	1539.0	CHEMBL3145	Homo sapiens	IC50	nM	1539.0
	18439858	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1ncc(-c2sc(NC(=O)CN)nc2C)cc1NS(=O)(=O)c1ccccc1		CHEMBL4173039	=	IC50	nM	8769.0	CHEMBL3145	Homo sapiens	IC50	nM	8769.0
	18439859	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)CN)sc1-c1cncc(NS(=O)(=O)c2ccccc2)c1		CHEMBL4177502	=	IC50	nM	422.1	CHEMBL3145	Homo sapiens	IC50	nM	422.1
	18439860	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)CN)sc1-c1ccc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4169638	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	18439861	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](C)N)sc1-c1cncc(NS(=O)(=O)c2ccccc2)c1		CHEMBL4169244	=	IC50	nM	19.5	CHEMBL3145	Homo sapiens	IC50	nM	19.5
	18439862	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@H](C)N)sc1-c1cncc(NS(=O)(=O)c2ccccc2)c1		CHEMBL4161316	=	IC50	nM	27.5	CHEMBL3145	Homo sapiens	IC50	nM	27.5
	18439863	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)C(C)(C)N)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4175297	=	IC50	nM	23.4	CHEMBL3145	Homo sapiens	IC50	nM	23.4
	18439864	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)C2(N)CC2)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4164664	=	IC50	nM	50.0	CHEMBL3145	Homo sapiens	IC50	nM	50.0
	18439865	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)CO)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4160179	=	IC50	nM	85.6	CHEMBL3145	Homo sapiens	IC50	nM	85.6
	18439866	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)[C@@H](C)O)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4168101	=	IC50	nM	57.2	CHEMBL3145	Homo sapiens	IC50	nM	57.2
	18439867	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	CC[C@H](N)C(=O)Nc1nc(C)c(-c2cnc(Cl)c(NS(=O)(=O)c3ccccc3)c2)s1		CHEMBL4168490	=	IC50	nM	82.1	CHEMBL3145	Homo sapiens	IC50	nM	82.1
	18439868	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	CC[C@@H](N)C(=O)Nc1nc(C)c(-c2cnc(Cl)c(NS(=O)(=O)c3ccccc3)c2)s1		CHEMBL4176347	=	IC50	nM	480.5	CHEMBL3145	Homo sapiens	IC50	nM	480.5
	18439869	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4171850	=	IC50	nM	98.8	CHEMBL3145	Homo sapiens	IC50	nM	98.8
	18439870	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4161241	=	IC50	nM	228.8	CHEMBL3145	Homo sapiens	IC50	nM	228.8
	18439871	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)C(N)C2CC2)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4170400	=	IC50	nM	124.2	CHEMBL3145	Homo sapiens	IC50	nM	124.2
	18439872	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)CC(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4159763	=	IC50	nM	119.3	CHEMBL3145	Homo sapiens	IC50	nM	119.3
	18439873	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	CCC(C)[C@H](N)C(=O)Nc1nc(C)c(-c2cnc(Cl)c(NS(=O)(=O)c3ccccc3)c2)s1		CHEMBL4159469	=	IC50	nM	84.2	CHEMBL3145	Homo sapiens	IC50	nM	84.2
	18439874	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)Cc2ccccc2)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4170084	=	IC50	nM	148.5	CHEMBL3145	Homo sapiens	IC50	nM	148.5
	18439875	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccc(C(F)(F)F)cc2)c1		CHEMBL4162831	=	IC50	nM	386.0	CHEMBL3145	Homo sapiens	IC50	nM	386.0
	18439876	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccc(C(C)C)cc2)c1		CHEMBL4173536	=	IC50	nM	317.1	CHEMBL3145	Homo sapiens	IC50	nM	317.1
	18439877	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)c1		CHEMBL4166285	=	IC50	nM	766.4	CHEMBL3145	Homo sapiens	IC50	nM	766.4
	18439878	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccc(-c3ccccc3)cc2)c1		CHEMBL4176901	=	IC50	nM	1761.0	CHEMBL3145	Homo sapiens	IC50	nM	1761.0
	18439879	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2c(F)cccc2F)c1		CHEMBL4169697	=	IC50	nM	62.5	CHEMBL3145	Homo sapiens	IC50	nM	62.5
	18439880	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1ccccc1S(=O)(=O)Nc1cc(-c2sc(NC(=O)[C@@H](N)C(C)C)nc2C)cnc1Cl		CHEMBL4161766	=	IC50	nM	243.7	CHEMBL3145	Homo sapiens	IC50	nM	243.7
	18439881	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1ccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)cc1		CHEMBL4164334	=	IC50	nM	155.9	CHEMBL3145	Homo sapiens	IC50	nM	155.9
	18439882	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	IC50	nM	284.0	CHEMBL3145	Homo sapiens	IC50	nM	284.0
	18439883	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2Cl)c1		CHEMBL4160624	=	IC50	nM	34.7	CHEMBL3145	Homo sapiens	IC50	nM	34.7
	18439884	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2cccc(Cl)c2)c1		CHEMBL4168546	=	IC50	nM	307.5	CHEMBL3145	Homo sapiens	IC50	nM	307.5
	18439885	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccc(Cl)cc2)c1		CHEMBL4175738	=	IC50	nM	201.5	CHEMBL3145	Homo sapiens	IC50	nM	201.5
	18439886	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2cccc(Cl)c2Cl)c1		CHEMBL4165122	=	IC50	nM	28.4	CHEMBL3145	Homo sapiens	IC50	nM	28.4
	18439887	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccc(Cl)cc2Cl)c1		CHEMBL4167465	=	IC50	nM	92.3	CHEMBL3145	Homo sapiens	IC50	nM	92.3
	18439888	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2cc(Cl)ccc2Cl)c1		CHEMBL4175347	=	IC50	nM	7.3	CHEMBL3145	Homo sapiens	IC50	nM	7.3
	18439889	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccc(Cl)c(Cl)c2)c1		CHEMBL4164028	=	IC50	nM	109.3	CHEMBL3145	Homo sapiens	IC50	nM	109.3
	18439890	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	845.5	CHEMBL3145	Homo sapiens	IC50	nM	845.5
	18439891	CHEMBL4156825	Inhibition of PI3Kbeta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	181.0	CHEMBL3145	Homo sapiens	IC50	nM	181.0
	18440382	CHEMBL4157206	Binding affinity to wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	14.0	CHEMBL3145	Homo sapiens	Activity	%	14.0
	18448452	CHEMBL4158818	Inhibition of p110beta in HUVEC assessed as inhibition of S1P-induced response at 10 uM	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cc(NS(C)(=O)=O)cc6[nH]ccc56)c34)n(-c3ccccc3)c(=O)c12		CHEMBL4167561	=	Inhibition	%	61.0	CHEMBL3145	Homo sapiens	INH	%	61.0
	18484338	CHEMBL4185985	Binding affinity to wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL3145	Homo sapiens	Activity	%	100.0
	18484822	CHEMBL4185985	Binding affinity to wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	50.0	CHEMBL3145	Homo sapiens	Activity	%	50.0
	18518771	CHEMBL4193535	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate by HTRF colorimetric assay	B	COc1ncc(-c2ccc3ncc(C(=O)NCCN4CCOCC4)n3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4213353	=	IC50	nM	89.0	CHEMBL3145	Homo sapiens	IC50	nM	89.0
	18518772	CHEMBL4193535	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate by HTRF colorimetric assay	B	COc1ncc(-c2ccc3ncc(C(=O)NCCCN4CCOCC4)n3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4207685	=	IC50	nM	106.0	CHEMBL3145	Homo sapiens	IC50	nM	106.0
	18518773	CHEMBL4193535	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate by HTRF colorimetric assay	B	COc1ncc(-c2ccc3ncn(CCCN4CCOCC4)c(=O)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4207150	=	IC50	nM	108.0	CHEMBL3145	Homo sapiens	IC50	nM	108.0
	18518774	CHEMBL4193535	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate by HTRF colorimetric assay	B	CCOC(=O)c1cnc2ccc(-c3cncc(NS(=O)(=O)c4ccccc4)c3)cn12		CHEMBL1765463	=	IC50	nM	59.0	CHEMBL3145	Homo sapiens	IC50	nM	59.0
	18521175	CHEMBL4193873	Inhibition of recombinant human PI3K p110beta using PIP2/PS as substrate after 1 hr by ADP-Glo luminescence assay	B	O=S(=O)(Nc1cc(-c2cnc3[nH]ccc3c2)cnc1Cl)c1ccccc1		CHEMBL4214320	=	IC50	nM	35.0	CHEMBL3145	Homo sapiens	IC50	nM	35.0
	18521176	CHEMBL4193873	Inhibition of recombinant human PI3K p110beta using PIP2/PS as substrate after 1 hr by ADP-Glo luminescence assay	B	O=S(=O)(Nc1cc(-c2cnc3[nH]ncc3c2)cnc1Cl)c1ccccc1		CHEMBL4204119	=	IC50	nM	29.0	CHEMBL3145	Homo sapiens	IC50	nM	29.0
	18521177	CHEMBL4193873	Inhibition of recombinant human PI3K p110beta using PIP2/PS as substrate after 1 hr by ADP-Glo luminescence assay	B	O=S(=O)(Nc1cc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4204586	=	IC50	nM	39.0	CHEMBL3145	Homo sapiens	IC50	nM	39.0
	18521178	CHEMBL4193873	Inhibition of recombinant human PI3K p110beta using PIP2/PS as substrate after 1 hr by ADP-Glo luminescence assay	B	O=S(=O)(Nc1cc(-c2cnc3[nH]nc(-c4ccccc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4216255	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
	18521179	CHEMBL4193873	Inhibition of recombinant human PI3K p110beta using PIP2/PS as substrate after 1 hr by ADP-Glo luminescence assay	B	O=S(=O)(Nc1cc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4217725	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	nM	2.0
	18521180	CHEMBL4193873	Inhibition of recombinant human PI3K p110beta using PIP2/PS as substrate after 1 hr by ADP-Glo luminescence assay	B	O=S(=O)(Nc1cc(-c2cnc3[nH]nc(-c4ccncc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4212775	=	IC50	nM	4.0	CHEMBL3145	Homo sapiens	IC50	nM	4.0
	18521181	CHEMBL4193873	Inhibition of recombinant human PI3K p110beta using PIP2/PS as substrate after 1 hr by ADP-Glo luminescence assay	B	O=S(=O)(Nc1cc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)cnc1Cl)c1ccccc1F		CHEMBL4213317	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
	18521182	CHEMBL4193873	Inhibition of recombinant human PI3K p110beta using PIP2/PS as substrate after 1 hr by ADP-Glo luminescence assay	B	O=S(=O)(Nc1cc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)cnc1Cl)c1ccc(F)cc1		CHEMBL4208385	=	IC50	nM	2.0	CHEMBL3145	Homo sapiens	IC50	nM	2.0
	18536355	CHEMBL4196436	Inhibition of PI3K p110beta (unknown origin) using PIP2 as substrate by ELISA	B	CCS(=O)(=O)Nc1cc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cnc1OC		CHEMBL4207750	=	IC50	nM	9412.0	CHEMBL3145	Homo sapiens	IC50	nM	9412.0
	18536356	CHEMBL4196436	Inhibition of PI3K p110beta (unknown origin) using PIP2 as substrate by ELISA	B	CCS(=O)(=O)Nc1cc(-c2ccc3ncnc(Nc4cccc(C(=O)OC)c4)c3c2)cnc1OC		CHEMBL4206585	=	IC50	nM	4936.0	CHEMBL3145	Homo sapiens	IC50	nM	4936.0
Not Determined	18536357	CHEMBL4196436	Inhibition of PI3K p110beta (unknown origin) using PIP2 as substrate by ELISA	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		IC50			CHEMBL3145	Homo sapiens	IC50		
	18536358	CHEMBL4196436	Inhibition of PI3K p110beta (unknown origin) using PIP2 as substrate by ELISA	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	35.9	CHEMBL3145	Homo sapiens	IC50	nM	35.9
	18556314	CHEMBL4200471	Inhibition of recombinant human PI3Kbeta using PIP2 as substrate pretreated for 20 mins followed by substrate addition and measured after 80 mins by luminescence assay	B	C[C@H](Nc1c(C(N)=O)nnc2ccc(-c3ccc(OCCCN(C)C)nc3)cc12)C1CCOCC1		CHEMBL4217549	=	IC50	nM	8100.0	CHEMBL3145	Homo sapiens	IC50	uM	8.1
	18556315	CHEMBL4200471	Inhibition of recombinant human PI3Kbeta using PIP2 as substrate pretreated for 20 mins followed by substrate addition and measured after 80 mins by luminescence assay	B	CNC(=O)c1nnc2ccc(-c3ccc(OCCCN(C)C)nc3)cc2c1N[C@@H](C)C1CCOCC1		CHEMBL4218854	=	IC50	nM	10300.0	CHEMBL3145	Homo sapiens	IC50	uM	10.3
	18556326	CHEMBL4200477	Inhibition of PI3Kbeta in human MDA-MB-231 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by fluorescence assay	B	C[C@H](Nc1c(C(N)=O)nnc2ccc(-c3ccc(OCCCN(C)C)nc3)cc12)C1CCOCC1		CHEMBL4217549	>	IC50	nM	15000.0	CHEMBL3145	Homo sapiens	IC50	uM	15.0
	18556327	CHEMBL4200477	Inhibition of PI3Kbeta in human MDA-MB-231 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by fluorescence assay	B	CNC(=O)c1nnc2ccc(-c3ccc(OCCCN(C)C)nc3)cc2c1N[C@@H](C)C1CCOCC1		CHEMBL4218854	>	IC50	nM	19000.0	CHEMBL3145	Homo sapiens	IC50	uM	19.0
	18569198	CHEMBL4220373	Inhibition of recombinant human N-terminal GST-tagged PI3Kbeta catalytic domain (155 to 1383 residues) expressed in baculovirus expression system using PIP2 as substrate measured after 1 hr by Kinase-Glo luminescence assay	B	COc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4226082	=	IC50	nM	1.2	CHEMBL3145	Homo sapiens	IC50	nM	1.2
	18569199	CHEMBL4220373	Inhibition of recombinant human N-terminal GST-tagged PI3Kbeta catalytic domain (155 to 1383 residues) expressed in baculovirus expression system using PIP2 as substrate measured after 1 hr by Kinase-Glo luminescence assay	B	COc1ncc(-c2cc3c(C)nc(NC(C)=O)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4228946	=	IC50	nM	3.4	CHEMBL3145	Homo sapiens	IC50	nM	3.4
	18573349	CHEMBL4221485	Inhibition of PI3K-beta (unknown origin) by cell free biochemical assay	B	Cc1ccccc1-n1c(Cn2cc(-c3ccccc3)nn2)nc2cccc(C)c2c1=O	Outside typical range	CHEMBL4229035	=	IC50	nM	430000.0	CHEMBL3145	Homo sapiens	IC50	uM	430.0
	18573350	CHEMBL4221485	Inhibition of PI3K-beta (unknown origin) by cell free biochemical assay	B	COc1ccc(-c2cn(Cc3nc4cccc(C)c4c(=O)n3-c3ccccc3C)nn2)c(C)c1	Outside typical range	CHEMBL4228200	=	IC50	nM	355000.0	CHEMBL3145	Homo sapiens	IC50	uM	355.0
	18573351	CHEMBL4221485	Inhibition of PI3K-beta (unknown origin) by cell free biochemical assay	B	Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O	Outside typical range	CHEMBL1213082	=	IC50	nM	200000.0	CHEMBL3145	Homo sapiens	IC50	uM	200.0
	18578148	CHEMBL4222371	Inhibition of PI3K p110beta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CC5)C4)c3c2)cn1		CHEMBL4228563	=	IC50	nM	220.3	CHEMBL3145	Homo sapiens	IC50	nM	220.3
	18578149	CHEMBL4222371	Inhibition of PI3K p110beta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	120.1	CHEMBL3145	Homo sapiens	IC50	nM	120.1
	18578196	CHEMBL4222371	Inhibition of PI3K p110beta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3c2)cc1C#N		CHEMBL4227381	=	IC50	nM	263.8	CHEMBL3145	Homo sapiens	IC50	nM	263.8
	18578197	CHEMBL4222371	Inhibition of PI3K p110beta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3c2)cc1[N+](=O)[O-]		CHEMBL4228571	=	IC50	nM	584.5	CHEMBL3145	Homo sapiens	IC50	nM	584.5
	18580284	CHEMBL4222684	Inhibition of PI3Kbeta (unknown origin)	B	CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4)n3)c2c1		CHEMBL4228654	=	IC50	nM	360.0	CHEMBL3145	Homo sapiens	IC50	uM	0.36
	18580311	CHEMBL4222705	Inhibition of PI3Kbeta (unknown origin) at 1 uM	B	CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4)n3)c2c1		CHEMBL4228654	>	Inhibition	%	70.0	CHEMBL3145	Homo sapiens	INH	%	70.0
	18653439	CHEMBL4230184	Inhibition of PI3K-beta (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	1.0	CHEMBL3145	Homo sapiens	INH	%	1.0
	18653440	CHEMBL4230184	Inhibition of PI3K-beta (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	-5.0	CHEMBL3145	Homo sapiens	INH	%	-5.0
	18655350	CHEMBL4230885	Binding affinity to wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL3145	Homo sapiens	Activity	%	100.0
	18658771	CHEMBL4231679	Inhibition of PI3Kbeta (unknown origin) using Biotin-S11S12 as substrate after 60 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1cccc(C)c1-n1c(Cn2nc(-c3ccc4[nH]ccc4c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4245221	=	IC50	nM	3369.0	CHEMBL3145	Homo sapiens	IC50	nM	3369.0
	18658772	CHEMBL4231679	Inhibition of PI3Kbeta (unknown origin) using Biotin-S11S12 as substrate after 60 mins in presence of ATP by ADPGlo luminescence assay	B	COc1ccc(-c2nn(Cc3nc4cccc(F)c4c(=O)n3-c3c(C)cccc3C)c3ncnc(N)c23)cc1OC		CHEMBL4249477	=	IC50	nM	6955.0	CHEMBL3145	Homo sapiens	IC50	nM	6955.0
	18658773	CHEMBL4231679	Inhibition of PI3Kbeta (unknown origin) using Biotin-S11S12 as substrate after 60 mins in presence of ATP by ADPGlo luminescence assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	129.0	CHEMBL3145	Homo sapiens	IC50	nM	129.0
	18664636	CHEMBL4233124	Inhibition of recombinant human PI3K-beta using PIP2:3PS as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by ADP-Glo assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	35.9	CHEMBL3145	Homo sapiens	IC50	nM	35.9
	18664637	CHEMBL4233124	Inhibition of recombinant human PI3K-beta using PIP2:3PS as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by ADP-Glo assay	B	COc1ncc(-c2ccc3c(c2)N(CCCN2CCOCC2)C(=O)CO3)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4251210	=	IC50	nM	382.3	CHEMBL3145	Homo sapiens	IC50	nM	382.3
	18673659	CHEMBL4235175	Inhibition of PI3Kbeta (unknown origin)	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
	18673660	CHEMBL4235175	Inhibition of PI3Kbeta (unknown origin)	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	=	IC50	nM	63.0	CHEMBL3145	Homo sapiens	IC50	nM	63.0
	18694017	CHEMBL4253470	Inhibition of PI3K beta (unknown origin) at 0.1 uM by ADP-Glo assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	18694099	CHEMBL4253552	Inhibition of PI3K beta (unknown origin) at 1 uM by ADP-Glo assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	11.0	CHEMBL3145	Homo sapiens	INH	%	11.0
	18751194	CHEMBL4263903	Inhibition of PI3K-BETA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	6.0	CHEMBL3145	Homo sapiens	INH	%	6.0
	18752137	CHEMBL4264474	Binding affinity to wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL3145	Homo sapiens	Activity	%	100.0
	18771138	CHEMBL4268352	Inhibition of PI3Kbeta (unknown origin) after 40 mins by kinase-Glo reagent based luminescence assay	B	Oc1ccc(-c2n[nH]cc2-c2ccc(Cl)c(Cl)c2)c(O)c1O		CHEMBL4280001	=	EC50	nM	5700.0	CHEMBL3145	Homo sapiens	EC50	uM	5.7
	18771179	CHEMBL4268352	Inhibition of PI3Kbeta (unknown origin) after 40 mins by kinase-Glo reagent based luminescence assay	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	EC50	nM	44.0	CHEMBL3145	Homo sapiens	EC50	uM	0.044
	18771192	CHEMBL4268352	Inhibition of PI3Kbeta (unknown origin) after 40 mins by kinase-Glo reagent based luminescence assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	EC50	nM	15.0	CHEMBL3145	Homo sapiens	EC50	uM	0.015
	18780187	CHEMBL4269916	Binding affinity to human PI3Kbeta after 1 hr by KINOMEscan assay	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Kd	nM	7.6	CHEMBL3145	Homo sapiens	Kd	nM	7.6
	18780188	CHEMBL4269916	Binding affinity to human PI3Kbeta after 1 hr by KINOMEscan assay	B	CO/C=C/C(=O)c1cc2c3c(c(N)cc(NC(=O)C(C)C)c3n1)N=C2		CHEMBL4293970	=	Kd	nM	5.7	CHEMBL3145	Homo sapiens	Kd	nM	5.7
	18797209	CHEMBL4273926	Inhibition of PI3K-beta (unknown origin) after 40 mins by Kinase-Glo assay	A	Fc1ccccc1-c1cc2nc(-c3ccco3)c(-c3ccco3)nc2cc1Br		CHEMBL4291904	=	EC50	nM	3340.0	CHEMBL3145	Homo sapiens	EC50	uM	3.34
	18797210	CHEMBL4273926	Inhibition of PI3K-beta (unknown origin) after 40 mins by Kinase-Glo assay	A	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	EC50	nM	44.0	CHEMBL3145	Homo sapiens	EC50	uM	0.044
	18797211	CHEMBL4273926	Inhibition of PI3K-beta (unknown origin) after 40 mins by Kinase-Glo assay	A	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	EC50	nM	15.0	CHEMBL3145	Homo sapiens	EC50	uM	0.015
	18813243	CHEMBL4276431	Inhibition of human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	Nc1cc(C(F)F)c(-c2nc(N3C4CCC3COC4)nc(N3C4CCC3COC4)n2)cn1		CHEMBL4286698	=	Kd	nM	22000.0	CHEMBL3145	Homo sapiens	Kd	nM	22000.0
	18813244	CHEMBL4276431	Inhibition of human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21		CHEMBL3545097	=	Kd	nM	81.0	CHEMBL3145	Homo sapiens	Kd	nM	81.0
	18813245	CHEMBL4276431	Inhibition of human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	CCC(CC)n1cnc2c(-c3cnc(N)cn3)nc(N3CC4CCC(C3)O4)nc21		CHEMBL4279703	=	Kd	nM	20000.0	CHEMBL3145	Homo sapiens	Kd	nM	20000.0
	18813246	CHEMBL4276431	Inhibition of human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	120.0	CHEMBL3145	Homo sapiens	Kd	nM	120.0
	18813247	CHEMBL4276431	Inhibition of human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	CO[C@H]1CC[C@H](N2C(=O)CNc3ncc(-c4ccc(C(C)(C)O)nc4)nc32)CC1		CHEMBL3586404	=	Kd	nM	18000.0	CHEMBL3145	Homo sapiens	Kd	nM	18000.0
	18813248	CHEMBL4276431	Inhibition of human PI3Kbeta (118 to 1070 residues) expressed in mammalian expression system by KINOMEscan assay	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	=	Kd	nM	3300.0	CHEMBL3145	Homo sapiens	Kd	nM	3300.0
	18851032	CHEMBL4305778	Inhibition of PI3K beta (unknown origin) using lipid substrate measured after 40 mins in presence of ATP by Kinase-Glo plus reagent based luminescence assay	B	COc1ncc(-c2ccc3ncnc(NCCN4CCOCC4)c3c2)cc1NS(C)(=O)=O		CHEMBL4439145	=	IC50	nM	16.0	CHEMBL3145	Homo sapiens	IC50	nM	16.0
	18851033	CHEMBL4305778	Inhibition of PI3K beta (unknown origin) using lipid substrate measured after 40 mins in presence of ATP by Kinase-Glo plus reagent based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCN(C(C)=O)C4)c3c2)cc1NS(C)(=O)=O		CHEMBL4449091	=	IC50	nM	5.0	CHEMBL3145	Homo sapiens	IC50	nM	5.0
	18851034	CHEMBL4305778	Inhibition of PI3K beta (unknown origin) using lipid substrate measured after 40 mins in presence of ATP by Kinase-Glo plus reagent based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3c2)cc1NS(C)(=O)=O		CHEMBL4542688	=	IC50	nM	5.6	CHEMBL3145	Homo sapiens	IC50	nM	5.6
	18851035	CHEMBL4305778	Inhibition of PI3K beta (unknown origin) using lipid substrate measured after 40 mins in presence of ATP by Kinase-Glo plus reagent based luminescence assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	421.0	CHEMBL3145	Homo sapiens	IC50	nM	421.0
	18851036	CHEMBL4305778	Inhibition of PI3K beta (unknown origin) using lipid substrate measured after 40 mins in presence of ATP by Kinase-Glo plus reagent based luminescence assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	134.0	CHEMBL3145	Homo sapiens	IC50	nM	134.0
	18858138	CHEMBL4307984	Binding affinity to wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	89.0	CHEMBL3145	Homo sapiens	Activity	%	89.0
	18861733	CHEMBL4308956	Inhibition of PI3K p110beta (unknown origin)	B	CC(C)C(=O)CN1c2nc(N3CCOC[C@H]3C)cc(=O)n2CC[C@H]1C(F)(F)F		CHEMBL4586628	=	IC50	nM	4500.0	CHEMBL3145	Homo sapiens	IC50	uM	4.5
	18861734	CHEMBL4308956	Inhibition of PI3K p110beta (unknown origin)	B	CS(=O)(=O)O.CS(=O)(=O)O.O.O.c1cnc2ccc(Nc3nc(NC4CC4)c4nc[nH]c4n3)cc2c1		CHEMBL4545915	=	IC50	nM	699.4	CHEMBL3145	Homo sapiens	IC50	nM	699.4
	18861746	CHEMBL4308951	Inhibition of wild type human PI3K p110beta using PIP2 as substrate by TR-FRET assay	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	=	IC50	nM	6.0	CHEMBL3145	Homo sapiens	IC50	nM	6.0
	18882267	CHEMBL4312258	Inhibition of recombinant human PIK3CB using PIP2 as substrate incubated for 1 hr by ADP-glo assay	B	COc1ncc(-c2cc(OCCCCCCC(=O)NO)c3ncnc(C)c3c2)cc1F		CHEMBL4536105	=	IC50	nM	101.0	CHEMBL3145	Homo sapiens	IC50	nM	101.0
	18882268	CHEMBL4312258	Inhibition of recombinant human PIK3CB using PIP2 as substrate incubated for 1 hr by ADP-glo assay	B	COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1		CHEMBL3622533	=	IC50	nM	16.0	CHEMBL3145	Homo sapiens	IC50	nM	16.0
	18882269	CHEMBL4312258	Inhibition of recombinant human PIK3CB using PIP2 as substrate incubated for 1 hr by ADP-glo assay	B	COc1ccc(-c2cc(OCCN(C)c3ncc(C(=O)NO)cn3)c3ncnc(C)c3c2)cn1		CHEMBL4462577	=	IC50	nM	279.0	CHEMBL3145	Homo sapiens	IC50	nM	279.0
	18918187	CHEMBL4322505	Binding affinity to human wild-type partial length PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system by kinome scan assay	B	C[C@@H]1COCCN1c1nc(-c2ccc(N)nc2)nc2c1C[C@@H]1COCCN21		CHEMBL4594206	=	Kd	nM	4100.0	CHEMBL3145	Homo sapiens	Kd	nM	4100.0
	18918188	CHEMBL4322505	Binding affinity to human wild-type partial length PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system by kinome scan assay	B	C[C@@H]1COCCN1c1nc(-c2cnc(N)nc2)nc2c1C[C@@H]1COCCN21		CHEMBL4436124	=	Kd	nM	1400.0	CHEMBL3145	Homo sapiens	Kd	nM	1400.0
	18918189	CHEMBL4322505	Binding affinity to human wild-type partial length PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system by kinome scan assay	B	C[C@@H]1COCCN1c1nc(-c2cnc(N)cn2)nc2c1C[C@@H]1COCCN21		CHEMBL4551080	=	Kd	nM	7500.0	CHEMBL3145	Homo sapiens	Kd	nM	7500.0
	18918190	CHEMBL4322505	Binding affinity to human wild-type partial length PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system by kinome scan assay	B	Nc1cc(C(F)F)c(-c2nc(N3C4CCC3COC4)nc(N3C4CCC3COC4)n2)cn1		CHEMBL4286698	=	Kd	nM	22000.0	CHEMBL3145	Homo sapiens	Kd	nM	22000.0
	18929648	CHEMBL4325322	Binding affinity to PI3Kbeta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	A	COc1ncc(-c2cc3c(c(OCCN4CCC(C(C)(C)O)CC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4556087	=	Kd	nM	50.12	CHEMBL3145	Homo sapiens	pKd(app)		7.3
	18929649	CHEMBL4325322	Binding affinity to PI3Kbeta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	A	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@H]4CN(C5COC5)CCO4)c2)COC3)cnc1OC		CHEMBL4579923	=	Kd	nM	158.49	CHEMBL3145	Homo sapiens	pKd(app)		6.8
Active	18933159	CHEMBL4326471	Inhibition of partial length human PI3Kbeta expressed in mammalian system at 10 uM by active site-directed competition binding based KINOMEscan assay	B	Cc1nc2c(-c3nnc[nH]3)cc(-c3ccnc(N)c3F)cc2n1-c1ccnc2c(F)ccc(F)c12		CHEMBL4470860		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	18952521	CHEMBL4331750	Inhibition of PI3Kbeta (unknown origin)	B	C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3039502	=	IC50	nM	85.0	CHEMBL3145	Homo sapiens	IC50	nM	85.0
	18952522	CHEMBL4331750	Inhibition of PI3Kbeta (unknown origin)	B	O=C1NC(=O)/C(=C/c2ccc3nccnc3c2)S1		CHEMBL568150	=	IC50	nM	2700.0	CHEMBL3145	Homo sapiens	IC50	nM	2700.0
	18952523	CHEMBL4331750	Inhibition of PI3Kbeta (unknown origin)	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	IC50	nM	1200.0	CHEMBL3145	Homo sapiens	IC50	nM	1200.0
	18952524	CHEMBL4331750	Inhibition of PI3Kbeta (unknown origin)	B	C[C@H](NC(=O)c1c(N)nn2cccnc12)c1cc2cccc(C#Cc3cnn(C)c3)c2c(=O)n1-c1ccccc1		CHEMBL3984425	=	IC50	nM	82.0	CHEMBL3145	Homo sapiens	IC50	nM	82.0
	18958622	CHEMBL4333569	Binding affinity to wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	90.0	CHEMBL3145	Homo sapiens	Activity	%	90.0
	18993977	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccccc3)cc12		CHEMBL4532366	=	IC50	nM	32650.0	CHEMBL3145	Homo sapiens	IC50	uM	32.65
	18993978	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	Cc1ccc(S(=O)(=O)n2cc3c(=O)oc4ccccc4c3n2)cc1		CHEMBL4520000	=	IC50	nM	4640.0	CHEMBL3145	Homo sapiens	IC50	uM	4.64
	18993979	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	COc1ccc(S(=O)(=O)n2cc3c(=O)oc4ccccc4c3n2)cc1		CHEMBL4573905	=	IC50	nM	22650.0	CHEMBL3145	Homo sapiens	IC50	uM	22.65
	18993980	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	CC(C)(C)c1ccc(S(=O)(=O)n2cc3c(=O)oc4ccccc4c3n2)cc1		CHEMBL4518471	=	IC50	nM	20840.0	CHEMBL3145	Homo sapiens	IC50	uM	20.84
	18993981	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccc(F)cc3)cc12		CHEMBL4581364	=	IC50	nM	67920.0	CHEMBL3145	Homo sapiens	IC50	uM	67.92
	18993982	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccc(Cl)cc3)cc12		CHEMBL4451925	=	IC50	nM	54870.0	CHEMBL3145	Homo sapiens	IC50	uM	54.87
	18993983	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccc(Br)cc3)cc12		CHEMBL4586115	=	IC50	nM	56740.0	CHEMBL3145	Homo sapiens	IC50	uM	56.74
	18993984	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccccc3[N+](=O)[O-])cc12		CHEMBL4536655	=	IC50	nM	22840.0	CHEMBL3145	Homo sapiens	IC50	uM	22.84
	18993985	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3cccc([N+](=O)[O-])c3)cc12		CHEMBL4545402	=	IC50	nM	18660.0	CHEMBL3145	Homo sapiens	IC50	uM	18.66
	18993986	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccc([N+](=O)[O-])cc3)cc12		CHEMBL4440911	=	IC50	nM	9580.0	CHEMBL3145	Homo sapiens	IC50	uM	9.58
	18993987	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4451013	=	IC50	nM	11320.0	CHEMBL3145	Homo sapiens	IC50	uM	11.32
	18993988	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	Cc1ccc(C)c(S(=O)(=O)n2cc3c(=O)oc4ccccc4c3n2)c1		CHEMBL4469594	=	IC50	nM	1680.0	CHEMBL3145	Homo sapiens	IC50	uM	1.68
	18993989	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccc(Cl)c([N+](=O)[O-])c3)cc12		CHEMBL4566022	=	IC50	nM	2490.0	CHEMBL3145	Homo sapiens	IC50	uM	2.49
	18993990	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	Cc1cc(C)c(S(=O)(=O)n2cc3c(=O)oc4ccccc4c3n2)c(C)c1		CHEMBL4591567	=	IC50	nM	1130.0	CHEMBL3145	Homo sapiens	IC50	uM	1.13
	18993991	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	CC(C)c1cc(C(C)C)c(S(=O)(=O)n2cc3c(=O)oc4ccccc4c3n2)c(C(C)C)c1		CHEMBL4532073	=	IC50	nM	900.0	CHEMBL3145	Homo sapiens	IC50	uM	0.9
	18993992	CHEMBL4341860	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	980.0	CHEMBL3145	Homo sapiens	IC50	uM	0.98
	19054043	CHEMBL4356091	Inhibition of human PIK3CB by alphascreen assay	B	Cc1cc([C@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3979323	=	IC50	nM	2300.0	CHEMBL3145	Homo sapiens	IC50	uM	2.3
	19054044	CHEMBL4356091	Inhibition of human PIK3CB by alphascreen assay	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	=	IC50	nM	40.0	CHEMBL3145	Homo sapiens	IC50	uM	0.04
	19054046	CHEMBL4356084	Inhibition of His-tagged recombinant human PIK3CB	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	4000.0	CHEMBL3145	Homo sapiens	IC50	uM	4.0
	19059762	CHEMBL4358063	Binding affinity to wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL3145	Homo sapiens	Activity	%	100.0
	19078292	CHEMBL4363189	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	CC(C)(C)c1ccc(S(=O)(=O)N2CCN(Cn3cc4c(=O)oc5ccccc5c4n3)CC2)cc1		CHEMBL4519664	=	IC50	nM	2650.0	CHEMBL3145	Homo sapiens	IC50	uM	2.65
	19078293	CHEMBL4363189	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4ccc(F)cc4)CC3)cc12		CHEMBL4513423	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	19078294	CHEMBL4363189	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4ccc(Cl)cc4)CC3)cc12		CHEMBL4441408	=	IC50	nM	2190.0	CHEMBL3145	Homo sapiens	IC50	uM	2.19
	19078295	CHEMBL4363189	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4ccc(Br)cc4)CC3)cc12		CHEMBL4540508	=	IC50	nM	9710.0	CHEMBL3145	Homo sapiens	IC50	uM	9.71
	19078296	CHEMBL4363189	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)CC3)cc12		CHEMBL4568307	=	IC50	nM	4140.0	CHEMBL3145	Homo sapiens	IC50	uM	4.14
	19078297	CHEMBL4363189	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4cccc([N+](=O)[O-])c4)CC3)cc12		CHEMBL4469318	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	19078298	CHEMBL4363189	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4ccccc4[N+](=O)[O-])CC3)cc12		CHEMBL4593416	=	IC50	nM	9140.0	CHEMBL3145	Homo sapiens	IC50	uM	9.14
	19078299	CHEMBL4363189	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4ccc(C(F)(F)F)cc4)CC3)cc12		CHEMBL4452143	=	IC50	nM	5750.0	CHEMBL3145	Homo sapiens	IC50	uM	5.75
	19078300	CHEMBL4363189	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	Cc1ccc(C)c(S(=O)(=O)N2CCN(Cn3cc4c(=O)oc5ccccc5c4n3)CC2)c1		CHEMBL4445433	=	IC50	nM	850.0	CHEMBL3145	Homo sapiens	IC50	uM	0.85
	19078301	CHEMBL4363189	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4ccc(Cl)c([N+](=O)[O-])c4)CC3)cc12		CHEMBL4468039	=	IC50	nM	120.0	CHEMBL3145	Homo sapiens	IC50	uM	0.12
	19078302	CHEMBL4363189	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	Cc1cc(C)c(S(=O)(=O)N2CCN(Cn3cc4c(=O)oc5ccccc5c4n3)CC2)c(C)c1		CHEMBL4437551	=	IC50	nM	410.0	CHEMBL3145	Homo sapiens	IC50	uM	0.41
	19078303	CHEMBL4363189	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	CC(C)c1cc(C(C)C)c(S(=O)(=O)N2CCN(Cn3cc4c(=O)oc5ccccc5c4n3)CC2)c(C(C)C)c1		CHEMBL4448759	=	IC50	nM	210.0	CHEMBL3145	Homo sapiens	IC50	uM	0.21
	19078304	CHEMBL4363189	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	980.0	CHEMBL3145	Homo sapiens	IC50	uM	0.98
	19078305	CHEMBL4363189	Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	64.0	CHEMBL3145	Homo sapiens	IC50	uM	0.064
	19090327	CHEMBL4365901	Inhibition of wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL3145	Homo sapiens	Activity	%	100.0
	19107018	CHEMBL4369713	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate after 2 hrs by ADP-Glo assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	281.0	CHEMBL3145	Homo sapiens	IC50	nM	281.0
	19107019	CHEMBL4369713	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate after 2 hrs by ADP-Glo assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(F)c2c(=O)n1C1CCCC1		CHEMBL4591557	=	IC50	nM	1554.0	CHEMBL3145	Homo sapiens	IC50	nM	1554.0
	19107020	CHEMBL4369713	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate after 2 hrs by ADP-Glo assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(F)c2c(=O)n1Cc1ccccc1		CHEMBL4592798	=	IC50	nM	6237.0	CHEMBL3145	Homo sapiens	IC50	nM	6237.0
	19112766	CHEMBL4370796	Inhibition of recombinant human PI3Kbeta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4ccnc(NCC5CCOCC5)c4)c3C2)cc1C		CHEMBL4467692	=	IC50	nM	8900.0	CHEMBL3145	Homo sapiens	IC50	nM	8900.0
	19112767	CHEMBL4370796	Inhibition of recombinant human PI3Kbeta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4ccnc(NC5CCOCC5)c4)c3C2)cc1C		CHEMBL4554894	=	IC50	nM	5400.0	CHEMBL3145	Homo sapiens	IC50	nM	5400.0
	19112768	CHEMBL4370796	Inhibition of recombinant human PI3Kbeta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COCC(=O)N1CCC(Nc2cc(-c3ncnc4c3CN(c3cnc(OC)c(C)c3)CC4)ccn2)CC1		CHEMBL4530810	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	19112769	CHEMBL4370796	Inhibition of recombinant human PI3Kbeta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4ccnc(NC5CCN(C)CC5)c4)c3C2)cc1C		CHEMBL4453747	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	19112770	CHEMBL4370796	Inhibition of recombinant human PI3Kbeta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4ccnc(NC5CCNCC5)c4)c3C2)cc1C		CHEMBL4514389	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	19112771	CHEMBL4370796	Inhibition of recombinant human PI3Kbeta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	CCN1CCC(Nc2cc(-c3ncnc4c3CN(c3cnc(OC)c(C)c3)CC4)ccn2)CC1		CHEMBL4528263	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	19133339	CHEMBL4375327	Binding affinity to wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system measured after 1 hr by kinomescan method	B	O=C(Nc1ccc2cc(C(=O)Nc3nccs3)ccc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL4445812	=	Kd	nM	7110.0	CHEMBL3145	Homo sapiens	Kd	uM	7.11
	19139804	CHEMBL4376367	Inhibition of PI3Kbeta (unknown origin)	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	3.0	CHEMBL3145	Homo sapiens	IC50	nM	3.0
	19139809	CHEMBL4376362	Reversible competitive inhibition of PI3K p110beta (unknown origin)	B	COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1		CHEMBL3360203	=	IC50	nM	36.0	CHEMBL3145	Homo sapiens	IC50	nM	36.0
	19139814	CHEMBL4376358	Inhibition of PI3K p110beta (unknown origin)	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	=	IC50	nM	113.0	CHEMBL3145	Homo sapiens	IC50	nM	113.0
	19139817	CHEMBL4376371	Competitive inhibition of PI3Kbeta (unknown origin)	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	44.0	CHEMBL3145	Homo sapiens	IC50	nM	44.0
	19139822	CHEMBL4376358	Inhibition of PI3K p110beta (unknown origin)	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	=	IC50	nM	166.0	CHEMBL3145	Homo sapiens	IC50	nM	166.0
	19139824	CHEMBL4376367	Inhibition of PI3Kbeta (unknown origin)	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	=	IC50	nM	3.7	CHEMBL3145	Homo sapiens	IC50	nM	3.7
	19151937	CHEMBL4380329	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo plus luminescence assay	B	Nc1cc(C(F)(F)F)c(-c2nc3c(c(N4CCOCC4)n2)CCN(C(=O)c2cc(Cc4n[nH]c(=O)c5ccccc45)ccc2F)C3)cn1		CHEMBL4470724	=	IC50	nM	288.4	CHEMBL3145	Homo sapiens	pIC50		6.54
	19151938	CHEMBL4380329	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo plus luminescence assay	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	=	IC50	nM	165.96	CHEMBL3145	Homo sapiens	pIC50		6.78
	19156948	CHEMBL4381557	Inhibition of PI3Kbeta (unknown origin)	B	C[C@H]1COCCN1c1nc(N2CCOC[C@H]2C)c2nc(-c3cc[nH]n3)sc2n1		CHEMBL4518369	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	19156949	CHEMBL4381557	Inhibition of PI3Kbeta (unknown origin)	B	C[C@H]1COCCN1c1nc(N2CCOC[C@H]2C)c2nc(-c3cccc4[nH]ccc34)[nH]c2n1		CHEMBL4514031	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	19159590	CHEMBL4382694	Binding affinity to wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	100.0	CHEMBL3145	Homo sapiens	Activity	%	100.0
	19172338	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	COc1ncc(C2=CCOCC2)cc1NS(=O)(=O)c1cn(Cc2ccccc2)c(C)n1		CHEMBL4435246	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
	19172339	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	COc1ncc(C2=CCOCC2)cc1NS(=O)(=O)c1ccccc1		CHEMBL4469876	=	IC50	nM	398.11	CHEMBL3145	Homo sapiens	pIC50		6.4
	19172340	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	O=S(=O)(Nc1cc(-c2ccccc2)cnc1Cl)c1ccccc1		CHEMBL4555426	=	IC50	nM	15848.93	CHEMBL3145	Homo sapiens	pIC50		4.8
	19172341	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	O=S(=O)(Nc1cc(C2=CCOCC2)cnc1Cl)c1ccccc1		CHEMBL4466854	=	IC50	nM	125.89	CHEMBL3145	Homo sapiens	pIC50		6.9
	19172342	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	CS(=O)(=O)Nc1cc(-c2cnc(N)nc2)cnc1Cl		CHEMBL4462877	=	IC50	nM	158.49	CHEMBL3145	Homo sapiens	pIC50		6.8
	19172343	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	CS(=O)(=O)Nc1cc(C2=CCOCC2)cnc1Cl		CHEMBL4476588	=	IC50	nM	501.19	CHEMBL3145	Homo sapiens	pIC50		6.3
	19172344	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	c1cc(-c2ccc3ccncc3c2)c2cc[nH]c2c1		CHEMBL4580395	=	IC50	nM	15848.93	CHEMBL3145	Homo sapiens	pIC50		4.8
	19172345	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	CS(=O)(=O)Nc1cc(-c2ccc3ccncc3c2)cnc1Cl		CHEMBL4438305	=	IC50	nM	2511.89	CHEMBL3145	Homo sapiens	pIC50		5.6
	19172346	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	c1cc(-c2ccncc2)c2cc[nH]c2c1		CHEMBL4590704	<	IC50	nM	50118.72	CHEMBL3145	Homo sapiens	pIC50		4.3
	19172347	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	CS(=O)(=O)Nc1cc(-c2ccncc2)cnc1Cl		CHEMBL4474208	=	IC50	nM	794.33	CHEMBL3145	Homo sapiens	pIC50		6.1
	19172348	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	CS(=O)(=O)Nc1cc(-c2ccc3cn[nH]c3c2)cnc1Cl		CHEMBL4437969	=	IC50	nM	3981.07	CHEMBL3145	Homo sapiens	pIC50		5.4
	19172349	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	c1cc(-c2nnc(CN3CCOCC3)o2)c2cn[nH]c2c1		CHEMBL4552815	<	IC50	nM	50118.72	CHEMBL3145	Homo sapiens	pIC50		4.3
	19172350	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	COc1ncc(-c2ccc3cn[nH]c3c2)cc1NS(C)(=O)=O		CHEMBL4468849	=	IC50	nM	7943.28	CHEMBL3145	Homo sapiens	pIC50		5.1
	19172351	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	c1cc(-c2ccc3cn[nH]c3c2)c2cc[nH]c2c1		CHEMBL4449676	=	IC50	nM	25118.86	CHEMBL3145	Homo sapiens	pIC50		4.6
	19172352	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	COc1ncc(-c2cc(-c3ncc(CN4C[C@H](C)O[C@H](C)C4)o3)c3cn[nH]c3c2)cc1NS(C)(=O)=O		CHEMBL4434674	=	IC50	nM	2511.89	CHEMBL3145	Homo sapiens	pIC50		5.6
	19172353	CHEMBL4385118	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1		CHEMBL2216859	=	IC50	nM	1584.89	CHEMBL3145	Homo sapiens	pIC50		5.8
	19174521	CHEMBL4385717	Inhibition of His6-tagged recombinant full length human N-terminal PI3Kbeta expressed in baculovirus infected Sf21 cells using lipid substrate incubated for 2 hrs by ADP-Glo assay	B	C[C@H](Nc1ncnc2[nH]cnc12)C1=Nc2cccc(Cl)c2S(=O)(=O)N1c1ccccc1		CHEMBL4468379	=	IC50	nM	766.0	CHEMBL3145	Homo sapiens	IC50	nM	766.0
	19174522	CHEMBL4385717	Inhibition of His6-tagged recombinant full length human N-terminal PI3Kbeta expressed in baculovirus infected Sf21 cells using lipid substrate incubated for 2 hrs by ADP-Glo assay	B	C[C@@H](Nc1ncnc2[nH]cnc12)C1=Nc2cccc(Cl)c2S(=O)(=O)N1c1ccccc1		CHEMBL4520088	=	IC50	nM	3990.0	CHEMBL3145	Homo sapiens	IC50	nM	3990.0
	19174523	CHEMBL4385717	Inhibition of His6-tagged recombinant full length human N-terminal PI3Kbeta expressed in baculovirus infected Sf21 cells using lipid substrate incubated for 2 hrs by ADP-Glo assay	B	C[C@H](Nc1ncnc(N)c1C#N)C1=Nc2cccc(Cl)c2S(=O)(=O)N1c1ccccc1		CHEMBL4453364	=	IC50	nM	55.0	CHEMBL3145	Homo sapiens	IC50	nM	55.0
	19174524	CHEMBL4385717	Inhibition of His6-tagged recombinant full length human N-terminal PI3Kbeta expressed in baculovirus infected Sf21 cells using lipid substrate incubated for 2 hrs by ADP-Glo assay	B	C[C@@H](Nc1ncnc(N)c1C#N)C1=Nc2cccc(Cl)c2S(=O)(=O)N1c1ccccc1		CHEMBL4471020	=	IC50	nM	169.0	CHEMBL3145	Homo sapiens	IC50	nM	169.0
	19174525	CHEMBL4385717	Inhibition of His6-tagged recombinant full length human N-terminal PI3Kbeta expressed in baculovirus infected Sf21 cells using lipid substrate incubated for 2 hrs by ADP-Glo assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	154.0	CHEMBL3145	Homo sapiens	IC50	nM	154.0
	19191417	CHEMBL4389413	Inhibition of wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	94.0	CHEMBL3145	Homo sapiens	INH	%	94.0
	19192076	CHEMBL4389890	Inhibition of wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL3145	Homo sapiens	INH	%	100.0
	19200332	CHEMBL4391516	Binding affinity to wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	53.0	CHEMBL3145	Homo sapiens	Activity	%	53.0
	19207764	CHEMBL4392571	Inhibition of human PI3Kbeta using PIP2 as substrate after 1 hr	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	79.0	CHEMBL3145	Homo sapiens	IC50	nM	79.0
	19207765	CHEMBL4392571	Inhibition of human PI3Kbeta using PIP2 as substrate after 1 hr	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	571.0	CHEMBL3145	Homo sapiens	IC50	nM	571.0
	19207766	CHEMBL4392571	Inhibition of human PI3Kbeta using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc(OC)c(NS(C)(=O)=O)c5)ccc4ncc32)cc1		CHEMBL4560054	=	IC50	nM	589.0	CHEMBL3145	Homo sapiens	IC50	nM	589.0
	19207767	CHEMBL4392571	Inhibition of human PI3Kbeta using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3cnc4ccc(-c5cnc(OC)c(NS(C)(=O)=O)c5)cc4c32)cc1		CHEMBL4550603	=	IC50	nM	241.0	CHEMBL3145	Homo sapiens	IC50	nM	241.0
	19207787	CHEMBL4392571	Inhibition of human PI3Kbeta using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc6ccccc6c5)ccc4ncc32)cc1		CHEMBL4454741	=	IC50	nM	342.0	CHEMBL3145	Homo sapiens	IC50	nM	342.0
	19214477	CHEMBL4393766	Inhibition of N-terminal His6-tagged recombinant full length human PI3Kbeta using biotinylated PIP3 as substrate by HTRF analysis	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12	Non standard unit for type	CHEMBL98350	=	INH	nM	17.0	CHEMBL3145	Homo sapiens	INH	nM	17.0
	19214485	CHEMBL4393773	Inhibition of N-terminal His-tagged truncated human PI3Kbeta (deltaN 1 to 108 residues) after 2 hrs in presence of [33P]ATP by BetaPlate liquid scintillation counting analysis	B	O/C(=C\C1=Nc2ccccc2C2=NCCN12)c1ccccc1		CHEMBL4577796	=	IC50	nM	4000.0	CHEMBL3145	Homo sapiens	IC50	nM	4000.0
	19214487	CHEMBL4393773	Inhibition of N-terminal His-tagged truncated human PI3Kbeta (deltaN 1 to 108 residues) after 2 hrs in presence of [33P]ATP by BetaPlate liquid scintillation counting analysis	B	O=C(NC1=Nc2ccccc2C2=NCCN12)c1cccnc1		CHEMBL4532985	=	IC50	nM	1.0	CHEMBL3145	Homo sapiens	IC50	nM	1.0
	19214489	CHEMBL4393773	Inhibition of N-terminal His-tagged truncated human PI3Kbeta (deltaN 1 to 108 residues) after 2 hrs in presence of [33P]ATP by BetaPlate liquid scintillation counting analysis	B	COc1cc2c(cc1OC)C1=NCCN1C(NC(=O)c1cccnc1)=N2		CHEMBL4455565	=	IC50	nM	1700.0	CHEMBL3145	Homo sapiens	IC50	nM	1700.0
	19214493	CHEMBL4393774	Inhibition of PI3Kbeta (unknown origin)	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	=	IC50	nM	3.7	CHEMBL3145	Homo sapiens	IC50	nM	3.7
	19214500	CHEMBL4393774	Inhibition of PI3Kbeta (unknown origin)	B	Cc1nc(C(=O)Nc2cc(-c3cnc(Cl)c(NS(=O)(=O)c4ccccc4)c3)cc3[nH]ncc23)cs1		CHEMBL4576860	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
	19214504	CHEMBL4393774	Inhibition of PI3Kbeta (unknown origin)	B	COc1ncc(-c2cc(-c3ncc(CN4C[C@H](C)O[C@H](C)C4)o3)c3cn[nH]c3c2)cc1NS(C)(=O)=O		CHEMBL4434674	=	Ki	nM	630.96	CHEMBL3145	Homo sapiens	pKi		6.2
	19242057	CHEMBL4399811	Inhibition of PI3K beta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)C(C)N)C4)c3c2)cc1C#N		CHEMBL4473306	=	IC50	nM	147.4	CHEMBL3145	Homo sapiens	IC50	nM	147.4
	19242058	CHEMBL4399811	Inhibition of PI3K beta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)CN(C)C)C4)c3c2)cc1C#N		CHEMBL4476303	=	IC50	nM	150.1	CHEMBL3145	Homo sapiens	IC50	nM	150.1
	19242059	CHEMBL4399811	Inhibition of PI3K beta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)c5cccnc5)C4)c3c2)cc1C#N		CHEMBL4468088	=	IC50	nM	9.1	CHEMBL3145	Homo sapiens	IC50	nM	9.1
	19242060	CHEMBL4399811	Inhibition of PI3K beta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)c5coc([N+](=O)[O-])c5)C4)c3c2)cc1C#N		CHEMBL4457318	=	IC50	nM	31.4	CHEMBL3145	Homo sapiens	IC50	nM	31.4
	19242061	CHEMBL4399811	Inhibition of PI3K beta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	139.1	CHEMBL3145	Homo sapiens	IC50	nM	139.1
	19260484	CHEMBL4403987	Inhibition of PI3Kbeta in human MDA-MB-468 cells assessed as reduction in AKT phosphorylation at T208 residue measured after 2 hrs by QuantaBlu substrate based fluorescence assay	A	Cc1cc2ncnn2cc1Nc1ncc2c(n1)n(C1CCOCC1)c(=O)n2C		CHEMBL4439259	>	IC50	nM	30000.0	CHEMBL3145	Homo sapiens	IC50	uM	30.0
	19265823	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(CNC(=O)c3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4522666	=	IC50	nM	379.0	CHEMBL3145	Homo sapiens	IC50	nM	379.0
	19265824	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(CNc3ncc(C(=O)NO)cn3)c2c(=O)n1-c1ccccc1		CHEMBL4583074	=	IC50	nM	273.0	CHEMBL3145	Homo sapiens	IC50	nM	273.0
	19265825	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(CCCCCC(=O)NO)c2c(=O)n1-c1ccccc1		CHEMBL4451623	=	IC50	nM	286.0	CHEMBL3145	Homo sapiens	IC50	nM	286.0
Not Determined	19265826	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(CCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4555432		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	19265827	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(-c3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4563838		IC50			CHEMBL3145	Homo sapiens	IC50		
	19265828	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(CCCCCC(=O)NO)c2c(=O)n1-c1ccccc1		CHEMBL4550648	=	IC50	nM	33.0	CHEMBL3145	Homo sapiens	IC50	nM	33.0
	19265829	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(CCCCCC(=O)NO)c2c(=O)n1-c1ccccc1		CHEMBL4443378	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	nM	12.0
	19265830	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1nc(N)ncc1C)c1nc2cccc(CCCCCC(=O)NO)c2c(=O)n1-c1ccccc1		CHEMBL4525968	=	IC50	nM	5210.0	CHEMBL3145	Homo sapiens	IC50	nM	5210.0
	19265831	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(CCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4450613	=	IC50	nM	26.0	CHEMBL3145	Homo sapiens	IC50	nM	26.0
	19265832	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCCCCC(=O)NO)c2c(=O)n1-c1ccccc1		CHEMBL4544187	=	IC50	nM	279.0	CHEMBL3145	Homo sapiens	IC50	nM	279.0
	19265833	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4464812	=	IC50	nM	842.0	CHEMBL3145	Homo sapiens	IC50	nM	842.0
	19265834	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4460447	=	IC50	nM	159.0	CHEMBL3145	Homo sapiens	IC50	nM	159.0
	19265835	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	Cc1nc(N)nc(N[C@@H](C)c2nc3cccc(NCc4ccc(C(=O)NO)cc4)c3c(=O)n2-c2ccccc2)c1C#N		CHEMBL4526673	=	IC50	nM	188.0	CHEMBL3145	Homo sapiens	IC50	nM	188.0
	19265836	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	7.0	CHEMBL3145	Homo sapiens	IC50	nM	7.0
Not Determined	19265837	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	O=C(NCC1(c2nc(-c3ccccc3)cs2)CCOCC1)c1cccc(-c2noc(C(F)(F)F)n2)c1		CHEMBL3110004		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	19265838	CHEMBL4405139	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC(/C=C/C(=O)NO)=C\[C@@H](C)C(=O)c1ccc(N(C)C)cc1		CHEMBL99		IC50			CHEMBL3145	Homo sapiens	IC50		
	19265909	CHEMBL4405143	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(CNc3ncc(C(=O)NO)s3)c2c(=O)n1-c1ccccc1		CHEMBL4439884	=	Inhibition	%	6.8	CHEMBL3145	Homo sapiens	INH	%	6.8
	19265910	CHEMBL4405143	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(-c3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4563838	=	Inhibition	%	44.0	CHEMBL3145	Homo sapiens	INH	%	44.0
	19265911	CHEMBL4405143	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(-c3ccc(CC(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4532505	=	Inhibition	%	37.5	CHEMBL3145	Homo sapiens	INH	%	37.5
	19265912	CHEMBL4405143	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(-c3nc4ccc(C(=O)NO)cc4s3)c2c(=O)n1-c1ccccc1		CHEMBL4445486	=	Inhibition	%	38.6	CHEMBL3145	Homo sapiens	INH	%	38.6
	19265913	CHEMBL4405143	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(NCc3ccc(C(=O)NO)nc3)c2c(=O)n1-c1ccccc1		CHEMBL4445210	=	Inhibition	%	4.4	CHEMBL3145	Homo sapiens	INH	%	4.4
	19265914	CHEMBL4405143	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(NCc3ccc(C(=O)NO)o3)c2c(=O)n1-c1ccccc1		CHEMBL4461365	=	Inhibition	%	3.8	CHEMBL3145	Homo sapiens	INH	%	3.8
	19265915	CHEMBL4405143	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(CNCc3nc(C(=O)NO)cs3)c2c(=O)n1-c1ccccc1		CHEMBL4454137	=	Inhibition	%	5.3	CHEMBL3145	Homo sapiens	INH	%	5.3
	19265916	CHEMBL4405143	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(CNCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4582716	=	Inhibition	%	-6.0	CHEMBL3145	Homo sapiens	INH	%	-6.0
	19265917	CHEMBL4405143	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Inhibition	%	13.0	CHEMBL3145	Homo sapiens	INH	%	13.0
Not Determined	19265918	CHEMBL4405143	Inhibition of human PI3Kbeta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC(/C=C/C(=O)NO)=C\[C@@H](C)C(=O)c1ccc(N(C)C)cc1		CHEMBL99		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	19290460	CHEMBL4410919	Inhibition of PI3Kbeta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]-ATP based scintillation counting method	B	CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(F)c1[C@@H]1CNC(=O)C1		CHEMBL4297615	>	IC50	nM	20000.0	CHEMBL3145	Homo sapiens	IC50	nM	20000.0
Not Active	19290498	CHEMBL4410967	Inhibition of wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system at 10 uM by Kinomescan method	B	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(=O)[nH]cnc21		CHEMBL4585005		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	19313639	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4589808	=	IC50	nM	2511.89	CHEMBL3145	Homo sapiens	pIC50		5.6
	19313646	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4583106	=	IC50	nM	1995.26	CHEMBL3145	Homo sapiens	pIC50		5.7
	19313652	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4472462	=	IC50	nM	3162.28	CHEMBL3145	Homo sapiens	pIC50		5.5
	19313659	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4580111	=	IC50	nM	501.19	CHEMBL3145	Homo sapiens	pIC50		6.3
	19313666	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4456577	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
	19313673	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1)S(C)(=O)=O		CHEMBL4590897	=	IC50	nM	1584.89	CHEMBL3145	Homo sapiens	pIC50		5.8
	19313679	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4467891	=	IC50	nM	158.49	CHEMBL3145	Homo sapiens	pIC50		6.8
	19313686	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1)S(C)(=O)=O		CHEMBL4453879	=	IC50	nM	251.19	CHEMBL3145	Homo sapiens	pIC50		6.6
	19313693	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4538734	=	IC50	nM	251.19	CHEMBL3145	Homo sapiens	pIC50		6.6
	19313700	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	1995.26	CHEMBL3145	Homo sapiens	pIC50		5.7
	19313704	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	251.19	CHEMBL3145	Homo sapiens	pIC50		6.6
	19313708	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4580546	=	IC50	nM	1258.93	CHEMBL3145	Homo sapiens	pIC50		5.9
	19313715	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4435258	=	IC50	nM	3981.07	CHEMBL3145	Homo sapiens	pIC50		5.4
	19313722	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4465671	=	IC50	nM	501.19	CHEMBL3145	Homo sapiens	pIC50		6.3
	19313729	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4514181	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
	19313736	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4569614	=	IC50	nM	3162.28	CHEMBL3145	Homo sapiens	pIC50		5.5
	19313743	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4560843	=	IC50	nM	501.19	CHEMBL3145	Homo sapiens	pIC50		6.3
	19313750	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4469156	=	IC50	nM	1995.26	CHEMBL3145	Homo sapiens	pIC50		5.7
	19313757	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4470887	=	IC50	nM	2511.89	CHEMBL3145	Homo sapiens	pIC50		5.6
	19313764	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4463677	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
	19313771	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4464201	=	IC50	nM	630.96	CHEMBL3145	Homo sapiens	pIC50		6.2
	19313778	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4579430	=	IC50	nM	3162.28	CHEMBL3145	Homo sapiens	pIC50		5.5
	19313785	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4469603	=	IC50	nM	1995.26	CHEMBL3145	Homo sapiens	pIC50		5.7
	19313792	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4441686	=	IC50	nM	6309.57	CHEMBL3145	Homo sapiens	pIC50		5.2
	19313799	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL4468444	=	IC50	nM	1584.89	CHEMBL3145	Homo sapiens	pIC50		5.8
	19313806	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4585433	=	IC50	nM	3981.07	CHEMBL3145	Homo sapiens	pIC50		5.4
	19313813	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4468356	=	IC50	nM	3981.07	CHEMBL3145	Homo sapiens	pIC50		5.4
	19313820	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL4456813	=	IC50	nM	794.33	CHEMBL3145	Homo sapiens	pIC50		6.1
	19313827	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4575913	=	IC50	nM	2511.89	CHEMBL3145	Homo sapiens	pIC50		5.6
	19313834	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4456189	=	IC50	nM	3162.28	CHEMBL3145	Homo sapiens	pIC50		5.5
	19313841	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL4472147	=	IC50	nM	630.96	CHEMBL3145	Homo sapiens	pIC50		6.2
	19313848	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4456953	=	IC50	nM	630.96	CHEMBL3145	Homo sapiens	pIC50		6.2
	19313855	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4581849	=	IC50	nM	1258.93	CHEMBL3145	Homo sapiens	pIC50		5.9
	19313862	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL4451928	=	IC50	nM	398.11	CHEMBL3145	Homo sapiens	pIC50		6.4
	19313869	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4555758	=	IC50	nM	2511.89	CHEMBL3145	Homo sapiens	pIC50		5.6
	19313876	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4465563	=	IC50	nM	6309.57	CHEMBL3145	Homo sapiens	pIC50		5.2
	19313883	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4448306	=	IC50	nM	1995.26	CHEMBL3145	Homo sapiens	pIC50		5.7
	19313890	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4442020	=	IC50	nM	6309.57	CHEMBL3145	Homo sapiens	pIC50		5.2
	19313897	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4584477	=	IC50	nM	6309.57	CHEMBL3145	Homo sapiens	pIC50		5.2
	19313904	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4443297	=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	19313911	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4440799	=	IC50	nM	2511.89	CHEMBL3145	Homo sapiens	pIC50		5.6
	19313918	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4593752	=	IC50	nM	7943.28	CHEMBL3145	Homo sapiens	pIC50		5.1
	19313925	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4592893	=	IC50	nM	1995.26	CHEMBL3145	Homo sapiens	pIC50		5.7
	19313932	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4473276	=	IC50	nM	1258.93	CHEMBL3145	Homo sapiens	pIC50		5.9
	19313939	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4444453	=	IC50	nM	7943.28	CHEMBL3145	Homo sapiens	pIC50		5.1
	19313946	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4476490	=	IC50	nM	316.23	CHEMBL3145	Homo sapiens	pIC50		6.5
	19313953	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4576565	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
	19313960	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4472331	=	IC50	nM	630.96	CHEMBL3145	Homo sapiens	pIC50		6.2
	19313967	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4441333	=	IC50	nM	5011.87	CHEMBL3145	Homo sapiens	pIC50		5.3
	19313974	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4461502	=	IC50	nM	1584.89	CHEMBL3145	Homo sapiens	pIC50		5.8
	19313981	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1)S(C)(=O)=O		CHEMBL4532070	=	IC50	nM	501.19	CHEMBL3145	Homo sapiens	pIC50		6.3
	19313988	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1)S(C)(=O)=O		CHEMBL4543271	=	IC50	nM	1584.89	CHEMBL3145	Homo sapiens	pIC50		5.8
	19313995	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1)S(C)(=O)=O		CHEMBL4534127	=	IC50	nM	251.19	CHEMBL3145	Homo sapiens	pIC50		6.6
	19314002	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4458909	=	IC50	nM	1995.26	CHEMBL3145	Homo sapiens	pIC50		5.7
	19314009	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL4437468	=	IC50	nM	398.11	CHEMBL3145	Homo sapiens	pIC50		6.4
	19314016	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4568963	=	IC50	nM	1584.89	CHEMBL3145	Homo sapiens	pIC50		5.8
	19314023	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL4580893	=	IC50	nM	630.96	CHEMBL3145	Homo sapiens	pIC50		6.2
	19314030	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1)S(C)(=O)=O		CHEMBL4472123	=	IC50	nM	1258.93	CHEMBL3145	Homo sapiens	pIC50		5.9
	19314037	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1)S(C)(=O)=O		CHEMBL4445065	=	IC50	nM	5011.87	CHEMBL3145	Homo sapiens	pIC50		5.3
	19314044	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4516194	=	IC50	nM	2511.89	CHEMBL3145	Homo sapiens	pIC50		5.6
	19314051	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4556864	=	IC50	nM	1995.26	CHEMBL3145	Homo sapiens	pIC50		5.7
	19314058	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4443987	=	IC50	nM	1995.26	CHEMBL3145	Homo sapiens	pIC50		5.7
	19314065	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4473394	=	IC50	nM	6309.57	CHEMBL3145	Homo sapiens	pIC50		5.2
	19314072	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4437860	=	IC50	nM	1584.89	CHEMBL3145	Homo sapiens	pIC50		5.8
	19314079	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4452326	=	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	pIC50		5.0
	19314086	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4569315	=	IC50	nM	1995.26	CHEMBL3145	Homo sapiens	pIC50		5.7
	19314093	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1)S(C)(=O)=O		CHEMBL4580720	=	IC50	nM	2511.89	CHEMBL3145	Homo sapiens	pIC50		5.6
	19314100	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1)S(C)(=O)=O		CHEMBL4456215	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
	19314107	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N[C@@H]1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4444263	=	IC50	nM	1995.26	CHEMBL3145	Homo sapiens	pIC50		5.7
	19314115	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N[C@H]1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4537126	=	IC50	nM	3981.07	CHEMBL3145	Homo sapiens	pIC50		5.4
	19314123	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)[C@@H]1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4462986	=	IC50	nM	398.11	CHEMBL3145	Homo sapiens	pIC50		6.4
	19314131	CHEMBL4416686	Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)[C@H]1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4454271	=	IC50	nM	630.96	CHEMBL3145	Homo sapiens	pIC50		6.2
	19363834	CHEMBL4423378	Inhibition of PI3Kbeta (unknown origin) by ADP-gloassay	B	C=CC(=O)Nc1ccc(-n2c(=O)ccc3oc4ccc(-c5cccnc5)cc4c32)cc1		CHEMBL4246563	=	IC50	nM	838.0	CHEMBL3145	Homo sapiens	IC50	nM	838.0
	19363899	CHEMBL4423378	Inhibition of PI3Kbeta (unknown origin) by ADP-gloassay	B	C=CC(=O)Nc1cccc(-n2c(=O)ccc3oc4ccc(-c5cccnc5)cc4c32)c1		CHEMBL4559706	=	IC50	nM	2821.0	CHEMBL3145	Homo sapiens	IC50	nM	2821.0
	19429702	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CNC(=O)c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4470291	=	IC50	nM	2840.0	CHEMBL3145	Homo sapiens	IC50	nM	2840.0
	19429703	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CNCCNC(=O)c1c(-c2ccccc2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4438514	=	IC50	nM	15300.0	CHEMBL3145	Homo sapiens	IC50	nM	15300.0
	19429704	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C(=O)N2CC(O)C2)c1-c1ccccc1		CHEMBL4542785	=	IC50	nM	2720.0	CHEMBL3145	Homo sapiens	IC50	nM	2720.0
	19429705	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C(=O)N2CCNCC2)c1-c1ccccc1		CHEMBL4449576	=	IC50	nM	1100.0	CHEMBL3145	Homo sapiens	IC50	nM	1100.0
	19429706	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C(=O)N2CCS(=O)(=O)CC2)c1-c1ccccc1		CHEMBL4449366	=	IC50	nM	143.0	CHEMBL3145	Homo sapiens	IC50	nM	143.0
	19429707	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CC(C)NC(=O)c1c(-c2ccccc2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4461539	=	IC50	nM	8050.0	CHEMBL3145	Homo sapiens	IC50	nM	8050.0
	19429708	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CCNC(=O)c1c(-c2ccccc2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4464055	=	IC50	nM	17000.0	CHEMBL3145	Homo sapiens	IC50	nM	17000.0
	19429709	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C(=O)N(C)C)c1-c1ccccc1		CHEMBL4570159	=	IC50	nM	545.0	CHEMBL3145	Homo sapiens	IC50	nM	545.0
	19429710	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CNC(=O)c1c(-c2ccccc2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4516601	=	IC50	nM	1240.0	CHEMBL3145	Homo sapiens	IC50	nM	1240.0
	19429711	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C(N)=O)c1-c1ccccc1		CHEMBL4555334	=	IC50	nM	3540.0	CHEMBL3145	Homo sapiens	IC50	nM	3540.0
	19429712	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(-c2ccccn2)c1-c1ccccn1		CHEMBL3403678	=	IC50	nM	2800.0	CHEMBL3145	Homo sapiens	IC50	nM	2800.0
	19429713	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2ccc(F)cc2nc1-c1ccccn1		CHEMBL4303596	=	IC50	nM	2700.0	CHEMBL3145	Homo sapiens	IC50	nM	2700.0
	19429748	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CCNC(=O)c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4572863	=	IC50	nM	11000.0	CHEMBL3145	Homo sapiens	IC50	nM	11000.0
	19429749	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C(=O)N2CCNCC2)c1-c1ccccn1		CHEMBL4442808	=	IC50	nM	7160.0	CHEMBL3145	Homo sapiens	IC50	nM	7160.0
	19429750	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C(=O)N2CC(O)C2)c1-c1ccccn1		CHEMBL4594095	=	IC50	nM	4610.0	CHEMBL3145	Homo sapiens	IC50	nM	4610.0
	19429751	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CNCCNC(=O)c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4525494	=	IC50	nM	15600.0	CHEMBL3145	Homo sapiens	IC50	nM	15600.0
	19429752	CHEMBL4428710	Inhibition of polyHis tagged full length recombinant PI3Kbeta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CNC(=O)c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2cccc(F)c12		CHEMBL4443843	=	IC50	nM	2200.0	CHEMBL3145	Homo sapiens	IC50	nM	2200.0
	19429973	CHEMBL4428735	Inhibition of PI3Kbeta (unknown origin) assessed as reduction in AKT phosphorylation by cell based assay	B	CNC(=O)c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4470291	=	IC50	nM	3290.0	CHEMBL3145	Homo sapiens	IC50	nM	3290.0
	19429987	CHEMBL4428735	Inhibition of PI3Kbeta (unknown origin) assessed as reduction in AKT phosphorylation by cell based assay	B	CNC(=O)c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4470291	=	fIC50	nM	2882.0	CHEMBL3145	Homo sapiens	fIC50	nM	2882.0
	19434339	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	192.0	CHEMBL3145	Homo sapiens	IC50	uM	0.192
	19434340	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	c1ccc2ncc(-c3ccc4ncncc4c3)cc2c1		CHEMBL4450615	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	19434341	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	c1ccc(-c2ncnc3ccc(-c4cnc5ccccc5c4)cc23)cc1		CHEMBL4521863	=	IC50	nM	3200.0	CHEMBL3145	Homo sapiens	IC50	uM	3.2
	19434342	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	COc1ccc(-c2ncnc3ccc(-c4cnc5ccccc5c4)cc23)cc1OC		CHEMBL4475622	=	IC50	nM	1900.0	CHEMBL3145	Homo sapiens	IC50	uM	1.9
	19434343	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	CN1CCN(C(=O)c2cccc(-c3ncnc4ccc(-c5cnc6ccccc6c5)cc34)c2)CC1		CHEMBL4437791	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	19434344	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cc1OC		CHEMBL4588314	=	IC50	nM	2570.0	CHEMBL3145	Homo sapiens	IC50	uM	2.57
	19434345	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cc1C#N		CHEMBL4467868	=	IC50	nM	2630.0	CHEMBL3145	Homo sapiens	IC50	uM	2.63
	19434346	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cc1C(F)(F)F		CHEMBL4453497	=	IC50	nM	392.0	CHEMBL3145	Homo sapiens	IC50	uM	0.392
	19434347	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cn1		CHEMBL4581278	=	IC50	nM	4150.0	CHEMBL3145	Homo sapiens	IC50	uM	4.15
	19434348	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	COc1ccc(-c2ccc3ncnc(-c4cncc(C(=O)N5CCN(C)CC5)c4)c3c2)cn1		CHEMBL4460621	=	IC50	nM	6180.0	CHEMBL3145	Homo sapiens	IC50	uM	6.18
	19434349	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	COc1ccc(-c2ccc3ncnc(N4CCC[C@H](C(=O)N5CCN(C)CC5)C4)c3c2)cn1		CHEMBL4454454	=	IC50	nM	2040.0	CHEMBL3145	Homo sapiens	IC50	uM	2.04
	19434350	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	CC(=O)N1CCN(C(=O)c2cccc(-c3ncnc4ccc(-c5cnc6ccccc6c5)cc34)c2)CC1		CHEMBL4469006	=	IC50	nM	4270.0	CHEMBL3145	Homo sapiens	IC50	uM	4.27
	19434351	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1OC		CHEMBL3944013	=	IC50	nM	1940.0	CHEMBL3145	Homo sapiens	IC50	uM	1.94
	19434352	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cn1		CHEMBL3947814	=	IC50	nM	4840.0	CHEMBL3145	Homo sapiens	IC50	uM	4.84
	19434353	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C(F)(F)F		CHEMBL4521888	=	IC50	nM	536.0	CHEMBL3145	Homo sapiens	IC50	uM	0.536
	19434354	CHEMBL4430044	Inhibition of recombinant PI3Kbeta (unknown origin) using phosphatidyl inositol as substrate after 30 to 60 mins in presence of ATP by Kinase Glo luminescence assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	IC50	nM	1650.0	CHEMBL3145	Homo sapiens	IC50	uM	1.65
	19434404	CHEMBL4430047	Inhibition of human PI3Kbeta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	CN1CCN(C(=O)c2cccc(-c3ncnc4ccc(-c5cnc6ccccc6c5)cc34)c2)CC1		CHEMBL4437791	>	IC50	nM	12500.0	CHEMBL3145	Homo sapiens	IC50	uM	12.5
	19434405	CHEMBL4430047	Inhibition of human PI3Kbeta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cc1OC		CHEMBL4588314	=	IC50	nM	4890.0	CHEMBL3145	Homo sapiens	IC50	uM	4.89
	19434406	CHEMBL4430047	Inhibition of human PI3Kbeta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cc1C#N		CHEMBL4467868	=	IC50	nM	1910.0	CHEMBL3145	Homo sapiens	IC50	uM	1.91
	19434407	CHEMBL4430047	Inhibition of human PI3Kbeta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cc1C(F)(F)F		CHEMBL4453497	=	IC50	nM	380.0	CHEMBL3145	Homo sapiens	IC50	uM	0.38
	19434408	CHEMBL4430047	Inhibition of human PI3Kbeta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cn1		CHEMBL4581278	=	IC50	nM	1910.0	CHEMBL3145	Homo sapiens	IC50	uM	1.91
	19434409	CHEMBL4430047	Inhibition of human PI3Kbeta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ccc(-c2ccc3ncnc(-c4cncc(C(=O)N5CCN(C)CC5)c4)c3c2)cn1		CHEMBL4460621	=	IC50	nM	7540.0	CHEMBL3145	Homo sapiens	IC50	uM	7.54
	19434410	CHEMBL4430047	Inhibition of human PI3Kbeta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ccc(-c2ccc3ncnc(N4CCC[C@H](C(=O)N5CCN(C)CC5)C4)c3c2)cn1		CHEMBL4454454	=	IC50	nM	4620.0	CHEMBL3145	Homo sapiens	IC50	uM	4.62
	19434411	CHEMBL4430047	Inhibition of human PI3Kbeta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	CC(=O)N1CCN(C(=O)c2cccc(-c3ncnc4ccc(-c5cnc6ccccc6c5)cc34)c2)CC1		CHEMBL4469006	=	IC50	nM	4650.0	CHEMBL3145	Homo sapiens	IC50	uM	4.65
	19434412	CHEMBL4430047	Inhibition of human PI3Kbeta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1OC		CHEMBL3944013	=	IC50	nM	3380.0	CHEMBL3145	Homo sapiens	IC50	uM	3.38
	19434413	CHEMBL4430047	Inhibition of human PI3Kbeta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cn1		CHEMBL3947814	=	IC50	nM	3570.0	CHEMBL3145	Homo sapiens	IC50	uM	3.57
	19434414	CHEMBL4430047	Inhibition of human PI3Kbeta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C(F)(F)F		CHEMBL4521888	=	IC50	nM	2070.0	CHEMBL3145	Homo sapiens	IC50	uM	2.07
	19434415	CHEMBL4430047	Inhibition of human PI3Kbeta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	IC50	nM	6530.0	CHEMBL3145	Homo sapiens	IC50	uM	6.53
	19446975	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008	=	IC50	nM	396.0	CHEMBL3145	Homo sapiens	IC50	nM	396.0
	19446976	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	O=C(C[C@@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4555271	=	IC50	nM	146.0	CHEMBL3145	Homo sapiens	IC50	nM	146.0
	19446977	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	O=C(CN1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)[C@H]1CCCN1		CHEMBL4469651	=	IC50	nM	60.0	CHEMBL3145	Homo sapiens	IC50	nM	60.0
	19446978	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	O=C([C@@H]1CCCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4437231	=	IC50	nM	59.0	CHEMBL3145	Homo sapiens	IC50	nM	59.0
	19446979	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	O=C([C@H]1CCCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4528472	=	IC50	nM	775.0	CHEMBL3145	Homo sapiens	IC50	nM	775.0
	19446980	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	N[C@H]1CC[C@@H](C(=O)N2CCN(c3nc(N4CCOCC4)nc(-n4c(C(F)F)nc5ccccc54)n3)CC2)CC1		CHEMBL4552784	=	IC50	nM	3358.0	CHEMBL3145	Homo sapiens	IC50	nM	3358.0
	19446981	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	O=C(O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4459584	=	IC50	nM	217.0	CHEMBL3145	Homo sapiens	IC50	nM	217.0
	19446982	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	O=C(O)[C@H]1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL4522571	=	IC50	nM	215.0	CHEMBL3145	Homo sapiens	IC50	nM	215.0
	19446983	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	O=C(O)[C@@H]1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL4563601	=	IC50	nM	428.0	CHEMBL3145	Homo sapiens	IC50	nM	428.0
	19446984	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	NC(=O)CNC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4476840	=	IC50	nM	329.0	CHEMBL3145	Homo sapiens	IC50	nM	329.0
	19446985	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	NC(=O)[C@H](Cc1ccccc1)NC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4446958	=	IC50	nM	513.0	CHEMBL3145	Homo sapiens	IC50	nM	513.0
	19446986	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	C[C@H](NC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)C(N)=O		CHEMBL4463324	=	IC50	nM	207.0	CHEMBL3145	Homo sapiens	IC50	nM	207.0
	19446987	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	C[C@@H](NC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)C(N)=O		CHEMBL4451597	=	IC50	nM	601.0	CHEMBL3145	Homo sapiens	IC50	nM	601.0
	19446988	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	NC(=O)[C@H](CO)NC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4553967	=	IC50	nM	162.0	CHEMBL3145	Homo sapiens	IC50	nM	162.0
	19446989	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	CC(C)[C@H](NC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)C(N)=O		CHEMBL4560411	=	IC50	nM	602.0	CHEMBL3145	Homo sapiens	IC50	nM	602.0
	19446990	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	NC(=O)CNC(=O)[C@H]1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL4466025	=	IC50	nM	24.0	CHEMBL3145	Homo sapiens	IC50	nM	24.0
	19446991	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	NC(=O)CNC(=O)[C@@H]1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL4459749	=	IC50	nM	166.0	CHEMBL3145	Homo sapiens	IC50	nM	166.0
	19446992	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL4445145	=	IC50	nM	342.0	CHEMBL3145	Homo sapiens	IC50	nM	342.0
	19446993	CHEMBL4432765	Inhibition of PI3Kbeta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL4551404	=	IC50	nM	1722.0	CHEMBL3145	Homo sapiens	IC50	nM	1722.0
	19447053	CHEMBL4432769	Inhibition of full length His-tagged human recombinant PI3Kbeta expressed in baculovirus by select screen kinase profiling assay	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008	=	IC50	nM	565.0	CHEMBL3145	Homo sapiens	IC50	nM	565.0
	19469077	CHEMBL4478192	Inhibition of human recombinant PI3Kbeta using PIP2/ATP as substrate incubated for 20 mins followed by substrate addition by Kinase Glo reagent based luminescence assay	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	IC50	nM	133.0	CHEMBL3145	Homo sapiens	IC50	uM	0.133
	19469078	CHEMBL4478192	Inhibition of human recombinant PI3Kbeta using PIP2/ATP as substrate incubated for 20 mins followed by substrate addition by Kinase Glo reagent based luminescence assay	B	O=c1cc(-c2cccc3c2Sc2ccccc2C3)oc(N2CCOCC2)c1		CHEMBL4569967	=	IC50	nM	2140.0	CHEMBL3145	Homo sapiens	IC50	uM	2.14
	19469079	CHEMBL4478192	Inhibition of human recombinant PI3Kbeta using PIP2/ATP as substrate incubated for 20 mins followed by substrate addition by Kinase Glo reagent based luminescence assay	B	COc1cc2ncnc(-n3nc(-c4ccccn4)nc3N)c2cc1OC		CHEMBL2143829	=	IC50	nM	5440.0	CHEMBL3145	Homo sapiens	IC50	uM	5.44
	19469080	CHEMBL4478192	Inhibition of human recombinant PI3Kbeta using PIP2/ATP as substrate incubated for 20 mins followed by substrate addition by Kinase Glo reagent based luminescence assay	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(C#N)cc12		CHEMBL4593348	=	IC50	nM	5740.0	CHEMBL3145	Homo sapiens	IC50	uM	5.74
	19469081	CHEMBL4478192	Inhibition of human recombinant PI3Kbeta using PIP2/ATP as substrate incubated for 20 mins followed by substrate addition by Kinase Glo reagent based luminescence assay	B	C[C@@H](Nc1c(C(N)=O)cnc2ccc(C#N)cc12)c1ccc(Cl)cc1		CHEMBL4527822	=	IC50	nM	139.0	CHEMBL3145	Homo sapiens	IC50	uM	0.139
	19469082	CHEMBL4478192	Inhibition of human recombinant PI3Kbeta using PIP2/ATP as substrate incubated for 20 mins followed by substrate addition by Kinase Glo reagent based luminescence assay	B	C[C@@H](Nc1c(C(N)=O)cnc2ccc(-c3cccnc3)cc12)c1ccc(Cl)cc1		CHEMBL4565988	=	IC50	nM	21.0	CHEMBL3145	Homo sapiens	IC50	uM	0.021
	19469083	CHEMBL4478192	Inhibition of human recombinant PI3Kbeta using PIP2/ATP as substrate incubated for 20 mins followed by substrate addition by Kinase Glo reagent based luminescence assay	B	COCc1ccc(-c2ccc3ncc(C(N)=O)c(N[C@@H](C)C4CCOCC4)c3c2)cn1		CHEMBL4218734	>	IC50	nM	27000.0	CHEMBL3145	Homo sapiens	IC50	uM	27.0
	19469084	CHEMBL4478192	Inhibition of human recombinant PI3Kbeta using PIP2/ATP as substrate incubated for 20 mins followed by substrate addition by Kinase Glo reagent based luminescence assay	B	COCc1ccc(-c2cc3c(N[C@@H](C)c4ccn(C)n4)c(C(N)=O)cnc3cc2F)cn1		CHEMBL4166405	=	IC50	nM	12800.0	CHEMBL3145	Homo sapiens	IC50	uM	12.8
	19469131	CHEMBL4478218	Inhibition of PI3Kbeta (unknown origin) by cell based assay	B	COCc1ccc(-c2ccc3ncc(C(N)=O)c(N[C@@H](C)C4CCOCC4)c3c2)cn1		CHEMBL4218734	>	IC50	nM	30000.0	CHEMBL3145	Homo sapiens	IC50	uM	30.0
	19469132	CHEMBL4478218	Inhibition of PI3Kbeta (unknown origin) by cell based assay	B	COCc1ccc(-c2cc3c(N[C@@H](C)c4ccn(C)n4)c(C(N)=O)cnc3cc2F)cn1		CHEMBL4166405	>	IC50	nM	17500.0	CHEMBL3145	Homo sapiens	IC50	uM	17.5
	19474571	CHEMBL4479331	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of biotin-labeled PIP3 by HTRF assay	B	COc1ncc(-c2ccc3cn[nH]c3c2)cc1NS(C)(=O)=O		CHEMBL4468849	=	IC50	nM	7943.28	CHEMBL3145	Homo sapiens	pIC50		5.1
	19474572	CHEMBL4479331	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of biotin-labeled PIP3 by HTRF assay	B	COc1ncc(-c2ccc3c(c2)COC3)cc1NS(C)(=O)=O		CHEMBL4583379	=	IC50	nM	1995.26	CHEMBL3145	Homo sapiens	pIC50		5.7
	19474573	CHEMBL4479331	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of biotin-labeled PIP3 by HTRF assay	B	COc1ncc(-c2cc(-c3ncc(CN4C[C@H](C)O[C@H](C)C4)o3)c3cn[nH]c3c2)cc1NS(C)(=O)=O		CHEMBL4434674	=	IC50	nM	630.96	CHEMBL3145	Homo sapiens	pIC50		6.2
	19479788	CHEMBL4480259	Inhibition of PI3Kbeta (unknown origin) assessed as reduction in ATP depletion using lipid substrate after 40 mins by Kinase-Glo luminescent assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	421.0	CHEMBL3145	Homo sapiens	IC50	nM	421.0
	19479789	CHEMBL4480259	Inhibition of PI3Kbeta (unknown origin) assessed as reduction in ATP depletion using lipid substrate after 40 mins by Kinase-Glo luminescent assay	B	COc1ncc(-c2ccc3ncnc(NCCN4CCOCC4)c3c2)cc1C#N		CHEMBL4577046	=	IC50	nM	300.0	CHEMBL3145	Homo sapiens	IC50	nM	300.0
Not Determined	19479790	CHEMBL4480259	Inhibition of PI3Kbeta (unknown origin) assessed as reduction in ATP depletion using lipid substrate after 40 mins by Kinase-Glo luminescent assay	B	COc1ncc(-c2ccc3ncnc(NCCN4CCCCC4)c3c2)cc1[N+](=O)[O-]		CHEMBL4587019		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	19479791	CHEMBL4480259	Inhibition of PI3Kbeta (unknown origin) assessed as reduction in ATP depletion using lipid substrate after 40 mins by Kinase-Glo luminescent assay	B	COc1ncc(-c2ccc3ncnc(NCCN(C)C)c3c2)cc1C#N		CHEMBL4539481		IC50			CHEMBL3145	Homo sapiens	IC50		
	20639577	CHEMBL4612727	Inhibition of PI3Kbeta (unknown origin)	B	C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4647810	=	IC50	nM	3270.0	CHEMBL3145	Homo sapiens	IC50	nM	3270.0
	20664561	CHEMBL4619048	Inhibition of PI3Kbeta in PTEN-deficient human PC3 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay	B	Cc1nc2c(-c3nnc[nH]3)cc(-c3ccnc(C#N)c3)cc2n1-c1ccnc2c(F)ccc(F)c12		CHEMBL4647791	=	EC50	nM	12.0	CHEMBL3145	Homo sapiens	EC50	nM	12.0
	20664562	CHEMBL4619048	Inhibition of PI3Kbeta in PTEN-deficient human PC3 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay	B	Cc1nc2c(-c3nnc[nH]3)cc(-c3ccnc(N)c3F)cc2n1-c1ccnc2c(F)ccc(F)c12		CHEMBL4470860	=	EC50	nM	9.0	CHEMBL3145	Homo sapiens	EC50	nM	9.0
	20664563	CHEMBL4619048	Inhibition of PI3Kbeta in PTEN-deficient human PC3 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	=	EC50	nM	23.0	CHEMBL3145	Homo sapiens	EC50	nM	23.0
	20664564	CHEMBL4619049	Inhibition of PI3Kbeta in PTEN-deficient human LNCaP C4-2 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay	B	Cc1nc2c(-c3nnc[nH]3)cc(-c3ccnc(C#N)c3)cc2n1-c1ccnc2c(F)ccc(F)c12		CHEMBL4647791	=	EC50	nM	24.0	CHEMBL3145	Homo sapiens	EC50	nM	24.0
	20664565	CHEMBL4619049	Inhibition of PI3Kbeta in PTEN-deficient human LNCaP C4-2 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay	B	Cc1nc2c(-c3nnc[nH]3)cc(-c3ccnc(N)c3F)cc2n1-c1ccnc2c(F)ccc(F)c12		CHEMBL4470860	=	EC50	nM	15.0	CHEMBL3145	Homo sapiens	EC50	nM	15.0
	20664566	CHEMBL4619049	Inhibition of PI3Kbeta in PTEN-deficient human LNCaP C4-2 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	=	EC50	nM	42.0	CHEMBL3145	Homo sapiens	EC50	nM	42.0
	20664567	CHEMBL4619050	Inhibition of PI3Kbeta in PTEN-deficient human LNCAP cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay	B	Cc1nc2c(-c3nnc[nH]3)cc(-c3ccnc(C#N)c3)cc2n1-c1ccnc2c(F)ccc(F)c12		CHEMBL4647791	=	EC50	nM	31.0	CHEMBL3145	Homo sapiens	EC50	nM	31.0
	20664568	CHEMBL4619050	Inhibition of PI3Kbeta in PTEN-deficient human LNCAP cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay	B	Cc1nc2c(-c3nnc[nH]3)cc(-c3ccnc(N)c3F)cc2n1-c1ccnc2c(F)ccc(F)c12		CHEMBL4470860	=	EC50	nM	53.0	CHEMBL3145	Homo sapiens	EC50	nM	53.0
	20664569	CHEMBL4619050	Inhibition of PI3Kbeta in PTEN-deficient human LNCAP cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	=	EC50	nM	178.0	CHEMBL3145	Homo sapiens	EC50	nM	178.0
	20664570	CHEMBL4619051	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-415 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay	B	Cc1nc2c(-c3nnc[nH]3)cc(-c3ccnc(C#N)c3)cc2n1-c1ccnc2c(F)ccc(F)c12		CHEMBL4647791	=	EC50	nM	15.0	CHEMBL3145	Homo sapiens	EC50	nM	15.0
	20664571	CHEMBL4619051	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-415 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay	B	Cc1nc2c(-c3nnc[nH]3)cc(-c3ccnc(N)c3F)cc2n1-c1ccnc2c(F)ccc(F)c12		CHEMBL4470860	=	EC50	nM	12.0	CHEMBL3145	Homo sapiens	EC50	nM	12.0
	20664572	CHEMBL4619051	Inhibition of PI3Kbeta in PTEN-deficient human MDA-MB-415 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	=	EC50	nM	40.0	CHEMBL3145	Homo sapiens	EC50	nM	40.0
	20664573	CHEMBL4619052	Inhibition of PI3Kbeta in PTEN-deficient human ZR-75-1 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay	B	Cc1nc2c(-c3nnc[nH]3)cc(-c3ccnc(C#N)c3)cc2n1-c1ccnc2c(F)ccc(F)c12		CHEMBL4647791	=	EC50	nM	5.0	CHEMBL3145	Homo sapiens	EC50	nM	5.0
	20664574	CHEMBL4619052	Inhibition of PI3Kbeta in PTEN-deficient human ZR-75-1 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay	B	Cc1nc2c(-c3nnc[nH]3)cc(-c3ccnc(N)c3F)cc2n1-c1ccnc2c(F)ccc(F)c12		CHEMBL4470860	=	EC50	nM	6.0	CHEMBL3145	Homo sapiens	EC50	nM	6.0
	20664575	CHEMBL4619052	Inhibition of PI3Kbeta in PTEN-deficient human ZR-75-1 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	=	EC50	nM	28.0	CHEMBL3145	Homo sapiens	EC50	nM	28.0
	20670759	CHEMBL4620659	Inhibition of human PI3K p110beta by HTRF assay	B	CNC(=O)c1cc2c(N3CCOCC3)nc(-c3cnc(N)cc3C(F)(F)F)nn2c1		CHEMBL4633095	=	IC50	nM	1293.0	CHEMBL3145	Homo sapiens	IC50	nM	1293.0
	20670760	CHEMBL4620659	Inhibition of human PI3K p110beta by HTRF assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	324.0	CHEMBL3145	Homo sapiens	IC50	nM	324.0
	20676500	CHEMBL4621801	Inhibition of PI3Kbeta (unknown origin)	B	COc1ncc(N2CCOc3ccc(CN(C)C)cc32)cc1NS(C)(=O)=O		CHEMBL4645570	=	IC50	nM	7943.28	CHEMBL3145	Homo sapiens	pIC50		5.1
	20676521	CHEMBL4621801	Inhibition of PI3Kbeta (unknown origin)	B	COc1ncc2cc1NS(=O)(=O)CCN(C)Cc1ccc3c(c1)N2CCO3		CHEMBL4638471	=	IC50	nM	1258.93	CHEMBL3145	Homo sapiens	pIC50		5.9
	20677475	CHEMBL4621933	Inhibition of PI3Kbeta in human MDA-MB-468 cells assessed as reduction in AKT phosphorylation at residue S473 measured after 30 mins by sandwich ELISA	A	CNC(=O)[C@H](C)Cn1cnc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4Cl)c3)cc2c1=O		CHEMBL4632970	=	IC50	nM	1393.0	CHEMBL3145	Homo sapiens	IC50	nM	1393.0
Not Determined	22392396	CHEMBL4667357	Inhibition of PI3Kbeta (unknown origin) using lipid as substrate incubated for 15 mins followed by substrate addition and measured after 60 mins ADPGloTM reagent based assay	B	COc1ncc(-c2ccc3ncnc(Nc4cnn(CCO)c4)c3c2)cc1NS(C)(=O)=O		CHEMBL4745877		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	22392397	CHEMBL4667357	Inhibition of PI3Kbeta (unknown origin) using lipid as substrate incubated for 15 mins followed by substrate addition and measured after 60 mins ADPGloTM reagent based assay	B	COc1ncc(-c2ccc3ncnc(Nc4cnn(CCO)c4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4780201	=	IC50	nM	2.99	CHEMBL3145	Homo sapiens	IC50	nM	2.99
	22392398	CHEMBL4667357	Inhibition of PI3Kbeta (unknown origin) using lipid as substrate incubated for 15 mins followed by substrate addition and measured after 60 mins ADPGloTM reagent based assay	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	=	IC50	nM	1.64	CHEMBL3145	Homo sapiens	IC50	nM	1.64
	22421720	CHEMBL4673693	Inhibition of PI3K-beta (unknown origin) by HTRF assay	B	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21		CHEMBL3545097	>	IC50	nM	200.0	CHEMBL3145	Homo sapiens	IC50	nM	200.0
	22441638	CHEMBL4678712	Inhibition of recombinant human PI3Kbeta using PIP2 as substrate by ADP-Glo reagent based assay	B	COc1ncc(-c2cc3c(N4CCOCC4)ncnc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4745332	=	IC50	nM	50.0	CHEMBL3145	Homo sapiens	IC50	nM	50.0
	22441639	CHEMBL4678712	Inhibition of recombinant human PI3Kbeta using PIP2 as substrate by ADP-Glo reagent based assay	B	COc1ncc(-c2nc3c(N4CCOCC4)ncnc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4798343	=	IC50	nM	5.3	CHEMBL3145	Homo sapiens	IC50	nM	5.3
	22463038	CHEMBL4683366	Inhibition of human PI3Kbeta by ADP-Glo kinase assay	A	CNC(=O)c1ccc(-c2cnc3cnc(C(=O)N(C)c4ccc(Cl)cc4)cn23)cc1		CHEMBL3325608	=	IC50	nM	2728.0	CHEMBL3145	Homo sapiens	IC50	nM	2728.0
	22463039	CHEMBL4683366	Inhibition of human PI3Kbeta by ADP-Glo kinase assay	A	CNC(=O)c1cncc(-c2cnc(Cl)c(NS(=O)(=O)c3ccccc3)c2)c1		CHEMBL4752128	=	IC50	nM	392.0	CHEMBL3145	Homo sapiens	IC50	nM	392.0
	22488636	CHEMBL4689248	Inhibition of PI3Kbeta (unknown origin) measured after 1 hr by ADP-glo plus luminescence assay	B	O=S(=O)(c1ccc(O)cc1)N1CCN(c2nc(NCCN3CCOCC3)nc(N3CCOCC3)n2)CC1		CHEMBL4789747	=	IC50	nM	12.34	CHEMBL3145	Homo sapiens	IC50	nM	12.34
	22759648	CHEMBL4701776	Inhibition of human PI3kbeta at 1 uM using fluorescently labeled peptide substrate measured after 3 hrs by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)c1ccc(Oc2nc(-c3cnc(N)s3)nc(N3CCOCC3)n2)cc1		CHEMBL4782133	=	Inhibition	%	42.0	CHEMBL3145	Homo sapiens	INH	%	42.0
Active	22775208	CHEMBL4705413	Binding affinity to human PI3Kbeta at 1 uM by KINOMEscan binding assay	B	CC[C@@H](c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccc(OC)c(F)c2)c2c(N)ncnc21		CHEMBL4781849		Activity			CHEMBL3145	Homo sapiens	Activity		
Not Determined	22780994	CHEMBL4707196	Inhibition of human PI3Kbeta incubated for 1 hr by ADP-Glo kinase assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851		IC50			CHEMBL3145	Homo sapiens	IC50		
	22780995	CHEMBL4707196	Inhibition of human PI3Kbeta incubated for 1 hr by ADP-Glo kinase assay	B	Nc1ccc(-c2nc(N3CCOCC3)c3ncn(CCCCCCC(=O)NO)c3n2)cn1		CHEMBL4785064	=	IC50	nM	1656.0	CHEMBL3145	Homo sapiens	IC50	nM	1656.0
	22780996	CHEMBL4707196	Inhibition of human PI3Kbeta incubated for 1 hr by ADP-Glo kinase assay	B	O=C(CCCCCCn1cnc2c(N3CCOCC3)nc(-c3cccc(CO)c3)nc21)NO		CHEMBL4749655	=	IC50	nM	212.0	CHEMBL3145	Homo sapiens	IC50	nM	212.0
	22780997	CHEMBL4707196	Inhibition of human PI3Kbeta incubated for 1 hr by ADP-Glo kinase assay	B	Nc1ncc(-c2nc(N3CCOCC3)c3ncn(CCCCCCC(=O)NO)c3n2)cn1		CHEMBL4787267	=	IC50	nM	648.0	CHEMBL3145	Homo sapiens	IC50	nM	648.0
	22780998	CHEMBL4707196	Inhibition of human PI3Kbeta incubated for 1 hr by ADP-Glo kinase assay	B	COc1ncc(-c2nc(N3CCOCC3)c3ncn(CCCCCCC(=O)NO)c3n2)cn1		CHEMBL4799530	=	IC50	nM	1403.0	CHEMBL3145	Homo sapiens	IC50	nM	1403.0
	22780999	CHEMBL4707196	Inhibition of human PI3Kbeta incubated for 1 hr by ADP-Glo kinase assay	B	Nc1ncc(-c2nc(N3CCOCC3)c3ccn(CCCCCCC(=O)NO)c3n2)cn1		CHEMBL4744689	=	IC50	nM	87.0	CHEMBL3145	Homo sapiens	IC50	nM	87.0
	22781000	CHEMBL4707196	Inhibition of human PI3Kbeta incubated for 1 hr by ADP-Glo kinase assay	B	COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1		CHEMBL3622533	=	IC50	nM	21.0	CHEMBL3145	Homo sapiens	IC50	nM	21.0
	22781001	CHEMBL4707196	Inhibition of human PI3Kbeta incubated for 1 hr by ADP-Glo kinase assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
Not Determined	22781416	CHEMBL4707345	Inhibition of human wild type partial length PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system by Kinomescan method	B	O=C(CCCCCCn1cnc2c(N3CCOCC3)nc(-c3cccc(CO)c3)nc21)NO		CHEMBL4749655		Kd			CHEMBL3145	Homo sapiens	Kd		
Not Determined	22781417	CHEMBL4707345	Inhibition of human wild type partial length PI3Kbeta (P118 to S1070 residues) expressed in mammalian expression system by Kinomescan method	B	Nc1ncc(-c2nc(N3CCOCC3)c3ccn(CCCCCCC(=O)NO)c3n2)cn1		CHEMBL4744689		Kd			CHEMBL3145	Homo sapiens	Kd		
	22800355	CHEMBL4711320	Inhibition of PI3Kbeta (unknown origin)	A	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	2927.0	CHEMBL3145	Homo sapiens	IC50	nM	2927.0
	22800356	CHEMBL4711320	Inhibition of PI3Kbeta (unknown origin)	A	C=CC(=O)Nc1cc(Nc2ncnc3ccc(-c4cnc5ccccc5c4)cc23)ccc1C		CHEMBL4796749	=	IC50	nM	19613.8	CHEMBL3145	Homo sapiens	IC50	nM	19613.8
	22806104	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	CC(C)(C)OC(=O)N1CC[C@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3901131	=	IC50	nM	640.0	CHEMBL3145	Homo sapiens	IC50	nM	640.0
	22806105	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	CC(=O)N1CC[C@@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3949404	=	IC50	nM	95.0	CHEMBL3145	Homo sapiens	IC50	nM	95.0
	22806106	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	CNC(=O)N1CC[C@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3938876	=	IC50	nM	410.0	CHEMBL3145	Homo sapiens	IC50	nM	410.0
	22806107	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	COC(=O)N1CC[C@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3963659	=	IC50	nM	45.0	CHEMBL3145	Homo sapiens	IC50	nM	45.0
	22806108	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	C[C@]1(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)CCN(S(C)(=O)=O)C1		CHEMBL3908620	=	IC50	nM	150.0	CHEMBL3145	Homo sapiens	IC50	nM	150.0
	22806109	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	CNS(=O)(=O)N1CC[C@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3970592	=	IC50	nM	170.0	CHEMBL3145	Homo sapiens	IC50	nM	170.0
	22806110	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	CC(C)C(=O)N1CC[C@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3920965	=	IC50	nM	260.0	CHEMBL3145	Homo sapiens	IC50	nM	260.0
	22806111	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	CC(C)(O)C(=O)N1CC[C@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3954652	=	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	22806112	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	CC(C)(N)C(=O)N1CC[C@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3932221	=	IC50	nM	330.0	CHEMBL3145	Homo sapiens	IC50	nM	330.0
	22806113	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	CC(C)(C)OC(=O)N1CC[C@](C)(Nc2cc(-c3cnc(N)nc3)nc(N3CCOCC3)n2)C1		CHEMBL4754889	=	IC50	nM	5000.0	CHEMBL3145	Homo sapiens	IC50	nM	5000.0
	22806114	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	CC(C)(C)OC(=O)N1CC[C@](CO)(Nc2cc(-c3cnc(N)nc3)nc(N3CCOCC3)n2)C1		CHEMBL4780701	=	IC50	nM	4600.0	CHEMBL3145	Homo sapiens	IC50	nM	4600.0
	22806115	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	CC(C)C(=O)N1CC[C@](CO)(Nc2cc(-c3cnc(N)nc3)nc(N3CCOCC3)n2)C1		CHEMBL4742651	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	22806116	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	COC(=O)N1CC[C@](CO)(Nc2cc(-c3cnc(N)nc3)nc(N3CCOCC3)n2)C1		CHEMBL4764484	=	IC50	nM	1800.0	CHEMBL3145	Homo sapiens	IC50	nM	1800.0
	22806117	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	CS(=O)(=O)N1CC[C@](CO)(Nc2cc(-c3cnc(N)nc3)nc(N3CCOCC3)n2)C1		CHEMBL4747197	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	nM	10000.0
	22806118	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	Nc1ncc(-c2cc(N[C@@]3(CO)CCN(C(=O)OCC(F)F)C3)nc(N3CCOCC3)n2)cn1		CHEMBL4778025	=	IC50	nM	1900.0	CHEMBL3145	Homo sapiens	IC50	nM	1900.0
	22806119	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	COC(=O)N1CC[C@](CO)(Nc2nc(N3CCOCC3)nc(-c3cnc(N)nc3)c2F)C1		CHEMBL4752678	=	IC50	nM	360.0	CHEMBL3145	Homo sapiens	IC50	nM	360.0
	22806120	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	Nc1ncc(-c2nc(N3CCOCC3)nc(N[C@@]3(CO)CCN(C(=O)OCC(F)F)C3)c2F)cn1		CHEMBL4756555	=	IC50	nM	360.0	CHEMBL3145	Homo sapiens	IC50	nM	360.0
	22806121	CHEMBL4712572	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110beta expressed in rat Rat1 cells	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	=	IC50	nM	3400.0	CHEMBL3145	Homo sapiens	IC50	nM	3400.0
	22850941	CHEMBL4723571	Binding affinity to wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in HEK293 cells measured after 1 hr by Kinomescan method	B	C[C@H]1COC[C@@H](C)N1c1nc(-c2cnc(N)cc2C(F)F)nc(N2CCOC[C@H]2C)n1		CHEMBL4749352	=	Kd	nM	1450.0	CHEMBL3145	Homo sapiens	Kd	nM	1450.0
	22850942	CHEMBL4723571	Binding affinity to wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in HEK293 cells measured after 1 hr by Kinomescan method	B	C[C@@H]1COCCN1c1nc(-c2cnc(N)cc2C(F)F)nc(N2CCOCC2(C)C)n1		CHEMBL4741511	=	Kd	nM	1350.0	CHEMBL3145	Homo sapiens	Kd	nM	1350.0
	22851165	CHEMBL4723691	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo plus luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	=	IC50	nM	190.0	CHEMBL3145	Homo sapiens	IC50	uM	0.19
	22851166	CHEMBL4723691	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo plus luminescence assay	B	COc1ccc(CNC(=O)Cc2nnc(-c3ccc4ncccc4c3)o2)cc1OC		CHEMBL4750370	=	IC50	nM	4100.0	CHEMBL3145	Homo sapiens	IC50	uM	4.1
	22851167	CHEMBL4723691	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo plus luminescence assay	B	O=C(Cc1nnc(-c2ccc3ncccc3c2)o1)NCCc1ccc(Cl)cc1		CHEMBL4786631	=	IC50	nM	2600.0	CHEMBL3145	Homo sapiens	IC50	uM	2.6
	22852643	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	=	IC50	nM	48.0	CHEMBL3145	Homo sapiens	IC50	nM	48.0
	22852644	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	Cc1nc(N)nc(N[C@@H](C)c2c(-c3ccccc3)c(=O)n3cc(F)ccc3c2-c2ccc(F)cc2)c1C#N		CHEMBL4463183	=	IC50	nM	78.0	CHEMBL3145	Homo sapiens	IC50	nM	78.0
Not Determined	22852645	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	Cc1nc(N)nc(N[C@@H](C)c2c(-c3ccccc3)c(=O)n3cc(F)ccc3c2C)c1C#N		CHEMBL4784743		IC50			CHEMBL3145	Homo sapiens	IC50		
	22852646	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4756563	=	IC90	nM	8050.0	CHEMBL3145	Homo sapiens	IC90	nM	8050.0
	22852647	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4756563	=	IC50	nM	208.0	CHEMBL3145	Homo sapiens	IC50	nM	208.0
Not Determined	22852648	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	COc1ccc(-c2c([C@H](C)Nc3nc(N)nc(N)c3C#N)c(-c3ccccc3)c(=O)n3cc(F)ccc23)cc1		CHEMBL4795389		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852649	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccc(C(N)=O)cc1		CHEMBL4750646		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852650	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccccc1		CHEMBL4749521		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852651	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1C1CC1		CHEMBL4751779		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852652	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	Cc1c([C@H](C)Nc2nc(N)nc(N)c2C#N)c(-c2ccccc2)c(=O)n2cc(F)ccc12		CHEMBL4791717		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852653	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(C2CC2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4778687		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852654	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1c(C2CC2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4748330		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852655	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	Cc1c([C@H](C)Nc2ncnc(N)c2C#N)c(-c2ccc(F)cc2)c2ccc(F)cn2c1=O		CHEMBL4797361		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852656	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1cc(F)cc(F)c1		CHEMBL4755417		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852657	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1cc(F)cc(F)c1		CHEMBL4749578		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852658	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4777036		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852659	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1cccc(F)c1		CHEMBL4792005		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852660	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1ccccc1		CHEMBL4748043		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852661	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1ccccc1		CHEMBL4742693		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852662	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc2ccc(F)cn2c(=O)c1-c1cc(F)cc(F)c1		CHEMBL4752055		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852663	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	Cc1cc(F)cc(-c2c([C@H](C)Nc3nc(N)nc(N)c3C#N)cc3ccc(F)cn3c2=O)c1		CHEMBL4750109		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852664	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc2ccc(F)cn2c(=O)c1-c1ccc(F)cc1		CHEMBL4784696		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852665	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	Cc1cccc(-c2c([C@H](C)Nc3nc(N)nc(N)c3C#N)cc3ccc(F)cn3c2=O)c1		CHEMBL4754291		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852666	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	Cc1nc(N)nc(N[C@@H](C)c2cc3ccc(F)cn3c(=O)c2-c2ccccc2)c1C#N		CHEMBL4787382		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852667	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	Cc1nc(N)c(C#N)c(N[C@@H](C)c2cc3ccc(F)cn3c(=O)c2-c2ccccc2)n1		CHEMBL4747142		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852668	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1ccnc(N)n1)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4746288		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852669	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1nc(N)ncc1C#N)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4742973		IC50			CHEMBL3145	Homo sapiens	IC50		
	22852670	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4794328	=	IC50	nM	241.0	CHEMBL3145	Homo sapiens	IC50	nM	241.0
	22852671	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4749877	=	IC50	nM	191.0	CHEMBL3145	Homo sapiens	IC50	nM	191.0
Not Determined	22852672	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	Cc1c(F)ccc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n12		CHEMBL4783353		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852673	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	Cc1ccc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n2c1		CHEMBL4750875		IC50			CHEMBL3145	Homo sapiens	IC50		
Not Determined	22852674	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	Cc1ccc2cc([C@H](C)Nc3ncnc4[nH]cnc34)c(-c3ccccc3)c(=O)n2c1		CHEMBL4777399		IC50			CHEMBL3145	Homo sapiens	IC50		
	22852675	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	Cc1cccc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n12		CHEMBL4787659	=	IC50	nM	134.0	CHEMBL3145	Homo sapiens	IC50	nM	134.0
	22852676	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	Cc1cccc2cc([C@H](C)Nc3ncnc4[nH]cnc34)c(-c3ccccc3)c(=O)n12		CHEMBL4782337	=	IC50	nM	515.0	CHEMBL3145	Homo sapiens	IC50	nM	515.0
Not Determined	22852677	CHEMBL4724043	Inhibition of PI3Kbeta in human 786-O cells assessed as reduction in phosphorylation of AKT at 473 measured after 1 hr by alpha screen assay	B	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2ccccn2c(=O)c1-c1ccccc1		CHEMBL4755607		IC50			CHEMBL3145	Homo sapiens	IC50		
	22852963	CHEMBL4724091	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	=	IC50	nM	21.7	CHEMBL3145	Homo sapiens	IC50	nM	21.7
	22852964	CHEMBL4724091	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4756563	=	IC90	nM	12194.0	CHEMBL3145	Homo sapiens	IC90	nM	12194.0
	22852965	CHEMBL4724091	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4756563	=	IC50	nM	241.6	CHEMBL3145	Homo sapiens	IC50	nM	241.6
	22885839	CHEMBL4728124	Inhibition of PI3Kbeta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4CCCC4)C(=O)C3)cc2n1		CHEMBL4750636	>	IC50	nM	500.0	CHEMBL3145	Homo sapiens	IC50	nM	500.0
	22885840	CHEMBL4728124	Inhibition of PI3Kbeta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4CCCC4)CC3=O)cc2n1		CHEMBL4753342	>	IC50	nM	500.0	CHEMBL3145	Homo sapiens	IC50	nM	500.0
	22885841	CHEMBL4728124	Inhibition of PI3Kbeta (unknown origin)	B	C=CCN1CCN(Cc2cc3nc(-n4c(CC)nc5ccccc54)nc(N4CCOCC4)c3s2)C(=O)C1		CHEMBL4788725	=	IC50	nM	232.0	CHEMBL3145	Homo sapiens	IC50	nM	232.0
	22885842	CHEMBL4728124	Inhibition of PI3Kbeta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C(=O)C4CC4)CC3=O)cc2n1		CHEMBL4788952	=	IC50	nM	137.0	CHEMBL3145	Homo sapiens	IC50	nM	137.0
	22885843	CHEMBL4728124	Inhibition of PI3Kbeta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C(=O)C4CCC4)CC3=O)cc2n1		CHEMBL4752490	=	IC50	nM	165.0	CHEMBL3145	Homo sapiens	IC50	nM	165.0
	22885844	CHEMBL4728124	Inhibition of PI3Kbeta (unknown origin)	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	IC50	nM	500.0	CHEMBL3145	Homo sapiens	IC50	nM	500.0
	22885895	CHEMBL4728135	Inhibition of recombinant human His-tagged PI3Kbeta expressed in insect cell expression system using PIP2:PS as substrate incubated for 1 hr by invitrogen adapta assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	565.0	CHEMBL3145	Homo sapiens	IC50	nM	565.0
Active	22909103	CHEMBL4733880	Inhibition of PI3Kbeta (unknown origin) transfected in human Rh30 cells assessed as reduction in AKT phosphorylation at Ser473 residue at 10XIC50 by western blot analysis	B	COC(=O)Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)c3cc(CN4CCN(S(C)(=O)=O)CC4)cn3n2)cn1		CHEMBL4800252		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
Active	22909104	CHEMBL4733881	Inhibition of PI3Kbeta (unknown origin) transfected in human Rh30 cells assessed as reduction in AKT phosphorylation at Thr308 residue at 10XIC50 by western blot analysis	B	COC(=O)Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)c3cc(CN4CCN(S(C)(=O)=O)CC4)cn3n2)cn1		CHEMBL4800252		Inhibition	%		CHEMBL3145	Homo sapiens	INH		
	22915914	CHEMBL4735509	Inhibition of PI3Kbeta (unknown origin)	B	NC(=O)c1cccc2cc(C(=O)N3CCN(c4nc(-c5cnc(NC(=O)CN6CCOCC6)cc5C(F)(F)F)nc(N5CCOCC5)n4)CC3)oc12		CHEMBL4761383	=	IC50	nM	375.9	CHEMBL3145	Homo sapiens	IC50	nM	375.9
	22926322	CHEMBL4737604	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo assay	B	COc1ncc(-c2ccc3nccc(/C(C)=C/C(=O)N4CCN(C)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4739883	=	IC50	nM	0.67	CHEMBL3145	Homo sapiens	IC50	nM	0.67
	22926323	CHEMBL4737604	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo assay	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	=	IC50	nM	0.19	CHEMBL3145	Homo sapiens	IC50	nM	0.19
	22926363	CHEMBL4737642	Inhibition of human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by kinome scan method relative to control	B	COc1ncc(-c2ccc3nccc(/C(C)=C/C(=O)N4CCN(C)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4739883	=	Activity	%	0.0	CHEMBL3145	Homo sapiens	Activity	%	0.0
	22949907	CHEMBL4765902	Inhibition of PI3K p110beta in human PC-3 cells assessed as reduction in AKT phosphorylation at S473 residue measured after 2 hrs by TR-FRET analysis	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1)C1CC1		CHEMBL3928407	=	EC50	nM	42.0	CHEMBL3145	Homo sapiens	EC50	nM	42.0
	22980781	CHEMBL4772816	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr in presence of ATP by ADP-Glo reagent based assay	B	NC(=O)[C@H]1CCCN1C(=O)c1ccc2nc(Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)[nH]c2c1		CHEMBL4790315	=	IC50	nM	21300.0	CHEMBL3145	Homo sapiens	IC50	uM	21.3
	22980782	CHEMBL4772816	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr in presence of ATP by ADP-Glo reagent based assay	B	NC(=O)C1CCN(C(=O)c2ccc3nc(Nc4ccc(-c5nc(N6CCOCC6)nc(N6CCOCC6)n5)cc4)[nH]c3c2)CC1		CHEMBL4787035	=	IC50	nM	34000.0	CHEMBL3145	Homo sapiens	IC50	uM	34.0
	22980783	CHEMBL4772816	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr in presence of ATP by ADP-Glo reagent based assay	B	C[C@H](NC(=O)c1ccc2nc(Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)[nH]c2c1)C(N)=O		CHEMBL4794018	=	IC50	nM	72000.0	CHEMBL3145	Homo sapiens	IC50	uM	72.0
	22980784	CHEMBL4772816	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr in presence of ATP by ADP-Glo reagent based assay	B	O=C(c1ccc2nc(Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)[nH]c2c1)N1CCOCC1	Outside typical range	CHEMBL4778112	=	IC50	nM	233000.0	CHEMBL3145	Homo sapiens	IC50	uM	233.0
	22980785	CHEMBL4772816	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr in presence of ATP by ADP-Glo reagent based assay	B	CN1CCN(C(=O)c2ccc3nc(Nc4ccc(-c5nc(N6CCOCC6)nc(N6CCOCC6)n5)cc4)[nH]c3c2)CC1		CHEMBL4788677	=	IC50	nM	28000.0	CHEMBL3145	Homo sapiens	IC50	uM	28.0
	22980786	CHEMBL4772816	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr in presence of ATP by ADP-Glo reagent based assay	B	CN(C)C1CCN(C(=O)c2cccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)c2)CC1		CHEMBL4778200	=	IC50	nM	27800.0	CHEMBL3145	Homo sapiens	IC50	uM	27.8
	22990748	CHEMBL4775168	Inhibition of PI3K beta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	970.0	CHEMBL3145	Homo sapiens	IC50	uM	0.97
	23120896	CHEMBL4804467	Inhibition of PIK3CB in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	23100.0	CHEMBL3145	Homo sapiens	IC50	uM	23.1
	23120897	CHEMBL4804467	Inhibition of PIK3CB in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	1900.0	CHEMBL3145	Homo sapiens	IC50	uM	1.9
	23120898	CHEMBL4804467	Inhibition of PIK3CB in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-74900.0	CHEMBL3145	Homo sapiens	IC50	uM	-74.9
	23120899	CHEMBL4804467	Inhibition of PIK3CB in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	7200.0	CHEMBL3145	Homo sapiens	IC50	uM	7.2
	23120900	CHEMBL4804467	Inhibition of PIK3CB in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	14600.0	CHEMBL3145	Homo sapiens	IC50	uM	14.6
	23120901	CHEMBL4804467	Inhibition of PIK3CB in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	14600.0	CHEMBL3145	Homo sapiens	IC50	uM	14.6
	23121936	CHEMBL4804649	Inhibition of PIK3CB in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	23121937	CHEMBL4804649	Inhibition of PIK3CB in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	23121938	CHEMBL4804649	Inhibition of PIK3CB in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	23121939	CHEMBL4804649	Inhibition of PIK3CB in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	23121940	CHEMBL4804649	Inhibition of PIK3CB in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	23121941	CHEMBL4804649	Inhibition of PIK3CB in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL3145	Homo sapiens	INH	%	0.0
	23127308	CHEMBL4807580	Inhibition of PI3Kbeta (unknown origin)	B	Cc1c(Cn2c(C)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089106	=	IC50	nM	16.0	CHEMBL3145	Homo sapiens	IC50	nM	16.0
	23127309	CHEMBL4807580	Inhibition of PI3Kbeta (unknown origin)	B	CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21		CHEMBL1684984	=	IC50	nM	500.0	CHEMBL3145	Homo sapiens	IC50	nM	500.0
	23183466	CHEMBL4817106	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo plus luminescence assay	B	Cc1c(CN2CCN(C(=O)c3cc4cccc(C(N)=O)c4o3)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL4865059	=	IC50	nM	43.0	CHEMBL3145	Homo sapiens	IC50	nM	43.0
	23183467	CHEMBL4817106	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo plus luminescence assay	B	NC(=O)c1cccc2cc(C(=O)N3CCN(Cc4cc5nc(-c6cnc(N)nc6)nc(N6CCOCC6)c5s4)CC3)oc12		CHEMBL4871210	=	IC50	nM	11.0	CHEMBL3145	Homo sapiens	IC50	nM	11.0
	23183468	CHEMBL4817106	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo plus luminescence assay	B	NC(=O)c1cccc2cc(C(=O)N3CCN(Cc4cc5nc(-c6cnc(N)nc6)nc(N6CCOCC6)c5o4)CC3)oc12		CHEMBL4868231	=	IC50	nM	69.0	CHEMBL3145	Homo sapiens	IC50	nM	69.0
	23183469	CHEMBL4817106	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo plus luminescence assay	B	Cc1c(CN2CCN(C(=O)c3cc(Cc4n[nH]c(=O)c5ccccc45)ccc3F)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL4858564	=	IC50	nM	53.0	CHEMBL3145	Homo sapiens	IC50	nM	53.0
	23193729	CHEMBL4819300	Inhibition of human PI3K beta by ADP-Glo luminescent kinase assay	B	COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1		CHEMBL3622533	=	IC50	nM	54.0	CHEMBL3145	Homo sapiens	IC50	nM	54.0
	23207301	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(NCCCc1ccccc1)cc2-c1cccc(O)c1		CHEMBL4857908	=	IC50	nM	921.0	CHEMBL3145	Homo sapiens	IC50	nM	921.0
	23207302	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(NCCCN1CCOCC1)cc2-c1cccc(O)c1		CHEMBL4860874	=	IC50	nM	5149.0	CHEMBL3145	Homo sapiens	IC50	nM	5149.0
	23207303	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(NCCCc1ccccc1)cc2-c1cc(O)cc(F)c1		CHEMBL4855277	=	IC50	nM	383.0	CHEMBL3145	Homo sapiens	IC50	nM	383.0
	23207304	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	O=C1NCc2c1cccc2-c1cc(O)cc(F)c1		CHEMBL4848881	=	IC50	nM	6018.0	CHEMBL3145	Homo sapiens	IC50	nM	6018.0
	23207305	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(-c1cccc(F)c1)cc2-c1cc(O)cc(F)c1		CHEMBL4855554	=	IC50	nM	712.0	CHEMBL3145	Homo sapiens	IC50	nM	712.0
	23207306	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	C[C@H]1CN(c2cc(-c3cc4c(c(-c5cc(O)cc(F)c5)c3)CNC4=O)ccn2)C[C@@H](C)O1		CHEMBL4856718	=	IC50	nM	649.0	CHEMBL3145	Homo sapiens	IC50	nM	649.0
	23207307	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	C[C@H]1CN(Cc2nnc(-c3cc4c(c(-c5cc(O)cc(F)c5)c3)CNC4=O)o2)C[C@@H](C)O1		CHEMBL4868375	=	IC50	nM	6290.0	CHEMBL3145	Homo sapiens	IC50	nM	6290.0
	23207308	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(O[C@@H]1CCN(C(=O)C3CCOCC3)C1)cc2-c1cc(O)cc(F)c1		CHEMBL4878320	=	IC50	nM	756.0	CHEMBL3145	Homo sapiens	IC50	nM	756.0
	23207309	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(O[C@@H]1CCN(C(=O)C3CC(F)(F)C3)C1)cc2-c1cc(O)cc(F)c1		CHEMBL4873442	=	IC50	nM	186.0	CHEMBL3145	Homo sapiens	IC50	nM	186.0
	23207310	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(O[C@@H]1CCN(C(=O)C3CC3)C1)cc2-c1cc(O)cc(F)c1		CHEMBL4852413	=	IC50	nM	381.0	CHEMBL3145	Homo sapiens	IC50	nM	381.0
	23207311	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	COc1ccc(-c2cc(O[C@@H]3CCN(C(=O)C4CC4)C3)cc3c2CNC3=O)cn1		CHEMBL4859469	=	IC50	nM	1990.0	CHEMBL3145	Homo sapiens	IC50	nM	1990.0
	23207312	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(O[C@@H]1CCN(C(=O)C3CC3)C1)cc2-c1cncc(O)c1		CHEMBL4848004	=	IC50	nM	623.0	CHEMBL3145	Homo sapiens	IC50	nM	623.0
	23207313	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(O[C@@H]1CCN(C(=O)C3CC3)C1)cc2-c1cnc(F)c(O)c1		CHEMBL4877330	=	IC50	nM	340.0	CHEMBL3145	Homo sapiens	IC50	nM	340.0
	23207314	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	Cc1ncc(-c2cc(O[C@@H]3CCN(C(=O)C4CC4)C3)cc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4852562	=	IC50	nM	357.0	CHEMBL3145	Homo sapiens	IC50	nM	357.0
	23207315	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	COc1ncc(-c2cc(O[C@@H]3CCN(C(=O)C4CC4)C3)cc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4847971	=	IC50	nM	190.0	CHEMBL3145	Homo sapiens	IC50	nM	190.0
	23207316	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	COc1ncc(-c2cccc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4878413	=	IC50	nM	1266.0	CHEMBL3145	Homo sapiens	IC50	nM	1266.0
	23207317	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	COc1cc2c(c(-c3cnc(OC)c(NS(C)(=O)=O)c3)c1)CNC2=O		CHEMBL4846554	=	IC50	nM	290.0	CHEMBL3145	Homo sapiens	IC50	nM	290.0
	23207318	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	COc1ncc(-c2cc(OC(C)C)cc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4867589	=	IC50	nM	339.0	CHEMBL3145	Homo sapiens	IC50	nM	339.0
	23207319	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	CCOc1cc2c(c(-c3cnc(OC)c(NS(C)(=O)=O)c3)c1)CNC2=O		CHEMBL4863164	=	IC50	nM	489.0	CHEMBL3145	Homo sapiens	IC50	nM	489.0
	23207320	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	COc1ncc(-c2cc(OC3CCC3)cc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4849053	=	IC50	nM	103.0	CHEMBL3145	Homo sapiens	IC50	nM	103.0
	23207321	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	COc1ncc(-c2cc(OCC3CCC3)cc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4850175	=	IC50	nM	167.0	CHEMBL3145	Homo sapiens	IC50	nM	167.0
	23207322	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	COc1ncc(-c2cc(OC3CN(C(=O)C4CC4)C3)cc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4874239	=	IC50	nM	768.0	CHEMBL3145	Homo sapiens	IC50	nM	768.0
	23207323	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	C#Cc1ccc(-c2cc3c(c(-c4cnc(OC)c(NS(C)(=O)=O)c4)c2)CNC3=O)cn1		CHEMBL4867101	=	IC50	nM	250.0	CHEMBL3145	Homo sapiens	IC50	nM	250.0
	23207324	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	COc1ncc(-c2cc(-c3ccnc(N4C[C@H](C)O[C@H](C)C4)c3)cc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4863978	=	IC50	nM	107.0	CHEMBL3145	Homo sapiens	IC50	nM	107.0
	23207325	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	Cn1ncc2cc(-c3cc(OC4CN(C(=O)C5CC5)C4)cc4c3CNC4=O)cnc21		CHEMBL4851164	=	IC50	nM	2905.0	CHEMBL3145	Homo sapiens	IC50	nM	2905.0
	23207326	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(OC1CN(C(=O)C3CC3)C1)cc2-c1cnc(Cl)c(OC(F)F)c1		CHEMBL4858005	=	IC50	nM	2255.0	CHEMBL3145	Homo sapiens	IC50	nM	2255.0
	23207327	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	Nc1ncc(-c2cc(OC3CN(C(=O)C4CC4)C3)cc3c2CNC3=O)cc1C(F)(F)F		CHEMBL4861797	=	IC50	nM	2117.0	CHEMBL3145	Homo sapiens	IC50	nM	2117.0
	23207328	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(OC1CN(C(=O)C3CC3)C1)cc2-c1ccc(OC(F)F)nc1		CHEMBL4861306	=	IC50	nM	5807.0	CHEMBL3145	Homo sapiens	IC50	nM	5807.0
	23207329	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	CNc1ncc(-c2cc(OC3CN(C(=O)C4C[C@H]4C)C3)cc3c2CNC3=O)cc1C(F)(F)F		CHEMBL4860971	=	IC50	nM	2386.0	CHEMBL3145	Homo sapiens	IC50	nM	2386.0
	23207330	CHEMBL4821972	Inhibition of PI3Kbeta (unknown origin) by HTRF assay	B	Cc1ncc(-c2cc(-c3ccnc(N4C[C@H](C)O[C@H](C)C4)c3)cc3c2CNC3=O)cn1		CHEMBL4852744	=	IC50	nM	7410.0	CHEMBL3145	Homo sapiens	IC50	nM	7410.0
	23222883	CHEMBL4824999	Inhibition of PI3Kbeta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(N4CCOCC4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4850400	=	IC50	nM	14.5	CHEMBL3145	Homo sapiens	IC50	nM	14.5
	23222884	CHEMBL4824999	Inhibition of PI3Kbeta (unknown origin)	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	7.11	CHEMBL3145	Homo sapiens	IC50	nM	7.11
	23222885	CHEMBL4824999	Inhibition of PI3Kbeta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(N4CCCC4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4845684	=	IC50	nM	5.41	CHEMBL3145	Homo sapiens	IC50	nM	5.41
	23222886	CHEMBL4824999	Inhibition of PI3Kbeta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(N4CCCCC4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4876806	=	IC50	nM	4.6	CHEMBL3145	Homo sapiens	IC50	nM	4.6
	23222887	CHEMBL4824999	Inhibition of PI3Kbeta (unknown origin)	B	CC1CCN(c2cnnc3ccc(-c4cnc(Cl)c(NS(=O)(=O)c5ccccc5)c4)cc23)CC1		CHEMBL4878126	=	IC50	nM	5.33	CHEMBL3145	Homo sapiens	IC50	nM	5.33
	23222888	CHEMBL4824999	Inhibition of PI3Kbeta (unknown origin)	B	CCOc1cnnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccccc4)c3)cc12		CHEMBL4860613	=	IC50	nM	5.61	CHEMBL3145	Homo sapiens	IC50	nM	5.61
	23222889	CHEMBL4824999	Inhibition of PI3Kbeta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(-n4ccnc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4871213	=	IC50	nM	2.39	CHEMBL3145	Homo sapiens	IC50	nM	2.39
	23222890	CHEMBL4824999	Inhibition of PI3Kbeta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(-c4ccncc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4864419	=	IC50	nM	1.7	CHEMBL3145	Homo sapiens	IC50	nM	1.7
	23222891	CHEMBL4824999	Inhibition of PI3Kbeta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(-c4ccc(N5CCOCC5)cc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4853440	=	IC50	nM	3.04	CHEMBL3145	Homo sapiens	IC50	nM	3.04
	23222892	CHEMBL4824999	Inhibition of PI3Kbeta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(-c4cnc(N5CCOCC5)nc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4871838	=	IC50	nM	4.72	CHEMBL3145	Homo sapiens	IC50	nM	4.72
	23222893	CHEMBL4824999	Inhibition of PI3Kbeta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(-c4ccc(N5CCOCC5)nc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4872728	=	IC50	nM	1.54	CHEMBL3145	Homo sapiens	IC50	nM	1.54
	23258663	CHEMBL4832740	Inhibition of PI3Kbeta (unknown origin) using L-alpha-phosphatidylinositol as substrate incubated for 30 to 60 mins in presence of ATP by Kinase Glo luminescence kinase assay	B	Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](O)CC2)cc1-c1cnc(N)c(C(=O)C2CC2)n1		CHEMBL4859017	=	IC50	nM	400.0	CHEMBL3145	Homo sapiens	IC50	nM	400.0
	23258664	CHEMBL4832740	Inhibition of PI3Kbeta (unknown origin) using L-alpha-phosphatidylinositol as substrate incubated for 30 to 60 mins in presence of ATP by Kinase Glo luminescence kinase assay	B	CCn1nnc(CCNC(=O)Nc2nc(C)c(-c3ccc(S(C)(=O)=O)c(F)c3)s2)n1		CHEMBL2071342	=	IC50	nM	360.0	CHEMBL3145	Homo sapiens	IC50	nM	360.0
	23258665	CHEMBL4832740	Inhibition of PI3Kbeta (unknown origin) using L-alpha-phosphatidylinositol as substrate incubated for 30 to 60 mins in presence of ATP by Kinase Glo luminescence kinase assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3ccc(F)c(F)c3)c2)cnc1N		CHEMBL4857001	=	IC50	nM	700.0	CHEMBL3145	Homo sapiens	IC50	nM	700.0
	23258670	CHEMBL4832743	Inhibition of recombinant human PI3Kbeta assessed as reduction in PIP3 formation by AlphaScreen assay	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	=	IC50	nM	10.0	CHEMBL3145	Homo sapiens	IC50	nM	10.0
	23258674	CHEMBL4832747	Inhibition of recombinant full-length human His-tagged PI3Kbeta expressed in insect cells by Selectscreen kinase assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	564.0	CHEMBL3145	Homo sapiens	IC50	nM	564.0
	23258677	CHEMBL4832750	Inhibition of human PI3Kbeta expressed in rat fibroblast cells assessed as reduction in AKT phosphorylation at Ser473 residue incubated for 1 hr by AlphaScreen assay	B	Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](O)CC2)cc1-c1cnc(N)c(C(=O)C2CC2)n1		CHEMBL4859017	=	IC50	nM	2200.0	CHEMBL3145	Homo sapiens	IC50	nM	2200.0
	23258678	CHEMBL4832750	Inhibition of human PI3Kbeta expressed in rat fibroblast cells assessed as reduction in AKT phosphorylation at Ser473 residue incubated for 1 hr by AlphaScreen assay	B	CCn1nnc(CCNC(=O)Nc2nc(C)c(-c3ccc(S(C)(=O)=O)c(F)c3)s2)n1		CHEMBL2071342	=	IC50	nM	2360.0	CHEMBL3145	Homo sapiens	IC50	nM	2360.0
	23258679	CHEMBL4832750	Inhibition of human PI3Kbeta expressed in rat fibroblast cells assessed as reduction in AKT phosphorylation at Ser473 residue incubated for 1 hr by AlphaScreen assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3ccc(F)c(F)c3)c2)cnc1N		CHEMBL4857001	>	IC50	nM	10000.0	CHEMBL3145	Homo sapiens	IC50	uM	10.0
	23279957	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	613.0	CHEMBL3145	Homo sapiens	IC50	nM	613.0
	23279958	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	O=c1c2cc(F)ccc2nc([C@@H](Nc2ncnc3nc[nH]c23)C2CC2)n1-c1ccccc1		CHEMBL4874404	=	IC50	nM	200.0	CHEMBL3145	Homo sapiens	IC50	nM	200.0
	23279959	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	C[C@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4845946	=	IC50	nM	145.0	CHEMBL3145	Homo sapiens	IC50	nM	145.0
	23279960	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	CCC[C@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4874496	=	IC50	nM	440.0	CHEMBL3145	Homo sapiens	IC50	nM	440.0
	23279961	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	CC(C)[C@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4847494	=	IC50	nM	1670.0	CHEMBL3145	Homo sapiens	IC50	nM	1670.0
	23279962	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	O=c1c2c(F)cccc2nc([C@@H](Nc2ncnc3nc[nH]c23)C2CC2)n1-c1ccccc1		CHEMBL4852166	=	IC50	nM	199.0	CHEMBL3145	Homo sapiens	IC50	nM	199.0
	23279963	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	O=c1c2c(F)cccc2nc([C@@H](Nc2ncnc3nc[nH]c23)C2CCC2)n1-c1ccccc1		CHEMBL4870032	=	IC50	nM	854.0	CHEMBL3145	Homo sapiens	IC50	nM	854.0
	23279964	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	CCC[C@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL4876309	=	IC50	nM	129.0	CHEMBL3145	Homo sapiens	IC50	nM	129.0
	23279965	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	CC(C)[C@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL4853740	=	IC50	nM	1040.0	CHEMBL3145	Homo sapiens	IC50	nM	1040.0
	23279966	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	O=c1c2c(Cl)cccc2nc([C@@H](Nc2ncnc3nc[nH]c23)C2CC2)n1-c1ccccc1		CHEMBL4862467	=	IC50	nM	87.6	CHEMBL3145	Homo sapiens	IC50	nM	87.6
	23279967	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	O=c1c2c(Cl)cccc2nc([C@@H](Nc2ncnc3nc[nH]c23)C2CCC2)n1-c1ccccc1		CHEMBL4876188	=	IC50	nM	470.0	CHEMBL3145	Homo sapiens	IC50	nM	470.0
	23279968	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	CCC[C@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(C(F)(F)F)c2c(=O)n1-c1ccccc1		CHEMBL4854194	>	IC50	nM	1000.0	CHEMBL3145	Homo sapiens	IC50	nM	1000.0
	23279969	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	Cc1cccc2nc([C@@H](Nc3ncnc4nc[nH]c34)C3CC3)n(-c3ccccc3)c(=O)c12		CHEMBL4868117	=	IC50	nM	162.0	CHEMBL3145	Homo sapiens	IC50	nM	162.0
	23279970	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	C[C@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(N)c2c(=O)n1-c1ccccc1		CHEMBL4871071	=	IC50	nM	250.0	CHEMBL3145	Homo sapiens	IC50	nM	250.0
	23279971	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	CC[C@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(N)c2c(=O)n1-c1ccccc1		CHEMBL4852863	=	IC50	nM	287.0	CHEMBL3145	Homo sapiens	IC50	nM	287.0
	23279972	CHEMBL4836859	Inhibition of recombinant human full length His-tagged p110beta expressed in baculovirus expression system measured after 60 mins in presence of ATP by ATP-competitive binding assay	B	Nc1cccc2nc([C@@H](Nc3ncnc4nc[nH]c34)C3CC3)n(-c3ccccc3)c(=O)c12		CHEMBL4858100	=	IC50	nM	562.0	CHEMBL3145	Homo sapiens	IC50	nM	562.0
	23290505	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	OCc1cccc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)c1		CHEMBL4860637	=	IC50	nM	4040.0	CHEMBL3145	Homo sapiens	IC50	nM	4040.0
	23290506	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	CN(C)CCCOc1ccc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)cn1		CHEMBL4876439	>	IC50	nM	20000.0	CHEMBL3145	Homo sapiens	IC50	nM	20000.0
	23290507	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	FC(F)c1cccc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)c1		CHEMBL4877926	=	IC50	nM	1620.0	CHEMBL3145	Homo sapiens	IC50	nM	1620.0
	23290508	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	FC(F)c1ccc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)cc1		CHEMBL4864349	>	IC50	nM	18000.0	CHEMBL3145	Homo sapiens	IC50	nM	18000.0
	23290509	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	Clc1cccc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)c1		CHEMBL4862738	=	IC50	nM	6450.0	CHEMBL3145	Homo sapiens	IC50	nM	6450.0
	23290510	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	FC(F)(F)Oc1cccc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)c1		CHEMBL4878956	=	IC50	nM	5000.0	CHEMBL3145	Homo sapiens	IC50	nM	5000.0
	23290511	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	NS(=O)(=O)c1cccc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)c1		CHEMBL4857669	=	IC50	nM	1650.0	CHEMBL3145	Homo sapiens	IC50	nM	1650.0
	23290512	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	CS(=O)(=O)c1ccc(F)c(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)c1		CHEMBL4865490	>	IC50	nM	20000.0	CHEMBL3145	Homo sapiens	IC50	nM	20000.0
	23290513	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	CS(=O)(=O)c1cccc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)c1		CHEMBL4873491	=	IC50	nM	5300.0	CHEMBL3145	Homo sapiens	IC50	nM	5300.0
	23290514	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	Cc1cncc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)c1		CHEMBL4855691	=	IC50	nM	10100.0	CHEMBL3145	Homo sapiens	IC50	nM	10100.0
	23290515	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	FC(F)c1cncc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)c1		CHEMBL4867528	=	IC50	nM	2120.0	CHEMBL3145	Homo sapiens	IC50	nM	2120.0
	23290516	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	NS(=O)(=O)c1cncc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)c1		CHEMBL4863567	=	IC50	nM	762.0	CHEMBL3145	Homo sapiens	IC50	nM	762.0
	23290517	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	CS(=O)(=O)c1cncc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)c1		CHEMBL4851045	=	IC50	nM	2290.0	CHEMBL3145	Homo sapiens	IC50	nM	2290.0
	23290518	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	FC(F)(F)c1cncc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)c1		CHEMBL4868065	=	IC50	nM	5080.0	CHEMBL3145	Homo sapiens	IC50	nM	5080.0
	23290519	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	Cc1cc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)cnc1F		CHEMBL4865476	=	IC50	nM	11300.0	CHEMBL3145	Homo sapiens	IC50	nM	11300.0
	23290520	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	Cc1nc2ccc(-c3cncc(C(F)F)c3)cc2n2c(C3CCOCC3)nnc12		CHEMBL4847559	>	IC50	nM	20000.0	CHEMBL3145	Homo sapiens	IC50	nM	20000.0
	23290521	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	Fc1c(-c2cncc(C(F)F)c2)ccc2ncc3nnc(C4CCOCC4)n3c12		CHEMBL4850455	=	IC50	nM	5170.0	CHEMBL3145	Homo sapiens	IC50	nM	5170.0
	23290522	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	Fc1cc(-c2cncc(C(F)F)c2)cc2c1ncc1nnc(C3CCOCC3)n12		CHEMBL4879247	=	IC50	nM	3460.0	CHEMBL3145	Homo sapiens	IC50	nM	3460.0
	23290523	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	FC(F)c1cncc(-c2ccc3ncc4[nH]nc(C5CCOCC5)c4c3c2)c1		CHEMBL4869632	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	nM	12.0
	23290524	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	Cn1nc(C2CCOCC2)c2c3cc(-c4cncc(C(F)F)c4)ccc3ncc21		CHEMBL4870563	=	IC50	nM	22.0	CHEMBL3145	Homo sapiens	IC50	nM	22.0
	23290525	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	Cn1nc2cnc3ccc(-c4cncc(C(F)F)c4)cc3c2c1C1CCOCC1		CHEMBL4868400	=	IC50	nM	12.0	CHEMBL3145	Homo sapiens	IC50	nM	12.0
	23290526	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	Cc1nc(C2CCOCC2)n2c1cnc1ccc(-c3cncc(C(F)F)c3)cc12		CHEMBL4852502	=	IC50	nM	43.0	CHEMBL3145	Homo sapiens	IC50	nM	43.0
	23290527	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	FC(F)c1cncc(-c2ccc3ncc4nnc([C@H]5[C@@H]6COC[C@@H]65)n4c3c2)c1		CHEMBL4873263	=	IC50	nM	198.0	CHEMBL3145	Homo sapiens	IC50	nM	198.0
	23290528	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	FC(F)c1cncc(-c2ccc3ncc4nnc(C5=CCOCC5)n4c3c2)c1		CHEMBL4849035	=	IC50	nM	147.0	CHEMBL3145	Homo sapiens	IC50	nM	147.0
	23290529	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	FC(F)c1cncc(-c2ccc3ncc4nnc(C5=CCCOCC5)n4c3c2)c1		CHEMBL4851439	=	IC50	nM	117.0	CHEMBL3145	Homo sapiens	IC50	nM	117.0
	23290530	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	FC(F)c1cncc(-c2ccc3ncc4nnc([C@@H]5[C@H]6CCC[C@H]65)n4c3c2)c1		CHEMBL4871998	=	IC50	nM	63.0	CHEMBL3145	Homo sapiens	IC50	nM	63.0
	23290531	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	FC(F)c1cncc(-c2ccc3ncc4nnc(C5=CCCCC5)n4c3c2)c1		CHEMBL4875626	=	IC50	nM	69.0	CHEMBL3145	Homo sapiens	IC50	nM	69.0
	23290532	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	FC(F)c1cncc(-c2ccc3ncc4nnc(C5=CCCCCC5)n4c3c2)c1		CHEMBL4860779	=	IC50	nM	36.0	CHEMBL3145	Homo sapiens	IC50	nM	36.0
	23290533	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	CO[C@H]1CC[C@@H](c2nnc3cnc4ccc(-c5cncc(C(F)F)c5)cc4n32)CC1		CHEMBL4850640	=	IC50	nM	508.0	CHEMBL3145	Homo sapiens	IC50	nM	508.0
	23290534	CHEMBL4839367	Inhibition of PI3Kbeta (unknown origin) using PI(4,5)P2 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	CO[C@H]1CC[C@H](c2nnc3cnc4ccc(-c5cncc(C(F)F)c5)cc4n32)CC1		CHEMBL4860129	=	IC50	nM	178.0	CHEMBL3145	Homo sapiens	IC50	nM	178.0
	23296140	CHEMBL4840761	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2cnc3[nH]ncc3c2)cnc1Cl)c1ccccc1		CHEMBL4204119	=	IC50	nM	29.0	CHEMBL3145	Homo sapiens	IC50	nM	29.0
	23296141	CHEMBL4840761	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2cnc3[nH]cnc3c2)cnc1Cl)c1ccccc1		CHEMBL4861979	=	IC50	nM	26.0	CHEMBL3145	Homo sapiens	IC50	nM	26.0
	23296142	CHEMBL4840761	Inhibition of PI3Kbeta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2cnc3[nH]ccc3n2)cnc1Cl)c1ccccc1		CHEMBL4867808	=	IC50	nM	80.0	CHEMBL3145	Homo sapiens	IC50	nM	80.0
Not Active	23317583	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	99.0	CHEMBL3145	Homo sapiens	% Control	%	99.0
Not Active	23318051	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23318717	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	96.0	CHEMBL3145	Homo sapiens	% Control	%	96.0
Not Active	23319201	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	75.0	CHEMBL3145	Homo sapiens	% Control	%	75.0
Not Active	23319838	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	56.9	CHEMBL3145	Homo sapiens	% Control	%	56.9
Not Active	23320313	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23320991	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23321459	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	74.0	CHEMBL3145	Homo sapiens	% Control	%	74.0
Not Active	23322089	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	73.0	CHEMBL3145	Homo sapiens	% Control	%	73.0
Not Active	23322557	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	92.0	CHEMBL3145	Homo sapiens	% Control	%	92.0
Not Active	23323246	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	89.0	CHEMBL3145	Homo sapiens	% Control	%	89.0
Not Active	23323714	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23324568	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23325203	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	80.0	CHEMBL3145	Homo sapiens	% Control	%	80.0
Not Active	23325671	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	66.0	CHEMBL3145	Homo sapiens	% Control	%	66.0
Not Active	23326318	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	84.0	CHEMBL3145	Homo sapiens	% Control	%	84.0
Not Active	23326786	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23327486	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	68.0	CHEMBL3145	Homo sapiens	% Control	%	68.0
Not Active	23327954	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	75.0	CHEMBL3145	Homo sapiens	% Control	%	75.0
Not Active	23328541	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	83.0	CHEMBL3145	Homo sapiens	% Control	%	83.0
Not Active	23329009	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23329955	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23330423	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	94.0	CHEMBL3145	Homo sapiens	% Control	%	94.0
Not Active	23331179	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	66.0	CHEMBL3145	Homo sapiens	% Control	%	66.0
Not Active	23331647	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	99.0	CHEMBL3145	Homo sapiens	% Control	%	99.0
Not Active	23332234	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	89.1	CHEMBL3145	Homo sapiens	% Control	%	89.1
Not Active	23332700	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23333418	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23334057	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	96.0	CHEMBL3145	Homo sapiens	% Control	%	96.0
Not Active	23334525	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	89.0	CHEMBL3145	Homo sapiens	% Control	%	89.0
Not Active	23335504	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	76.0	CHEMBL3145	Homo sapiens	% Control	%	76.0
Not Active	23335972	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	82.0	CHEMBL3145	Homo sapiens	% Control	%	82.0
Not Active	23336599	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23337067	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	84.0	CHEMBL3145	Homo sapiens	% Control	%	84.0
Not Active	23338148	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23338616	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	96.0	CHEMBL3145	Homo sapiens	% Control	%	96.0
Not Active	23339228	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	98.0	CHEMBL3145	Homo sapiens	% Control	%	98.0
Not Active	23339696	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	87.0	CHEMBL3145	Homo sapiens	% Control	%	87.0
Not Active	23340333	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23340801	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	93.0	CHEMBL3145	Homo sapiens	% Control	%	93.0
Not Active	23341458	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23341926	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23342542	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23343010	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23343640	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	88.0	CHEMBL3145	Homo sapiens	% Control	%	88.0
Not Active	23344108	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	82.0	CHEMBL3145	Homo sapiens	% Control	%	82.0
Not Active	23344746	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	82.0	CHEMBL3145	Homo sapiens	% Control	%	82.0
Not Active	23345319	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	62.0	CHEMBL3145	Homo sapiens	% Control	%	62.0
Not Active	23345787	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23346364	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23346832	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	77.1	CHEMBL3145	Homo sapiens	% Control	%	77.1
Not Active	23347434	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	81.5	CHEMBL3145	Homo sapiens	% Control	%	81.5
Not Active	23347924	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23348503	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23348971	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23349558	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23350176	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23350644	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23351249	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	88.0	CHEMBL3145	Homo sapiens	% Control	%	88.0
Not Active	23351717	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23352741	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	59.0	CHEMBL3145	Homo sapiens	% Control	%	59.0
Not Active	23353209	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23354091	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23354559	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23355291	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23355759	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23356395	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	81.0	CHEMBL3145	Homo sapiens	% Control	%	81.0
Not Active	23356863	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	97.0	CHEMBL3145	Homo sapiens	% Control	%	97.0
Not Active	23357472	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23358119	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23358587	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	79.0	CHEMBL3145	Homo sapiens	% Control	%	79.0
Not Active	23359173	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	54.8	CHEMBL3145	Homo sapiens	% Control	%	54.8
Not Active	23359771	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	94.0	CHEMBL3145	Homo sapiens	% Control	%	94.0
Not Active	23360239	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	93.0	CHEMBL3145	Homo sapiens	% Control	%	93.0
Not Active	23360824	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	85.0	CHEMBL3145	Homo sapiens	% Control	%	85.0
Not Active	23361292	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	87.0	CHEMBL3145	Homo sapiens	% Control	%	87.0
Not Active	23361865	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	60.0	CHEMBL3145	Homo sapiens	% Control	%	60.0
Not Active	23362401	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	85.0	CHEMBL3145	Homo sapiens	% Control	%	85.0
Not Active	23362869	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	83.0	CHEMBL3145	Homo sapiens	% Control	%	83.0
Not Active	23364511	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23364979	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23365718	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23366261	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23366851	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23367319	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23368197	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	84.0	CHEMBL3145	Homo sapiens	% Control	%	84.0
Not Active	23368665	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	77.0	CHEMBL3145	Homo sapiens	% Control	%	77.0
Not Active	23369264	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23369732	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	82.0	CHEMBL3145	Homo sapiens	% Control	%	82.0
Not Active	23370700	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23371168	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	86.0	CHEMBL3145	Homo sapiens	% Control	%	86.0
Not Active	23371977	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	96.0	CHEMBL3145	Homo sapiens	% Control	%	96.0
Not Active	23372445	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	81.0	CHEMBL3145	Homo sapiens	% Control	%	81.0
	23372937	CHEMBL4884902	PIK3CB(PI3BCGRK) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
	23373346	CHEMBL4885193	PIK3CB(PI3BCGRK) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
	23373700	CHEMBL4885477	PIK3CB(PI3BCGRK) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3145	Homo sapiens	pIC50		6.0
Not Active	23375324	CHEMBL4886306	p21 protein -activated kinase 2 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-3.0	CHEMBL3145	Homo sapiens	% inhibition	%	-3.0
Not Active	23375330	CHEMBL4886312	phosphoinositide-3-kinase, catalytic, beta polypeptide  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	1.0	CHEMBL3145	Homo sapiens	% inhibition	%	1.0
Not Active	23375872	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	97.0	CHEMBL3145	Homo sapiens	% Control	%	97.0
Not Active	23376340	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23376917	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23377385	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23378245	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	94.0	CHEMBL3145	Homo sapiens	% Control	%	94.0
Not Active	23378713	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	97.0	CHEMBL3145	Homo sapiens	% Control	%	97.0
Slightly Active	23379880	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	36.0	CHEMBL3145	Homo sapiens	% Control	%	36.0
Not Active	23380348	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23381042	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23381690	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	99.0	CHEMBL3145	Homo sapiens	% Control	%	99.0
Not Active	23382158	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	97.0	CHEMBL3145	Homo sapiens	% Control	%	97.0
Slightly Active	23382782	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	45.0	CHEMBL3145	Homo sapiens	% Control	%	45.0
Not Active	23383250	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL3145	Homo sapiens	% Control	%	100.0
Not Active	23385165	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	65.0	CHEMBL3145	Homo sapiens	% Control	%	65.0
Not Active	23385632	CHEMBL4879889	KinomeScan assay: inhibition of PIK3CB	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	72.0	CHEMBL3145	Homo sapiens	% Control	%	72.0
